INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE
SCIENTIFIC DIVISION COMMITTEE ON NOMENCLATURE, PROPERTIES AND UNITS (C-NPU)#
and
INTERNATIONAL UNION OF PURE AND APPLIED CHEMISTRY
CHEMISTRY AND HUMAN HEALTH DIVISION CLINICAL CHEMISTRY SECTION COMMISSION ON NOMENCLATURE, PROPERTIES AND UNITS (C-NPU)§
PROPERTIES AND UNITS IN THE CLINICAL LABORATORY SCIENCES
X. PROPERTIES AND UNITS IN GENERAL CLINICAL CHEMISTRY (Technical report) (IFCCIUPAC 1999)
Prepared for publication by
Henrik Olesen1, Inge Ibsen1, Ivan Bruunshuus1, Desmond Kenny2, René Dybkær3, Xavier Fuentes-Arderiu4, Gilbert Hill5, Pedro Soares de Araujo6, Clem Mc Donald7
1Office of Laboratory Informatics, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark 2Dept. of Clinical Biochemistry, Our Lady’s Hospital for Sick Children, Dublin, Ireland 3Dept. of Standardisation in Laboratory Medicine, Kommunehospitalet, Copenhagen, Denmark 4Dept. of Clinical Biochemistry, Ciutat Sanitària i Universitària de Bellvitge, Barcelona, Spain 5Dept. of Clinical Chemistry, Hospital for Sick Children, Toronto, Canada 6Dept. of Biochemistry, IQUSP, São Paolo, Brazil 7Regenstrief Inst. for Health Care, Indiana University School of Med., Indianapolis, Indiana, United States of America
#§The combined Memberships of the Committee and the Commission (C-NPU) during the preparation of this report (1994 to 1996) were as follows: Chairman: 1989-1995 H. Olesen (Denmark); 1996 - D Kenny (Ireland). Members: X. Fuentes-Arderiu (Spain; 1991- 1997); J.G. Hill (Canada; 1987-1997); D. Kenny (Ireland; 1994-1997); H. Olesen (Denmark; 1985-1995); P.L. Storring (United Kingdom; 1989-1995); P. Soares de Araujo (Brazil; 1994-1997); R. Dybkær (Denmark; 1996-1997); C. McDonald (USA; 1996-1997).
Please forward comments to: H. Olesen, Office of Laboratory Informatics 76-6-1, Copenhagen University Hospital (Rigshospitalet), 9 Blegdamsvej, DK-2100 Copenhagen, Denmark. E-mail: [email protected]
1 Synopsis
A coding scheme has been prepared for general clinical chemistry.
Preface
The present document is part ten (X) of a series on properties and units in the clinical laboratory sciences initiated in 1987.
The series will comprise:
I Syntax and semantic rules [1] II Kinds-of-property [2] III Elements (of properties) and their code values [3] IV Properties and their code values [4] V Properties and units in Thrombosis and Haemostasis [5] VI Properties and units in IOC prohibited Drugs [6] VII Properties and units in Inborn Errors of Metabolism VIII Properties and units in Clinical Microbiology [7] IX Properties and units in Trace Elements [8] X Properties and units in General Clinical Chemistry (this report) XI Coding systems - structure and guidelines [9] XII Properties and units in Clinical Pharmacology and Toxicology [10] XIII Properties and units in Reproduction and Fertility [11] XVI Properties and units in Clinical Allergology [12]
The size and complexity of parts III and IV are such that their lists will be presented in electronic format. This is for ease of handling and to facilitate expression of concepts in different languages. At the end, systematic terms, elaborated according to international standards and recommendations should be available in the different domains of clinical laboratory sciences. The core of the series is code value strings representing concepts, that in combination delineate and define each type of property regardless of linguistic expression, thus avoiding errors during translation between languages.
Foreword and Scope
Clinical Laboratory Sciences are characterised by the exacting nature of the work performed and the demand for an accurate presentation of the outcome. Further the domain is transnational, international or "global". The adherent informatics system therefore needs to identify the findings accurately and to present them with the degree of detail required. At the same time it has to facilitate the transfer over linguistic and cultural barriers without distortion or loss of clarity, in order to promote clear, unambiguous, meaningful and fully informative communication in different terminologies. The degree to which a message (such as a laboratory report) needs to be expressed in a formal, systematic language depends on the geographical, linguistic, social or professional distance between the communicating parties. The greater the distance, the greater the risk of misunderstanding. Within one laboratory, local jargon terms may be used which are usually well understood between colleagues, but which would not be sufficiently widely known for communication with the outside world. Likewise, a laboratory and its local community of users, such as hospital or community physicians, may use a "local dialect" of the language of laboratory medicine which is well understood by all concerned; but when the communication possibilities are wider, even transnational, risks of serious misunderstanding arise. The purpose of this document is to apply the IFCC–IUPAC recommended syntax structures for request and report and to create a systematic terminology which can be used as the basis for encoding laboratory messages in the domain of general clinical chemistry. This is to facilitate
2 communication of messages about such properties through computing and telecommunication between databases, messages that contain sufficient information to allow translation from and to the required "local dialect" at each end. Each entry in the list is formed following the rules given in [1] and in [9].
The systematic names recommended here are primarily for the purpose of unambiguous data exchange. Their use in routine language by clinician or laboratory practitioners is optional but encouraged.
Elements of an Entry
The terms recommended are given in bold, that is: the systematic term for the type of property, the unit and the code value.
1 Name of system and parenthetic specification spelled out in full, and followed by a long dash (em dash). 2 Alphanumeric chemical prefixes to component name. 3 Recommended name of component and parenthetic specification. Shifted to the left for alphabetical sorting and searching, and followed by a semicolon. 4 Kind-of-property and parenthetic specification. 5 Unit. 6 Presently recommended calibrator 7 Previous calibrators 8 Other term(s) 9 Authority: Code value for the international organization recommending the name of the component or the combined elements of an entry 10 Note(s) with any further information 11 [NPUXXXXX] Coding scheme identifier and code value, intended for interlaboratory transmission between databases 12 Example in abbreviated form.
3 References
1. Commission/Committee on Nomenclature, properties and units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry– International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. I. Syntax and semantic rules. Prepared for publication by H Olesen. Pure & Appl Chem 1995; 67: 1563-74; Eur J Clin Chem Clin Biochem 1995; 33: 627-36; Clin Chim Acta 1996; 245: S5-S21. 2. Commission/Committee on Nomenclature, properties and units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry– International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. II. Kinds-of-property. Prepared for publication by D Kenny, H Olesen. Pure & Appl Chem 1997; 68: 1015-42. Eur J Clin Chem Clin Biochem, 1997; 35: 317-44. 3. Commission/Committee on Nomenclature, properties and units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. III. Elements (of properties) and their code values. Technical report 1997. Prepared for publication by I Bruunshuus, W Frederiksen, H Olesen, I Ibsen. Pure & Appl Chem 1997; 69: 2577-82. 4. Commission/Committee on Nomenclature, properties and units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. IV. Properties and their code values. Technical report 1997. Prepared for publication by H Olesen, D Kenny, I Bruunshuus, I Ibsen, K Jørgensen, R Dybkær. Pure & Appl Chem 1997; 69: 2583-91. 5. Scientific and Standardization Committee of the ISTH (International Society on Thrombosis and Haemostasis) and Commission/Committee on Nomenclature, properties and units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. V. Properties and units in thrombosis and haemostasis. Prepared for publication by M Blombäck, R Dybkær, K Jørgensen, H Olesen, S Thorsen. Thrombosis and Haemostasis 1994; 71-375-94. Eur J Clin Chem Clin Biochem 1995; 33: 637-60. Pure & Appl Chem 1997; 69: 1043-79. 6. Commission/Committee on Nomenclature, properties and units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. VI. Properties and units in IOC prohibited drugs. Recommendations 1997. Prepared for publication by H Olesen, D Cowan, I Bruunshuus, K lempel, G Hill. Pure & Appl Chem 1997; 69: 1081-1136. Eur J Clin Chem Clin Biochem 1997; 35: 805-31. 7. Commission/Committee on Nomenclature, properties and units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. VIII. Properties and units in Clinical microbiology. Technical report 1999. Prepared for publication by U Forsum, H Olesen, W Frederiksen, B Persson. Pure & Appl Chem, in press. Eur J Clin Chem Clin Biochem, in press. 8. Commission/Committee on Nomenclature, properties and units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. IX. Properties and units in Trace elements. Technical report 1997. Prepared for publication by R Cornelis, X Fuentes- Arderiu, I Bruunshuus, D Templeton. Pure & Appl Chem 1997; 69: 2593-2606. Eur J Clin Chem Clin Biochem 1997; 35:833-843. 9. Commission/Committee on Nomenclature, properties and units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. XI. Coding systems - structure and guidelines. Technical report 1997. Prepared for publication by R Cornelis, H Olesen, I Ibsen, I Bruunshuus, D Kenny. Pure & Appl Chem 1997; 69: 2607-20.
4 10. Commission/Committee on Nomenclature, properties and units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. XII. Properties and units in Clinical pharmacology and toxicology. Technical report 1999. Prepared for publication by H Olesen, D Cowan, Rafael de la Torre, I Bruunshuus, M Rohde, D Kenny. Pure & Appl Chem, in press. Eur J Clin Chem Clin Biochem, in press. 11. Commission/Committee on Nomenclature, properties and units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. XIII. Properties and units in Reproduction and fertility. Technical report 1997. Prepared for publication by H Olesen, A Giwercman, DM de Kretser, D Mortimer, H Oshima, Troen. Pure & Appl Chem 1997; 69: 2621-28. Clin Chem Lab Med 1998; 36: 57-65. 12. Commission/Committee on Nomenclature, properties and units of the IUPAC–IFCC (International Union of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Properties and units in the clinical laboratory sciences. XVI. Properties and units in Clinical allergology. Technical report 1999. Prepared for publication by I Bruunshuus, LK Poulsen, H Olesen. Pure & Appl Chem, in press. Eur J Clin Chem Clin Biochem, in press.
Index of Abbreviations
CAS Chemical Abstract Service IFCC International Federation of Clinical Chemistry and Laboratory Medicine INN International Nonproprietary Names of WHO *INN Name to be approved ISO International Organization for Standardization IUPAC International Union of Pure and Applied Chemistry MSH Medical Subject Headings WHO World Health Organization
5 6 List of Properties in General Clinical Chemistry
Blood— Patient(Urine)— Acanthocytes; N- arbitrary concentration(procedure) Acetylasparaginate; NPU17074 substance rate B—Acanthocytes; arb.c.(proc.) = ? micromol/day NPU17781 Erythrocytes(Blood)— Pt(U)—N-Acetylasparaginate; subst.rate = ? µmol/d Acanthocytes; number fraction Amniotic fluid— NPU14348 Acetylcholinesterase; Ercs(B)—Acanthocytes; num.fr. = ? catalytic-activity concentration(20 °C; procedure) nanokatal/litre Blood— Other term(s): AChE; Cholinesterase; Choline esterase I; True cholinesterase Acetaldehyde; NPU14657 substance concentration Amf—Acetylcholinesterase; cat.c.(20 °C; proc.) = ? nkat/l micromol/litre M = 44,05 g/mol Amniotic fluid— NPU01005 Acetylcholinesterase; B—Acetaldehyde; subst.c. = ? µmol/l catalytic-activity concentration(37 °C; procedure) microkatal/litre Urine— Other term(s): AChE; Cholinesterase; Choline esterase I; True cholinesterase Acetaldehyde; NPU01034 substance concentration Amf—Acetylcholinesterase; cat.c.(37 °C; proc.) = ? µkat/l micromol/litre M = 44,05 g/mol Erythrocytes(Blood)— NPU01006 Acetylcholinesterase; U—Acetaldehyde; subst.c. = ? µmol/l entitic catalytic activity(37 °C; procedure) attokatal Urine— Other term(s): AChE; Cholinesterase; Choline esterase I; True cholinesterase Acetoacetate; NPU01035 arbitrary concentration(procedure) Ercs(B)—Acetylcholinesterase; entitic cat.act.(37 °C; proc.) = ? akat NPU10504 U—Acetoacetate; arb.c.(proc.) = ? Plasma— Acetylcholinreceptor antibody(Immunoglobulin G); Urine— arbitrary substance concentration(procedure) Acetoacetate; arbitrary unit/litre substance concentration(120 minutes after challenge; procedure) NPU01036 millimol/litre P—Acetylcholinreceptor antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l NPU10316 U—Acetoacetate; subst.c.(120 min; proc.) = ? mmol/l Urine— beta- Urine— Acetylglucosamine/Creatininium; Acetoacetate; substance ratio substance concentration(procedure) 10-3 millimol/litre NPU14183 NPU01012 U—beta-Acetylglucosamine/Creatininium; subst.ratio = ? × 10-3 U—Acetoacetate; subst.c.(proc.) = ? mmol/l Urine— Cerebrospinal fluid— beta- Acetoacetate; Acetylglucosamine; substance concentration substance concentration millimol/litre micromol/litre NPU01010 NPU01325 Csf—Acetoacetate; subst.c. = ? mmol/l U—beta-Acetylglucosamine; subst.c. = ? µmol/l
Plasma— Patient(Urine)— Acetoacetate; beta- substance concentration Acetylglucosamine; millimol/litre substance rate NPU01011 micromol/day P—Acetoacetate; subst.c. = ? mmol/l NPU10283 Pt(U)—beta-Acetylglucosamine; subst.rate = ? µmol/d Secretion(Conjunctiva; specification)— Acetoacetate; Urine— substance concentration N- millimol/litre Acetyl-L-cystathionine/Creatininium; NPU09351 substance ratio Secr(Conj; spec.)—Acetoacetate; subst.c. = ? mmol/l 10-3 NPU14179 Urine— U—N-Acetyl-L-cystathionine/Creatininium; subst.ratio = ? × 10-3 Acetoacetate; substance concentration Urine— millimol/litre N- NPU04166 Acetyl-L-cystathionine; U—Acetoacetate; subst.c. = ? mmol/l substance concentration micromol/litre Patient(Urine)— M = 264,3 g/mol Acetoacetate; NPU01022 substance rate U—N-Acetyl-L-cystathionine; subst.c. = ? µmol/l micromol/day NPU17845 Urine— Pt(U)—Acetoacetate; subst.rate = ? µmol/d N- Acetyl-L-cystine/Creatininium; substance ratio 10-3 NPU14180 U—N-Acetyl-L-cystine/Creatininium; subst.ratio = ? × 10-3
7 Patient(capillary Blood)— Urine— Acid base status; N- property(list; procedure) Acetyl-L-cystine; NPU12479 substance concentration Pt(cB)—Acid base status; prop.(list; proc.) micromol/litre NPU12520 P(cB)—Base excess(H+binding group); subst.c.(actual-norm) = ? M = 282,3 g/mol mmol/l + NPU01023 NPU12480 P(cB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; 37 U—N-Acetyl-L-cystine; subst.c. = ? µmol/l ºC; actual-norm) = ? mmol/l NPU04034 Pt(spec.)—Blood; temp. = ? °C Urine— NPU08676 Pt—Body; temp. = ? °C N-alpha- NPU12482 P(cB)—Carbon dioxide(free); subst.c. = ? mmol/l Acetyl-L-lysine/Creatininium; NPU12481 P(cB)—Carbon dioxide(free); tension(37 °C) = ? kPa substance ratio NPU12528 P(cB)—Carbon dioxide(free); tension(body temp.) = ? kPa 10-3 NPU12485 P(cB)—Carbon dioxide(tot.); subst.c. = ? mmol/l NPU14181 NPU01473 Hb(Fe; B)—Carbon monoxide haemoglobin(Fe); subst.fr. = ? U—N-alpha-Acetyl-L-lysine/Creatininium; subst.ratio = ? × 10-3 NPU02319 B—Haemoglobin(Fe); subst.c. = ? mmol/l NPU14264 P(cB)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l Urine— NPU02410 P—Hydrogen carbonate; subst.c.(pCO2 = 5,3 kPa; 37 ºC) = ? mmol/l N-epsilon- NPU12490 P(cB)—Hydrogen ion; pH(37 °C) = ? Acetyl-L-lysine/Creatininium; NPU12491 P(cB)—Hydrogen ion; pH(body temp.) = ? substance ratio NPU12494 P(cB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l NPU14182 NPU12497 P(cB)—Hydrogen ion; subst.c.(body temp.) = ? nmol/l U—N-epsilon-Acetyl-L-lysine/Creatininium; subst.ratio = ? NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); subst.fr. = ? NPU12514 Gas(cB)—Oxygen(O2); part.pr. = ? kPa Urine— NPU10197 Hb(tot.; cB)—Oxygen(O2); sat.fr. = ? N-epsilon- NPU12500 P(cB)—Oxygen(O2); tension = ? kPa Acetyl-L-lysine; NPU03010 Hb(B)—Oxygen(O2); tension(halfsat.) = ? kPa substance concentration NPU12503 P(cB)—Oxygen(O2; free); subst.c. = ? mmol/l mol/litre NPU12506 B(cB)—Oxygen(O2; total); subst.c. = ? mmol/l M = 188,2 g/mol NPU12510 Hb(Fe; deoxy+oxy; cB)—Oxyhaemoglobin(Fe); subst.fr. = ? NPU01025 NPU10754 Hb(Fe; tot.; cB)—Oxyhaemoglobin(Fe); subst.fr. = ? U—N-epsilon-Acetyl-L-lysine; subst.c.= ? prefix ? mol/l Patient(cord Blood)— Urine— Acid base status; N-alpha- property(list; procedure) Acetyl-L-lysine; NPU12516 substance concentration Pt(cordB)—Acid base status; prop.(list; proc.) micromol/litre NPU12519 P(cordB)—Base excess(H+binding group); subst.c.(actual-norm) = ? M = 188,2 g/mol mmol/l + NPU01024 NPU10219 P(cordB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; U—N-alpha-Acetyl-L-lysine; subst.c. = ? µmol/l 37 ºC; actual-norm) = ? mmol/l NPU04034 Pt(spec.)—Blood; temp. = ? °C Patient(arterial Blood)— NPU08676 Pt—Body; temp. = ? °C Acid base status; NPU12483 P(cordB)—Carbon dioxide(free); subst.c. = ? mmol/l property(list; procedure) NPU10030 P(cordB)—Carbon dioxide(free); tension(37 °C) = ? kPa NPU04197 NPU12527 P(cordB)—Carbon dioxide(free); tension(body temp.) = ? kPa Pt(aB)—Acid base status; prop.(list; proc.) NPU12517 P(cordB)—Carbon dioxide(tot.); subst.c. = ? mmol/l NPU12518 P(aB)—Base excess(H+binding group); subst.c.(actual-norm) = ? NPU01473 Hb(Fe; B)—Carbon monoxide haemoglobin(Fe); subst.fr. = ? mmol/l NPU02319 B—Haemoglobin(Fe); subst.c. = ? mmol/l + NPU01348 P(aB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; 37 NPU14265 P(cordB)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l ºC; actual-norm) = ? mmol/l NPU02410 P—Hydrogen carbonate; subst.c.(pCO2 = 5,3 kPa; 37 ºC) = ? mmol/l NPU04034 Pt(spec.)—Blood; temp. = ? °C NPU10016 P(cordB)—Hydrogen ion; pH = ? NPU08676 Pt—Body; temp. = ? °C NPU12493 P(cordB)—Hydrogen ion; pH(body temp.) = ? NPU12476 P(aB)—Carbon dioxide(free); subst.c. = ? mmol/l NPU12496 P(cordB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l NPU01470 P(aB)—Carbon dioxide(free); tension(37 °C) = ? kPa NPU12499 P(cordB)—Hydrogen ion; subst.c.(body temp.) = ? nmol/l NPU12526 P(aB)—Carbon dioxide(free); tension(body temp.) = ? kPa NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); subst.fr. = ? NPU01471 P(aB)—Carbon dioxide(tot.); subst.c. = ? mmol/l NPU12513 Gas(cordB)—Oxygen(O2); part.pr. = ? kPa NPU01473 Hb(Fe; B)—Carbon monoxide haemoglobin(Fe); subst.fr. = ? NPU12508 Hb(tot.; cordB)—Oxygen(O2); sat.fr. = ? NPU08753 Hb(tot.; aB)—Deoxyhaemoglobin; subst.fr. = ? NPU12502 P(cordB)—Oxygen(O2); tension = ? kPa NPU02319 B—Haemoglobin(Fe); subst.c. = ? mmol/l NPU03010 Hb(B)—Oxygen(O2); tension(halfsat.) = ? kPa NPU02409 P(aB)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l NPU12478 P(cordB)—Oxygen(O2; free); subst.c. = ? mmol/l NPU02410 P—Hydrogen carbonate; subst.c.(pCO2 = 5,3 kPa; 37 ºC) = ? mmol/l NPU12505 B(cordB)—Oxygen(O2; total); subst.c. = ? mmol/l NPU12474 P(aB)—Hydrogen ion; pH(37 °C) = ? NPU12509 Hb(Fe; deoxy+oxy; cordB)—Oxyhaemoglobin(Fe); subst.fr. = ? NPU02412 P(aB)—Hydrogen ion; pH(body temp.) = ? NPU12512 Hb(Fe; tot.; cordB)—Oxyhaemoglobin(Fe); subst.fr. = ? NPU12475 P(aB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l NPU02413 P(aB)—Hydrogen ion; subst.c.(body temp.) = ? nmol/l NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); subst.fr. = ? NPU03009 Gas(aB)—Oxygen(O2); part.pr. = ? kPa NPU03011 Hb(tot.; aB)—Oxygen(O2); sat.fr. = ? NPU08977 P(aB)—Oxygen(O2); tension = ? kPa NPU03010 Hb(B)—Oxygen(O2); tension(halfsat.) = ? kPa NPU03012 P(aB)—Oxygen(O2; free); subst.c. = ? mmol/l NPU03849 B(aB)—Oxygen(O2; total); subst.c. = ? mmol/l NPU03014 Hb(Fe; deoxy+oxy; aB)—Oxyhaemoglobin(Fe); subst.fr. = ? NPU03013 Hb(Fe; tot.; aB)—Oxyhaemoglobin(Fe); subst.fr. = ?
8 Patient(cord Blood; arterial Blood)— Patient(mixed Blood)— Acid base status; Acid base status; property(list; procedure) property(list; procedure) NPU17131 NPU09208 Pt(cordB; aB)—Acid base status; prop.(list; proc.) Pt(mixB)—Acid base status; prop.(list; proc.) NPU17133 P(cordB; aB)—Base excess(H+binding group); subst.c.(actual-norm) NPU09200 P(mixB)—Base excess(H+binding group); subst.c.(actual-norm) = ? = ? mmol/l mmol/l + + NPU17135 P(cordB; aB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 NPU09201 P(mixB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; kPa; 37 ºC; actual-norm) = ? mmol/l 37 ºC; actual-norm) = ? mmol/l NPU04034 Pt(spec.)—Blood; temp. = ? °C NPU04034 Pt(spec.)—Blood; temp. = ? °C NPU08676 Pt—Body; temp. = ? °C NPU08676 Pt—Body; temp. = ? °C NPU17137 P(cordB; aB)—Carbon dioxide(free); subst.c. = ? mmol/l NPU09204 P(mixB)—Carbon dioxide(free); subst.c. = ? mmol/l NPU17139 P(cordB; aB)—Carbon dioxide(free); tension(37 °C) = ? kPa NPU09202 P(mixB)—Carbon dioxide(free); tension(37 °C) = ? kPa NPU17141 P(cordB; aB)—Carbon dioxide(free); tension(body temp.) = ? kPa NPU09203 P(mixB)—Carbon dioxide(free); tension(body temp.) = ? kPa NPU17143 P(cordB; aB)—Carbon dioxide(tot.); subst.c. = ? mmol/l NPU09206 P(mixB)—Carbon dioxide(tot.); subst.c. = ? mmol/l NPU01473 Hb(Fe; B)—Carbon monoxide haemoglobin(Fe); subst.fr. = ? NPU01473 Hb(Fe; B)—Carbon monoxide haemoglobin(Fe); subst.fr. = ? NPU02319 B—Haemoglobin(Fe); subst.c. = ? mmol/l NPU02319 B—Haemoglobin(Fe); subst.c. = ? mmol/l NPU17145 P(cordB; aB)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l NPU09209 P(mixB)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l NPU02410 P—Hydrogen carbonate; subst.c.(pCO2 = 5,3 kPa; 37 ºC) = ? mmol/l NPU02410 P—Hydrogen carbonate; subst.c.(pCO2 = 5,3 kPa; 37 ºC) = ? mmol/l NPU17147 P(cordB; aB)—Hydrogen ion; pH = ? NPU09210 P(mixB)—Hydrogen ion; pH(37 °C) = ? NPU17149 P(cordB; aB)—Hydrogen ion; pH(body temp.) = ? NPU09211 P(mixB)—Hydrogen ion; pH(body temp.) = ? NPU17151 P(cordB; aB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l NPU09212 P(mixB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l NPU17153 P(cordB; aB)—Hydrogen ion; subst.c.(body temp.) = ? nmol/l NPU09213 P(mixB)—Hydrogen ion; subst.c.(body temp.) = ? nmol/l NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); subst.fr. = ? NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); subst.fr. = ? NPU17170 Gas(cordB; aB)—Oxygen(O2); part.pr. = ? kPa NPU09214 Gas(mixB)—Oxygen(O2); part.pr. = ? kPa NPU12508 Hb(tot.; cordB)—Oxygen(O2); sat.fr. = ? NPU09218 Hb(tot.; mixB)—Oxygen(O2); sat.fr. = ? NPU17155 P(cordB; aB)—Oxygen(O2); tension = ? kPa NPU09215 P(mixB)—Oxygen(O2); tension = ? kPa NPU03010 Hb(B)—Oxygen(O2); tension(halfsat.) = ? kPa NPU03010 Hb(B)—Oxygen(O2); tension(halfsat.) = ? kPa NPU17157 P(cordB; aB)—Oxygen(O2; free); subst.c. = ? mmol/l NPU09216 P(mixB)—Oxygen(O2; free); subst.c. = ? mmol/l NPU12505 B(cordB)—Oxygen(O2; total); subst.c. = ? mmol/l NPU09217 B(mixB)—Oxygen(O2; total); subst.c. = ? mmol/l NPU12509 Hb(Fe; deoxy+oxy; cordB)—Oxyhaemoglobin(Fe); subst.fr. = ? NPU09219 Hb(Fe; deoxy+oxy; mixB)—Oxyhaemoglobin(Fe); subst.fr. = ? NPU12512 Hb(Fe; tot.; cordB)—Oxyhaemoglobin(Fe); subst.fr. = ? NPU09220 Hb(Fe; tot.; mixB)—Oxyhaemoglobin(Fe); subst.fr. = ?
Patient(cord Blood; venous Blood)— Patient(venous Blood)— Acid base status; Acid base status; property(list; procedure) property(list; procedure) NPU17132 NPU10755 Pt(cordB; vB)—Acid base status; prop.(list; proc.) Pt(vB)—Acid base status; prop.(list; proc.) NPU17134 P(cordB; vB)—Base excess(H+binding group); subst.c.(actual-norm) NPU12521 P(vB)—Base excess(H+binding group); subst.c.(actual-norm) = ? = ? mmol/l mmol/l + + NPU17136 P(cordB; vB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 NPU08970 P(vB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; 37 kPa; 37 ºC; actual-norm) = ? mmol/l ºC; actual-norm) = ? mmol/l NPU04034 Pt(spec.)—Blood; temp. = ? °C NPU04034 Pt(spec.)—Blood; temp. = ? °C NPU08676 Pt—Body; temp. = ? °C NPU08676 Pt—Body; temp. = ? °C NPU17138 P(cordB; vB)—Carbon dioxide(free); subst.c. = ? mmol/l NPU12484 P(vB)—Carbon dioxide(free); subst.c. = ? mmol/l NPU17140 P(cordB; vB)—Carbon dioxide(free); tension(37 °C) = ? kPa NPU10029 P(vB)—Carbon dioxide(free); tension(37 °C) = ? kPa NPU17142 P(cordB; vB)—Carbon dioxide(free); tension(body temp.) = ? kPa NPU12529 P(vB)—Carbon dioxide(free); tension(body temp.) = ? kPa NPU17144 P(cordB; vB)—Carbon dioxide(tot.); subst.c. = ? mmol/l NPU01472 P(vB)—Carbon dioxide(tot.); subst.c. = ? mmol/l NPU01473 Hb(Fe; B)—Carbon monoxide haemoglobin(Fe); subst.fr. = ? NPU01473 Hb(Fe; B)—Carbon monoxide haemoglobin(Fe); subst.fr. = ? NPU02319 B—Haemoglobin(Fe); subst.c. = ? mmol/l NPU02319 B—Haemoglobin(Fe); subst.c. = ? mmol/l NPU17146 P(cordB; vB)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l NPU14266 P(vB)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l NPU02410 P—Hydrogen carbonate; subst.c.(pCO2 = 5,3 kPa; 37 ºC) = ? mmol/l NPU02410 P—Hydrogen carbonate; subst.c.(pCO2 = 5,3 kPa; 37 ºC) = ? mmol/l NPU17148 P(cordB; vB)—Hydrogen ion; pH = ? NPU12489 P(vB)—Hydrogen ion; pH(37 °C) = ? NPU17150 P(cordB; vB)—Hydrogen ion; pH(body temp.) = ? NPU12492 P(vB)—Hydrogen ion; pH(body temp.) = ? NPU17152 P(cordB; vB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l NPU12495 P(vB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l NPU17154 P(cordB; vB)—Hydrogen ion; subst.c.(body temp.) = ? nmol/l NPU12498 P(vB)—Hydrogen ion; subst.c.(body temp.) = ? nmol/l NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); subst.fr. = ? NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); subst.fr. = ? NPU17171 Gas(cordB; vB)—Oxygen(O2); part.pr. = ? kPa NPU03847 Gas(vB)—Oxygen(O2); part.pr. = ? kPa NPU12508 Hb(tot.; cordB)—Oxygen(O2); sat.fr. = ? NPU10199 Hb(tot.; vB)—Oxygen(O2); sat.fr. = ? NPU17156 P(cordB; vB)—Oxygen(O2); tension = ? kPa NPU12501 P(vB)—Oxygen(O2); tension = ? kPa NPU03010 Hb(B)—Oxygen(O2); tension(halfsat.) = ? kPa NPU03010 Hb(B)—Oxygen(O2); tension(halfsat.) = ? kPa NPU17158 P(cordB; vB)—Oxygen(O2; free); subst.c. = ? mmol/l NPU12504 P(vB)—Oxygen(O2; free); subst.c. = ? mmol/l NPU12505 B(cordB)—Oxygen(O2; total); subst.c. = ? mmol/l NPU12507 B(vB)—Oxygen(O2; total); subst.c. = ? mmol/l NPU12509 Hb(Fe; deoxy+oxy; cordB)—Oxyhaemoglobin(Fe); subst.fr. = ? NPU12511 Hb(Fe; deoxy+oxy; vB)—Oxyhaemoglobin(Fe); subst.fr. = ? NPU12512 Hb(Fe; tot.; cordB)—Oxyhaemoglobin(Fe); subst.fr. = ? NPU10265 Hb(Fe; tot.; vB)—Oxyhaemoglobin(Fe); subst.fr. = ?
Plasma— Acid phosphatase, prostatic type; catalytic-activity concentration(37 °C; procedure) microkatal/litre NPU01065 P—Acid phosphatase, prostatic type; cat.c.(37 °C; proc.) = ? µkat/l
Synovial fluid(specification)— Acid phosphatase, prostatic type; catalytic-activity concentration(37 °C; procedure) microkatal/litre NPU10609 Synf(spec.)—Acid phosphatase, prostatic type; cat.c.(37 °C; proc.) = ? µkat/l
Plasma— Acid phosphatase, prostatic type; substance concentration micromol/litre NPU01066 P—Acid phosphatase, prostatic type; subst.c. = ? µmol/l
9 Plasma— Plasma— Acid phosphatase; Adrenalinium; catalytic-activity concentration(37 °C; procedure) substance concentration(5 minutes before challenge) microkatal/litre micromol/litre NPU01064 M = 183,20 g/mol P—Acid phosphatase; cat.c.(37 °C; proc.) = ? µkat/l NPU10667 P—Adrenalinium; subst.c.(-5 min)= ? µmol/l Synovial fluid(specification)— Acid phosphatase; Plasma— catalytic-activity concentration(37 °C; procedure) Adrenalinium; microkatal/litre substance concentration(0 minutes after challenge) NPU10617 micromol/litre Synf(spec.)—Acid phosphatase; cat.c.(37 °C; proc.) = ? µkat/l M = 183,20 g/mol NPU10537 Urine— P—Adrenalinium; subst.c.(0 min)= ? µmol/l Adenosyl-L-homocysteine/Creatininium; substance ratio Plasma— 10-3 Adrenalinium; NPU14184 substance concentration(60 minutes after challenge) U—Adenosyl-L-homocysteine/Creatininium; subst.ratio = ? × 10-3 micromol/litre M = 183,20 g/mol Urine— NPU10538 Adenosyl-L-homocysteine; P—Adrenalinium; subst.c.(60 min)= ? µmol/l substance concentration micromol/litre Plasma— M = 384,4 g/mol Adrenalinium; NPU01084 substance concentration(120 minutes after challenge) U—Adenosyl-L-homocysteine; subst.c. = ? µmol/l micromol/litre M = 183,20 g/mol Urine— NPU10539 Adenosyl-L-methionine/Creatininium; P—Adrenalinium; subst.c.(120 min)= ? µmol/l substance ratio 10-3 Plasma— NPU14185 Adrenalinium; U—Adenosyl-L-methionine/Creatininium; subst.ratio = ? × 10-3 substance concentration(180 minutes after challenge) micromol/litre Plasma— M = 183,20 g/mol Adenosyl-L-methionine; NPU10540 substance concentration P—Adrenalinium; subst.c.(180 min)= ? µmol/l micromol/litre M = 399,4 g/mol Plasma— NPU01085 Adrenalinium; P—Adenosyl-L-methionine; subst.c. = ? µmol/l substance concentration micromol/litre Urine— M = 183,20 g/mol Adenosyl-L-methionine; NPU14042 substance concentration P—Adrenalinium; subst.c.= ? µmol/l micromol/litre M = 399,4 g/mol Urine— NPU01086 Adrenalinium; U—Adenosyl-L-methionine; subst.c. = ? µmol/l substance concentration micromol/litre Urine— M = 183,20 g/mol Adipate; Other term(s): Epinephrine substance concentration Authority: IUPAC-IUB 83 micromol/litre NPU14041 M = 146,14 g/mol U—Adrenalinium; subst.c. = ? µmol/l NPU01104 U—Adipate; subst.c. = ? µmol/l Patient(Urine)— Adrenalinium; Patient— substance rate(procedure) Adrenalinium secretion; micromol/day substance rate(clonidine, oral administration; list; procedure) NPU14043 Other term(s): Epinephrine secretion Pt(U)—Adrenalinium; subst.rate(proc.) = ? µmol/d Note: _M_ (clonidine) = 230,10 g/mol; _M_ (adrenalinium) = 183,20 g/mol NPU10541 Patient— Pt—Adrenalinium secretion; subst.rate(clonidine p.o.; list; proc.) Adrenalinium+noradrenalinium secretion; NPU10536 Pt—Clonidine(administered); am.s.(p.o.) = ? µmol substance rate(clonidine, oral administration; list; procedure) NPU10666 P—Adrenalinium; subst.c.(-15 min)= ? µmol/l Other term(s): Epinephrine+norepinephrine secretion NPU10667 P—Adrenalinium; subst.c.(-5 min)= ? µmol/l Note: _M_ (clonidine) = 230,10 g/mol; _M_ (adrenalinium) = 183,20 g/mol; NPU10537 P—Adrenalinium; subst.c.(0 min)= ? µmol/l _M_ (noradrenalinium) = 169,18 g/mol NPU10538 P—Adrenalinium; subst.c.(60 min)= ? µmol/l NPU10546 NPU10539 P—Adrenalinium; subst.c.(120 min)= ? µmol/l Pt—Adrenalinium+noradrenalinium secretion; subst.rate(clonidine p.o.; list; NPU10540 P—Adrenalinium; subst.c.(180 min)= ? µmol/l proc.) NPU10536 Pt—Clonidine(administered); am.s.(p.o.) = ? µmol Urine— NPU10620 P—Adrenalinium+Noradrenalinium; subst.c.(-15 min)= ? µmol/l Adrenalinium; NPU10621 P—Adrenalinium+Noradrenalinium; subst.c.(-5 min)= ? µmol/l amount-of-substance(procedure) NPU10542 P—Adrenalinium+Noradrenalinium; subst.c.(0 min)= ? µmol/l micromol NPU10543 P—Adrenalinium+Noradrenalinium; subst.c.(60 min)= ? µmol/l NPU17545 NPU10544 P—Adrenalinium+Noradrenalinium; subst.c.(120 min)= ? µmol/l U—Adrenalinium; am.s.(proc.) = ? µmol NPU10545 P—Adrenalinium+Noradrenalinium; subst.c.(180 min)= ? µmol/l
Plasma— Urine— Adrenalinium; Adrenalinium+Noradrenalinium; substance concentration(15 minutes before challenge) amount-of-substance(procedure) micromol/litre micromol M = 183,20 g/mol NPU17624 NPU10666 U—Adrenalinium+Noradrenalinium; am.s.(proc.) = ? µmol P—Adrenalinium; subst.c.(-15 min)= ? µmol/l
10 Plasma— Room— Adrenalinium+Noradrenalinium; Air; substance concentration(15 minutes before challenge) Celsius temperature micromol/litre degree Celsius NPU10620 NPU04082 P—Adrenalinium+Noradrenalinium; subst.c.(-15 min)= ? µmol/l Room—Air; temp. = ? °C
Plasma— Lung(specification)— Adrenalinium+Noradrenalinium; Air; substance concentration(5 minutes before challenge) volume micromol/litre litre NPU10621 NPU03789 P—Adrenalinium+Noradrenalinium; subst.c.(-5 min)= ? µmol/l Lung(spec.)—Air; vol. = ? l
Plasma— Amniotic fluid— Adrenalinium+Noradrenalinium; Alanine transaminase; substance concentration(0 minutes after challenge) catalytic-activity concentration(37 °C; procedure) micromol/litre microkatal/litre NPU10542 Other term(s): Glutamic-pyruvic transaminase; Glutamic-alanine transaminase; P—Adrenalinium+Noradrenalinium; subst.c.(0 min)= ? µmol/l Alanine transaminase NPU03911 Plasma— Amf—Alanine transaminase; cat.c.(37 °C; proc.) = ? µkat/l Adrenalinium+Noradrenalinium; substance concentration(60 minutes after challenge) Plasma— micromol/litre Alanine transaminase; NPU10543 catalytic-activity concentration(37 °C; procedure) P—Adrenalinium+Noradrenalinium; subst.c.(60 min)= ? µmol/l microkatal/litre Other term(s): Glutamic-pyruvic transaminase; Glutamic-alanine transaminase; Plasma— Alanine transaminase Adrenalinium+Noradrenalinium; NPU01121 substance concentration(120 minutes after challenge) P—Alanine transaminase; cat.c.(37 °C; proc.) = ? µkat/l micromol/litre NPU10544 Urine— P—Adrenalinium+Noradrenalinium; subst.c.(120 min)= ? µmol/l beta- Alanine/Creatininium; Plasma— substance ratio Adrenalinium+Noradrenalinium; 10-3 substance concentration(180 minutes after challenge) NPU14187 micromol/litre U—beta-Alanine/Creatininium; subst.ratio = ? × 10-3 NPU10545 P—Adrenalinium+Noradrenalinium; subst.c.(180 min)= ? µmol/l Urine— Alanine/Creatininium; Plasma— substance ratio Adrenalinium+Noradrenalinium; 10-3 substance concentration NPU14186 micromol/litre U—Alanine/Creatininium; subst.ratio = ? × 10-3 Other term(s): Epinephrine+norepinephrine Note: _M_ (adrenalin) = 183,20 g/mol; _M_ (noradrenalin) = 169,18 g/mol Cerebrospinal fluid— NPU14044 beta- P—Adrenalinium+Noradrenalinium; subst.c. = ? µmol/l Alanine; substance concentration Urine— micromol/litre Adrenalinium+Noradrenalinium; M = 89,09 g/mol substance concentration Authority: IUPAC-IUB 84 micromol/litre NPU09017 Other term(s): Epinephrine+norepinephrine Csf—beta-Alanine; subst.c. = ? µmol/l Note: _M_ (adrenalin) = 183,20 g/mol; _M_ (noradrenalin) = 169,18 g/mol NPU14120 Plasma— U—Adrenalinium+Noradrenalinium; subst.c. = ? µmol/l beta- Alanine; Patient(Urine)— substance concentration Adrenalinium+Noradrenalinium; micromol/litre substance rate(procedure) M = 89,09 g/mol micromol/day Authority: IUPAC-IUB 84 Other term(s): Catecholamines; Levarterenol NPU01119 NPU01105 P—beta-Alanine; subst.c. = ? µmol/l Pt(U)—Adrenalinium+Noradrenalinium; subst.rate(proc.) = ? µmol/d Urine— Plasma— beta- Adrenocortex antibody(Immunoglobulin G); Alanine; arbitrary concentration(procedure) substance concentration NPU12545 micromol/litre P—Adrenocortex antibody(IgG); arb.c.(proc.) = ? M = 89,09 g/mol Authority: IUPAC-IUB 84 Plasma— NPU01120 Adrenocortex antibody; U—beta-Alanine; subst.c. = ? µmol/l arbitrary substance concentration(procedure) arbitrary unit/litre Cerebrospinal fluid— NPU01106 Alanine; P—Adrenocortex antibody; arb.subst.c.(proc.) = ? arb.unit/l substance concentration micromol/litre Room— M = 89,09 g/mol Air; Authority: IUPAC-IUB 84 pressure NPU01116 kilopascal Csf—Alanine; subst.c. = ? µmol/l NPU04078 Room—Air; pr. = ? kPa
11 Plasma— Amniotic fluid— Alanine; Albumin; substance concentration substance concentration micromol/litre micromol/litre M = 89,09 g/mol M = 66 000 g/mol Authority: IUPAC-IUB 84 NPU08600 NPU01117 Amf—Albumin; subst.c. = ? µmol/l P—Alanine; subst.c. = ? µmol/l Ascites— Urine— Albumin; Alanine; substance concentration substance concentration micromol/litre micromol/litre M = 66 000 g/mol M = 89,09 g/mol NPU03920 Authority: IUPAC-IUB 84 Asc—Albumin; subst.c. = ? µmol/l NPU01118 U—Alanine; subst.c. = ? µmol/l Cerebrospinal fluid— Albumin; Kidney— substance concentration Albumin clearance/Creatininium clearance; micromol/litre volume rate ratio M = 66 000 g/mol 10-3 NPU01130 NPU04125 Csf—Albumin; subst.c. = ? µmol/l Kidn.—Albumin clearance/Creatininium clearance; vol.rate ratio = ? × 10-3 Dialysis solution— Intestine, small— Albumin; Albumin loss; substance concentration substance rate(procedure) micromol/litre micromol/day M = 66 000 g/mol M = 66 000 g/mol NPU10018 NPU04041 Dialysis solution—Albumin; subst.c. = ? µmol/l Intest., small—Albumin loss; subst.rate(proc.) = ? µmol/d Drain fluid(specification)— Urine— Albumin; Albumin/Creatininium; substance concentration substance ratio micromol/litre 10-3 NPU17046 Note: _M_ (albumin) = 60 000 g/mol; _M_ (creatininium) = 113,12 Drain fluid(spec.)—Albumin; subst.c. = ? µmol/l NPU03918 U—Albumin/Creatininium; subst.ratio = ? × 10-3 Expectorate— Albumin; Urine— substance concentration Albumin; micromol/litre amount-of-substance(procedure) M = 66 000 g/mol micromol NPU10272 M = 66 000 g/mol Ex—Albumin; subst.c. = ? µmol/l NPU10270 U—Albumin; am.s.(proc.) = ? µmol Plasma— Albumin; System(specification)— substance concentration Albumin; micromol/litre mass concentration M = 66 000 g/mol gram/litre NPU01132 NPU14338 P—Albumin; subst.c. = ? µmol/l Syst(spec.)—Albumin; mass c. = ? g/l Pleural fluid(specification)— Protein(Cerebrospinal fluid)— Albumin; Albumin; substance concentration mass fraction micromol/litre NPU04949 M = 66 000 g/mol Prot.(Csf)—Albumin; mass fr. = ? NPU03919 Plf(spec.)—Albumin; subst.c. = ? µmol/l Protein(Plasma)— Albumin; Saliva— mass fraction Albumin; NPU04939 substance concentration Prot.(P)—Albumin; mass fr. = ? micromol/litre M = 66 000 g/mol Protein(Urine)— NPU10019 Albumin; Saliva—Albumin; subst.c. = ? µmol/l mass fraction NPU04944 Secretion(specification)— Prot.(U)—Albumin; mass fr. = ? Albumin; substance concentration Cerebrospinal fluid— micromol/litre Albumin; M = 66 000 g/mol relative substance concentration(Cerebrospinal fluid/Plasma) NPU10271 M = 66 000 g/mol Secr(spec.)—Albumin; subst.c. = ? µmol/l NPU04980 Csf—Albumin; rel.subst.c.(Csf/P) = ? Synovial fluid(specification)— Albumin; Urine— substance concentration Albumin; micromol/litre substance concentration(procedure) M = 66 000 g/mol micromol/litre NPU03921 M = 66 000 g/mol Synf(spec.)—Albumin; subst.c. = ? µmol/l NPU01134 U—Albumin; subst.c.(proc.) = ? µmol/l
12 Urine— Albumin; Urine— substance concentration Aldosterone; micromol/litre substance concentration M = 66 000 g/mol picomol/litre NPU03903 M = 360,44 g/mol U—Albumin; subst.c. = ? µmol/l Authority: IUPAC-IUB 89 NPU03853 Patient(Urine)— U—Aldosterone; subst.c. = ? pmol/l Albumin; substance rate(procedure) Patient(Urine)— micromol/day Aldosterone; NPU01131 substance rate(procedure) Pt(U)—Albumin; subst.rate(proc.) = ? µmol/d nanomol/day Authority: IUPAC-IUB89 Plasma— NPU01136 Aldolase; Pt(U)—Aldosterone; subst.rate(proc.) = ? nmol/d catalytic-activity concentration(37 °C; procedure) microkatal/litre Plasma— Other term(s): 1,6-Diphosphate aldolase; Aldolase A; Fructose-1,6- Aliphatic carboxylate(C10-C26); bisphosphate triosephosphate-lyase substance concentration Authority: IUB 84 millimol/litre NPU02116 Other term(s): Non esterified fatty acids; NEFA P—Aldolase; cat.c.(37 °C; proc.) = ? µkat/l NPU01139 P—Aliphatic carboxylate(C10-C26); subst.c. = ? mmol/l Leukocytes(Blood)— Aldosterone receptor; Intestine, small— arbitrary entitic number(procedure) Aliphatic carboxylate(C14-C26) absorption; NPU04063 substance rate(procedure) Lkcs(B)—Aldosterone receptor; arb.entitic num.(proc.) = ? millimol/day NPU01138 Leukocytes(Blood)— Intest., small—Aliphatic carboxylate(C14-C26) absorption; subst.rate(proc.) = Aldosterone receptor; ? mmol/d entitic number(procedure) NPU01137 Faeces— Lkcs(B)—Aldosterone receptor; entitic num.(proc.) = ? Aliphatic carboxylate(C14-C26); substance content Adrenal cortex— millimol/kilogram Aldosterone secretion; NPU03926 substance rate(furosemide, oral administration; list; procedure) F—Aliphatic carboxylate(C14-C26); subst.cont. = ? mmol/kg Note: _M_ (furosemide) = 330,75 g/mol; _M_ (aldosterone) = 360,44 g/mol NPU10686 Patient(Faeces)— Adrenal cortex—Aldosterone secretion; subst.rate(furosemide p.o.; list; proc.) Aliphatic carboxylate(C14-C26)+esters; NPU10419 Pt—Furosemide(administered); am.s.(p.o.) = ? µmol substance rate(procedure) NPU10684 P—Aldosterone; subst.c.(0 min) = ? pmol/l millimol/day NPU10685 P—Aldosterone; subst.c.(300 min) = ? pmol/l NPU01140 Pt(F)—Aliphatic carboxylate(C14-C26)+esters; subst.rate(proc.) = ? mmol/d Plasma— Aldosterone; Plasma— substance concentration(0 minutes after challenge) Aliphatic carboxylate(C22:0)/Aliphatic carboxylate(C26:0); picomol/litre substance ratio M = 360,44 g/mol NPU01142 Authority: IUPAC-IUB 89 P—Aliphatic carboxylate(C22:0)/Aliphatic carboxylate(C26:0); subst.ratio = ? NPU10684 P—Aldosterone; subst.c.(0 min) = ? pmol/l Plasma— Aliphatic carboxylate(C24:0)/Aliphatic carboxylate(C22:0); Plasma— substance ratio Aldosterone; NPU01141 substance concentration(300 minutes after challenge) P—Aliphatic carboxylate(C24:0)/Aliphatic carboxylate(C22:0); subst.ratio = ? picomol/litre M = 360,44 g/mol Plasma— NPU10685 Alkaline phosphatase type; P—Aldosterone; subst.c.(300 min) = ? pmol/l catalytic-activity concentration(list; 37 °C; procedure) NPU04589 Plasma— P—Alkaline phosphatase type; cat.c.(list; 37 °C; proc.) Aldosterone; NPU01145 P—Alkaline phosphatase, bone type; cat.c.(37 °C; proc.) = ? µkat/l substance concentration NPU10601 P—Alkaline phosphatase, liver canaliculus type; cat.c.(37 °C; proc.) nanomol/litre = ? µkat/l M = 360,44 g/mol NPU10600 P—Alkaline phosphatase, liver endothelial type; cat.c.(37 °C; proc.) Authority: IUPAC-IUB 89 = ? µkat/l NPU14040 NPU01013 P—Alkaline phosphatase, liver type; cat.c.(37 °C; proc.) = ? µkat/l P—Aldosterone; subst.c. = ? nmol/l NPU01483 P—Alkaline phosphatase, placental type; cat.c.(37 °C; proc.) = ? µkat/l Urine— NPU01530 P—Alkaline phosphatase, intestinal type; cat.c.(37 °C; proc.) = ? Aldosterone; µkat/l substance concentration NPU10602 P—Alkaline phosphatase, 'other' type(spec.); cat.c.(37 °C; proc.) = ? nanomol/litre µkat/l M = 360,44 g/mol Authority: IUPAC-IUB 89 Plasma— NPU14039 Alkaline phosphatase, bone type; U—Aldosterone; subst.c. = ? nmol/l catalytic-activity concentration(37 °C; procedure) microkatal/litre Plasma— NPU01145 Aldosterone; P—Alkaline phosphatase, bone type; cat.c.(37 °C; proc.) = ? µkat/l substance concentration picomol/litre M = 360,44 g/mol Authority: IUPAC-IUB 89 NPU01135 P—Aldosterone; subst.c. = ? pmol/l
13 Plasma— Protein(Plasma)— Alkaline phosphatase, intestinal type; Alpha-1-globulin; catalytic-activity concentration(37 °C; procedure) mass fraction microkatal/litre NPU04940 NPU01530 Prot.(P)—Alpha-1-globulin; mass fr. = ? P—Alkaline phosphatase, intestinal type; cat.c.(37 °C; proc.) = ? µkat/l Protein(Urine)— Plasma— Alpha-1-globulin; Alkaline phosphatase, liver canaliculus type; mass fraction catalytic-activity concentration(37 °C; procedure) NPU04945 microkatal/litre Prot.(U)—Alpha-1-globulin; mass fr. = ? NPU10601 P—Alkaline phosphatase, liver canaliculus type; cat.c.(37 °C; proc.) = ? µkat/l Plasma— Alpha-2-globulin; Plasma— mass concentration Alkaline phosphatase, liver endothelial type; gram/litre catalytic-activity concentration(37 °C; procedure) NPU04651 microkatal/litre P—Alpha-2-globulin; mass c. = ? g/l NPU10600 P—Alkaline phosphatase, liver endothelial type; cat.c.(37 °C; proc.) = ? µkat/l Cerebrospinal fluid— Alpha-2-globulin; Plasma— mass concentration Alkaline phosphatase, liver type; milligram/litre catalytic-activity concentration(37 °C; procedure) NPU04659 microkatal/litre Csf—Alpha-2-globulin; mass c. = ? mg/l NPU01013 P—Alkaline phosphatase, liver type; cat.c.(37 °C; proc.) = ? µkat/l Urine— Alpha-2-globulin; Plasma— mass concentration Alkaline phosphatase, 'other' type(specification); milligram/litre catalytic-activity concentration(37 °C; procedure) NPU04655 microkatal/litre U—Alpha-2-globulin; mass c. = ? mg/l NPU10602 P—Alkaline phosphatase, 'other' type(spec.); cat.c.(37 °C; proc.) = ? µkat/l Protein(Cerebrospinal fluid)— Alpha-2-globulin; Plasma— mass fraction Alkaline phosphatase, placental type; NPU04951 catalytic-activity concentration(37 °C; procedure) Prot.(Csf)—Alpha-2-globulin; mass fr. = ? microkatal/litre NPU01483 Protein(Plasma)— P—Alkaline phosphatase, placental type; cat.c.(37 °C; proc.) = ? µkat/l Alpha-2-globulin; mass fraction Leukocytes(Blood)— NPU04941 Alkaline phosphatase; Prot.(P)—Alpha-2-globulin; mass fr. = ? arbitrary catalytic activity(procedure) NPU01143 Protein(Urine)— Lkcs(B)—Alkaline phosphatase; arb.cat.act.(proc.) = ? Alpha-2-globulin; mass fraction Plasma— NPU04946 Alkaline phosphatase; Prot.(U)—Alpha-2-globulin; mass fr. = ? catalytic-activity concentration(37 °C; procedure) microkatal/litre Plasma— NPU01144 Alpha-globulin; P—Alkaline phosphatase; cat.c.(37 °C; proc.) = ? µkat/l mass concentration gram/litre Urine— NPU09261 Alkaline phosphatase; P—Alpha-globulin; mass c. = ? g/l catalytic-activity concentration(37 °C; procedure) microkatal/litre Cerebrospinal fluid— NPU10020 Alpha-globulin; U—Alkaline phosphatase; cat.c.(37 °C; proc.) = ? µkat/l mass concentration milligram/litre Plasma— NPU14035 Alpha-1-globulin; Csf—Alpha-globulin; mass c. = ? mg/l mass concentration gram/litre Urine— NPU04650 Alpha-globulin; P—Alpha-1-globulin; mass c. = ? g/l mass concentration milligram/litre Cerebrospinal fluid— NPU14037 Alpha-1-globulin; U—Alpha-globulin; mass c. = ? mg/l mass concentration milligram/litre Protein(Cerebrospinal fluid)— NPU04658 Alpha-globulin; Csf—Alpha-1-globulin; mass c. = ? mg/l mass fraction NPU14038 Urine— Prot.(Csf)—Alpha-globulin; mass fr. = ? Alpha-1-globulin; mass concentration Protein(Plasma)— milligram/litre Alpha-globulin; NPU04654 mass fraction U—Alpha-1-globulin; mass c. = ? mg/l NPU09264 Prot.(P)—Alpha-globulin; mass fr. = ? Protein(Cerebrospinal fluid)— Alpha-1-globulin; Protein(Urine)— mass fraction Alpha-globulin; NPU04950 mass fraction Prot.(Csf)—Alpha-1-globulin; mass fr. = ? NPU14036 Prot.(U)—Alpha-globulin; mass fr. = ?
14 Plasma— Urine— Aluminium; Amino acid/Creatininium; substance concentration substance ratio(list; procedure) micromol/litre NPU14178 M = 26,98 g/mol U—Amino acid/Creatininium; subst.ratio(list; proc.) Authority: IUPAC/VII-C-TOX NPU14186 U—Alanine/Creatininium; subst.ratio = ? × 10-3 NPU01157 NPU14187 U—beta-Alanine/Creatininium; subst.ratio = ? × 10-3 P—Aluminium; subst.c. = ? µmol/l NPU14188 U—Amino-2-piperidone/Creatininium; subst.ratio = ? × 10-3 NPU14189 U—alpha-Amino-n-butyrate/Creatininium; subst.ratio = ? × 10-3 Urine— NPU14190 U—alpha-Aminoadipate/Creatininium; subst.ratio = ? × 10-3 Aluminium; NPU14191 U—alpha-Aminobutyrate/Creatininium; subst.ratio = ? × 10-3 substance concentration NPU14192 U—gamma-Aminobutyrate/Creatininium; subst.ratio = ? × 10-3 micromol/litre NPU14193 U—beta-Aminoisobutyrate/Creatininium; subst.ratio = ? × 10-3 M = 26,98 g/mol NPU14194 U—gamma-Aminoisobutyrate/Creatininium; subst.ratio = ? × 10-3 Authority: IUPAC/VII-C-TOX NPU14200 U—gamma-Carboxyglutamate/Creatininium; subst.ratio = ? × 10-3 NPU01158 NPU14201 U—N-epsilon-Carboxymethyl lysine/Creatininium; subst.ratio = ? × U—Aluminium; subst.c. = ? µmol/l 10-3 NPU14202 U—Carnitine/Creatininium; subst.ratio = ? × 10-3 Cells(Blood)— NPU14203 U—Carnosine/Creatininium; subst.ratio = ? × 10-3 Aluminium; NPU14204 U—Citrulline/Creatininium; subst.ratio = ? × 10-3 substance content NPU14205 U—Cystathionine/Creatininium; subst.ratio = ? × 10-3 micromol/kilogram NPU14206 U—Cysteine-L-homocysteine disulfide/Creatininium; subst.ratio = ? M = 26,98 g/mol × 10-3 Authority: IUPAC/VII-C-TOX NPU14207 U—Cystine/Creatininium; subst.ratio = ? × 10-3 NPU01155 NPU14208 U—Ethanolamine/Creatininium; subst.ratio = ? × 10-3 Cells(B)—Aluminium; subst.cont. = ? µmol/kg NPU14209 U—Glutamate/Creatininium; subst.ratio = ? × 10-3 NPU14210 U—Glutamine/Creatininium; subst.ratio = ? × 10-3 Hair— NPU14211 U—Glycine/Creatininium; subst.ratio = ? × 10-3 Aluminium; NPU14212 U—Glycolate/Creatininium; subst.ratio = ? × 10-3 substance content NPU14213 U—Histidine/Creatininium; subst.ratio = ? × 10-3 micromol/kilogram NPU14214 U—Homoarginine/Creatininium; subst.ratio = ? × 10-3 M = 26,98 g/mol NPU14215 U—Homocarnosine/Creatininium; subst.ratio = ? × 10-3 Authority: IUPAC/VII-C-TOX NPU14216 U—Homocitrulline/Creatininium; subst.ratio = ? × 10-3 NPU01156 NPU14217 U—Homocystine/Creatininium; subst.ratio = ? × 10-3 Hair—Aluminium; subst.cont. = ? µmol/kg NPU14218 U—Homoserine/Creatininium; subst.ratio = ? × 10-3 NPU10164 U—Homovanillate/Creatininium; subst.ratio = ? × 10-3 NPU14220 U—3-Hydroxy-3-carboxy-n-propylthio-cystine/Creatininium; subst.ratio = ? × 10-3 NPU14221 U—alpha-Hydroxy-beta-chito-gamma-aminobutyrate/Creatininium; subst.ratio = ? × 10-3 NPU14222 U—3-Hydroxyasparagine/Creatininium; subst.ratio = ? × 10-3 NPU14223 U—3-Hydroxyisovalerate/Creatininium; subst.ratio = ? × 10-3 NPU14224 U—3-Hydroxykynurenine/Creatininium; subst.ratio = ? × 10-3 NPU14225 U—5-Hydroxylysine/Creatininium; subst.ratio = ? × 10-3 NPU14226 U—4-Hydroxyproline/Creatininium; subst.ratio = ? × 10-3 NPU04210 U—Hydroxyproline/Creatininium; subst.ratio= ? × 10-3 NPU14228 U—3-Hydroxyproline/Creatininium; subst.ratio = ? × 10-3 NPU14229 U—Isoleucine/Creatininium; subst.ratio = ? × 10-3 NPU14230 U—Kynurenine/Creatininium; subst.ratio = ? × 10-3 NPU14231 U—Leucine/Creatininium; subst.ratio = ? × 10-3 NPU14232 U—Levodopa/Creatininium; subst.ratio = ? × 10-3 NPU14233 U—Lysine/Creatininium; subst.ratio = ? × 10-3 NPU14234 U—Malate/Creatininium; subst.ratio = ? × 10-3 NPU14235 U—Methionine/Creatininium; subst.ratio = ? × 10-3 NPU14236 U—Methionine sulfoxide/Creatininium; subst.ratio = ? × 10-3 NPU14237 U—Methylcitrate/Creatininium; subst.ratio = ? × 10-3 NPU14238 U—1-Methylhistidine/Creatininium; subst.ratio = ? × 10-3 NPU14239 U—3-Methylhistidine/Creatininium; subst.ratio = ? × 10-3 NPU14240 U—Ornithine/Creatininium; subst.ratio = ? × 10-3 NPU14241 U—Phenylalanine/Creatininium; subst.ratio = ? × 10-3 NPU14242 U—Phosphoethanolamine/Creatininium; subst.ratio = ? × 10-3 NPU14243 U—Phosphoserine/Creatininium; subst.ratio = ? × 10-3 NPU14244 U—Pipecolate/Creatininium; subst.ratio = ? × 10-3 NPU14245 U—Proline/Creatininium; subst.ratio = ? × 10-3 NPU14246 U—delta-1-Pyrroline-5-carboxylate/Creatininium; subst.ratio = ? × 10-3 NPU14247 U—Saccharopine/Creatininium; subst.ratio = ? × 10-3 NPU14248 U—Sarcosine/Creatininium; subst.ratio = ? × 10-3 NPU14249 U—Serine/Creatininium; subst.ratio = ? × 10-3 NPU14250 U—Sulfo-L-cysteine/Creatininium; subst.ratio = ? × 10-3 NPU14251 U—Taurine/Creatininium; subst.ratio = ? × 10-3 NPU14252 U—Threonine/Creatininium; subst.ratio = ? × 10-3 NPU14253 U—Tryptophan/Creatininium; subst.ratio = ? × 10-3 NPU14254 U—Tyramine-O-sulphate/Creatininium; subst.ratio = ? × 10-3 NPU14255 U—Tyramine/Creatininium; subst.ratio = ? × 10-3 NPU14256 U—Tyrosine/Creatininium; subst.ratio = ? × 10-3 NPU14257 U—Valine/Creatininium; subst.ratio = ? × 10-3 NPU14258 U—Xylosylserine/Creatininium; subst.ratio = ? × 10-3
15 Cerebrospinal fluid— Urine— Amino acid; Amino acid; substance concentration(list; procedure) substance concentration(list; procedure) NPU09013 NPU09012 Csf—Amino acid; subst.c.(list; proc.) U—Amino acid; subst.c.(list; proc.) NPU01116 Csf—Alanine; subst.c. = ? µmol/l NPU01118 U—Alanine; subst.c. = ? µmol/l NPU09017 Csf—beta-Alanine; subst.c. = ? µmol/l NPU01120 U—beta-Alanine; subst.c. = ? µmol/l NPU09018 Csf—alpha-Aminobutyrate; subst.c. = ? µmol/l NPU09015 U—alpha-Aminobutyrate; subst.c. = ? µmol/l NPU09019 Csf—beta-Aminoisobutyrate; subst.c. = ? µmol/l NPU01208 U—beta-Aminoisobutyrate; subst.c. = ? µmol/l NPU01297 Csf—Arginine; subst.c. = ? µmol/l NPU01299 U—Arginine; subst.c. = ? µmol/l NPU01318 Csf—Asparagine; subst.c. = ? µmol/l NPU01320 U—Asparagine; subst.c. = ? µmol/l NPU01321 Csf—Aspartate; subst.c. = ? µmol/l NPU01323 U—Aspartate; subst.c. = ? µmol/l NPU09020 Csf—Citrulline; subst.c. = ? µmol/l NPU01612 U—Citrulline; subst.c. = ? µmol/l NPU09021 Csf—Cystine; subst.c. = ? µmol/l NPU01828 U—Cystine; subst.c. = ? µmol/l NPU02228 Csf—Glutamate; subst.c. = ? µmol/l NPU02230 U—Glutamate; subst.c. = ? µmol/l NPU09022 Csf—Glutamine; subst.c. = ? µmol/l NPU02250 U—Glutamine; subst.c. = ? µmol/l NPU02288 Csf—Glycine; subst.c. = ? µmol/l NPU02290 U—Glycine; subst.c. = ? µmol/l NPU09023 Csf—Histidine; subst.c. = ? µmol/l NPU02374 U—Histidine; subst.c. = ? µmol/l NPU09025 Csf—3-Hydroxyproline; subst.c. = ? µmol/l NPU09024 U—3-Hydroxyproline; subst.c. = ? µmol/l NPU09026 Csf—4-Hydroxyproline; subst.c. = ? µmol/l NPU02465 U—4-Hydroxyproline; subst.c. = ? µmol/l NPU09027 Csf—Isoleucine; subst.c. = ? µmol/l NPU02511 U—Isoleucine; subst.c. = ? µmol/l NPU09028 Csf—Leucine; subst.c. = ? µmol/l NPU02590 U—Leucine; subst.c. = ? µmol/l NPU09029 Csf—Lysine; subst.c. = ? µmol/l NPU02640 U—Lysine; subst.c. = ? µmol/l NPU09030 Csf—Methionine; subst.c. = ? µmol/l NPU02727 U—Methionine; subst.c. = ? µmol/l NPU09031 Csf—Ornithine; subst.c. = ? µmol/l NPU02937 U—Ornithine; subst.c. = ? µmol/l NPU03069 Csf—Phenylalanine; subst.c. = ? µmol/l NPU03071 U—Phenylalanine; subst.c. = ? µmol/l NPU03255 Csf—Proline; subst.c. = ? µmol/l NPU03257 U—Proline; subst.c. = ? µmol/l NPU03414 Csf—Serine; subst.c. = ? µmol/l NPU03416 U—Serine; subst.c. = ? µmol/l NPU03540 Csf—Taurine; subst.c. = ? µmol/l NPU03542 U—Taurine; subst.c. = ? µmol/l NPU03557 Csf—Threonine; subst.c. = ? µmol/l NPU03559 U—Threonine; subst.c. = ? µmol/l NPU03653 Csf—Tryptophan; subst.c. = ? µmol/l NPU03654 U—Tryptophan; subst.c. = ? µmol/l NPU09033 Csf—Tyrosine; subst.c. = ? µmol/l NPU03660 U—Tyrosine; subst.c. = ? µmol/l NPU03732 Csf—Valine; subst.c. = ? µmol/l NPU03734 U—Valine; subst.c. = ? µmol/l
Plasma— Urine— Amino acid; Amino-2-piperidone/Creatininium; substance concentration(list; procedure) substance ratio NPU09011 10-3 P—Amino acid; subst.c.(list; proc.) NPU14188 NPU01117 P—Alanine; subst.c. = ? µmol/l U—Amino-2-piperidone/Creatininium; subst.ratio = ? × 10-3 NPU01119 P—beta-Alanine; subst.c. = ? µmol/l NPU01203 P—alpha-Aminoadipate; subst.c. = ? µmol/l Urine— NPU09014 P—alpha-Aminobutyrate; subst.c. = ? µmol/l Amino-2-piperidone; NPU01207 P—beta-Aminoisobutyrate; subst.c. = ? µmol/l substance concentration NPU10401 P—gamma-Aminoisobutyrate; subst.c. = ? µmol/l micromol/litre NPU01267 P—Anserine; subst.c. = ? µmol/l NPU01173 NPU01298 P—Arginine; subst.c. = ? µmol/l U—Amino-2-piperidone; subst.c. = ? µmol/l NPU01319 P—Asparagine; subst.c. = ? µmol/l NPU01322 P—Aspartate; subst.c. = ? µmol/l Urine— NPU01503 P—Carnosine; subst.c. = ? µmol/l alpha- NPU01611 P—Citrulline; subst.c. = ? µmol/l Aminoadipate/Creatininium; NPU01820 P—Cystathionine; subst.c. = ? µmol/l substance ratio NPU01826 P—Cystine; subst.c. = ? µmol/l 10-3 NPU02229 P—Glutamate; subst.c. = ? µmol/l NPU14190 NPU02249 P—Glutamine; subst.c. = ? µmol/l U—alpha-Aminoadipate/Creatininium; subst.ratio = ? × 10-3 NPU02289 P—Glycine; subst.c. = ? µmol/l NPU02373 P—Histidine; subst.c. = ? µmol/l Plasma— NPU02397 P—Homocystine; subst.c. = ? µmol/l alpha- NPU02433 P—5-Hydroxylysine; subst.c. = ? µmol/l Aminoadipate; NPU02463 P—3-Hydroxyproline; subst.c. = ? µmol/l substance concentration NPU02464 P—4-Hydroxyproline; subst.c. = ? µmol/l micromol/litre NPU02510 P—Isoleucine; subst.c. = ? µmol/l NPU01203 NPU02589 P—Leucine; subst.c. = ? µmol/l P—alpha-Aminoadipate; subst.c. = ? µmol/l NPU02639 P—Lysine; subst.c. = ? µmol/l NPU02726 P—Methionine; subst.c. = ? µmol/l Urine— NPU02776 P—1-Methylhistidine; subst.c. = ? µmol/l alpha- NPU02778 P—3-Methylhistidine; subst.c. = ? µmol/l Aminoadipate; NPU02936 P—Ornithine; subst.c. = ? µmol/l substance concentration NPU03070 P—Phenylalanine; subst.c. = ? µmol/l micromol/litre NPU03114 P—Phosphoethanolamine; subst.c. = ? µmol/l NPU01204 NPU10399 P—Phosphoserine; subst.c. = ? µmol/l U—alpha-Aminoadipate; subst.c. = ? µmol/l NPU03256 P—Proline; subst.c. = ? µmol/l NPU03396 P—Sarcosine; subst.c. = ? µmol/l Urine— NPU03415 P—Serine; subst.c. = ? µmol/l alpha- NPU03541 P—Taurine; subst.c. = ? µmol/l Aminobutyrate/Creatininium; NPU03558 P—Threonine; subst.c. = ? µmol/l substance ratio NPU03655 P—Tryptophan(free); subst.c. = ? µmol/l 10-3 NPU03659 P—Tyrosine; subst.c. = ? µmol/l NPU14191 NPU03733 P—Valine; subst.c. = ? µmol/l U—alpha-Aminobutyrate/Creatininium; subst.ratio = ? × 10-3
Urine— gamma- Aminobutyrate/Creatininium; substance ratio 10-3 NPU14192 U—gamma-Aminobutyrate/Creatininium; subst.ratio = ? × 10-3
16 Cerebrospinal fluid— alpha- Urine— Aminobutyrate; 5- substance concentration Aminolevulinate/Creatininium; micromol/litre substance ratio NPU09018 10-3 Csf—alpha-Aminobutyrate; subst.c. = ? µmol/l NPU09006 U—5-Aminolevulinate/Creatininium; subst.ratio = ? × 10-3 Plasma— alpha- Plasma— Aminobutyrate; 5- substance concentration Aminolevulinate; micromol/litre substance concentration NPU09014 micromol/litre P—alpha-Aminobutyrate; subst.c. = ? µmol/l Other term(s): delta-Aminolevulinate NPU01210 Urine— P—5-Aminolevulinate; subst.c. = ? µmol/l alpha- Aminobutyrate; Urine— substance concentration 5- micromol/litre Aminolevulinate; NPU09015 substance concentration U—alpha-Aminobutyrate; subst.c. = ? µmol/l micromol/litre NPU04159 Plasma— U—5-Aminolevulinate; subst.c. = ? µmol/l gamma- Aminobutyrate; Patient(Urine)— substance concentration 5- micromol/litre Aminolevulinate; Other term(s): GABA substance rate(procedure) NPU01205 micromol/day P—gamma-Aminobutyrate; subst.c. = ? µmol/l NPU01209 Pt(U)—5-Aminolevulinate; subst.rate(proc.) = ? µmol/d Urine— gamma- Urine— Aminobutyrate; alpha- substance concentration Amino-n-butyrate/Creatininium; micromol/litre substance ratio Other term(s): GABA 10-3 NPU01206 NPU14189 U—gamma-Aminobutyrate; subst.c. = ? µmol/l U—alpha-Amino-n-butyrate/Creatininium; subst.ratio = ? × 10-3
Urine— Cerebrospinal fluid— beta- alpha- Aminoisobutyrate/Creatininium; Amino-n-butyrate; substance ratio substance concentration 10-3 micromol/litre NPU14193 M = 103,1 g/mol U—beta-Aminoisobutyrate/Creatininium; subst.ratio = ? × 10-3 Note: D-form of acid:CAS2623-91-8; DL-form of acid:CAS2835-81-6; L-form of acid:CAS1492-24-6 Urine— NPU01184 gamma- Csf—alpha-Amino-n-butyrate; subst.c. = ? µmol/l Aminoisobutyrate/Creatininium; substance ratio Plasma— 10-3 alpha- NPU14194 Amino-n-butyrate; U—gamma-Aminoisobutyrate/Creatininium; subst.ratio = ? × 10-3 substance concentration micromol/litre Cerebrospinal fluid— NPU01185 beta- P—alpha-Amino-n-butyrate; subst.c. = ? µmol/l Aminoisobutyrate; substance concentration Urine— micromol/litre alpha- NPU09019 Amino-n-butyrate; Csf—beta-Aminoisobutyrate; subst.c. = ? µmol/l substance concentration micromol/litre Plasma— NPU01186 beta- U—alpha-Amino-n-butyrate; subst.c. = ? µmol/l Aminoisobutyrate; substance concentration Calculus(Urine)— micromol/litre Ammonium; NPU01207 arbitrary content(procedure) P—beta-Aminoisobutyrate; subst.c. = ? µmol/l Note: _M_(ammonia) = 17,04 g/mol NPU09232 Urine— Calculus(U)—Ammonium; arb.cont.(proc.) = ? beta- Aminoisobutyrate; Plasma— substance concentration Ammonium; micromol/litre substance concentration NPU01208 micromol/litre U—beta-Aminoisobutyrate; subst.c. = ? µmol/l Authority: IFCC/C-BGE Note: _M_ (ammonia) = 17,04 g/mol Plasma— NPU03928 gamma- P—Ammonium; subst.c. = ? µmol/l Aminoisobutyrate; substance concentration micromol/litre Authority: IUPAC-IUB84 NPU10401 P—gamma-Aminoisobutyrate; subst.c. = ? µmol/l
17 Plasma(arterial Blood)— Drain fluid(specification)— Ammonium; Amylase, pancreatic type 3+4+5; substance concentration catalytic-activity concentration(37 °C; procedure) micromol/litre microkatal/litre Authority: IFCC/C-BGE NPU08590 Note: _M_ (ammonia) = 17,04 g/mol Drain fluid(spec.)—Amylase, pancreatic type 3+4+5; cat.c.(37 °C; proc.) = ? NPU01226 µkat/l P(aB)—Ammonium; subst.c. = ? µmol/l Plasma— Urine— Amylase, pancreatic type 3+4+5; Ammonium; catalytic-activity concentration(37 °C; procedure) substance concentration microkatal/litre micromol/litre NPU08591 Authority: IFCC/C-BGE P—Amylase, pancreatic type 3+4+5; cat.c.(37 °C; proc.) = ? µkat/l Note: _M_ (ammonia) = 17,04 g/mol NPU01227 Urine— U—Ammonium; subst.c. = ? µmol/l Amylase, pancreatic type 3+4+5; catalytic-activity concentration(37 °C; procedure) Calculus(Urine)— microkatal/litre Ammonium; NPU08969 substance content U—Amylase, pancreatic type 3+4+5; cat.c.(37 °C; proc.) = ? µkat/l mol/kilogram Note: _M_(ammonia) = 17,04 g/mol Plasma— NPU09238 Amylase, pancreatic type 4+5; Calculus(U)—Ammonium; subst.cont. = ? mol/kg catalytic-activity concentration(37 °C; procedure) microkatal/litre Patient(Urine)— NPU03964 Ammonium; P—Amylase, pancreatic type 4+5; cat.c.(37 °C; proc.) = ? µkat/l substance rate(procedure) micromol/day Amylase(Plasma)— Authority: IFCC/C-BGE Amylase, pancreatic type 4+5; Note: _M_ (ammonia) = 17,04 g/mol catalytic-activity fraction(37 °C; procedure) NPU01225 NPU04165 Pt(U)—Ammonium; subst.rate(proc.) = ? µmol/d Amylase(P)—Amylase, pancreatic type 4+5; cat.fr.(37 °C; proc.) = ?
Patient— Plasma— Amniotic fluid; Amylase, saliva type; relative volumic mass(20 °C/water, 20 °C; procedure) catalytic-activity concentration(37 °C; procedure) NPU10184 microkatal/litre Pt—Amniotic fluid; rel.volumic mass(20 °C/water, 20 °C; proc.) = ? NPU03923 P—Amylase, saliva type; cat.c.(37 °C; proc.) = ? µkat/l Pancreas— Amylase production; Amylase(Plasma)— catalytic-activity rate(37 °C; procedure) Amylase, saliva type; microkatal/second catalytic-activity fraction(37 °C; procedure) NPU01241 NPU04164 Pancreas—Amylase production; cat.rate(37 °C; proc.) = ? µkat/s Amylase(P)—Amylase, saliva type; cat.fr.(37 °C; proc.) = ?
Plasma— Duodenal fluid— Amylase type; Amylase; catalytic-activity concentration(list; 37 °C; procedure) catalytic-activity concentration(0-20 minutes postprandial; 37 °C) NPU01242 microkatal/litre P—Amylase type; cat.c.(list; 37 °C; proc.) NPU09245 NPU03922 P—Amylase, pancreatic type 3; cat.c.(37 °C; proc.) = ? µkat/l Duodf—Amylase; cat.c.(0-20 min; 37 °C) = ? µkat/l NPU08591 P—Amylase, pancreatic type 3+4+5; cat.c.(37 °C; proc.) = ? µkat/l NPU03964 P—Amylase, pancreatic type 4+5; cat.c.(37 °C; proc.) = ? µkat/l Duodenal fluid— NPU03923 P—Amylase, saliva type; cat.c.(37 °C; proc.) = ? µkat/l Amylase; catalytic-activity concentration(20-40 minutes postprandial; 37 °C) Amylase(Plasma)— microkatal/litre Amylase type; NPU09246 catalytic-activity fraction(list; 37 °C; procedure) Duodf—Amylase; cat.c.(20-40 min; 37 °C) = ? µkat/l NPU04162 Amylase(P)—Amylase type; cat.fr.(list; 37 °C; proc.) Duodenal fluid— NPU04163 Amylase(P)—Amylase, pancreatic type 3; cat.fr.(37 °C; proc.) = ? Amylase; NPU04165 Amylase(P)—Amylase, pancreatic type 4+5; cat.fr.(37 °C; proc.) = ? catalytic-activity concentration(30-150 minutes postprandial; 37 °C) NPU04164 Amylase(P)—Amylase, saliva type; cat.fr.(37 °C; proc.) = ? microkatal/litre NPU01240 Plasma— Duodf—Amylase; cat.c.(30-150 min; 37 °C) = ? µkat/l Amylase, pancreatic type 3; catalytic-activity concentration(37 °C; procedure) Ascites— microkatal/litre Amylase; NPU03922 catalytic-activity concentration(37 °C; procedure) P—Amylase, pancreatic type 3; cat.c.(37 °C; proc.) = ? µkat/l microkatal/litre NPU10276 Amylase(Plasma)— Asc—Amylase; cat.c.(37 °C; proc.) = ? µkat/l Amylase, pancreatic type 3; catalytic-activity fraction(37 °C; procedure) Drain fluid(specification)— NPU04163 Amylase; Amylase(P)—Amylase, pancreatic type 3; cat.fr.(37 °C; proc.) = ? catalytic-activity concentration(37 °C; procedure) microkatal/litre Ascites— NPU17195 Amylase, pancreatic type 3+4+5; Drain fluid(spec.)—Amylase; cat.c.(37 °C; proc.) = ? µkat/l catalytic-activity concentration(37 °C; procedure) microkatal/litre Duodenal fluid— NPU08589 Amylase; Asc—Amylase, pancreatic type 3+4+5; cat.c.(37 °C; proc.) = ? µkat/l catalytic-activity concentration(37 °C; procedure) microkatal/litre NPU10603 Duodf—Amylase; cat.c.(37 °C; proc.) = ? µkat/l
18 Plasma— Urine— Amylase; Androstandione; catalytic-activity concentration(37 °C; procedure) substance concentration microkatal/litre nanomol/litre Other term(s): Glycogenase M = 288,43 g/mol NPU01238 NPU01251 P—Amylase; cat.c.(37 °C; proc.) = ? µkat/l U—Androstandione; subst.c. = ? nmol/l
Pleural fluid(specification)— Urine— Amylase; Androstanolone; catalytic-activity concentration(37 °C; procedure) arbitrary concentration(procedure) microkatal/litre M = 290,4 g/mol Other term(s): Glycogenase Other term(s): Stanolone NPU14072 NPU04906 Plf(spec.)—Amylase; cat.c.(37 °C; proc.) = ? µkat/l U—Androstanolone; arb.c.(proc.) = ?
Secretion(specification)— Plasma— Amylase; Androstanolone; catalytic-activity concentration(37 °C; procedure) substance concentration microkatal/litre nanomol/litre NPU08601 M = 290,4 g/mol Secr(spec.)—Amylase; cat.c.(37 °C; proc.) = ? µkat/l Other term(s): Dihydrotestosterone; Stanolone Authority: INN System(specification)— NPU01252 Amylase; P—Androstanolone; subst.c. = ? nmol/l catalytic-activity concentration(37 °C; procedure) microkatal/litre Urine— NPU10123 Androstanolone; Syst(spec.)—Amylase; cat.c.(37 °C; proc.) = ? µkat/l substance concentration nanomol/litre Urine— M = 290,4 g/mol Amylase; Other term(s): Stanolone catalytic-activity concentration(37 °C; procedure) NPU04907 microkatal/litre U—Androstanolone; subst.c. = ? nmol/l Other term(s): Glycogenase NPU01239 Plasma— U—Amylase; cat.c.(37 °C; proc.) = ? µkat/l Androstenedione; substance concentration Duodenal fluid— nanomol/litre Amylase; M = 286,42 g/mol catalytic-activity concentration(40-60 minutes postprandial; 37 °C) NPU01253 microkatal/litre P—Androstenedione; subst.c. = ? nmol/l NPU09247 Duodf—Amylase; cat.c.(40-60 min; 37 °C) = ? µkat/l Plasma— Androsterone; Duodenal fluid— substance concentration Amylase; nanomol/litre catalytic-activity concentration(60-80 minutes postprandial; 37 °C) M = 290,43 g/mol microkatal/litre Authority: IUPAC-IUB 84 NPU09248 NPU01255 Duodf—Amylase; cat.c.(60-80 min; 37 °C) = ? µkat/l P—Androsterone; subst.c. = ? nmol/l
Pancreas— Urine— Amylase+triacylglycerollipase secretion; Androsterone; catalytic-activity rate(postprandial; list; procedure) substance concentration NPU09254 nanomol/litre Pancreas—Amylase+triacylglycerollipase secretion; cat.rate(postprandial; list; M = 290,43 g/mol proc.) Authority: IUPAC-IUB 84 NPU09245 Duodf—Amylase; cat.c.(0-20 min; 37 °C) = ? µkat/l NPU09097 NPU09246 Duodf—Amylase; cat.c.(20-40 min; 37 °C) = ? µkat/l U—Androsterone; subst.c. = ? nmol/l NPU09247 Duodf—Amylase; cat.c.(40-60 min; 37 °C) = ? µkat/l NPU09248 Duodf—Amylase; cat.c.(60-80 min; 37 °C) = ? µkat/l Patient(Urine)— NPU01240 Duodf—Amylase; cat.c.(30-150 min; 37 °C) = ? µkat/l Androsterone; NPU09249 Duodf—Triacylglycerol lipase; cat.c.(0-20 min; 37 °C) = ? µkat/l substance rate NPU09250 Duodf—Triacylglycerol lipase; cat.c.(20-40 min; 37 °C) = ? µkat/l nanomol/day NPU09251 Duodf—Triacylglycerol lipase; cat.c.(40-60 min; 37 °C) = ? µkat/l NPU10133 NPU09252 Duodf—Triacylglycerol lipase; cat.c.(60-80 min; 37 °C) = ? µkat/l Pt(U)—Androsterone; subst.rate = ? nmol/d NPU09253 Duodf—Triacylglycerol lipase; cat.c.(30-150 min; 37 °C) = ? µkat/l Plasma— Urine— Angiotensin; Anabolic steroid; arbitrary substance concentration(procedure) taxon(procedure) arbitrary unit/litre NPU12014 M = 1 045 g/mol U—Anabolic steroid; taxon(proc.) = ? Other term(s): Angiotensin II Authority: IUPAC-IUB 74 Plasma— NPU01256 Androgen; P—Angiotensin; arb.subst.c.(proc.) = ? arb.unit/l substance concentration(list; procedure) NPU12019 Plasma— P—Androgen; subst.c.(list; proc.) Angiotensin; NPU01253 P—Androstenedione; subst.c. = ? nmol/l substance concentration NPU04121 P—Dehydroepiandrosterone sulfate; subst.c. = ? µmol/l picomol/litre NPU14568 P—Dehydroepiandrosterone sulfate; subst.c. = ? nmol/l M = 1 045 g/mol NPU01852 P—Prasterone; subst.c. = ? nmol/l Other term(s): Angiotensin II NPU03419 P—Sexual-hormone-binding-globulin; subst.c. = ? nmol/l Authority: IUPAC-IUB 74 NPU03543 P—Testosterone(tot.); subst.c. = ? nmol/l NPU01257 NPU03549 P—Testosterone(free); subst.c. = ? nmol/l P—Angiotensin; subst.c. = ? pmol/l
19 Plasma— Urine— Angiotensinogen; Antimony; substance concentration substance concentration micromol/litre nanomol/litre M = 60 000 g/mol M = 121,75 g/mol NPU01258 Authority: IUPAC/VII-C-TOX P—Angiotensinogen; subst.c. = ? µmol/l NPU01274 U—Antimony; subst.c. = ? nmol/l Blood— Annulocytes; Hair— arbitrary concentration(procedure) Antimony; NPU17078 substance content B—Annulocytes; arb.c.(proc.) = ? micromol/kilogram M = 121,75 g/mol Urine— Authority: IUPAC/VII-C-TOX Anorectic agent; NPU01272 taxon(procedure) Hair—Antimony; subst.cont. = ? µmol/kg NPU14339 U—Anorectic agent; taxon(proc.) = ? Antitrypsin(Plasma)— Antitrypsin Pi type; Urine— substance fraction(list; procedure) Anserine/Creatininium; NPU10388 substance ratio Atrp(P)—Antitrypsin Pi type; subst.fr.(list; proc.) 10-3 NPU10383 Atrp(P)—Antitrypsin Pi-subst.fr. = ? NPU14195 NPU10385 Atrp(P)—Antitrypsin PiM; subst.fr. = ? U—Anserine/Creatininium; subst.ratio = ? × 10-3 NPU10386 Atrp(P)—Antitrypsin PiP; subst.fr. = ? NPU10387 Atrp(P)—Antitrypsin PiS; subst.fr. = ? Cerebrospinal fluid— NPU10384 Atrp(P)—Antitrypsin PiZ; subst.fr. = ? Anserine; substance concentration Antitrypsin(Plasma)— micromol/litre Antitrypsin Pi-; M = 240,26 g/mol substance fraction NPU01266 NPU10383 Csf—Anserine; subst.c. = ? µmol/l Atrp(P)—Antitrypsin Pi-subst.fr. = ?
Plasma— Antitrypsin(Plasma)— Anserine; Antitrypsin PiM; substance concentration substance fraction micromol/litre NPU10385 M = 240,26 g/mol Atrp(P)—Antitrypsin PiM; subst.fr. = ? NPU01267 P—Anserine; subst.c. = ? µmol/l Antitrypsin(Plasma)— Antitrypsin PiP; Urine— substance fraction Anserine; NPU10386 substance concentration Atrp(P)—Antitrypsin PiP; subst.fr. = ? micromol/litre M = 240,26 g/mol Antitrypsin(Plasma)— NPU01268 Antitrypsin PiS; U—Anserine; subst.c. = ? µmol/l substance fraction NPU10387 Plasma— Atrp(P)—Antitrypsin PiS; subst.fr. = ? Antichymotrypsin; substance concentration Antitrypsin(Plasma)— micromol/litre Antitrypsin PiZ; M = 69 000 g/mol substance fraction NPU01270 NPU10384 P—Antichymotrypsin; subst.c. = ? µmol/l Atrp(P)—Antitrypsin PiZ; subst.fr. = ?
Kidney— Plasma— Antidiuretic effect; Antitrypsin type; property(desmopressin, intranasal administration; list; procedure) taxon(procedure) Note: _M_(desmopressin) = 1 069,23 g/mol NPU10618 NPU12874 P—Antitrypsin type; taxon(proc.) = ? Kidn.—Antidiuretic effect; prop.(desmopressin i.n.; list; proc.) NPU09117 Pt—Desmopressin(administered); am.s.(i.n.) = ? nmol Expectorate— NPU09118 Pt—Desmopressin(administered); subst.cont.(i.n.; am.s./body mass) Antitrypsin; = ? nmol/kg substance concentration NPU03434 U—Solute; molal.(proc.) = ? mmol/kg micromol/litre M = 54 300 g/mol Blood— NPU10273 Antimony; Ex—Antitrypsin; subst.c. = ? µmol/l substance concentration nanomol/litre Plasma— M = 121,75 g/mol Antitrypsin; Authority: IUPAC/VII-C-TOX substance concentration NPU01271 micromol/litre B—Antimony; subst.c. = ? nmol/l M = 54 300 g/mol Other term(s): Proteinase inhibitor; alpha 1-Pi Plasma— NPU03303 Antimony; P—Antitrypsin; subst.c. = ? µmol/l substance concentration nanomol/litre Plasma— M = 121,75 g/mol Apolipoprotein A; Authority: IUPAC/VII-C-TOX arbitrary substance concentration(procedure) NPU01273 arbitrary unit/litre P—Antimony; subst.c. = ? nmol/l NPU04042 P—Apolipoprotein A; arb.subst.c.(proc.) = ? arb.unit/l
20 Plasma(fasting Patient)— Plasma(fasting Patient)— Apolipoprotein A; Apolipoprotein B100; arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/litre arbitrary unit/litre NPU14148 NPU14152 P(fPt)—Apolipoprotein A; arb.subst.c.(proc.) = ? arb.unit/l P(fPt)—Apolipoprotein B100; arb.subst.c.(proc.) = ? arb.unit/l
Plasma— Plasma— Apolipoprotein A; Apolipoprotein B100; substance concentration substance concentration mol/litre mol/litre NPU01278 NPU01282 P—Apolipoprotein A; subst.c.= ? prefix ? mol/l P—Apolipoprotein B100; subst.c.= ? prefix ? mol/l
Plasma— Plasma— Apolipoprotein A1; Apolipoprotein B150; arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/litre arbitrary unit/litre NPU04043 NPU04047 P—Apolipoprotein A1; arb.subst.c.(proc.) = ? arb.unit/l P—Apolipoprotein B150; arb.subst.c.(proc.) = ? arb.unit/l
Plasma(fasting Patient)— Plasma(fasting Patient)— Apolipoprotein A1; Apolipoprotein B150; arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/litre arbitrary unit/litre NPU14149 NPU14153 P(fPt)—Apolipoprotein A1; arb.subst.c.(proc.) = ? arb.unit/l P(fPt)—Apolipoprotein B150; arb.subst.c.(proc.) = ? arb.unit/l
Plasma— Plasma— Apolipoprotein A1; Apolipoprotein B150; substance concentration substance concentration mol/litre mol/litre NPU01279 NPU01283 P—Apolipoprotein A1; subst.c.= ? prefix ? mol/l P—Apolipoprotein B150; subst.c.= ? prefix ? mol/l
Plasma— Plasma— Apolipoprotein A2; Apolipoprotein B48; arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/litre arbitrary unit/litre NPU04044 NPU04048 P—Apolipoprotein A2; arb.subst.c.(proc.) = ? arb.unit/l P—Apolipoprotein B48; arb.subst.c.(proc.) = ? arb.unit/l
Plasma(fasting Patient)— Plasma(fasting Patient)— Apolipoprotein A2; Apolipoprotein B48; arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/litre arbitrary unit/litre NPU14150 NPU14154 P(fPt)—Apolipoprotein A2; arb.subst.c.(proc.) = ? arb.unit/l P(fPt)—Apolipoprotein B48; arb.subst.c.(proc.) = ? arb.unit/l
Plasma— Plasma— Apolipoprotein A2; Apolipoprotein B48; substance concentration substance concentration mol/litre mol/litre NPU01280 NPU01284 P—Apolipoprotein A2; subst.c.= ? prefix ? mol/l P—Apolipoprotein B48; subst.c.= ? prefix ? mol/l
Plasma— Plasma— Apolipoprotein B/Apolipoprotein A1; Apolipoprotein C; substance ratio arbitrary substance concentration(procedure) NPU10238 arbitrary unit/litre P—Apolipoprotein B/Apolipoprotein A1; subst.ratio = ? NPU04049 P—Apolipoprotein C; arb.subst.c.(proc.) = ? arb.unit/l Plasma— Apolipoprotein B; Plasma(fasting Patient)— arbitrary substance concentration(procedure) Apolipoprotein C; arbitrary unit/litre arbitrary substance concentration(procedure) NPU04045 arbitrary unit/litre P—Apolipoprotein B; arb.subst.c.(proc.) = ? arb.unit/l NPU14155 P(fPt)—Apolipoprotein C; arb.subst.c.(proc.) = ? arb.unit/l Plasma(fasting Patient)— Apolipoprotein B; Plasma— arbitrary substance concentration(procedure) Apolipoprotein C; arbitrary unit/litre substance concentration NPU14151 mol/litre P(fPt)—Apolipoprotein B; arb.subst.c.(proc.) = ? arb.unit/l NPU01285 P—Apolipoprotein C; subst.c.= ? prefix ? mol/l Plasma— Apolipoprotein B; Plasma— substance concentration Apolipoprotein C1; mol/litre arbitrary substance concentration(procedure) NPU01281 arbitrary unit/litre P—Apolipoprotein B; subst.c.= ? prefix ? mol/l NPU04050 P—Apolipoprotein C1; arb.subst.c.(proc.) = ? arb.unit/l Plasma— Apolipoprotein B100; Plasma(fasting Patient)— arbitrary substance concentration(procedure) Apolipoprotein C1; arbitrary unit/litre arbitrary substance concentration(procedure) NPU04046 arbitrary unit/litre P—Apolipoprotein B100; arb.subst.c.(proc.) = ? arb.unit/l NPU14156 P(fPt)—Apolipoprotein C1; arb.subst.c.(proc.) = ? arb.unit/l
21 Plasma— Plasma— Apolipoprotein E; Apolipoprotein C1; substance concentration substance concentration mol/litre mol/litre NPU01290 NPU01286 P—Apolipoprotein E; subst.c.= ? prefix ? mol/l P—Apolipoprotein C1; subst.c.= ? prefix ? mol/l Plasma— Plasma— Apolipoprotein E2; Apolipoprotein C2; arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/litre arbitrary unit/litre NPU04055 NPU04051 P—Apolipoprotein E2; arb.subst.c.(proc.) = ? arb.unit/l P—Apolipoprotein C2; arb.subst.c.(proc.) = ? arb.unit/l Plasma(fasting Patient)— Plasma(fasting Patient)— Apolipoprotein E2; Apolipoprotein C2; arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/litre arbitrary unit/litre NPU14161 NPU14157 P(fPt)—Apolipoprotein E2; arb.subst.c.(proc.) = ? arb.unit/l P(fPt)—Apolipoprotein C2; arb.subst.c.(proc.) = ? arb.unit/l Plasma— Plasma— Apolipoprotein E2; Apolipoprotein C2; substance concentration substance concentration mol/litre mol/litre NPU01291 NPU01287 P—Apolipoprotein E2; subst.c.= ? prefix ? mol/l P—Apolipoprotein C2; subst.c.= ? prefix ? mol/l Plasma— Plasma— Apolipoprotein H; Apolipoprotein C3; arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/litre arbitrary unit/litre Other term(s): beta-2-glycoprotein 1 NPU04052 NPU04056 P—Apolipoprotein C3; arb.subst.c.(proc.) = ? arb.unit/l P—Apolipoprotein H; arb.subst.c.(proc.) = ? arb.unit/l
Plasma(fasting Patient)— Plasma(fasting Patient)— Apolipoprotein C3; Apolipoprotein H; arbitrary substance concentration(procedure) arbitrary substance concentration(procedure) arbitrary unit/litre arbitrary unit/litre NPU14158 NPU14162 P(fPt)—Apolipoprotein C3; arb.subst.c.(proc.) = ? arb.unit/l P(fPt)—Apolipoprotein H; arb.subst.c.(proc.) = ? arb.unit/l
Plasma— Plasma— Apolipoprotein C3; Apolipoprotein H; substance concentration substance concentration mol/litre mol/litre NPU01288 Other term(s): beta-2-glycoprotein 1 P—Apolipoprotein C3; subst.c.= ? prefix ? mol/l NPU01292 P—Apolipoprotein H; subst.c.= ? prefix ? mol/l Plasma— Apolipoprotein D; Plasma— arbitrary substance concentration(procedure) Apolipoprotein Lp(a); arbitrary unit/litre arbitrary substance concentration(procedure) NPU04053 arbitrary unit/litre P—Apolipoprotein D; arb.subst.c.(proc.) = ? arb.unit/l NPU04057 P—Apolipoprotein Lp(a); arb.subst.c.(proc.) = ? arb.unit/l Plasma(fasting Patient)— Apolipoprotein D; Plasma(fasting Patient)— arbitrary substance concentration(procedure) Apolipoprotein Lp(a); arbitrary unit/litre arbitrary substance concentration(procedure) NPU14159 arbitrary unit/litre P(fPt)—Apolipoprotein D; arb.subst.c.(proc.) = ? arb.unit/l NPU14163 P(fPt)—Apolipoprotein Lp(a); arb.subst.c.(proc.) = ? arb.unit/l Plasma— Apolipoprotein D; Plasma— substance concentration Apolipoprotein Lp(a); mol/litre substance concentration NPU01289 mol/litre P—Apolipoprotein D; subst.c.= ? prefix ? mol/l NPU01293 P—Apolipoprotein Lp(a); subst.c.= ? prefix ? mol/l Plasma— Apolipoprotein E; Plasma— arbitrary substance concentration(procedure) Apolipoprotein Lp(q); arbitrary unit/litre arbitrary substance concentration(procedure) NPU04054 arbitrary unit/litre P—Apolipoprotein E; arb.subst.c.(proc.) = ? arb.unit/l NPU04058 P—Apolipoprotein Lp(q); arb.subst.c.(proc.) = ? arb.unit/l Plasma(fasting Patient)— Apolipoprotein E; Plasma(fasting Patient)— arbitrary substance concentration(procedure) Apolipoprotein Lp(q); arbitrary unit/litre arbitrary substance concentration(procedure) NPU14160 arbitrary unit/litre P(fPt)—Apolipoprotein E; arb.subst.c.(proc.) = ? arb.unit/l NPU14164 P(fPt)—Apolipoprotein Lp(q); arb.subst.c.(proc.) = ? arb.unit/l
22 Plasma— Apolipoprotein Lp(q); Urine— substance concentration Argininosuccinate; mol/litre substance concentration NPU01294 micromol/litre P—Apolipoprotein Lp(q); subst.c.= ? prefix ? mol/l NPU01301 U—Argininosuccinate; subst.c. = ? µmol/l Plasma(fasting Patient)— Apolipoprotein; Blood— arbitrary substance concentration(list; procedure) Arsenic; Authority: MSH94 substance concentration NPU13817 nanomol/litre P(fPt)—Apolipoprotein; arb.subst.c.(list; proc.) M = 74,92 g/mol NPU14148 P(fPt)—Apolipoprotein A; arb.subst.c.(proc.) = ? arb.unit/l Authority: IUPAC/VII-C-TOX NPU14149 P(fPt)—Apolipoprotein A1; arb.subst.c.(proc.) = ? arb.unit/l NPU01306 NPU14150 P(fPt)—Apolipoprotein A2; arb.subst.c.(proc.) = ? arb.unit/l B—Arsenic; subst.c. = ? nmol/l NPU14151 P(fPt)—Apolipoprotein B; arb.subst.c.(proc.) = ? arb.unit/l NPU14152 P(fPt)—Apolipoprotein B100; arb.subst.c.(proc.) = ? arb.unit/l Plasma— NPU14153 P(fPt)—Apolipoprotein B150; arb.subst.c.(proc.) = ? arb.unit/l Arsenic; NPU14154 P(fPt)—Apolipoprotein B48; arb.subst.c.(proc.) = ? arb.unit/l substance concentration NPU14155 P(fPt)—Apolipoprotein C; arb.subst.c.(proc.) = ? arb.unit/l nanomol/litre NPU14156 P(fPt)—Apolipoprotein C1; arb.subst.c.(proc.) = ? arb.unit/l M = 74,92 g/mol NPU14157 P(fPt)—Apolipoprotein C2; arb.subst.c.(proc.) = ? arb.unit/l Authority: IUPAC/VII-C-TOX NPU14158 P(fPt)—Apolipoprotein C3; arb.subst.c.(proc.) = ? arb.unit/l NPU04903 NPU14159 P(fPt)—Apolipoprotein D; arb.subst.c.(proc.) = ? arb.unit/l P—Arsenic; subst.c. = ? nmol/l NPU14160 P(fPt)—Apolipoprotein E; arb.subst.c.(proc.) = ? arb.unit/l NPU14161 P(fPt)—Apolipoprotein E2; arb.subst.c.(proc.) = ? arb.unit/l Urine— NPU14162 P(fPt)—Apolipoprotein H; arb.subst.c.(proc.) = ? arb.unit/l Arsenic; NPU14163 P(fPt)—Apolipoprotein Lp(a); arb.subst.c.(proc.) = ? arb.unit/l substance concentration NPU14164 P(fPt)—Apolipoprotein Lp(q); arb.subst.c.(proc.) = ? arb.unit/l nanomol/litre M = 74,92 g/mol Cobalamin(Plasma)— Authority: IUPAC/VII-C-TOX Aquocobalamin; NPU01308 substance fraction U—Arsenic; subst.c. = ? nmol/l NPU04956 Cobalamin(P)—Aquocobalamin; subst.fr. = ? Hair— Arsenic; Patient— substance content Arginine(administered); micromol/kilogram substance content(intravenous administration; amount-of- M = 74,92 g/mol substance/body mass) Authority: IUPAC/VII-C-TOX mol/kilogram NPU01307 M = 174,20 g/mol Hair—Arsenic; subst.cont. = ? µmol/kg NPU09354 Pt—Arginine(administered); subst.cont.(i.v.; am.s./body mass) = ? mol/kg Cells(Blood)— Arsenic; Urine— substance content Arginine/Creatininium; nanomol/kilogram substance ratio M = 74,92 g/mol 10-3 Authority: IUPAC/VII-C-TOX NPU14196 NPU04807 U—Arginine/Creatininium; subst.ratio = ? × 10-3 Cells(B)—Arsenic; subst.cont. = ? nmol/kg
Cerebrospinal fluid— Plasma— Arginine; Ascorbate; substance concentration substance concentration micromol/litre micromol/litre M = 174,20 g/mol Other term(s): Vitamin C NPU01297 NPU01317 Csf—Arginine; subst.c. = ? µmol/l P—Ascorbate; subst.c. = ? µmol/l
Plasma— Plasma(fasting Patient)— Arginine; Ascorbate; substance concentration substance concentration micromol/litre micromol/litre M = 174,20 g/mol NPU04143 NPU01298 P(fPt)—Ascorbate; subst.c. = ? µmol/l P—Arginine; subst.c. = ? µmol/l Urine— Urine— Ascorbate; Arginine; substance concentration substance concentration micromol/litre micromol/litre NPU10017 M = 174,20 g/mol U—Ascorbate; subst.c. = ? µmol/l NPU01299 U—Arginine; subst.c. = ? µmol/l Urine— Asparagine/Creatininium; Urine— substance ratio Argininosuccinate/Creatininium; 10-3 substance ratio NPU14198 10-3 U—Asparagine/Creatininium; subst.ratio = ? × 10-3 NPU14197 U—Argininosuccinate/Creatininium; subst.ratio = ? × 10-3 Cerebrospinal fluid— Asparagine; Plasma— substance concentration Argininosuccinate; micromol/litre substance concentration M = 132,12 g/mol micromol/litre NPU01318 NPU01300 Csf—Asparagine; subst.c. = ? µmol/l P—Argininosuccinate; subst.c. = ? µmol/l
23 Plasma— Plasma(arterial Blood)— Asparagine; Atrial natriuretic peptide; substance concentration substance concentration micromol/litre picomol/litre M = 132,12 g/mol M = 3 081 g/mol NPU01319 Recommended calibrator: Synthetic human atrial natriuretic factor; WHO 1st IS P—Asparagine; subst.c. = ? µmol/l 85/669 Other term(s): Atrial natriuretic factor Urine— NPU01338 Asparagine; P(aB)—Atrial natriuretic peptide; subst.c. = ? pmol/l substance concentration micromol/litre Urine— M = 132,12 g/mol Atrial natriuretic peptide; NPU01320 substance concentration U—Asparagine; subst.c. = ? µmol/l picomol/litre M = 3 081 g/mol Amniotic fluid— Recommended calibrator: Synthetic human atrial natriuretic factor; WHO 1st IS Aspartate transaminase; 85/669 catalytic-activity concentration(37 °C; procedure) Other term(s): Atrial natriuretic peptide microkatal/litre NPU14005 Other term(s): Glutamic-aspartic transaminase; Glutamic-oxaloacetic U—Atrial natriuretic peptide; subst.c. = ? pmol/l transaminase; Transaminase A; NPU03908 Patient(Urine)— Amf—Aspartate transaminase; cat.c.(37 °C; proc.) = ? µkat/l Atrial natriuretic peptide; substance rate Plasma— picomol/day Aspartate transaminase; M = 3 081 g/mol catalytic-activity concentration(37 °C; procedure) Other term(s): Atrial natriuretic factor microkatal/litre NPU14006 Other term(s): Glutamic-aspartic transaminase; Glutamic- Pt(U)—Atrial natriuretic peptide; subst.rate = ? pmol/d oxaloacetictransaminase; Transaminase A; NPU01324 Blood— P—Aspartate transaminase; cat.c.(37 °C; proc.) = ? µkat/l Atypical cells; number concentration Urine— 109/litre Aspartate/Creatininium; NPU10762 substance ratio B—Atypical cells; num.c. = ? × 109/l 10-3 NPU14199 Urine— U—Aspartate/Creatininium; subst.ratio = ? × 10-3 Azithromycin; arbitrary concentration(procedure) Cerebrospinal fluid— M = 748,99 g/mol Aspartate; Authority: INN substance concentration NPU08775 micromol/litre U—Azithromycin; arb.c.(proc.) = ? NPU01321 Csf—Aspartate; subst.c. = ? µmol/l Urine— Azithromycin; Plasma— substance concentration Aspartate; mol/litre substance concentration M = 748,99 g/mol micromol/litre Authority: INN NPU01322 NPU08774 P—Aspartate; subst.c. = ? µmol/l U—Azithromycin; subst.c.= ? prefix ? mol/l
Urine— Plasma— Aspartate; Bactericidal permeability increasing protein antibody(Immunoglobulin G); substance concentration arbitrary concentration(procedure) micromol/litre NPU17670 NPU01323 P—Bactericidal permeability increasing protein antibody(IgG); arb.c.(proc.) = ? U—Aspartate; subst.c. = ? µmol/l Plasma— Plasma— Bactericidal permeability increasing protein antibody(Immunoglobulin G); Atrial natriuretic peptide; arbitrary substance concentration(anti-neutrophilocyte cytoplasma arbitrary substance concentration(IS 85/669; procedure) antibodies(IgG)) international unit/litre 10³ arbitrary unit/litre M = 3 081 g/mol NPU17705 Recommended calibrator: Synthetic human atrial natriuretic factor; WHO 1st IS P—Bactericidal permeability increasing protein antibody(IgG); arb.subst.c. 85/669 (ANCA) = ? × 10³ arb.unit/l Other term(s): Atrial natriuretic peptide NPU01337 Vaginal fluid— P—Atrial natriuretic peptide; arb.subst.c.(IS 85/669; proc.) = ? int. unit/l Bacterium(specification); arbitrary concentration(procedure) Plasma— NPU06687 Atrial natriuretic peptide; Vagf—Bacterium(spec.); arb.c.(proc.) = ? substance concentration picomol/litre Urine— M = 3 081 g/mol Bacterium, nitrite producing; Other term(s): Atrial natriuretic factor arbitrary concentration(procedure) NPU17180 NPU10506 P—Atrial natriuretic peptide; subst.c. = ? pmol/l U—Bacterium, nitrite producing; arb.c.(proc.) = ?
Urine— Bacterium, nitrite producing; number concentration(procedure) 109/litre NPU01341 U—Bacterium, nitrite producing; num.c.(proc.) = ? × 109/l
24 Urine— Bacterium; Plasma(capillary Blood)— arbitrary concentration(procedure) Base excess(H+binding group); NPU08592 substance concentration(pCO2 = 5,3 kPa; 37 ºC; actual-norm) U—Bacterium; arb.c.(proc.) = ? millimol/litre Note: standard: blood; pCO2 = 5,3 kPa; 37 ºC Plasma— NPU12480 + Barium; P(cB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; 37 ºC; actual- substance concentration norm) = ? mmol/l nanomol/litre M = 137,34 g/mol Plasma(cord Blood)— Authority: IUPAC/VII-C-TOX Base excess(H+binding group); NPU01346 substance concentration(pCO2 = 5,3 kPa; 37 ºC; actual-norm) P—Barium; subst.c. = ? nmol/l millimol/litre Authority: IFCC/C-BGE Urine— Note: standard: blood; pCO2 = 5,3 kPa; 37 øC Barium; NPU10219 + substance concentration P(cordB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; 37 ºC; nanomol/litre actual-norm) = ? mmol/l M = 137,34 g/mol Authority: IUPAC/VII-C-TOX Plasma(cord Blood; arterial Blood)— NPU01347 Base excess(H+binding group); U—Barium; subst.c. = ? nmol/l substance concentration(pCO2 = 5,3 kPa; 37 ºC; actual-norm) millimol/litre Extracellular fluid— Authority: IFCC/C-BGE + Base excess(H binding group); Note: standard: blood; pCO2 = 5,3 kPa; 37 °C substance concentration(actual-norm) NPU17135 + millimol/litre P(cordB; aB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; 37 ºC; Authority: IFCC/C-BGE actual-norm) = ? mmol/l NPU03815 Ecf—Base excess(H+binding group); subst.c.(actual-norm) = ? mmol/l Plasma(cord Blood; venous Blood)— Base excess(H+binding group); Plasma(arterial Blood)— substance concentration(pCO2 = 5,3 kPa; 37 ºC; actual-norm) Base excess(H+binding group); millimol/litre substance concentration(actual-norm) Authority: IFCC/C-BGE millimol/litre Note: standard: blood; pCO2 = 5,3 kPa; 37 °C NPU12518 NPU17136 + + P(aB)—Base excess(H binding group); subst.c.(actual-norm) = ? mmol/l P(cordB; vB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; 37 ºC; actual-norm) = ? mmol/l Plasma(capillary Blood)— Base excess(H+binding group); Plasma(mixed Blood)— substance concentration(actual-norm) Base excess(H+binding group); millimol/litre substance concentration(pCO2 = 5,3 kPa; 37 ºC; actual-norm) NPU12520 millimol/litre P(cB)—Base excess(H+binding group); subst.c.(actual-norm) = ? mmol/l Authority: IFCC/C-BGE Note: standard: blood; pCO2 = 5,3 kPa; 37 ºC Plasma(cord Blood)— NPU09201 + + Base excess(H binding group); P(mixB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; 37 ºC; substance concentration(actual-norm) actual-norm) = ? mmol/l millimol/litre NPU12519 Plasma(venous Blood)— P(cordB)—Base excess(H+binding group); subst.c.(actual-norm) = ? mmol/l Base excess(H+binding group); substance concentration(pCO2 = 5,3 kPa; 37 ºC; actual-norm) Plasma(cord Blood; arterial Blood)— millimol/litre Base excess(H+binding group); Authority: IFCC/C-BGE substance concentration(actual-norm) Note: standard: blood; pCO2 = 5,3 kPa; 37 ºC millimol/litre NPU08970 + NPU17133 P(vB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; 37 ºC; actual- P(cordB; aB)—Base excess(H+binding group); subst.c.(actual-norm) = ? mmol/l norm) = ? mmol/l
Plasma(cord Blood; venous Blood)— Blood— Base excess(H+binding group); Basophilocytes; substance concentration(actual-norm) number concentration millimol/litre 109/litre NPU17134 NPU01349 P(cordB; vB)—Base excess(H+binding group); subst.c.(actual-norm) = ? mmol/l B—Basophilocytes; num.c. = ? × 109/l
Plasma(mixed Blood)— Blood fraction(specification)— Base excess(H+binding group); Basophilocytes; substance concentration(actual-norm) number concentration millimol/litre 109/litre NPU09200 NPU17547 P(mixB)—Base excess(H+binding group); subst.c.(actual-norm) = ? mmol/l B fract.(spec.)—Basophilocytes; num.c. = ? × 109/l
Plasma(venous Blood)— Bone marrow— Base excess(H+binding group); Basophilocytes; substance concentration(actual-norm) number concentration millimol/litre 109/litre NPU12521 NPU04664 P(vB)—Base excess(H+binding group); subst.c.(actual-norm) = ? mmol/l Marrow—Basophilocytes; num.c. = ? × 109/l
Plasma(arterial Blood)— Leukocytes(Blood)— Base excess(H+binding group); Basophilocytes; substance concentration(pCO2 = 5,3 kPa; 37 ºC; actual-norm) number fraction millimol/litre NPU03968 Authority: IFCC/C-BGE Lkcs(B)—Basophilocytes; num.fr. = ? Note: standard: blood; pCO2 = 5,3 kPa; 37 °C NPU01348 + P(aB)—Base excess(H binding group); subst.c.(pCO2 = 5,3 kPa; 37 ºC; actual- norm) = ? mmol/l
25 Leukocytes(Bone marrow)— Urine— Basophilocytes; Beta-globulin; number fraction mass concentration NPU04666 milligram/litre Lkcs(Marrow)—Basophilocytes; num.fr. = ? NPU04656 U—Beta-globulin; mass c. = ? mg/l Urine— Bence Jones' protein; Protein(Cerebrospinal fluid)— arbitrary concentration(procedure) Beta-globulin; NPU01351 mass fraction U—Bence Jones' protein; arb.c.(proc.) = ? NPU04952 Prot.(Csf)—Beta-globulin; mass fr. = ? Urine— Bence Jones' protein; Protein(Plasma)— taxon(procedure) Beta-globulin; NPU09106 mass fraction U—Bence Jones' protein; taxon(proc.) = ? NPU04942 Prot.(P)—Beta-globulin; mass fr. = ? Plasma— Benzodiazepines; Protein(Urine)— arbitrary concentration(procedure) Beta-globulin; NPU17591 mass fraction P—Benzodiazepines; arb.c.(proc.) = ? NPU04947 Prot.(U)—Beta-globulin; mass fr. = ? Urine— Beryllium; Plasma(fasting Patient)— substance concentration(Toxicology) Bile salts; nanomol/litre substance concentration M = 9,01 g/mol micromol/litre NPU13480 NPU10607 U—Beryllium; subst.c.(Toxicology) = ? nmol/l P(fPt)—Bile salts; subst.c. = ? µmol/l
Plasma— Plasma— Beryllium; Bilirubin albumin; substance concentration substance concentration nanomol/litre micromol/litre M = 9,01 g/mol Other term(s): delta-Bilirubin Authority: IUPAC/VII-C-TOX NPU01367 NPU01364 P—Bilirubin albumin; subst.c. = ? µmol/l P—Beryllium; subst.c. = ? nmol/l Plasma(neonatal)— Urine— Bilirubin albumin; Beryllium; substance concentration substance concentration micromol/litre nanomol/litre NPU12531 M = 9,01 g/mol P(neonatal)—Bilirubin albumin; subst.c. = ? µmol/l Authority: IUPAC/VII-C-TOX NPU01365 Plasma— U—Beryllium; subst.c. = ? nmol/l Bilirubin glucuronide; substance concentration Plasma— micromol/litre Beta-1-globulin; Other term(s): Bilirubin, conjugated mass concentration Note: _M_ (bilirubin) = 584,65 g/mol gram/litre NPU01368 NPU09262 P—Bilirubin glucuronide; subst.c. = ? µmol/l P—Beta-1-globulin; mass c. = ? g/l Plasma(neonatal)— Protein(Plasma)— Bilirubin glucuronide; Beta-1-globulin; substance concentration mass fraction micromol/litre NPU09265 NPU12532 Prot.(P)—Beta-1-globulin; mass fr. = ? P(neonatal)—Bilirubin glucuronide; subst.c. = ? µmol/l
Plasma— Plasma— Beta-2-globulin; Bilirubin type; mass concentration substance concentration(list; procedure) gram/litre NPU10022 NPU09263 P—Bilirubin type; subst.c.(list; proc.) P—Beta-2-globulin; mass c. = ? g/l NPU01370 P—Bilirubins(tot.); subst.c. = ? µmol/l NPU01367 P—Bilirubin albumin; subst.c. = ? µmol/l Protein(Plasma)— NPU01368 P—Bilirubin glucuronide; subst.c. = ? µmol/l Beta-2-globulin; NPU17194 P—Bilirubin(conjugated); subst.c. = ? µmol/l mass fraction NPU01366 P—Bilirubin(non-complexed); subst.c. = ? µmol/l NPU09266 Prot.(P)—Beta-2-globulin; mass fr. = ? Plasma(neonatal)— Bilirubin type; Plasma— substance concentration(list; procedure) Beta-globulin; NPU10023 mass concentration P(neonatal)—Bilirubin type; subst.c.(list; proc.) gram/litre NPU04145 P(neonatal)—Bilirubins(tot.); subst.c. = ? µmol/l NPU04652 NPU12531 P(neonatal)—Bilirubin albumin; subst.c. = ? µmol/l P—Beta-globulin; mass c. = ? g/l NPU12532 P(neonatal)—Bilirubin glucuronide; subst.c. = ? µmol/l NPU17196 P(neonatal)—Bilirubin(conjugated); subst.c. = ? µmol/l Cerebrospinal fluid— NPU12530 P(neonatal)—Bilirubin(non-complexed); subst.c. = ? µmol/l Beta-globulin; mass concentration milligram/litre NPU04660 Csf—Beta-globulin; mass c. = ? mg/l
26 Plasma— Plasma(neonatal)— Bilirubin(conjugated); Bilirubins(total); substance concentration substance concentration micromol/litre micromol/litre NPU17194 Note: _M_ (bilirubin) = 584,65 g/mol P—Bilirubin(conjugated); subst.c. = ? µmol/l NPU04145 P(neonatal)—Bilirubins(tot.); subst.c. = ? µmol/l Plasma(neonatal)— Bilirubin(conjugated); Secretion(specification)— substance concentration Bilirubins(total); micromol/litre substance concentration NPU17196 micromol/litre P(neonatal)—Bilirubin(conjugated); subst.c. = ? µmol/l Note: _M_ (bilirubin) = 584,65 g/mol NPU01371 Plasma— Secr(spec.)—Bilirubins(tot.); subst.c. = ? µmol/l Bilirubin(non-complexed); substance concentration System(specification)— micromol/litre Bilirubins(total); M = 584,65 g/mol substance concentration Other term(s): Unconjugated bilirubin micromol/litre NPU01366 Note: _M_ (bilirubin) = 584,65 g/mol P—Bilirubin(non-complexed); subst.c. = ? µmol/l NPU10128 Syst(spec.)—Bilirubins(tot.); subst.c. = ? µmol/l Plasma(neonatal)— Bilirubin(non-complexed); Skin(specification)— substance concentration Bilirubins; micromol/litre arbitrary concentration(procedure) NPU12530 NPU17020 P(neonatal)—Bilirubin(non-complexed); subst.c. = ? µmol/l Skin(spec.)—Bilirubins; arb.c.(proc.) = ?
Urine— Plasma— Bilirubins(total); Bismuth; arbitrary concentration(procedure) substance concentration NPU01372 nanomol/litre U—Bilirubins(tot.); arb.c.(proc.) = ? M = 208,98 g/mol Authority: IUPAC/VII-C-TOX Urine— NPU01383 Bilirubins(total); P—Bismuth; subst.c. = ? nmol/l substance concentration(procedure) micromol/litre Urine— Note: _M_ (bilirubin) = 584,65 g/mol Bismuth; NPU17162 substance concentration U—Bilirubins(tot.); subst.c.(proc.) = ? µmol/l nanomol/litre M = 208,98 g/mol Amniotic fluid— Authority: IUPAC/VII-C-TOX Bilirubins(total); NPU01384 substance concentration U—Bismuth; subst.c. = ? nmol/l micromol/litre Note: _M_ (bilirubin) = 584,65 g/mol Blood— NPU01369 Blast cells; Amf—Bilirubins(tot.); subst.c. = ? µmol/l number concentration 109/litre Ascites— NPU03972 Bilirubins(total); B—Blast cells; num.c. = ? × 109/l substance concentration micromol/litre Blood fraction(specification)— Note: _M_ (bilirubin) = 584,65 g/mol Blast cells; NPU17031 number concentration Asc—Bilirubins(tot.); subst.c. = ? µmol/l 109/litre NPU17616 Cerebrospinal fluid(cell free)— B fract.(spec.)—Blast cells; num.c. = ? × 109/l Bilirubins(total); substance concentration Bone marrow— micromol/litre Blast cells; NPU08602 number concentration Csf(cell free)—Bilirubins(tot.); subst.c. = ? µmol/l 109/litre NPU04667 Drain fluid(specification)— Marrow—Blast cells; num.c. = ? × 109/l Bilirubins(total); substance concentration Leukocytes(Blood)— micromol/litre Blast cells; NPU17043 number fraction Drain fluid(spec.)—Bilirubins(tot.); subst.c. = ? µmol/l NPU03971 Lkcs(B)—Blast cells; num.fr. = ? Plasma— Bilirubins(total); Leukocytes(Bone marrow)— substance concentration Blast cells; micromol/litre number fraction Note: _M_ (bilirubin) = 584,65 g/mol NPU04668 NPU01370 Lkcs(Marrow)—Blast cells; num.fr. = ? P—Bilirubins(tot.); subst.c. = ? µmol/l Liver— Pleural fluid— Blood flow; Bilirubins(total); volume rate(procedure) substance concentration millilitre/second micromol/litre NPU03838 NPU17034 Liver—Blood flow; vol.rate(proc.) = ? ml/s Plf—Bilirubins(tot.); subst.c. = ? µmol/l
27 Patient— Plasma— Blood fraction; Bombesin; property(list; procedure) substance concentration NPU17593 picomol/litre Pt—Blood fraction; prop.(list; proc.) M = 2 805 g/mol NPU17563 B fract.(spec.)—Erythrocytes; num.c. = ? × 1012/l Other term(s): Mammalian bombesin; Gastrin releasing polypeptide NPU17565 B fract.(spec.)—Erythrocytes; vol.fr. = ? NPU02163 NPU17569 B fract.(spec.)—Haemoglobin(Fe); subst.c. = ? µmol/l P—Bombesin; subst.c. = ? pmol/l NPU17570 B fract.(spec.)—Haemoglobin(Fe); subst.c. = ? mmol/l NPU17571 B fract.(spec.)—Potassium ion; subst.c. = ? mmol/l Plasma— NPU17578 B fract.(spec.)—Leukocytes; num.c. = ? × 109/l Boron; NPU17583 B fract.(spec.)—Sodium ion; subst.c. = ? mmol/l substance concentration NPU17586 B fract.(spec.)—Thrombocytes; num.c. = ? × 109/l micromol/litre M = 10,81 g/mol Patient(specification)— Authority: IUPAC/VII-C-TOX Blood; NPU01400 Celsius temperature P—Boron; subst.c. = ? µmol/l degree Celsius NPU04034 Urine— Pt(spec.)—Blood; temp. = ? °C Boron; substance concentration Patient— micromol/litre Blood; M = 10,81 g/mol volume(procedure) Authority: IUPAC/VII-C-TOX litre NPU04809 NPU03795 U—Boron; subst.c. = ? µmol/l Pt—Blood; vol.(proc.) = ? l Hair— Patient— Boron; Blood; substance content volume content micromol/kilogram milliliter/kilogram M = 10,81 g/mol NPU03808 Authority: IUPAC/VII-C-TOX Pt—Blood; vol.cont. = ? ml/kg NPU04808 Hair—Boron; subst.cont. = ? µmol/kg Lavage fluid(specification)— Blood; Plasma— volume Brain natriuretic peptide; millilitre arbitrary substance concentration(procedure) NPU14045 arbitrary unit/litre Lavagef(spec.)—Blood; vol. = ? ml NPU17174 P—Brain natriuretic peptide; arb.subst.c.(proc.) = ? arb.unit/l Patient(Sampling)— Blood; Plasma— volume Brain natriuretic peptide; millilitre substance concentration NPU14379 picomol/litre Pt(Sampling)—Blood; vol. = ? ml NPU17181 P—Brain natriuretic peptide; subst.c. = ? pmol/l Patient— Body; Plasma(arterial Blood)— height Brain natriuretic peptide; metre substance concentration NPU03794 picomol/litre Pt—Body; height = ? m NPU17176 P(aB)—Brain natriuretic peptide; subst.c. = ? pmol/l Patient— Body; Urine— mass increment(procedure) Brain natriuretic peptide; kilogram substance concentration NPU03805 picomol/litre Pt—Body; mass incr.(proc.) = ? kg NPU17177 U—Brain natriuretic peptide; subst.c. = ? pmol/l Patient— Body; Patient(Urine)— mass Brain natriuretic peptide; kilogram substance rate NPU03804 picomol/day Pt—Body; mass = ? kg NPU17175 Pt(U)—Brain natriuretic peptide; subst.rate = ? pmol/d Patient— Body; Blood— Celsius temperature Bromide; degree Celsius substance concentration NPU08676 micromol/litre Pt—Body; temp. = ? °C M = 79,90 g/mol Authority: IUPAC/VII-C-TOX Cerebrospinal fluid— NPU04834 Bombesin; B—Bromide; subst.c. = ? µmol/l substance concentration picomol/litre Plasma— M = 2 805 g/mol Bromide; Other term(s): Mammalian bombesin; Gastrin releasing polypeptide substance concentration NPU02162 micromol/litre Csf—Bombesin; subst.c. = ? pmol/l M = 79,90 g/mol Authority: IUPAC/VII-C-TOX NPU01403 P—Bromide; subst.c. = ? µmol/l
28 Urine— Plasma— Bromide; Caesium; substance concentration substance concentration micromol/litre nanomol/litre M = 79,90 g/mol M = 132,90 g/mol Authority: IUPAC/VII-C-TOX Authority: IUPAC/VII-C-TOX NPU04870 NPU01430 U—Bromide; subst.c. = ? µmol/l P—Caesium; subst.c. = ? nmol/l
Urine— Urine— Bufotenine; Caesium; amount-of-substance(procedure) substance concentration micromol nanomol/litre M = 204,3 g/mol M = 132,90 g/mol Other term(s): Mappine Authority: IUPAC/VII-C-TOX NPU01406 NPU01431 U—Bufotenine; am.s.(proc.) = ? µmol U—Caesium; subst.c. = ? nmol/l
Urine— Hair— Cadmium/Creatininium; Caesium; substance ratio substance content 10-6 micromol/kilogram Note: _M_ (cadmium) = 112,41 g/mol; _M_ (creatininium) = 113,12 g/mol M = 132,90 g/mol NPU09005 Authority: IUPAC/VII-C-TOX U—Cadmium/Creatininium; subst.ratio = ? × 10-6 NPU01429 Hair—Caesium; subst.cont. = ? µmol/kg Blood— Cadmium; Cells(Blood)— substance concentration Caesium; nanomol/litre substance content M = 112,41 g/mol nanomol/kilogram Authority: IUPAC/VII-C-TOX M = 132,90 g/mol NPU04874 Authority: IUPAC/VII-C-TOX B—Cadmium; subst.c. = ? nmol/l NPU01428 Cells(B)—Caesium; subst.cont. = ? nmol/kg Plasma— Cadmium; Plasma— substance concentration Calcifediol; nanomol/litre substance concentration M = 112,41 g/mol nanomol/litre Authority: IUPAC/VII-C-TOX M = 400,65 g/mol NPU01425 Other term(s): Calcifediol; 25-Hydroxy-Vitamin D3 P—Cadmium; subst.c. = ? nmol/l Authority: IUPAC-IUB 81 NPU01435 Urine— P—Calcifediol; subst.c. = ? nmol/l Cadmium; substance concentration Plasma— nanomol/litre Calcifediol+25-Hydroxyergocalciferol; M = 112,41 g/mol substance concentration Authority: IUPAC/VII-C-TOX nanomol/litre NPU01426 NPU10267 U—Cadmium; subst.c. = ? nmol/l P—Calcifediol+25-Hydroxyergocalciferol; subst.c. = ? nmol/l
Hair— Plasma— Cadmium; Calcifediol+Ergocalciferol; substance content substance concentration micromol/kilogram nanomol/litre M = 112,41 g/mol M = 400,65 g/mol Authority: IUPAC/VII-C-TOX Authority: IUPAC-IUB 81 NPU01424 NPU09105 Hair—Cadmium; subst.cont. = ? µmol/kg P—Calcifediol+Ergocalciferol; subst.c. = ? nmol/l
Cells(Blood)— Plasma— Cadmium; Calciferol binding protein; substance content substance concentration nanomol/kilogram micromol/litre M = 112,41 g/mol M = 58 000 g/mol Authority: IUPAC/VII-C-TOX Other term(s): Gc-globulin; Vitamin D-binding protein NPU04881 NPU01436 Cells(B)—Cadmium; subst.cont. = ? nmol/kg P—Calciferol binding protein; subst.c. = ? µmol/l
Patient(Urine)— Plasma— Cadmium; Calciol; substance rate substance concentration nanomol/day nanomol/litre M = 112,41 g/mol M = 384,62 g/mol Authority: IUPAC/VII-C-TOX Other term(s): Colecalciferol; Vitamin D3 NPU10024 Authority: IUPAC-IUB 81 Pt(U)—Cadmium; subst.rate = ? nmol/d NPU01437 P—Calciol; subst.c. = ? nmol/l Blood— Caesium; Plasma— substance concentration Calcitonin gene related peptide; nanomol/litre substance concentration M = 132,90 g/mol picomol/litre Authority: IUPAC/VII-C-TOX NPU10605 NPU01427 P—Calcitonin gene related peptide; subst.c. = ? pmol/l B—Caesium; subst.c. = ? nmol/l
29 Urine— Plasma— Calcitonin gene related peptide; Calcitonin; substance concentration substance concentration(0 minutes after challenge) picomol/litre picomol/litre NPU14007 M = 3 425 g/mol U—Calcitonin gene related peptide; subst.c. = ? pmol/l NPU10478 P—Calcitonin; subst.c.(0 min) = ? pmol/l Patient(Urine)— Calcitonin gene related peptide; Plasma— substance rate Calcitonin; picomol/day substance concentration(1,5 minutes after challenge) NPU14008 picomol/litre Pt(U)—Calcitonin gene related peptide; subst.rate = ? pmol/d M = 3 425 g/mol NPU10479 Thyroid gland— P—Calcitonin; subst.c.(1,5 min) = ? pmol/l Calcitonin secretion; substance rate(calcium compound, intravenous administration; list; Plasma— procedure) Calcitonin; Note: _M_ (calcitonin) = 3 425 g/mol substance concentration(2 minutes after challenge) NPU10476 picomol/litre Thyroid gland—Calcitonin secretion; subst.rate(calcium compound i.v.; list; M = 3 425 g/mol proc.) NPU10376 NPU10472 Pt—Calcium compound(administered); subst.cont.(i.v.; am.s./body P—Calcitonin; subst.c.(2 min) = ? pmol/l mass) = ? mmol/kg NPU10478 P—Calcitonin; subst.c.(0 min) = ? pmol/l Plasma— NPU10480 P—Calcitonin; subst.c.(5 min) = ? pmol/l Calcitonin; NPU10473 P—Calcitonin; subst.c.(10 min) = ? pmol/l substance concentration(5 minutes after challenge) NPU10474 P—Calcitonin; subst.c.(180 min) = ? pmol/l picomol/litre NPU10475 P—Calcitonin; subst.c.(240 min) = ? pmol/l M = 3 425 g/mol NPU10480 Thyroid gland— P—Calcitonin; subst.c.(5 min) = ? pmol/l Calcitonin secretion; substance rate(pentagastrin, intravenous administration; list; procedure) Plasma— Note: _M_ (pentagastrin) = 770 g/mol; _M_ (calcitonin) = 3 425 g/mol Calcitonin; NPU10481 substance concentration(10 minutes after challenge) Thyroid gland—Calcitonin secretion; subst.rate(pentagastrin i.v.; list; proc.) picomol/litre NPU10477 Pt—Pentagastrin(administered); subst.cont.(i.v.; am.s./body mass) = M = 3 425 g/mol ? nmol/kg NPU10473 NPU10378 P—Calcitonin; subst.c.(-20 min) = ? pmol/l P—Calcitonin; subst.c.(10 min) = ? pmol/l NPU10377 P—Calcitonin; subst.c.(-10 min) = ? pmol/l NPU10478 P—Calcitonin; subst.c.(0 min) = ? pmol/l Plasma— NPU10479 P—Calcitonin; subst.c.(1,5 min) = ? pmol/l Calcitonin; NPU10376 P—Calcitonin; subst.c.(2 min) = ? pmol/l substance concentration(180 minutes after challenge) NPU10480 P—Calcitonin; subst.c.(5 min) = ? pmol/l picomol/litre M = 3 425 g/mol Plasma— NPU10474 Calcitonin; P—Calcitonin; subst.c.(180 min) = ? pmol/l arbitrary substance concentration(IRP 70/234; procedure) international unit/litre Plasma— M = 3 425 g/mol Calcitonin; Recommended calibrator: WHO 2nd IS 89/620 substance concentration(240 minutes after challenge) Calibrator(s): WHO 1st IRP 70/234 picomol/litre Other term(s): Thyrocalcitonin M = 3 425 g/mol Authority: IUPAC-IUB 74 NPU10475 NPU04002 P—Calcitonin; subst.c.(240 min) = ? pmol/l P—Calcitonin; arb.subst.c.(IRP 70/234; proc.) = ? int. unit/l Plasma— Plasma— Calcitonin; Calcitonin; substance concentration arbitrary substance concentration(IS 89/620; procedure) picomol/litre international unit/litre M = 3 425 g/mol M = 3 425 g/mol Other term(s): Thyrocalcitonin Recommended calibrator: WHO 2nd IS 89/620 Authority: IUPAC-IUB 74 Calibrator(s): WHO 1st IRP 70/234 NPU01439 Other term(s): Thyrocalcitonin P—Calcitonin; subst.c. = ? pmol/l Authority: IUPAC-IUB 74 NPU01438 Plasma— P—Calcitonin; arb.subst.c.(IS 89/620; proc.) = ? int. unit/l 1,25- Calcitriol; Plasma— substance concentration Calcitonin; picomol/litre substance concentration(20 minutes before challenge) M = 416,3 g/mol picomol/litre Other term(s): 1,25-Dihydroxy-cholecalciferol; 1,25-Dihydroxy-vitamin D3 M = 3 425 g/mol Authority: IUPAC-IUB 81; INN NPU10378 NPU01440 P—Calcitonin; subst.c.(-20 min) = ? pmol/l P—1,25-Calcitriol; subst.c. = ? pmol/l
Plasma— Plasma— Calcitonin; 1,25- substance concentration(10 minutes before challenge) Calcitriol+1,25-Dihydroxyergocalciferol; picomol/litre substance concentration M = 3 425 g/mol picomol/litre NPU10377 NPU10266 P—Calcitonin; subst.c.(-10 min) = ? pmol/l P—1,25-Calcitriol+1,25-Dihydroxyergocalciferol; subst.c. = ? pmol/l
30 Calculus(Urine)— Calcium carbonate; Urine— arbitrary content(procedure) Calcium(II; total); M = 100,09 g/mol amount-of-substance(procedure) NPU10364 millimol Calculus(U)—Calcium carbonate; arb.cont.(proc.) = ? NPU17550 U—Calcium(II; total); am.s.(proc.) = ? mmol Calculus(Urine)— Calcium carbonate; Calculus(Urine)— substance content Calcium(II; total); mol/kilogram arbitrary content(procedure) M = 100,09 g/mol M = 40,080 g/mol NPU01445 NPU09230 Calculus(U)—Calcium carbonate; subst.cont. = ? mol/kg Calculus(U)—Calcium(II; total); arb.cont.(proc.) = ?
Kidney— Plasma— Calcium clearance; Calcium(II; total); volume rate(procedure) substance concentration(corrected; procedure) millilitre/second millimol/litre NPU08595 M = 40,08 g/mol Kidn.—Calcium clearance; vol.rate(proc.) = ? ml/s NPU04169 P—Calcium(II; total); subst.c.(corr.; proc.) = ? mmol/l Patient— Calcium compound(administered); Plasma— substance content(intravenous administration; amount-of- Calcium(II; total); substance/body mass) substance concentration(list; corrected; procedure) millimol/kilogram Authority: IFCC/C-BGE NPU10472 NPU17123 Pt—Calcium compound(administered); subst.cont.(i.v.; am.s./body mass) = ? P—Calcium(II; total); subst.c.(list; corr.; proc.) mmol/kg NPU01132 P—Albumin; subst.c. = ? µmol/l NPU01443 P—Calcium(II; total); subst.c. = ? mmol/l Plasma— NPU04169 P—Calcium(II; total); subst.c.(corr.; proc.) = ? mmol/l Calcium ion(free); substance concentration(pH = 7,40; procedure) Amniotic fluid— millimol/litre Calcium(II; total); Authority: IFCC/C-BGE substance concentration NPU04144 millimol/litre P—Calcium ion(free); subst.c.(pH = 7,40; proc.) = ? mmol/l NPU08605 Amf—Calcium(II; total); subst.c. = ? mmol/l Plasma— Calcium ion(free); Ascites— substance concentration Calcium(II; total); millimol/litre substance concentration Other term(s): Coagulation factor IV millimol/litre Authority: IFCC/C-BGE M = 40,080 g/mol NPU01446 Authority: IFCC/C-BGE P—Calcium ion(free); subst.c. = ? mmol/l NPU08603 Asc—Calcium(II; total); subst.c. = ? mmol/l Calculus(Urine)— Calcium oxalate; Dialysis solution— arbitrary content(procedure) Calcium(II; total); M = 128,10 g/mol substance concentration NPU10365 millimol/litre Calculus(U)—Calcium oxalate; arb.cont.(proc.) = ? M = 40,080 g/mol Authority: IFCC/C-BGE Calculus(Urine)— NPU17172 Calcium oxalate; Dialysis solution—Calcium(II; total); subst.c. = ? mmol/l substance content mol/kilogram Plasma— M = 128,10 g/mol Calcium(II; total); NPU01447 substance concentration Calculus(U)—Calcium oxalate; subst.cont. = ? mol/kg millimol/litre M = 40,080 g/mol Calculus(Urine)— Authority: IFCC/C-BGE Calcium phosphate; NPU01443 arbitrary content(procedure) P—Calcium(II; total); subst.c. = ? mmol/l M = 310,20 g/mol NPU10366 System(specification)— Calculus(U)—Calcium phosphate; arb.cont.(proc.) = ? Calcium(II; total); substance concentration Calculus(Urine)— millimol/litre Calcium phosphate; M = 40,08 g/mol substance content NPU10289 mol/kilogram Syst(spec.)—Calcium(II; total); subst.c. = ? mmol/l M = 310,20 g/mol NPU08608 Urine— Calculus(U)—Calcium phosphate; subst.cont. = ? mol/kg Calcium(II; total); substance concentration Calculus(Synovial fluid; specification)— millimol/litre Calcium pyrophosphate; M = 40,08 g/mol arbitrary content(procedure) NPU04160 M = 310,20 g/mol U—Calcium(II; total); subst.c. = ? mmol/l NPU14141 Calculus(Synf; spec.)—Calcium pyrophosphate; arb.cont.(proc.) = ? Faeces— Calcium(II; total); Urine— substance content Calcium(II; total)/Creatininium; millimol/kilogram substance ratio M = 40,08 g/mol NPU03929 NPU04212 U—Calcium(II; total)/Creatininium; subst.ratio = ? F—Calcium(II; total); subst.cont. = ? mmol/kg
31 Urine— Faeces(specification)— Calculus composition; Calcium(II; total); arbitrary content(list; procedure) substance content NPU08868 millimol/kilogram U—Calculus composition; arb.cont.(list; proc.) NPU08606 NPU09232 Calculus(U)—Ammonium; arb.cont.(proc.) = ? F(spec.)—Calcium(II; total); subst.cont. = ? mmol/kg NPU10364 Calculus(U)—Calcium carbonate; arb.cont.(proc.) = ? NPU10365 Calculus(U)—Calcium oxalate; arb.cont.(proc.) = ? Calculus(Urine)— NPU10366 Calculus(U)—Calcium phosphate; arb.cont.(proc.) = ? Calcium(II; total); NPU09230 Calculus(U)—Calcium(II; total); arb.cont.(proc.) = ? substance content NPU09229 Calculus(U)—Carbonate; arb.cont.(proc.) = ? mol/kilogram NPU10367 Calculus(U)—Cystine; arb.cont.(proc.) = ? M = 40,080 g/mol NPU10368 Calculus(U)—Magnesium ammonium phosphate; arb.cont.(proc.) NPU09236 = ? Calculus(U)—Calcium(II; total); subst.cont. = ? mol/kg NPU09234 Calculus(U)—Magnesium(II; total); arb.cont.(proc.) = ? NPU09231 Calculus(U)—Oxalate; arb.cont.(proc.) = ? Patient(Faeces)— NPU09233 Calculus(U)—Phosphate(P; inorganic); arb.cont.(proc.) = ? Calcium(II; total); NPU10369 Calculus(U)—Urate; arb.cont.(proc.) = ? substance rate(procedure) millimol/day Urine— Authority: IFCC/C-BGE Calculus composition; NPU01441 substance content(list; procedure) Pt(F)—Calcium(II; total); subst.rate(proc.) = ? mmol/d NPU09359 U—Calculus composition; subst.cont.(list; proc.) Patient(Ileum)— NPU09238 Calculus(U)—Ammonium; subst.cont. = ? mol/kg Calcium(II; total); NPU01445 Calculus(U)—Calcium carbonate; subst.cont. = ? mol/kg substance rate(procedure) NPU09236 Calculus(U)—Calcium(II; total); subst.cont. = ? mol/kg millimol/day NPU01447 Calculus(U)—Calcium oxalate; subst.cont. = ? mol/kg NPU08607 NPU08608 Calculus(U)—Calcium phosphate; subst.cont. = ? mol/kg Pt(Ileum)—Calcium(II; total); subst.rate(proc.) = ? mmol/d NPU09235 Calculus(U)—Carbonate; subst.cont. = ? mol/kg NPU01827 Calculus(U)—Cystine; subst.cont. = ? mol/kg Patient(Urine)— NPU09240 Calculus(U)—Magnesium(II; total); subst.cont. = ? mol/kg Calcium(II; total); NPU02649 Calculus(U)—Magnesium ammonium phosphate; subst.cont. = ? substance rate(procedure) mol/kg millimol/day NPU09237 Calculus(U)—Oxalate; subst.cont. = ? mol/kg M = 40,080 g/mol NPU09239 Calculus(U)—Phosphate(P; inorganic); subst.cont. = ? mol/kg Authority: IFCC/C-BGE NPU03689 Calculus(U)—Urate; subst.cont. = ? mol/kg NPU01442 Pt(U)—Calcium(II; total); subst.rate(proc.) = ? mmol/d Faeces— Calprotectin; Kidney— substance content Calcium/Creatininium; millimol/kilogram volume rate ratio(procedure) NPU09255 NPU08596 F—Calprotectin; subst.cont. = ? mmol/kg Kidn.—Calcium/Creatininium; vol.rate ratio(proc.) = ? Cerebrospinal fluid— Faeces— Cancer antigen 125; Calcium; arbitrary substance concentration(procedure) amount-of-substance(procedure) 10³ arbitrary unit/litre millimol NPU10290 NPU17549 Csf—Cancer antigen 125; arb.subst.c.(proc.) = ? × 10³ arb.unit/l F—Calcium; am.s.(proc.) = ? mmol Plasma— Secretion(Ileum)— Cancer antigen 125; Calcium; arbitrary substance concentration(procedure) amount-of-substance(procedure) 10³ arbitrary unit/litre millimol NPU01448 NPU17623 P—Cancer antigen 125; arb.subst.c.(proc.) = ? × 10³ arb.unit/l Secr(Ileum)—Calcium; am.s.(proc.) = ? mmol Plasma— Secretion(Ileum)— Cancer antigen 15-3; Calcium; arbitrary substance concentration(procedure) substance concentration 10³ arbitrary unit/litre millimol/litre NPU01449 NPU17548 P—Cancer antigen 15-3; arb.subst.c.(proc.) = ? × 10³ arb.unit/l Secr(Ileum)—Calcium; subst.c. = ? mmol/l Plasma— Synovial fluid(specification)— Cancer antigen 19-9; Calculus composition; arbitrary substance concentration(procedure) arbitrary content(list; procedure) 10³ arbitrary unit/litre NPU14278 NPU01450 Synf(spec.)—Calculus composition; arb.cont.(list; proc.) P—Cancer antigen 19-9; arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU14141 Calculus(Synf; spec.)—Calcium pyrophosphate; arb.cont.(proc.) = ? NPU14109 Calculus(Synf; spec.)—Urate; arb.cont.(proc.) = ? Plasma— Cancer antigen 50; arbitrary substance concentration(procedure) 10³ arbitrary unit/litre NPU01451 P—Cancer antigen 50; arb.subst.c.(proc.) = ? × 10³ arb.unit/l
Kidney— Carbamide clearance; volume rate(procedure) millilitre/second NPU10028 Kidn.—Carbamide clearance; vol.rate(proc.) = ? ml/s
32 Ascites— Patient(Urine)— Carbamide; Carbamide; amount-of-substance(procedure) substance rate(procedure) millimol millimol/day M = 60,06 g/mol NPU01458 NPU08611 Pt(U)—Carbamide; subst.rate(proc.) = ? mmol/d Asc—Carbamide; am.s.(proc.) = ? mmol Plasma— Urine— Carbohydrate-deficient transferrin; Carbamide; arbitrary substance concentration(procedure) amount-of-substance(procedure) arbitrary unit/litre millimol NPU10005 NPU17551 P—Carbohydrate-deficient transferrin; arb.subst.c.(proc.) = ? arb.unit/l U—Carbamide; am.s.(proc.) = ? mmol Transferrin(Plasma)— Amniotic fluid— Carbohydrate-deficient transferrin; Carbamide; substance concentration substance concentration micromol/litre millimol/litre NPU17006 M = 60,06 g/mol Transferrin(P)—Carbohydrate-deficient transferrin; subst.c. = ? µmol/l NPU08610 Amf—Carbamide; subst.c. = ? mmol/l Transferrin(Plasma)— Carbohydrate-deficient transferrin; Ascites— substance fraction Carbamide; NPU10000 substance concentration Transferrin(P)—Carbohydrate-deficient transferrin; subst.fr. = ? millimol/litre M = 60,06 g/mol Plasma(arterial Blood)— NPU08609 Carbon dioxide(free); Asc—Carbamide; subst.c. = ? mmol/l substance concentration millimol/litre Cerebrospinal fluid— NPU12476 Carbamide; P(aB)—Carbon dioxide(free); subst.c. = ? mmol/l substance concentration millimol/litre Plasma(capillary Blood)— M = 60,06 g/mol Carbon dioxide(free); NPU09349 substance concentration Csf—Carbamide; subst.c. = ? mmol/l millimol/litre NPU12482 Dialysis solution— P(cB)—Carbon dioxide(free); subst.c. = ? mmol/l Carbamide; substance concentration Plasma(cord Blood)— millimol/litre Carbon dioxide(free); M = 60,06 g/mol substance concentration NPU10026 millimol/litre Dialysis solution—Carbamide; subst.c. = ? mmol/l NPU12483 P(cordB)—Carbon dioxide(free); subst.c. = ? mmol/l Drain fluid(specification)— Carbamide; Plasma(cord Blood; arterial Blood)— substance concentration Carbon dioxide(free); millimol/litre substance concentration NPU17047 millimol/litre Drain fluid(spec.)—Carbamide; subst.c. = ? mmol/l NPU17137 P(cordB; aB)—Carbon dioxide(free); subst.c. = ? mmol/l Plasma— Carbamide; Plasma(cord Blood; venous Blood)— substance concentration Carbon dioxide(free); millimol/litre substance concentration M = 60,06 g/mol millimol/litre NPU01459 NPU17138 P—Carbamide; subst.c. = ? mmol/l P(cordB; vB)—Carbon dioxide(free); subst.c. = ? mmol/l
Secretion(Conjunctiva; specification)— Plasma(mixed Blood)— Carbamide; Carbon dioxide(free); substance concentration substance concentration millimol/litre millimol/litre M = 60,06 g/mol NPU09204 NPU09353 P(mixB)—Carbon dioxide(free); subst.c. = ? mmol/l Secr(Conj; spec.)—Carbamide; subst.c. = ? mmol/l Plasma(venous Blood)— System(specification)— Carbon dioxide(free); Carbamide; substance concentration substance concentration millimol/litre millimol/litre NPU12484 M = 60,06 g/mol P(vB)—Carbon dioxide(free); subst.c. = ? mmol/l NPU10027 Syst(spec.)—Carbamide; subst.c. = ? mmol/l Plasma(arterial Blood)— Carbon dioxide(free); Urine— gas tension(37 °C) Carbamide; kilopascal substance concentration M = 44,01 g/mol millimol/litre Authority: IFCC/C-BGE M = 60,06 g/mol NPU01470 NPU03930 P(aB)—Carbon dioxide(free); tension(37 °C) = ? kPa U—Carbamide; subst.c. = ? mmol/l
33 Plasma(capillary Blood)— Plasma(mixed Blood)— Carbon dioxide(free); Carbon dioxide(free); gas tension(37 °C) gas tension(patient body temperature) kilopascal kilopascal NPU12481 NPU09203 P(cB)—Carbon dioxide(free); tension(37 °C) = ? kPa P(mixB)—Carbon dioxide(free); tension(body temp.) = ? kPa
Plasma(cord Blood)— Plasma(venous Blood)— Carbon dioxide(free); Carbon dioxide(free); gas tension(37 °C) gas tension(patient body temperature) kilopascal kilopascal M = 44,01 g/mol NPU12529 Authority: IFCC/C-BGE P(vB)—Carbon dioxide(free); tension(body temp.) = ? kPa NPU10030 P(cordB)—Carbon dioxide(free); tension(37 °C) = ? kPa Blood(arterial Blood)— Carbon dioxide(total); Plasma(cord Blood; arterial Blood)— substance concentration Carbon dioxide(free); millimol/litre gas tension(37 °C) NPU12522 kilopascal B(aB)—Carbon dioxide(tot.); subst.c. = ? mmol/l M = 44,01 g/mol Authority: IFCC/C-BGE Blood(capillary Blood)— NPU17139 Carbon dioxide(total); P(cordB; aB)—Carbon dioxide(free); tension(37 °C) = ? kPa substance concentration millimol/litre Plasma(cord Blood; venous Blood)— NPU12524 Carbon dioxide(free); B(cB)—Carbon dioxide(tot.); subst.c. = ? mmol/l gas tension(37 °C) kilopascal Blood(cord Blood)— M = 44,01 g/mol Carbon dioxide(total); Authority: IFCC/C-BGE substance concentration NPU17140 millimol/litre P(cordB; vB)—Carbon dioxide(free); tension(37 °C) = ? kPa NPU12523 B(cordB)—Carbon dioxide(tot.); subst.c. = ? mmol/l Plasma(mixed Blood)— Carbon dioxide(free); Blood(mixed Blood)— gas tension(37 °C) Carbon dioxide(total); kilopascal substance concentration M = 44,01 g/mol millimol/litre Authority: IFCC/C-BGE NPU09205 NPU09202 B(mixB)—Carbon dioxide(tot.); subst.c. = ? mmol/l P(mixB)—Carbon dioxide(free); tension(37 °C) = ? kPa Blood(venous Blood)— Plasma(venous Blood)— Carbon dioxide(total); Carbon dioxide(free); substance concentration gas tension(37 °C) millimol/litre kilopascal NPU12525 M = 44,01 g/mol B(vB)—Carbon dioxide(tot.); subst.c. = ? mmol/l Authority: IFCC/C-BGE NPU10029 Plasma(arterial Blood)— P(vB)—Carbon dioxide(free); tension(37 °C) = ? kPa Carbon dioxide(total); substance concentration Plasma(arterial Blood)— millimol/litre Carbon dioxide(free); M = 44,01 g/mol gas tension(patient body temperature) Authority: IFCC/C-BGE kilopascal NPU01471 NPU12526 P(aB)—Carbon dioxide(tot.); subst.c. = ? mmol/l P(aB)—Carbon dioxide(free); tension(body temp.) = ? kPa Plasma(capillary Blood)— Plasma(capillary Blood)— Carbon dioxide(total); Carbon dioxide(free); substance concentration gas tension(patient body temperature) millimol/litre kilopascal NPU12485 NPU12528 P(cB)—Carbon dioxide(tot.); subst.c. = ? mmol/l P(cB)—Carbon dioxide(free); tension(body temp.) = ? kPa Plasma(cord Blood)— Plasma(cord Blood)— Carbon dioxide(total); Carbon dioxide(free); substance concentration gas tension(patient body temperature) millimol/litre kilopascal NPU12517 NPU12527 P(cordB)—Carbon dioxide(tot.); subst.c. = ? mmol/l P(cordB)—Carbon dioxide(free); tension(body temp.) = ? kPa Plasma(cord Blood; arterial Blood)— Plasma(cord Blood; arterial Blood)— Carbon dioxide(total); Carbon dioxide(free); substance concentration gas tension(patient body temperature) millimol/litre kilopascal M = 44,01 g/mol NPU17141 Authority: IFCC/C-BGE P(cordB; aB)—Carbon dioxide(free); tension(body temp.) = ? kPa NPU17143 P(cordB; aB)—Carbon dioxide(tot.); subst.c. = ? mmol/l Plasma(cord Blood; venous Blood)— Carbon dioxide(free); Plasma(cord Blood; venous Blood)— gas tension(patient body temperature) Carbon dioxide(total); kilopascal substance concentration NPU17142 millimol/litre P(cordB; vB)—Carbon dioxide(free); tension(body temp.) = ? kPa M = 44,01 g/mol Authority: IFCC/C-BGE NPU17144 P(cordB; vB)—Carbon dioxide(tot.); subst.c. = ? mmol/l
34 Plasma(mixed Blood)— Urine— Carbon dioxide(total); N-epsilon- substance concentration Carboxymethyl lysine; millimol/litre substance concentration M = 44,01 g/mol micromol/litre Authority: IFCC/C-BGE NPU01477 NPU09206 U—N-epsilon-Carboxymethyl lysine; subst.c. = ? µmol/l P(mixB)—Carbon dioxide(tot.); subst.c. = ? mmol/l Plasma— Plasma(venous Blood)— Carcinoembryonic antigen; Carbon dioxide(total); arbitrary substance concentration(IRP 73/601; procedure) substance concentration international unit/litre millimol/litre Recommended calibrator: WHO 1st IRP 73/601 M = 44,01 g/mol Other term(s): CEA Authority: IFCC/C-BGE NPU01478 NPU01472 P—Carcinoembryonic antigen; arb.subst.c.(IRP 73/601; proc.) = ? int. unit/l P(vB)—Carbon dioxide(tot.); subst.c. = ? mmol/l Plasma— Alveolar gas— Carcinoembryonic antigen; Carbon dioxide; substance concentration partial pressure mol/litre kilopascal Other term(s): CEA NPU04079 NPU03931 Alveolar gas—Carbon dioxide; part.pr. = ? kPa P—Carcinoembryonic antigen; subst.c.= ? prefix ? mol/l
Haemoglobin(Fe; Blood)— Urine— Carbon monoxide haemoglobin(Fe); Carnitine/Creatine; substance fraction substance ratio Authority: IFCC/C-BGE NPU01502 NPU01473 U—Carnitine/Creatine; subst.ratio = ? Hb(Fe; B)—Carbon monoxide haemoglobin(Fe); subst.fr. = ? Urine— Erythrocytes(Blood)— Carnitine/Creatininium; Carbonate dehydratase; substance ratio entitic amount-of-substance(procedure) 10-3 attomol NPU14202 M = 30 000 g/mol U—Carnitine/Creatininium; subst.ratio = ? × 10-3 Other term(s): Carbonic anhydrase; Carbonate dehydratase type I NPU01474 Plasma— Ercs(B)—Carbonate dehydratase; entitic am.s.(proc.) = ? amol Carnitine; substance concentration Erythrocytes(Blood)— micromol/litre Carbonate dehydratase; M = 161,20 g/mol entitic catalytic activity(37 °C; procedure) NPU01482 attokatal P—Carnitine; subst.c. = ? µmol/l Other term(s): Carbonic anhydrase; Carbonate dehydratase NPU01475 Urine— Ercs(B)—Carbonate dehydratase; entitic cat.act.(37 °C; proc.) = ? akat Carnitine; substance concentration Calculus(Urine)— micromol/litre Carbonate; M = 161,20 g/mol arbitrary content(procedure) NPU01485 NPU09229 U—Carnitine; subst.c. = ? µmol/l Calculus(U)—Carbonate; arb.cont.(proc.) = ? Patient(Urine)— Calculus(Urine)— Carnitine; Carbonate; substance rate substance content micromol/day mol/kilogram M = 161,20 g/mol NPU09235 NPU10031 Calculus(U)—Carbonate; subst.cont. = ? mol/kg Pt(U)—Carnitine; subst.rate = ? µmol/d
Urine— Urine— gamma- Carnosine/Creatininium; Carboxyglutamate/Creatininium; substance ratio substance ratio 10-3 10-3 NPU14203 NPU14200 U—Carnosine/Creatininium; subst.ratio = ? × 10-3 U—gamma-Carboxyglutamate/Creatininium; subst.ratio = ? × 10-3 Plasma— Urine— Carnosine; gamma- substance concentration Carboxyglutamate; micromol/litre substance concentration M = 226,23 g/mol micromol/litre NPU01503 M = 191,14 g/mol P—Carnosine; subst.c. = ? µmol/l NPU01476 U—gamma-Carboxyglutamate; subst.c. = ? µmol/l Urine— Carnosine; Urine— substance concentration N-epsilon- micromol/litre Carboxymethyl lysine/Creatininium; M = 226,23 g/mol substance ratio NPU01504 10-3 U—Carnosine; subst.c. = ? µmol/l NPU14201 U—N-epsilon-Carboxymethyl lysine/Creatininium; subst.ratio = ? × 10-3
35 Plasma— Synovial fluid(specification)— Carotene; Cells; substance concentration number concentration micromol/litre 106/litre M = 536,85 g/mol NPU04229 NPU01505 Synf(spec.)—Cells; num.c. = ? × 106/l P—Carotene; subst.c. = ? µmol/l System(specification)— Faeces— Cells; Catalase; number concentration arbitrary content(procedure) 106/litre NPU04215 NPU10291 F—Catalase; arb.cont.(proc.)= ? Syst(spec.)—Cells; num.c. = ? × 106/l
Urine— Cerebrospinal fluid— Catecholamine; Cells; amount-of-substance(list) number concentration NPU17625 109/litre U—Catecholamine; am.s.(list) NPU08681 NPU17545 U—Adrenalinium; am.s.(proc.) = ? µmol Csf—Cells; num.c. = ? × 109/l NPU17624 U—Adrenalinium+Noradrenalinium; am.s.(proc.) = ? µmol NPU08619 U—Dopamine; am.s.(proc.) = ? µmol Synovial fluid(specification)— NPU17626 U—3-Methoxyadrenalinium+3-Methoxynoradrenalinium; am.s. Cells; (proc.) = ? µmol number concentration NPU17585 U—Noradrenalinium; am.s.(proc.) = ? µmol 109/litre NPU08684 Urine— Synf(spec.)—Cells; num.c. = ? × 109/l Catecholamine; substance concentration(list; procedure) Plasma— NPU17594 Centromer antibody(Immunoglobulin G); U—Catecholamine; subst.c.(list; proc.) arbitrary concentration(procedure) NPU14041 U—Adrenalinium; subst.c. = ? µmol/l NPU01518 NPU14120 U—Adrenalinium+Noradrenalinium; subst.c. = ? µmol/l P—Centromer antibody(IgG); arb.c.(proc.) = ? NPU01915 U—Dopamine; subst.c. = ? µmol/l NPU02740 U—3-Methoxyadrenalinium+3-Methoxynoradrenalinium; subst.c. = ? Plasma— µmol/l Centromer antibody(Immunoglobulin G); NPU17116 U—Noradrenalinium; subst.c. = ? µmol/l arbitrary substance concentration(procedure) arbitrary unit/litre Urine— NPU12015 Catecholmetabolite; P—Centromer antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l amount-of-substance(list; procedure) NPU17628 Leukocytes(Blood)— U—Catecholmetabolite; am.s.(list; proc.) Cerebroside-sulfatase; NPU17568 U—Homovanillate; am.s. = ? µmol entitic catalytic activity(37 °C; procedure) NPU17627 U—Vanillylmandelate; am.s.(proc.) = ? µmol attokatal Other term(s): Arylsulfatase A Urine— NPU09104 Catecholmetabolite; Lkcs(B)—Cerebroside-sulfatase; entitic cat.act.(37 °C; proc.) = ? akat substance concentration(list; procedure) NPU17595 Cerebrospinal fluid— U—Catecholmetabolite; subst.c.(list; proc.) Cerebrospinal fluid; NPU08685 U—Vanillylmandelate; subst.c. = ? µmol/l clarity(after spinning; procedure) NPU02402 U—Homovanillate; subst.c. = ? µmol/l NPU04225 Csf—Cerebrospinal fluid; clarity(after spinn.; proc.)= ? Plasma— Cefotaxime; Cerebrospinal fluid— substance concentration Cerebrospinal fluid; mol/litre clarity(before spinning; procedure) NPU17025 NPU04224 P—Cefotaxime; subst.c.= ? prefix ? mol/l Csf—Cerebrospinal fluid; clarity(before spinn.; proc.)= ?
System(specification)— Cerebrospinal fluid— Cells; Cerebrospinal fluid; arbitrary concentration(procedure) colour(procedure) NPU10292 NPU17026 Syst(spec.)—Cells; arb.c.(proc.) = ? Csf—Cerebrospinal fluid; colour(proc.)= ?
Ascites— Cerebrospinal fluid— Cells; Cerebrospinal fluid; number concentration property(list; procedure) 106/litre NPU14911 NPU08683 Csf—Cerebrospinal fluid; prop.(list; proc.) Asc—Cells; num.c. = ? × 106/l NPU01130 Csf—Albumin; subst.c. = ? µmol/l NPU04224 Csf—Cerebrospinal fluid; clarity(before spinn.; proc.)= ? Cerebrospinal fluid— NPU04225 Csf—Cerebrospinal fluid; clarity(after spinn.; proc.)= ? Cells; NPU01962 Csf—Erythrocytes; num.c. = ? × 106/l number concentration NPU02190 Csf—Glucose; subst.c. = ? mmol/l 106/litre NPU01523 Csf—Glucose; rel.subst.c.(Csf/P) = ? NPU04775 NPU02594 Csf—Leukocytes; num.c. = ? × 106/l Csf—Cells; num.c.= ? × 106/l NPU03276 Csf—Protein; mass c. = ? g/l
Pleural fluid(specification)— Urine— Cells; Chloride; number concentration amount-of-substance(procedure) 106/litre millimol NPU08682 NPU17539 Plf(spec.)—Cells; num.c. = ? × 106/l U—Chloride; am.s.(proc.) = ? mmol
36 Sweat(specification)— Plasma— Chloride; Cholesterol; substance concentration(stimulated; procedure) property(list; procedure) millimol/litre M = 386,64 g/mol M = 35,45 g/mol NPU17029 NPU04126 P—Cholesterol; prop.(list; proc.) Sweat(spec.)—Chloride; subst.c.(stim.; proc.) = ? mmol/l NPU01549 P—Cholesterol(non ester); subst.c. = ? mmol/l NPU01566 P—Cholesterol+ester; subst.c. = ? mmol/l Amniotic fluid— NPU01567 P—Cholesterol+ester, in HDL; subst.c. = ? mmol/l Chloride; NPU01568 P—Cholesterol+ester, in LDL; subst.c. = ? mmol/l substance concentration NPU01569 P—Cholesterol+ester, in VLDL; subst.c. = ? mmol/l millimol/litre NPU04146 P—Cholesterol+ester, in LDL/Cholesterol+ester, in HDL; subst.ratio M = 35,45 g/mol = ? NPU08612 NPU10293 P(fPt)—Cholesterol+ester/Cholesterol+ester, in HDL; subst.ratio = ? Amf—Chloride; subst.c. = ? mmol/l Ascites— Plasma— Cholesterol+ester, in HDL; Chloride; substance concentration substance concentration millimol/litre millimol/litre Other term(s): High density lipoprotein cholesterol M = 35,453 g/mol Note: (H)igh (D)ensity Authority: IFCC/C-BGE NPU17014 NPU01536 Asc—Cholesterol+ester, in HDL; subst.c. = ? mmol/l P—Chloride; subst.c. = ? mmol/l Plasma— Sweat— Cholesterol+ester, in HDL; Chloride; substance concentration substance concentration millimol/litre millimol/litre Other term(s): High density lipoprotein cholesterol M = 35,453 g/mol Note: (H)igh (D)ensity Authority: IFCC/C-BGE NPU01567 NPU01537 P—Cholesterol+ester, in HDL; subst.c. = ? mmol/l Sweat—Chloride; subst.c. = ? mmol/l Plasma(fasting Patient)— System(specification)— Cholesterol+ester, in HDL; Chloride; substance concentration substance concentration millimol/litre millimol/litre NPU10157 M = 35,453 g/mol P(fPt)—Cholesterol+ester, in HDL; subst.c. = ? mmol/l NPU10122 Syst(spec.)—Chloride; subst.c. = ? mmol/l Pleural fluid— Cholesterol+ester, in HDL; Urine— substance concentration Chloride; millimol/litre substance concentration Other term(s): High density lipoprotein cholesterol millimol/litre Note: (H)igh (D)ensity M = 35,45 g/mol NPU17016 NPU08613 Plf—Cholesterol+ester, in HDL; subst.c. = ? mmol/l U—Chloride; subst.c. = ? mmol/l Plasma— Faeces— Cholesterol+ester, in LDL/Cholesterol+ester, in HDL; Chloride; substance ratio substance content NPU04146 millimol/kilogram P—Cholesterol+ester, in LDL/Cholesterol+ester, in HDL; subst.ratio = ? NPU03816 F—Chloride; subst.cont. = ? mmol/kg Plasma(fasting Patient)— Cholesterol+ester, in LDL/Cholesterol+ester, in HDL; Patient(Urine)— substance ratio Chloride; NPU10172 substance rate(procedure) P(fPt)—Cholesterol+ester, in LDL/Cholesterol+ester, in HDL; subst.ratio = ? millimol/day Authority: IFCC/C-BGE Plasma— NPU01535 Cholesterol+ester, in LDL; Pt(U)—Chloride; subst.rate(proc.) = ? mmol/d substance concentration millimol/litre Plasma— Other term(s): Low density lipoprotein cholesterol Cholecystokinin; Note: (L)ow (D)ensity substance concentration NPU01568 picomol/litre P—Cholesterol+ester, in LDL; subst.c. = ? mmol/l NPU17555 P—Cholecystokinin; subst.c. = ? pmol/l Plasma(fasting Patient)— Cholesterol+ester, in LDL; Plasma— substance concentration Cholesterol(non ester); millimol/litre substance concentration NPU10171 millimol/litre P(fPt)—Cholesterol+ester, in LDL; subst.c. = ? mmol/l M = 386,64 g/mol NPU01549 Pleural fluid— P—Cholesterol(non ester); subst.c. = ? mmol/l Cholesterol+ester, in LDL; substance concentration millimol/litre Other term(s): Low density lipoprotein cholesterol Note: (L)ow (D)ensity NPU17017 Plf—Cholesterol+ester, in LDL; subst.c. = ? mmol/l
37 Plasma— Cholinesterase(Plasma)— Cholesterol+ester, in VLDL; Cholinesterase type; substance concentration catalytic-activity fraction(list; 25 °C; procedure) millimol/litre Note: obs the sum of fractions may be >1 Other term(s): Very low density lipoprotein cholesterol NPU03565 Note: (V)ery (L)ow (D)ensity ChE(P)—Cholinesterase type; cat.fr.(list; 25 °C; proc.) NPU01569 NPU04603 ChE(P)—Cholinesterase, cinchocaine inhibited; cat.fr.(25 °C; proc.) P—Cholesterol+ester, in VLDL; subst.c. = ? mmol/l = ? NPU04595 ChE(P)—Cholinesterase, dibucain inhibited; cat.fr.(25 °C; proc.) = ? Plasma(fasting Patient)— NPU04566 ChE(P)—Cholinesterase, fluoride inhibited; cat.fr.(25 °C; proc.)= ? Cholesterol+ester, in VLDL; NPU04494 ChE(P)—Cholinesterase, RO-20683 inhibited; cat.fr.(25 °C; substance concentration proc.)= ? millimol/litre NPU04594 ChE(P)—Cholinesterase, carbamide inhibited; cat.fr.(25 °C; Other term(s): Very low density lipoprotein cholesterol proc.)= ? Note: (V)ery (L)ow (D)ensity NPU09256 Cholinesterase(Plasma)— P(fPt)—Cholesterol+ester, in VLDL; subst.c. = ? mmol/l Cholinesterase type; catalytic-activity fraction(list; 37 °C; procedure) Pleural fluid— Note: Note 1: obs the sum of fractions may be >1 Cholesterol+ester, in VLDL; NPU03792 substance concentration ChE(P)—Cholinesterase type; cat.fr.(list; 37 °C; proc.) millimol/litre NPU04170 ChE(P)—Cholinesterase, cinchocaine inhibited; cat.fr.(37 °C; proc.) Other term(s): Very low density lipoprotein cholesterol = ? Note: (V)ery (L)ow (D)ensity NPU04601 ChE(P)—Cholinesterase, dibucain inhibited; cat.fr.(37 °C; proc.)= ? NPU17019 NPU04600 ChE(P)—Cholinesterase, fluoride inhibited; cat.fr.(37 °C; proc.)= ? Plf—Cholesterol+ester, in VLDL; subst.c. = ? mmol/l NPU04604 ChE(P)—Cholinesterase, RO-20683 inhibited; cat.fr.(37 °C; proc.)= ? Plasma(fasting Patient)— NPU04602 ChE(P)—Cholinesterase, carbamide inhibited; cat.fr.(37 °C; proc.) = Cholesterol+ester/Cholesterol+ester, in HDL; ? substance ratio NPU10293 Cholinesterase(Plasma)— P(fPt)—Cholesterol+ester/Cholesterol+ester, in HDL; subst.ratio = ? Cholinesterase, butan-1-ol inhibited; catalytic-activity fraction(25 °C; procedure) Amniotic fluid— Note: Fraction of total activity inhibited by butan-1-ol Cholesterol+ester; NPU08568 substance concentration ChE(P)—Cholinesterase, butan-1-ol inhibited; cat.fr.(25 °C; proc.) = ? millimol/litre NPU17784 Cholinesterase(Plasma)— Amf—Cholesterol+ester; subst.c. = ? mmol/l Cholinesterase, carbamide inhibited; catalytic-activity fraction(25 °C; procedure) Ascites— Note: fraction of total activity inhibited by urea Cholesterol+ester; NPU04594 substance concentration ChE(P)—Cholinesterase, carbamide inhibited; cat.fr.(25 °C; proc.)= ? millimol/litre M = 386,64 g/mol Cholinesterase(Plasma)— NPU10032 Cholinesterase, carbamide inhibited; Asc—Cholesterol+ester; subst.c. = ? mmol/l catalytic-activity fraction(37 °C; procedure) Note: fraction of total activity inhibited by urea Plasma— NPU04602 Cholesterol+ester; ChE(P)—Cholinesterase, carbamide inhibited; cat.fr.(37 °C; proc.) = ? substance concentration millimol/litre Cholinesterase(Plasma)— M = 386,64 g/mol Cholinesterase, cinchocaine inhibited; Other term(s): Cholesterol; Cholesterol, total catalytic-activity fraction(25 °C; procedure) NPU01566 Other term(s): Dibucaine; Cinchoine P—Cholesterol+ester; subst.c. = ? mmol/l Note: Fraction of total activity inhibited by cinchocaine NPU04603 Pleural fluid— ChE(P)—Cholinesterase, cinchocaine inhibited; cat.fr.(25 °C; proc.) = ? Cholesterol+ester; substance concentration Cholinesterase(Plasma)— millimol/litre Cholinesterase, cinchocaine inhibited; M = 386,64 g/mol catalytic-activity fraction(37 °C; procedure) Other term(s): Cholesterol; Cholesterol, total Other term(s): Dibucaine; Cinchoine NPU17028 Note: Fraction of total activity inhibited by cinchocaine Plf—Cholesterol+ester; subst.c. = ? mmol/l NPU04170 ChE(P)—Cholinesterase, cinchocaine inhibited; cat.fr.(37 °C; proc.) = ? System(specification)— Cholesterol+ester; Cholinesterase(Plasma)— substance concentration Cholinesterase, dibucain inhibited; millimol/litre catalytic-activity fraction(25 °C; procedure) M = 386,64 g/mol Note: Fraction of total activity inhibited by dibucain NPU10033 NPU04595 Syst(spec.)—Cholesterol+ester; subst.c. = ? mmol/l ChE(P)—Cholinesterase, dibucain inhibited; cat.fr.(25 °C; proc.) = ?
Plasma— Cholinesterase(Plasma)— Cholinesterase antibody; Cholinesterase, dibucain inhibited; arbitrary substance concentration(procedure) catalytic-activity fraction(37 °C; procedure) arbitrary unit/litre Note: Fraction of total activity inhibited by dibucain NPU12063 NPU04601 P—Cholinesterase antibody; arb.subst.c.(proc.) = ? arb.unit/l ChE(P)—Cholinesterase, dibucain inhibited; cat.fr.(37 °C; proc.)= ?
Cholinesterase(Plasma)— Cholinesterase, fluoride inhibited; catalytic-activity fraction(25 °C; procedure) Note: Fraction of total activity inhibited by fluoride NPU04566 ChE(P)—Cholinesterase, fluoride inhibited; cat.fr.(25 °C; proc.)= ?
38 Cholinesterase(Plasma)— Plasma— Cholinesterase, fluoride inhibited; Choriogonadotropin beta-chain core fragment; catalytic-activity fraction(37 °C; procedure) substance concentration Note: Fraction of total activity inhibited by fluoride picomol/litre NPU04600 Other term(s): hCG beta-cf ChE(P)—Cholinesterase, fluoride inhibited; cat.fr.(37 °C; proc.)= ? NPU08936 P—Choriogonadotropin beta-chain core fragment; subst.c. = ? pmol/l Cholinesterase(Plasma)— Cholinesterase, RO-20683 inhibited; Plasma— catalytic-activity fraction(25 °C; procedure) Choriogonadotropin beta-chain nicked; Note: Fraction of total activity inhibited by RO-20683 substance concentration NPU04494 picomol/litre ChE(P)—Cholinesterase, RO-20683 inhibited; cat.fr.(25 °C; proc.)= ? Other term(s): hCG beta-n NPU08938 Cholinesterase(Plasma)— P—Choriogonadotropin beta-chain nicked; subst.c. = ? pmol/l Cholinesterase, RO-20683 inhibited; catalytic-activity fraction(37 °C; procedure) Plasma— Note: Fraction of total activity inhibited by RO-20683 Choriogonadotropin beta-chain; NPU04604 arbitrary substance concentration(IRP 75/551; procedure) ChE(P)—Cholinesterase, RO-20683 inhibited; cat.fr.(37 °C; proc.)= ? international unit/litre M = 25 000 g/mol Plasma— Recommended calibrator: WHO 1st IRP 75/551 Cholinesterase; Other term(s): hCG beta catalytic-activity concentration(25 °C; procedure) NPU01580 microkatal/litre P—Choriogonadotropin beta-chain; arb.subst.c.(IRP 75/551; proc.) = ? int. unit/l Other term(s): Benzoylcholinesterase; Choline esterase II; Pseudocholinesterase Plasma— NPU04593 Choriogonadotropin beta-chain; P—Cholinesterase; cat.c.(25 °C; proc.) = ? µkat/l substance concentration picomol/litre Amniotic fluid— M = 25 000 g/mol Cholinesterase; Other term(s): hCG beta catalytic-activity concentration(37 °C; procedure) NPU01581 microkatal/litre P—Choriogonadotropin beta-chain; subst.c. = ? pmol/l NPU03914 Amf—Cholinesterase; cat.c.(37 °C; proc.) = ? µkat/l Plasma— Choriogonadotropin nicked; Plasma— substance concentration Cholinesterase; picomol/litre catalytic-activity concentration(37 °C; procedure) Other term(s): hCGn microkatal/litre NPU08937 Other term(s): Benzoylcholinesterase; Choline esterase II; P—Choriogonadotropin nicked; subst.c. = ? pmol/l Pseudocholinesterase NPU01570 Urine— P—Cholinesterase; cat.c.(37 °C; proc.) = ? µkat/l Choriogonadotropin; arbitrary concentration(procedure) Plasma— M = 39 000 g/mol Cholinesterase; Authority: IUPAC-IUB 74 substance concentration NPU10394 nanomol/litre U—Choriogonadotropin; arb.c.(proc.) = ? M = 300 000 g/mol Other term(s): Benzoylcholinesterase; Choline esterase II; Plasma— Pseudocholinesterase Choriogonadotropin; NPU10294 arbitrary substance concentration(IS 61/6; procedure) P—Cholinesterase; subst.c. = ? nmol/l international unit/litre M = 39 000 g/mol Urine— Recommended calibrator: WHO 2nd IS 61/6 Chondroitin sulfate; Other term(s): hCG substance concentration Authority: IUPAC-IUB 74 micromol/litre NPU04003 M = 50 000 g/mol P—Choriogonadotropin; arb.subst.c.(IS 61/6; proc.) = ? int. unit/l Authority: IUPAC-IUB85 NPU01571 Urine— U—Chondroitin sulfate; subst.c. = ? µmol/l Choriogonadotropin; arbitrary substance concentration(IS 61/6; procedure) Plasma— international unit/litre Choriogonadotropin alpha-chain; M = 39 000 g/mol arbitrary substance concentration(IRP 75/569; procedure) Recommended calibrator: WHO 2nd IS 61/6 international unit/litre Other term(s): hCG M = 14 000 g/mol Authority: IUPAC-IUB 74 Recommended calibrator: WHO 1st IRP 75/569 NPU01576 Other term(s): hCG alpha U—Choriogonadotropin; arb.subst.c.(IS 61/6; proc.) = ? int. unit/l NPU01578 P—Choriogonadotropin alpha-chain; arb.subst.c.(IRP 75/569; proc.) = ? int. Plasma— unit/l Choriogonadotropin; arbitrary substance concentration(IS 75/537; procedure) Plasma— international unit/litre Choriogonadotropin alpha-chain; M = 39 000 g/mol substance concentration Recommended calibrator: WHO 3rd IS 75/537 picomol/litre Calibrator(s): WHO 1st IRP 75/537 (for immunoassay; identical to 3rd IS M = 14 000 g/mol Other term(s): hCG Other term(s): hCG alpha Authority: IUPAC-IUB 74 NPU01579 NPU01572 P—Choriogonadotropin alpha-chain; subst.c. = ? pmol/l P—Choriogonadotropin; arb.subst.c.(IS 75/537; proc.) = ? int. unit/l
39 Urine— Urine— Choriogonadotropin; Chromium(III); arbitrary substance concentration(IS 75/537; procedure) substance concentration international unit/litre nanomol/litre M = 39 000 g/mol M = 52,00 g/mol Recommended calibrator: 3rd IS 75/537 Authority: IUPAC/VII-C-TOX Calibrator(s): 1st IRP 75/537 (identical to 3rd IS) NPU01590 Authority: IUPAC-IUB 74 U—Chromium(III); subst.c. = ? nmol/l NPU10034 U—Choriogonadotropin; arb.subst.c.(IS 75/537; proc.) = ? int. unit/l Hair— Chromium(III); Patient— substance content Choriogonadotropin; micromol/kilogram arbitrary substance content(intramuscular administration; arbitrary M = 52,00 g/mol amount-of-substance/body m; procedure; IS 75/537) Authority: IUPAC/VII-C-TOX international unit/kilogram NPU01588 NPU10423 Hair—Chromium(III); subst.cont. = ? µmol/kg Pt—Choriogonadotropin; arb.subst.cont.(i.m.; arb.am.s./body mass; proc.; IS 75/537)= ? int. unit/kg Cells(Blood)— Chromium(III); Plasma— substance content Choriogonadotropin; nanomol/kilogram substance concentration M = 52,00 g/mol picomol/litre Authority: IUPAC/VII-C-TOX M = 39 000 g/mol NPU01586 Other term(s): hCG Cells(B)—Chromium(III); subst.cont. = ? nmol/kg Authority: IUPAC-IUB 74 NPU01573 Air(specification)— P—Choriogonadotropin; subst.c. = ? pmol/l Chromium(IV); substance concentration Urine— micromol/(metre)³ Choriogonadotropin; M = 52,00 g/mol substance concentration Authority: IUPAC/VII-C-TOX picomol/litre NPU01591 M = 39 000 g/mol Air(spec.)—Chromium(IV); subst.c. = ? µmol/m³ Other term(s): hCG Authority: IUPAC-IUB 74 Kidney— NPU01577 Chromium-EDTA-clearance; U—Choriogonadotropin; subst.c. = ? pmol/l volume rate(procedure) millilitre/second Plasma— NPU10295 Choriogonadotropin+beta-chain; Kidn.—Chromium-EDTA-clearance; vol.rate(proc.) = ? ml/s arbitrary substance concentration(IS 75/537; procedure) international unit/litre Plasma— Recommended calibrator: WHO 3rd IS 75/537 Chromogranin A; Calibrator(s): 1st IRP 75/537 (identical to 3rd IS) arbitrary substance concentration(procedure) NPU01582 arbitrary unit/litre P—Choriogonadotropin+beta-chain; arb.subst.c.(IS 75/537; proc.) = ? int. unit/l NPU10614 P—Chromogranin A; arb.subst.c.(proc.) = ? arb.unit/l Plasma— Choriogonadotropin+beta-chain; Plasma— substance concentration Chromogranin A; picomol/litre substance concentration NPU01583 picomol/litre P—Choriogonadotropin+beta-chain; subst.c. = ? pmol/l NPU17556 P—Chromogranin A; subst.c. = ? pmol/l Plasma— Choriomammotropin; Plasma— arbitrary substance concentration(IRP 73/545; procedure) Chromogranin B; international unit/litre substance concentration M = 21 600 g/mol picomol/litre Recommended calibrator: WHO 1st IRP 73/545 NPU17557 Other term(s): Chorionic somatomammotropin; Chorionsomatomammotropin; P—Chromogranin B; subst.c. = ? pmol/l Human placenta lactogen Authority: IUPAC-IUB 74 Plasma— NPU01584 Chylomicrons; P—Choriomammotropin; arb.subst.c.(IRP 73/545; proc.) = ? int. unit/l arbitrary concentration(procedure) NPU10035 Plasma— P—Chylomicrons; arb.c.(proc.) = ? Choriomammotropin; substance concentration Faeces— nanomol/litre Chymotrypsin; M = 21 600 g/mol arbitrary content(procedure) Other term(s): Chorionic somatomammotropin; Chorionsomatomammotropin; NPU04850 Human placenta lactogen F—Chymotrypsin; arb.cont.(proc.)= ? Authority: IUPAC-IUB 74 NPU01585 Urine— P—Choriomammotropin; subst.c. = ? nmol/l Citrate; substance concentration Plasma— millimol/litre Chromium(III); NPU01594 substance concentration U—Citrate; subst.c. = ? mmol/l nanomol/litre M = 52,00 g/mol Patient(Urine)— Authority: IUPAC/VII-C-TOX Citrate; NPU01589 substance rate(procedure) P—Chromium(III); subst.c. = ? nmol/l millimol/day NPU14263 Pt(U)—Citrate; subst.rate(proc.) = ? mmol/d
40 Urine— Cobalamin(Plasma)— Citrulline/Creatininium; Cobalamin type; substance ratio substance fraction(list; procedure) 10-3 NPU01701 NPU14204 Cobalamin(P)—Cobalamin type; subst.fr.(list; proc.) U—Citrulline/Creatininium; subst.ratio = ? × 10-3 NPU04956 Cobalamin(P)—Aquocobalamin; subst.fr. = ? NPU04954 Cobalamin(P)—Cyanocobalamin; subst.fr. = ? Cerebrospinal fluid— NPU04959 Cobalamin(P)—Deoxycobalamin; subst.fr.= ? Citrulline; NPU04955 Cobalamin(P)—Hydroxocobalamin; subst.fr. = ? substance concentration NPU04958 Cobalamin(P)—Methylcobalamin; subst.fr.= ? micromol/litre NPU04957 Cobalamin(P)—Sulfitocobalamin; subst.fr. = ? M = 175,19 g/mol NPU09020 Patient— Csf—Citrulline; subst.c. = ? µmol/l Cobalamin(administered); amount-of-substance(intramuscular administration) Plasma— micromol Citrulline; NPU13809 substance concentration Pt—Cobalamin(administered); am.s.(i.m.) = ? µmol micromol/litre M = 175,19 g/mol Patient— NPU01611 57Co- P—Citrulline; subst.c. = ? µmol/l Cobalamin(administered); amount-of-substance(oral administration) Urine— picomol Citrulline; NPU13805 substance concentration Pt—57Co-Cobalamin(administered); am.s.(p.o.) = ? pmol micromol/litre M = 175,19 g/mol Patient— NPU01612 58Co- U—Citrulline; subst.c. = ? µmol/l Cobalamin(administered); amount-of-substance(oral administration) Patient— picomol Clonidine(administered); NPU13812 amount-of-substance(oral administration) Pt—58Co-Cobalamin(administered); am.s.(p.o.) = ? pmol micromol M = 230,10 g/mol Patient— NPU10536 57Co- Pt—Clonidine(administered); am.s.(p.o.) = ? µmol Cobalamin(administered); radioactivity(oral administration) Vaginal fluid— kilobecquerel Clue cells; NPU13808 arbitrary concentration(procedure) Pt—57Co-Cobalamin(administered); radioact.(p.o.) = ? kBq NPU14316 Vagf—Clue cells; arb.c.(proc.) = ? Patient— 58Co- Plasma— Cobalamin(administered); Coagulation, tissue factor-induced; radioactivity(oral administration) arbitrary substance concentration(procedure; BCR/CRM148/149R) kilobecquerel arbitrary unit/litre NPU13810 NPU14567 Pt—58Co-Cobalamin(administered); radioact.(p.o.) = ? kBq P—Coagulation, tissue factor-induced; arb.subst.c.(proc.; BCR/CRM148/149R) = ? arb.unit/l Patient(Urine)— 57Co- Synovial fluid— Cobalamin; 57 Coagulum; relative amount-of-substance( Co-B12 and intrinsic factor, oral arbitrary concentration(procedure) administration; urine 1 d/intake; procedure) NPU17067 M = 1 355 g/mol Synf—Coagulum; arb.c.(proc.) = ? Other term(s): Schilling test II NPU01698 57 57 Intestine, small— Pt(U)— Co-Cobalamin; rel.ams.( Co-B12 and IF p.o.; U 1 d/intake; proc.) = ? Cobalamin absorption; substance rate(Intrinsic factor; oral administration; list; procedure) Patient(Urine)— NPU13813 57Co- Intest., small—Cobalamin absorption; subst.rate(Intrinsic factor; p.o.; list; proc.) Cobalamin; 57 NPU13809 Pt—Cobalamin(administered); am.s.(i.m.) = ? µmol relative amount-of-substance( Co-B12, oral administration; urine 1 NPU13805 Pt—57Co-Cobalamin(administered); am.s.(p.o.) = ? pmol d/intake; procedure) NPU13812 Pt—58Co-Cobalamin(administered); am.s.(p.o.) = ? pmol M = 1 355 g/mol NPU13808 Pt—57Co-Cobalamin(administered); radioact.(p.o.) = ? kBq Other term(s): Schilling test I NPU13810 Pt—58Co-Cobalamin(administered); radioact.(p.o.) = ? kBq NPU01699 57 57 57 NPU13807 Pt(U)— Co-Cobalamin; rel.radioact.(U 1 d/intake) = ? Pt(U)— Co-Cobalamin; rel.ams.( Co-B12 p.o.; U 1 d/intake; proc.) = ? NPU13811 Pt(U)—58Co-Cobalamin; rel.radioact.(U 1 d/intake) = ? Patient(Faeces)— Intestine, small— 58Co- Cobalamin absorption; Cobalamin; 58 substance rate(no intrinsic factor; list; procedure) relative amount-of-substance( Co-B12 and intrinsic factor, oral NPU13804 administration; faeces/intake; procedure) Intest., small—Cobalamin absorption; subst.rate(no intrinsic factor; list; proc.) M = 1 355 g/mol NPU13809 Pt—Cobalamin(administered); am.s.(i.m.) = ? µmol Other term(s): ISA-test; Incomplete Stool Absorption test NPU13805 Pt—57Co-Cobalamin(administered); am.s.(p.o.) = ? pmol NPU01696 58 58 58 NPU13812 Pt— Co-Cobalamin(administered); am.s.(p.o.) = ? pmol Pt(F)— Co-Cobalamin; rel.ams.( Co-B12 and IF p.o.; F/intake; proc.) = ? NPU13808 Pt—57Co-Cobalamin(administered); radioact.(p.o.) = ? kBq NPU13810 Pt—58Co-Cobalamin(administered); radioact.(p.o.) = ? kBq Patient(Faeces)— NPU13807 Pt(U)—57Co-Cobalamin; rel.radioact.(U 1 d/intake) = ? 58Co- NPU13811 Pt(U)—58Co-Cobalamin; rel.radioact.(U 1 d/intake) = ? Cobalamin; 58 relative amount-of-substance( Co-B12, oral administration; faeces/intake; procedure) M = 1 355 g/mol Other term(s): ISA-test; Incomplete Stool Absorption test NPU01695 58 58 Pt(F)— Co-Cobalamin; rel.ams.( Co-B12 p.o.; F/intake; proc.) = ?
41 Plasma— Patient(Urine)— Complement activity, antibody-induced; 57Co- property(erythrolysis; procedure) Cobalamin; Other term(s): Hemolytic complement titer classical system; CH50; AP50 relative radioactivity(urine 1 d/intake) Authority: ICW91 NPU13807 NPU01715 Pt(U)—57Co-Cobalamin; rel.radioact.(U 1 d/intake) = ? P—Complement activity, antibody-induced; prop.(erythrol.; proc.) = ?
Patient(Urine)— Plasma— 58Co- Complement activity, cell-surface-induced; Cobalamin; property(erythrolysis; procedure) relative radioactivity(urine 1 d/intake) Other term(s): Hemolytic complement titer alternative system NPU13811 Authority: ICW91 Pt(U)—58Co-Cobalamin; rel.radioact.(U 1 d/intake) = ? NPU01716 P—Complement activity, cell-surface-induced; prop.(erythrol.; proc.) = ? Plasma— Cobalamin; Plasma— substance concentration Complement C1 esterase inhibitor; picomol/litre arbitrary concentration(enzymatic; procedure) NPU01700 M = 105 000 g/mol P—Cobalamin; subst.c. = ? pmol/l Other term(s): C1 Inactivator; C1 INA; C1IA; C1 esterase inhibitor; C1 INH; C1 inhibitor Air(specification)— Authority: ICW91 Cobalt; NPU01718 substance concentration P—Complement C1 esterase inhibitor; arb.c.(enz.; proc.) = ? micromol/(metre)³ M = 58,93 g/mol Plasma— Authority: IUPAC/VII-C-TOX Complement C1 esterase inhibitor; NPU01702 arbitrary concentration(immunological; procedure) Air(spec.)—Cobalt; subst.c. = ? µmol/m³ M = 105 000 g/mol Other term(s): C1 Inactivator; C1 INA; C1IA; C1 esterase inhibitor; C1 INH; C1 Blood— inhibitor Cobalt; Authority: ICW91 substance concentration NPU01719 nanomol/litre P—Complement C1 esterase inhibitor; arb.c.(imm.; proc.) = ? M = 58,93 g/mol Authority: IUPAC/VII-C-TOX Plasma— NPU01703 Complement C1 esterase inhibitor; B—Cobalt; subst.c. = ? nmol/l arbitrary substance concentration(enzymatic; procedure) NPU14340 Plasma— P—Complement C1 esterase inhibitor; arb.subst.c.(enz.; proc.) = ? Cobalt; substance concentration Plasma— nanomol/litre Complement C1 esterase inhibitor; M = 58,93 g/mol substance concentration(procedure) Authority: IUPAC/VII-C-TOX micromol/litre NPU04904 M = 105 000 g/mol P—Cobalt; subst.c. = ? nmol/l Other term(s): C1 Inactivator; C1 INA; C1IA; C1 esterase inhibitor; C1 INH; C1 inhibitor Urine— Authority: ICW91 Cobalt; NPU01720 substance concentration P—Complement C1 esterase inhibitor; subst.c.(proc.) = ? µmol/l nanomol/litre M = 58,93 g/mol Plasma— Authority: IUPAC/VII-C-TOX Complement C1q; NPU01705 arbitrary concentration(erythrolysis; procedure) U—Cobalt; subst.c. = ? nmol/l M = 462 000 g/mol Authority: ICW91 Hair— NPU01721 Cobalt; P—Complement C1q; arb.c.(erythrol.; proc.) = ? substance content micromol/kilogram Plasma— M = 58,93 g/mol Complement C1q; Authority: IUPAC/VII-C-TOX arbitrary concentration(immunological; procedure) NPU01704 M = 462 000 g/mol Hair—Cobalt; subst.cont. = ? µmol/kg Authority: ICW91 NPU03857 Plasma— P—Complement C1q; arb.c.(imm.; proc.) = ? Coeliac disease antibody; property(list; procedure) Plasma— NPU14503 Complement C1q; P—Coeliac disease antibody; prop.(list; proc.) substance concentration(procedure) NPU12538 P—Endomysium antibody(IgA); arb.c.(proc.) = ? micromol/litre NPU08945 P—Gliadin antibody(IgA); arb.subst.c.(proc.) = ? × 10³ arb.unit/l M = 462 000 g/mol NPU08944 P—Gliadin antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Authority: ICW91 NPU12247 P—Reticulin antibody(IgA); arb.c.(proc.) = ? NPU01722 NPU12248 P—Reticulin antibody(IgG); arb.c.(proc.) = ? P—Complement C1q; subst.c.(proc.) = ? µmol/l NPU17704 P—Transglutaminase antibody(IgA); arb.c.(proc.) = ? NPU14566 P—Transglutaminase antibody(IgA); arb.subst.c.(proc.) = ? × 10³ Plasma— arb.unit/l Complement C1r2-C1s2; arbitrary concentration(erythrolysis; procedure) Plasma— M = 332 000 g/mol Colistin; Authority: ICW91 substance concentration NPU01723 mol/litre P—Complement C1r2-C1s2; arb.c.(erythrol.; proc.) = ? NPU10297 P—Colistin; subst.c.= ? prefix ? mol/l
42 Plasma— Plasma— Complement C1r2-C1s2; Complement C3a; arbitrary concentration(immunological; procedure) substance concentration M = 332 000 g/mol micromol/litre Authority: ICW91 M = 9 000 g/mol NPU03858 Authority: ICW91 P—Complement C1r2-C1s2; arb.c.(imm.; proc.) = ? NPU01729 P—Complement C3a; subst.c. = ? µmol/l Plasma— Complement C1r2-C1s2; Plasma— substance concentration(procedure) Complement C3b; micromol/litre arbitrary concentration(procedure) M = 332 000 g/mol M = 176 000 g/mol Authority: ICW91 Authority: ICW91 NPU01724 NPU03863 P—Complement C1r2-C1s2; subst.c.(proc.) = ? µmol/l P—Complement C3b; arb.c.(proc.) = ?
Plasma— Plasma— Complement C1s; Complement C3b; arbitrary substance concentration(immunological; procedure) substance concentration arbitrary unit/litre micromol/litre NPU03900 M = 176 000 g/mol P—Complement C1s; arb.subst.c.(imm.; proc.) = ? arb.unit/l Authority: ICW91 NPU01730 Plasma— P—Complement C3b; subst.c. = ? µmol/l Complement C2; arbitrary concentration(erythrolysis; procedure) Erythrocytes(Blood)— M = 102 000 g/mol Complement C3b-C4b receptor; Authority: ICW91 arbitrary entitic number(procedure) NPU01725 Other term(s): Complement receptor type 1; CR 1 P—Complement C2; arb.c.(erythrol.; proc.) = ? NPU03869 Ercs(B)—Complement C3b-C4b receptor; arb.entitic num.(proc.) = ? Plasma— Complement C2; Erythrocytes(Blood)— arbitrary concentration(immunological; procedure) Complement C3b-C4b receptor; M = 102 000 g/mol entitic number(procedure) Authority: ICW91 Other term(s): Complement receptor type 1; CR 1 NPU03859 Authority: ICW91 P—Complement C2; arb.c.(imm.; proc.) = ? NPU01731 Ercs(B)—Complement C3b-C4b receptor; entitic num.(proc.) = ? Plasma— Complement C2; Plasma— substance concentration(procedure) Complement C3c; micromol/litre arbitrary concentration(procedure) M = 102 000 g/mol M = 134 000 g/mol Authority: ICW91 Authority: ICW91 NPU01726 NPU03864 P—Complement C2; subst.c.(proc.) = ? µmol/l P—Complement C3c; arb.c.(proc.) = ?
Erythrocytes(Blood)— Plasma— Complement C3 fragment; Complement C3c; arbitrary entitic number(procedure) substance concentration Authority: ICW91 micromol/litre NPU01728 M = 134 000 g/mol Ercs(B)—Complement C3 fragment; arb.entitic num.(proc.) = ? Authority: ICW91 NPU01732 Erythrocytes(Blood)— P—Complement C3c; subst.c. = ? µmol/l Complement C3 fragment; entitic number(procedure) Plasma— Authority: ICW91 Complement C3d,g; NPU03885 arbitrary concentration(procedure) Ercs(B)—Complement C3 fragment; entitic num.(proc.) = ? M = 40 000 g/mol Authority: ICW91 Plasma— NPU01735 Complement C3; P—Complement C3d,g; arb.c.(proc.) = ? arbitrary concentration(procedure) M = 185 000 g/mol Plasma— Other term(s): beta-1-C-globulin; Factor A Complement C3d,g; Authority: ICW91 substance concentration NPU03861 micromol/litre P—Complement C3; arb.c.(proc.) = ? M = 40 000 g/mol Authority: ICW91 Plasma— NPU03865 Complement C3; P—Complement C3d,g; subst.c. = ? µmol/l substance concentration micromol/litre Erythrocytes(Blood)— M = 185 000 g/mol Complement C3d; Other term(s): beta1-C-globulin; Factor A arbitrary entitic number(procedure) Authority: ICW91 Authority: ICW91 NPU01727 NPU01733 P—Complement C3; subst.c. = ? µmol/l Ercs(B)—Complement C3d; arb.entitic num.(proc.) = ?
Plasma— Plasma— Complement C3a; Complement C3d; arbitrary concentration(procedure) arbitrary substance concentration M = 9 000 g/mol arbitrary unit/litre Authority: ICW91 Authority: ICW91 NPU03862 NPU10298 P—Complement C3a; arb.c.(proc.) = ? P—Complement C3d; arb.subst.c. = ? arb.unit/l
43 Erythrocytes(Blood)— Erythrocytes(Blood)— Complement C3d; Complement C4d; entitic number(procedure) entitic number(procedure) Authority: ICW91 Authority: ICW91 NPU03886 NPU03887 Ercs(B)—Complement C3d; entitic num.(proc.) = ? Ercs(B)—Complement C4d; entitic num.(proc.) = ?
B-lymphocytes(Blood)— Plasma— Complement C3d-C3d,g-iC3b receptor; Complement C5; arbitrary entitic number(procedure) arbitrary concentration(adhesion; procedure) Other term(s): Complement receptor type 2; CR 2 M = 190 000 g/mol Authority: ICW91 Other term(s): beta1-F-globulin NPU01734 Authority: ICW91 B-lymphocs(B)—Complement C3d-C3d,g-iC3b receptor; arb.entitic num.(proc.) NPU01741 = ? P—Complement C5; arb.c.(adhesion; proc.) = ?
Plasma— Plasma— Complement C4; Complement C5; arbitrary concentration(adhesion; procedure) arbitrary substance concentration(immunological; procedure) M = 205 000 g/mol arbitrary unit/litre Authority: ICW91 M = 190 000 g/mol NPU01736 Other term(s): beta1-F-globulin P—Complement C4; arb.c.(adhesion; proc.) = ? Authority: ICW91 NPU03873 Plasma— P—Complement C5; arb.subst.c.(imm.; proc.) = ? arb.unit/l Complement C4; arbitrary substance concentration(immunological; procedure) Plasma— arbitrary unit/litre Complement C5; M = 205 000 g/mol substance concentration(procedure) Other term(s): beta1-E-globulin micromol/litre Authority: ICW91 M = 190 000 g/mol NPU03860 Other term(s): beta1-F-globulin P—Complement C4; arb.subst.c.(imm.; proc.) = ? arb.unit/l Authority: ICW91 NPU01742 Plasma— P—Complement C5; subst.c.(proc.) = ? µmol/l Complement C4; substance concentration(procedure) Plasma— micromol/litre Complement C5a; M = 205 000 g/mol arbitrary concentration(procedure) Other term(s): beta1-E-globulin M = 11 000 g/mol Authority: ICW91 Authority: ICW91 NPU01737 NPU03874 P—Complement C4; subst.c.(proc.) = ? µmol/l P—Complement C5a; arb.c.(proc.) = ?
Plasma— Plasma— Complement C4a; Complement C5a; arbitrary concentration(immunological; procedure) substance concentration(procedure) M = 7 000 g/mol micromol/litre Authority: ICW91 M = 11 000 g/mol NPU03866 Authority: ICW91 P—Complement C4a; arb.c.(imm.; proc.) = ? NPU01743 P—Complement C5a; subst.c.(proc.) = ? µmol/l Plasma— Complement C4a; Plasma— substance concentration(procedure) Complement C6; micromol/litre arbitrary concentration(adhesion; procedure) M = 7 000 g/mol M = 120 000 g/mol Authority: ICW91 Authority: ICW91 NPU01738 NPU01744 P—Complement C4a; subst.c.(proc.) = ? µmol/l P—Complement C6; arb.c.(adhesion; proc.) = ?
Plasma— Plasma— Complement C4b binding protein; Complement C6; arbitrary concentration(immunological; procedure) arbitrary concentration(immunological; procedure) M = 500 000 g/mol M = 120 000 g/mol Authority: ICW91 Authority: ICW91 NPU03867 NPU03875 P—Complement C4b binding protein; arb.c.(imm.; proc.) = ? P—Complement C6; arb.c.(imm.; proc.) = ?
Plasma— Plasma— Complement C4b binding protein; Complement C6; substance concentration(procedure) substance concentration(procedure) micromol/litre micromol/litre M = 500 000 g/mol M = 120 000 g/mol Authority: ICW91 Authority: ICW91 NPU01739 NPU01745 P—Complement C4b binding protein; subst.c.(proc.) = ? µmol/l P—Complement C6; subst.c.(proc.) = ? µmol/l
Erythrocytes(Blood)— Plasma— Complement C4d; Complement C7; arbitrary entitic number(procedure) arbitrary concentration(adhesion; procedure) Authority: ICW91 M = 110 000 g/mol NPU01740 Authority: ICW91 Ercs(B)—Complement C4d; arb.entitic num.(proc.) = ? NPU01746 P—Complement C7; arb.c.(adhesion; proc.) = ?
44 Plasma— Plasma— Complement C7; Complement factor B; arbitrary concentration(immunological; procedure) arbitrary concentration(adhesion; procedure) M = 110 000 g/mol M = 92 000 g/mol Authority: ICW91 Other term(s): C3 proactivator; Complement C3 proactivator+activator; Glycine- NPU03876 rich beta-glycoprotein; Heat labile factor P—Complement C7; arb.c.(imm.; proc.) = ? Authority: ICW91 NPU01753 Plasma— P—Complement factor B; arb.c.(adhesion; proc.) = ? Complement C7; substance concentration(procedure) Plasma— micromol/litre Complement factor B; M = 110 000 g/mol arbitrary concentration(immunological; procedure) Authority: ICW91 M = 92 000 g/mol NPU01747 Other term(s): C3 proactivator; Complement C3 proactivator+activator; Glycine- P—Complement C7; subst.c.(proc.) = ? µmol/l rich beta-glycoprotein; Heat labile factor Authority: ICW91 Plasma— NPU03880 Complement C8; P—Complement factor B; arb.c.(imm.; proc.) = ? arbitrary concentration(adhesion; procedure) M = 150 000 g/mol Plasma— Authority: ICW91 Complement factor B; NPU01748 arbitrary substance concentration(immunological; procedure) P—Complement C8; arb.c.(adhesion; proc.) = ? arbitrary unit/litre NPU12891 Plasma— P—Complement factor B; arb.subst.c.(imm.; proc.) = ? arb.unit/l Complement C8; arbitrary concentration(immunological; procedure) Plasma— M = 150 000 g/mol Complement factor B; Authority: ICW91 substance concentration(procedure) NPU03877 micromol/litre P—Complement C8; arb.c.(imm.; proc.) = ? M = 92 000 g/mol Other term(s): C3 proactivator; Complement C3 proactivator+activator; Glycine- Plasma— rich beta-glycoprotein; Heat labile factor Complement C8; Authority: ICW91 substance concentration(procedure) NPU01754 micromol/litre P—Complement factor B; subst.c.(proc.) = ? µmol/l M = 150 000 g/mol Authority: ICW91 Plasma— NPU01749 Complement factor Ba; P—Complement C8; subst.c.(proc.) = ? µmol/l arbitrary concentration(immunological; procedure) M = 33 000 g/mol Plasma— Authority: ICW91 Complement C9; NPU03881 arbitrary concentration(immunological; procedure) P—Complement factor Ba; arb.c.(imm.; proc.) = ? M = 71 000 g/mol Authority: ICW91 Plasma— NPU03878 Complement factor Ba; P—Complement C9; arb.c.(imm.; proc.) = ? substance concentration(procedure) micromol/litre Erythrocytes(Blood)— M = 33 000 g/mol Complement C9; Authority: ICW91 arbitrary entitic number(adhesion; procedure) NPU01755 M = 71 000 g/mol P—Complement factor Ba; subst.c.(proc.) = ? µmol/l Authority: ICW91 NPU01750 Plasma— Ercs(B)—Complement C9; arb.entitic num.(adhesion; proc.) = ? Complement factor Bb; arbitrary concentration(immunological; procedure) Plasma— M = 60 000 g/mol Complement C9; Authority: ICW91 substance concentration(procedure) NPU03882 micromol/litre P—Complement factor Bb; arb.c.(imm.; proc.) = ? M = 71 000 g/mol Authority: ICW91 Plasma— NPU01751 Complement factor Bb; P—Complement C9; subst.c.(proc.) = ? µmol/l substance concentration(procedure) micromol/litre Erythrocytes(Blood)— M = 60 000 g/mol Complement decay accelerating factor; Authority: ICW91 arbitrary entitic number(immunological; procedure) NPU01756 Other term(s): DAF; Cluster of differentiation 55; CD 55 P—Complement factor Bb; subst.c.(proc.) = ? µmol/l Authority: ICW91 NPU03879 Plasma— Ercs(B)—Complement decay accelerating factor; arb.entitic num.(imm.; proc.) = Complement factor D; ? arbitrary concentration(adhesion; procedure) M = 24 000 g/mol Erythrocytes(Blood)— Other term(s): C3 proactivator convertase; GBGase Complement decay accelerating factor; Authority: ICW91 entitic number(immunological; procedure) NPU01757 Other term(s): DAF P—Complement factor D; arb.c.(adhesion; proc.) = ? Authority: ICW91 Note: Other name: Cluster of differentiation 55; CD 55 Plasma— NPU01752 Complement factor D; Ercs(B)—Complement decay accelerating factor; entitic num.(imm.; proc.) = ? arbitrary concentration(immunological; procedure) M = 24 000 g/mol Other term(s): C3 proactivator convertase; GBGase Authority: ICW91 NPU03889 P—Complement factor D; arb.c.(imm.; proc.) = ?
45 Plasma— Granulocytes(Blood)— Complement factor D; Complement iC3b receptor; substance concentration(procedure) entitic number(procedure) micromol/litre M = 260 000 g/mol M = 24 000 g/mol Authority: ICW91 Other term(s): C3 proactivator convertase; GBGase NPU01766 Authority: ICW91 Granulocytes(B)—Complement iC3b receptor; entitic num.(proc.) = ? NPU01758 P—Complement factor D; subst.c.(proc.) = ? µmol/l Plasma— Complement membrane attack complex(C5b-C6-C7-C8-C9n); Plasma— arbitrary concentration(immunological; procedure) Complement factor H; Other term(s): MAC arbitrary concentration(immunological; procedure) Authority: ICW91 M = 150 000 g/mol Note: molar mass: 1-2 x 10E6 Other term(s): beta1H; C3bINA accelerator NPU01767 Authority: ICW91 P—Complement membrane attack complex(C5b-C6-C7-C8-C9n); arb.c.(imm.; NPU01759 proc.) = ? P—Complement factor H; arb.c.(imm.; proc.) = ? B-lymphocytes(Blood)— Plasma— Complement membrane C3b-C4b cofactor protein; Complement factor H; arbitrary entitic number(procedure) substance concentration(procedure) Authority: ICW91 micromol/litre Note: Molar Mass: 45 000-70 000 M = 150 000 g/mol NPU01768 Other term(s): beta1H; C3bINA accelerator B-lymphocs(B)—Complement membrane C3b-C4b cofactor protein; arb.entitic Authority: ICW91 num.(proc.) = ? NPU01760 P—Complement factor H; subst.c.(proc.) = ? µmol/l B-lymphocytes(Blood)— Complement membrane C3b-C4b cofactor protein; Plasma— entitic number Complement factor I; Authority: ICW91 arbitrary concentration(immunological; procedure) Note: Molar Mass: 45 000-70 000 M = 88 000 g/mol NPU03888 Other term(s): C3b inactivator; C4b inactivator; KAF B-lymphocs(B)—Complement membrane C3b-C4b cofactor protein; entitic num. NPU01761 = ? P—Complement factor I; arb.c.(imm.; proc.) = ? Erythrocytes(Blood)— Plasma— Complement+Immunoglobulin; Complement factor I; arbitrary entitic number(adhesion; procedure) substance concentration(procedure) Other term(s): Coomb's direct test; Anti globulin reaction micromol/litre Authority: ICW91 M = 88 000 g/mol NPU01717 Other term(s): C3b inactivator; C4b inactivator; KAF Ercs(B)—Complement+Immunoglobulin; arb.entitic num.(adhesion; proc.) = ? NPU01762 P—Complement factor I; subst.c.(proc.) = ? µmol/l Erythrocytes(Blood)— Complement+Immunoglobulin; Plasma— entitic number(procedure) Complement factor P; Other term(s): Coomb's direct test; Anti globulin reaction arbitrary concentration(immunological; procedure) Authority: ICW91 M = 220 000 g/mol NPU03868 Other term(s): Properdin Ercs(B)—Complement+Immunoglobulin; entitic num.(proc.) = ? Authority: ICW91 NPU01763 Urine— P—Complement factor P; arb.c.(imm.; proc.) = ? Copper; amount-of-substance(procedure) Plasma— micromol Complement factor P; M = 63,55 g/mol substance concentration(procedure) NPU08635 micromol/litre U—Copper; am.s.(proc.) = ? µmol M = 220 000 g/mol Other term(s): Properdin Plasma— Authority: ICW91 Copper; NPU01764 substance concentration P—Complement factor P; subst.c.(proc.) = ? µmol/l micromol/litre M = 63,55 g/mol Plasma— Authority: IUPAC/VII-C-TOX Complement iC3; NPU01773 arbitrary concentration(procedure) P—Copper; subst.c. = ? µmol/l M = 174 000 g/mol Authority: ICW91 Urine— NPU03883 Copper; P—Complement iC3; arb.c.(proc.) = ? substance concentration micromol/litre Plasma— M = 63,55 g/mol Complement iC3; Authority: IUPAC/VII-C-TOX substance concentration NPU01774 micromol/litre U—Copper; subst.c. = ? µmol/l M = 174 000 g/mol Authority: ICW91 Cells(Blood)— NPU01765 Copper; P—Complement iC3; subst.c. = ? µmol/l substance content micromol/kilogram Granulocytes(Blood)— M = 63,55 g/mol Complement iC3b receptor; Authority: IUPAC/VII-C-TOX arbitrary entitic number(procedure) NPU04905 M = 260 000 g/mol Cells(B)—Copper; subst.cont. = ? µmol/kg Authority: ICW91 NPU03871 Granulocytes(B)—Complement iC3b receptor; arb.entitic num.(proc.) = ?
46 Chorionic villus cell protein— Patient— Copper; Corticotropin secretion; substance content substance rate(corticoliberin, intravenous administration; list; procedure) micromol/kilogram Other term(s): CRH test M = 63,55 g/mol Note: _M_ (corticotropin releasing hormone) = 4 757,5 g/mol; _M_ NPU01771 (corticotropin) = 4 542 g/mol Chor.villus cell prot.—Copper; subst.cont. = ? µmol/kg NPU10482 Pt—Corticotropin secretion; subst.rate(corticoliberin i.v.; list; proc.) Hair— NPU10484 Pt—Corticoliberin(administered); am.s.(i.v.) = ? nmol Copper; NPU10483 Pt—Corticoliberin(administered); subst.cont.(i.v.; am.s./body mass) substance content = ? nmol/kg micromol/kilogram NPU10622 P—Corticotropin; subst.c.(-15 min) = ? pmol/l M = 63,55 g/mol NPU10485 P—Corticotropin; subst.c.(0 min) = ? pmol/l Authority: IUPAC/VII-C-TOX NPU10486 P—Corticotropin; subst.c.(1 min) = ? pmol/l NPU01772 NPU10487 P—Corticotropin; subst.c.(5 min) = ? pmol/l Hair—Copper; subst.cont. = ? µmol/kg NPU10623 P—Corticotropin; subst.c.(10 min) = ? pmol/l NPU10624 P—Corticotropin; subst.c.(15 min) = ? pmol/l Patient(Urine)— NPU10625 P—Corticotropin; subst.c.(20 min) = ? pmol/l Copper; NPU10488 P—Corticotropin; subst.c.(30 min) = ? pmol/l substance rate(procedure) NPU10626 P—Corticotropin; subst.c.(40 min) = ? pmol/l micromol/day NPU10489 P—Corticotropin; subst.c.(45 min) = ? pmol/l NPU08976 NPU10490 P—Corticotropin; subst.c.(60 min) = ? pmol/l Pt(U)—Copper; subst.rate(proc.) = ? µmol/d NPU10627 P—Cortisol; subst.c.(-15 min) = ? nmol/l NPU04139 P—Cortisol; subst.c.(0 min) = ? nmol/l Urine— NPU10409 P—Cortisol; subst.c.(1 min) = ? nmol/l Coproporphyrin; NPU10410 P—Cortisol; subst.c.(5 min) = ? nmol/l substance concentration NPU10628 P—Cortisol; subst.c.(10 min) = ? nmol/l nanomol/litre NPU04966 P—Cortisol; subst.c.(15 min) = ? nmol/l NPU10300 NPU04140 P—Cortisol; subst.c.(30 min) = ? nmol/l U—Coproporphyrin; subst.c. = ? nmol/l NPU10631 P—Cortisol; subst.c.(40 min) = ? nmol/l NPU04967 P—Cortisol; subst.c.(45 min) = ? nmol/l Faeces— NPU04968 P—Cortisol; subst.c.(60 min) = ? nmol/l Coproporphyrin; substance content Patient— micromol/kilogram Corticotropin secretion; NPU10299 substance rate(insulin, intravenous administration; list; procedure) F—Coproporphyrin; subst.cont. = ? µmol/kg Note: _M_ (insulin) = 5 807,65 g/mol; _M_ (corticotropin) = 4 542 g/mol NPU10554 Patient— Pt—Corticotropin secretion; subst.rate(insulin i.v.; list; proc.) Corticoliberin(administered); NPU10547 Pt—Insulin(administered); subst.cont.(i.v.; am.s./body mass) = ? amount-of-substance(intravenous administration) µmol/kg nanomol NPU10548 Pt—Insulin(administered); arb.subst.cont.(i.v.; arb.am.s./body mass; Other term(s): Corticotropin-releasing factor; CRF; Corticotropin releasing proc.) = ? int. unit/kg hormone; CRH NPU10485 P—Corticotropin; subst.c.(0 min) = ? pmol/l NPU10484 NPU10488 P—Corticotropin; subst.c.(30 min) = ? pmol/l Pt—Corticoliberin(administered); am.s.(i.v.) = ? nmol NPU10489 P—Corticotropin; subst.c.(45 min) = ? pmol/l NPU10490 P—Corticotropin; subst.c.(60 min) = ? pmol/l Patient— NPU10553 P—Corticotropin; subst.c.(90 min) = ? pmol/l Corticoliberin(administered); NPU10641 P—Corticotropin; subst.c.(120 min) = ? pmol/l substance content(intravenous administration; amount-of-substance/body NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l mass) NPU04186 P—Glucose; subst.c.(15 min) = ? mmol/l nanomol/kilogram NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l Other term(s): Corticotropin-releasing factor; CRF; Corticotropin releasing NPU04187 P—Glucose; subst.c.(45 min) = ? mmol/l hormone; CRH NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l NPU10483 NPU04965 P—Glucose; subst.c.(75 min) = ? mmol/l Pt—Corticoliberin(administered); subst.cont.(i.v.; am.s./body mass) = ? nmol/kg NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l Plasma(fasting Patient)— NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l Corticoliberin; NPU04981 P—Glucose; subst.c.(min.; proc.) = ? mmol/l substance concentration picomol/litre Patient— Other term(s): Corticotropin-releasing factor; CRF; Corticotropin releasing Corticotropin(administered); hormone; CRH amount-of-substance(intramuscular administration) NPU14068 nanomol P(fPt)—Corticoliberin; subst.c. = ? pmol/l M = 4 542 g/mol Other term(s): ACTH; Adrenocorticotropic hormone Urine— Authority: IUPAC-IUB 74 Corticoliberin; NPU10375 substance concentration Pt—Corticotropin(administered); am.s.(i.m.) = ? nmol picomol/litre Other term(s): Corticotropin-releasing factor; CRF; Corticotropin releasing Patient— hormone; CRH Corticotropin(administered); NPU14069 amount-of-substance(intravenous administration) U—Corticoliberin; subst.c. = ? pmol/l nanomol M = 4 542 g/mol Patient(Urine)— Other term(s): ACTH; Adrenocorticotropic hormone Corticoliberin; Authority: IUPAC-IUB 74 substance rate NPU10531 picomol/day Pt—Corticotropin(administered); am.s.(i.v.) = ? nmol Other term(s): Corticotropin-releasing factor; CRF; Corticotropin releasing hormone; CRH Patient— NPU14070 Corticotropin(administered); Pt(U)—Corticoliberin; subst.rate = ? pmol/d substance rate(intramuscular administration; 3 days) nanomol/day M = 4 542 g/mol Other term(s): ACTH; Adrenocorticotropic hormone Authority: IUPAC-IUB 74 NPU10556 Pt—Corticotropin(administered); subst.rate(i.m.; 3 d) = ? nmol/d
47 Urine— Plasma— Corticotropin; Corticotropin; arbitrary concentration(procedure) substance concentration(60 minutes after challenge) M = 4 542 g/mol picomol/litre Other term(s): ACTH; Adrenocorticotropic hormone NPU10490 NPU04892 P—Corticotropin; subst.c.(60 min) = ? pmol/l U—Corticotropin; arb.c.(proc.) = ? Plasma— Plasma— Corticotropin; Corticotropin; substance concentration(90 minutes after challenge) arbitrary substance concentration(procedure) picomol/litre arbitrary unit/litre NPU10553 M = 4 542 g/mol P—Corticotropin; subst.c.(90 min) = ? pmol/l Other term(s): ACTH; Adrenocorticotropic hormone Authority: IUPAC-IUB 74 Plasma— NPU01784 Corticotropin; P—Corticotropin; arb.subst.c.(proc.) = ? arb.unit/l substance concentration(120 minutes after challenge) picomol/litre Plasma— NPU10641 Corticotropin; P—Corticotropin; subst.c.(120 min) = ? pmol/l substance concentration(15 minutes before challenge) picomol/litre Plasma— NPU10622 Corticotropin; P—Corticotropin; subst.c.(-15 min) = ? pmol/l substance concentration(135 minutes after challenge) picomol/litre Plasma— NPU10642 Corticotropin; P—Corticotropin; subst.c.(135 min) = ? pmol/l substance concentration(0 minutes after challenge) picomol/litre Plasma— NPU10485 Corticotropin; P—Corticotropin; subst.c.(0 min) = ? pmol/l substance concentration(150 minutes after challenge) picomol/litre Plasma— NPU10643 Corticotropin; P—Corticotropin; subst.c.(150 min) = ? pmol/l substance concentration(1 minute after challenge) picomol/litre Plasma— NPU10486 Corticotropin; P—Corticotropin; subst.c.(1 min) = ? pmol/l substance concentration(180 minutes after challenge) picomol/litre Plasma— NPU10644 Corticotropin; P—Corticotropin; subst.c.(180 min) = ? pmol/l substance concentration(5 minutes after challenge) picomol/litre Plasma— NPU10487 Corticotropin; P—Corticotropin; subst.c.(5 min) = ? pmol/l substance concentration picomol/litre Plasma— M = 4 542 g/mol Corticotropin; Other term(s): ACTH; Adrenocorticotropic hormone substance concentration(10 minutes after challenge) Authority: IUPAC-IUB 74 picomol/litre NPU01785 NPU10623 P—Corticotropin; subst.c. = ? pmol/l P—Corticotropin; subst.c.(10 min) = ? pmol/l Urine— Plasma— Corticotropin; Corticotropin; substance concentration substance concentration(15 minutes after challenge) picomol/litre picomol/litre M = 4 542 g/mol NPU10624 Other term(s): ACTH; Adrenocorticotropic hormone P—Corticotropin; subst.c.(15 min) = ? pmol/l Authority: IFCC/C-LDA NPU04895 Plasma— U—Corticotropin; subst.c. = ? pmol/l Corticotropin; substance concentration(20 minutes after challenge) Adrenal cortex— picomol/litre Cortisol secretion; NPU10625 substance rate(corticotropin, intramuscular administration; list; P—Corticotropin; subst.c.(20 min) = ? pmol/l procedure) Note: _M_(corticotropin) = 4 542 g/mol Plasma— NPU10555 Corticotropin; Adrenal cortex—Cortisol secretion; subst.rate(corticotropin i.m.; list; proc.) substance concentration(30 minutes after challenge) NPU10375 Pt—Corticotropin(administered); am.s.(i.m.) = ? nmol picomol/litre NPU10556 Pt—Corticotropin(administered); subst.rate(i.m.; 3 d) = ? nmol/d NPU10488 NPU04139 P—Cortisol; subst.c.(0 min) = ? nmol/l P—Corticotropin; subst.c.(30 min) = ? pmol/l NPU04140 P—Cortisol; subst.c.(30 min) = ? nmol/l NPU04968 P—Cortisol; subst.c.(60 min) = ? nmol/l Plasma— NPU04972 P—Cortisol; subst.c.(480 min) = ? nmol/l Corticotropin; NPU10533 P—Cortisol; subst.c.(1 d) = ? nmol/l substance concentration(40 minutes after challenge) NPU10593 P—Cortisol; subst.c.(1,5 d) = ? nmol/l picomol/litre NPU10588 P—Cortisol; subst.c.(2 d) = ? nmol/l NPU10626 NPU04973 U—Cortisol; am.s.(-1d - 0 d) = ? nmol P—Corticotropin; subst.c.(40 min) = ? pmol/l NPU04974 U—Cortisol; am.s.(0-1 d) = ? nmol NPU04975 U—Cortisol; am.s.(1-2 d) = ? nmol Plasma— NPU04976 U—Cortisol; am.s.(2-3 d) = ? nmol Corticotropin; NPU10557 U—Creatininium; am.s.(-1d - 0 d) = ? mmol substance concentration(45 minutes challenge) NPU10558 U—Creatininium; am.s.(0-1 d) = ? mmol picomol/litre NPU10559 U—Creatininium; am.s.(1-2 d) = ? mmol NPU10489 NPU10560 U—Creatininium; am.s.(2-3 d) = ? mmol P—Corticotropin; subst.c.(45 min) = ? pmol/l
48 Adrenal cortex— Adrenal cortex— Cortisol secretion; Cortisol secretion; substance rate(dexamethasone, oral administration; list; procedure) substance rate(tetracosactide, intramuscular administration; list; Note: _M_(dexamethasone) = 392,5 g/mol; _M_ (cortisol) = 362,47 g/mol procedure) NPU01792 Note: _M_(tetracosactide) = 2 933,57 g/mol; _M_ (cortisol) = 362,47 g/mol Adrenal cortex—Cortisol secretion; subst.rate(dexamethasone p.o.; list; proc.) NPU01791 NPU10532 Pt—Dexamethasone(administered); am.s.(single dose p.o.) = ? Adrenal cortex—Cortisol secretion; subst.rate(tetracosactide i.m.; list; proc.) µmol NPU10534 Pt—Tetracosactide(administered); am.s.(i.m.) = ? nmol NPU04139 P—Cortisol; subst.c.(0 min) = ? nmol/l NPU10671 U—Cortisol; am.s.(-2 d - -1d) = ? nmol NPU04972 P—Cortisol; subst.c.(480 min) = ? nmol/l NPU04973 U—Cortisol; am.s.(-1d - 0 d) = ? nmol NPU10533 P—Cortisol; subst.c.(1 d) = ? nmol/l NPU04974 U—Cortisol; am.s.(0-1 d) = ? nmol NPU10588 P—Cortisol; subst.c.(2 d) = ? nmol/l NPU04975 U—Cortisol; am.s.(1-2 d) = ? nmol NPU10587 P—Cortisol; subst.c.(3 d) = ? nmol/l NPU04976 U—Cortisol; am.s.(2-3 d) = ? nmol NPU04973 U—Cortisol; am.s.(-1d - 0 d) = ? nmol NPU10672 U—Creatininium; am.s.(-2 d - -1d) = ? mmol NPU04974 U—Cortisol; am.s.(0-1 d) = ? nmol NPU10557 U—Creatininium; am.s.(-1d - 0 d) = ? mmol NPU04975 U—Cortisol; am.s.(1-2 d) = ? nmol NPU10558 U—Creatininium; am.s.(0-1 d) = ? mmol NPU04976 U—Cortisol; am.s.(2-3 d) = ? nmol NPU10559 U—Creatininium; am.s.(1-2 d) = ? mmol NPU10557 U—Creatininium; am.s.(-1d - 0 d) = ? mmol NPU10560 U—Creatininium; am.s.(2-3 d) = ? mmol NPU10558 U—Creatininium; am.s.(0-1 d) = ? mmol NPU10559 U—Creatininium; am.s.(1-2 d) = ? mmol Adrenal cortex— NPU10560 U—Creatininium; am.s.(2-3 d) = ? mmol Cortisol secretion; substance rate(tetracosactide, intravenous administration; list; Adrenal cortex— procedure) Cortisol secretion; Other term(s): ACTH test substance rate(insulin, intravenous administration; list; procedure) Note: _M_(tetracosactide) = 2 933,57 g/mol; _M_ (cortisol) = 362,47 g/mol Other term(s): Insulin hypoglycemic test; ITT NPU01789 Note: _M_(insulin) = 5 807,65 g/mol; _M_ (cortisol) = 362,47 g/mol Adrenal cortex—Cortisol secretion; subst.rate(tetracosactide i.v.; list; proc.) NPU01790 NPU10534 Pt—Tetracosactide(administered); am.s.(i.m.) = ? nmol Adrenal cortex—Cortisol secretion; subst.rate(insulin i.v.; list; proc.) NPU04139 P—Cortisol; subst.c.(0 min) = ? nmol/l NPU10547 Pt—Insulin(administered); subst.cont.(i.v.; am.s./body mass) = ? NPU04966 P—Cortisol; subst.c.(15 min) = ? nmol/l µmol/kg NPU04140 P—Cortisol; subst.c.(30 min) = ? nmol/l NPU10548 Pt—Insulin(administered); arb.subst.cont.(i.v.; arb.am.s./body mass; NPU04967 P—Cortisol; subst.c.(45 min) = ? nmol/l proc.) = ? int. unit/kg NPU04968 P—Cortisol; subst.c.(60 min) = ? nmol/l NPU04139 P—Cortisol; subst.c.(0 min) = ? nmol/l NPU04969 P—Cortisol; subst.c.(75 min) = ? nmol/l NPU04966 P—Cortisol; subst.c.(15 min) = ? nmol/l NPU04970 P—Cortisol; subst.c.(90 min) = ? nmol/l NPU04140 P—Cortisol; subst.c.(30 min) = ? nmol/l NPU04971 P—Cortisol; subst.c.(120 min) = ? nmol/l NPU04967 P—Cortisol; subst.c.(45 min) = ? nmol/l NPU10673 P—Cortisol; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? nmol/l NPU04968 P—Cortisol; subst.c.(60 min) = ? nmol/l NPU04969 P—Cortisol; subst.c.(75 min) = ? nmol/l Plasma— NPU04970 P—Cortisol; subst.c.(90 min) = ? nmol/l Cortisol(free); NPU04971 P—Cortisol; subst.c.(120 min) = ? nmol/l substance concentration NPU08711 P—Cortisol; subst.c.(max.; proc.) = ? nmol/l nanomol/litre NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l M = 362,47 g/mol NPU04186 P—Glucose; subst.c.(15 min) = ? mmol/l Other term(s): Compound F NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l Authority: IUPAC-IUB 89 NPU04187 P—Glucose; subst.c.(45 min) = ? mmol/l NPU10301 NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l P—Cortisol(free); subst.c. = ? nmol/l NPU04965 P—Glucose; subst.c.(75 min) = ? mmol/l NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l Patient(Urine)— NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l Cortisol(free); NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l substance rate(procedure) NPU04981 P—Glucose; subst.c.(min.; proc.) = ? mmol/l nanomol/day Authority: IUPAC-IUB 89 Adrenal cortex— NPU14495 Cortisol secretion; Pt(U)—Cortisol(free); subst.rate(proc.) = ? nmol/d substance rate(metyrapone, oral administration; list; procedure) Note: _M_ (metyrapone) = 226,27 g/mol; _M_ (cortisol) = 362,47 g/mol Urine— NPU10530 Cortisol; Adrenal cortex—Cortisol secretion; subst.rate(metyrapone p.o.; list; proc.) amount-of-substance(2 days to 1 day before challenge) NPU09113 Pt—Metyrapone(administered); number of doses = ? nanomol NPU09114 Pt—Metyrapone(administered); time int.(between doses) = ? min NPU10671 NPU10524 Pt—Metyrapone(administered); am.s.(p.o.) = ? mmol U—Cortisol; am.s.(-2 d - -1d) = ? nmol NPU04139 P—Cortisol; subst.c.(0 min) = ? nmol/l NPU10408 P—Cortisol; subst.c.(240 min) = ? nmol/l Urine— NPU04972 P—Cortisol; subst.c.(480 min) = ? nmol/l Cortisol; NPU10589 P—Cortisol; subst.c.(540 min) = ? nmol/l amount-of-substance(1 day to 0 day before challenge) NPU10533 P—Cortisol; subst.c.(1 d) = ? nmol/l nanomol NPU10526 P—Cortodoxone; subst.c.(0 min) = ? nmol/l NPU04973 NPU10527 P—Cortodoxone; subst.c.(240 min) = ? nmol/l U—Cortisol; am.s.(-1d - 0 d) = ? nmol NPU10528 P—Cortodoxone; subst.c.(480 min) = ? nmol/l NPU10529 P—Cortodoxone; subst.c.(540 min) = ? nmol/l Urine— NPU10632 P—Cortodoxone; subst.c.(1 d) = ? nmol/l Cortisol; amount-of-substance(0-1 day after challenge) nanomol NPU04974 U—Cortisol; am.s.(0-1 d) = ? nmol
Urine— Cortisol; amount-of-substance(1-2 days after challenge) nanomol NPU04975 U—Cortisol; am.s.(1-2 d) = ? nmol
Urine— Cortisol; amount-of-substance(2-3 days after challenge) nanomol NPU04976 U—Cortisol; am.s.(2-3 d) = ? nmol
49 Plasma— Urine— Cortisol; Cortisol; substance concentration(75 minutes after challenge) amount-of-substance(procedure) nanomol/litre nanomol NPU04969 NPU17629 P—Cortisol; subst.c.(75 min) = ? nmol/l U—Cortisol; am.s.(proc.) =? nmol Plasma— Plasma— Cortisol; Cortisol; substance concentration(90 minutes after challenge) substance concentration(15 minutes before challenge) nanomol/litre nanomol/litre NPU04970 NPU10627 P—Cortisol; subst.c.(90 min) = ? nmol/l P—Cortisol; subst.c.(-15 min) = ? nmol/l Plasma— Plasma— Cortisol; Cortisol; substance concentration(120 minutes after challenge) substance concentration(0 minutes after challenge) nanomol/litre nanomol/litre NPU04971 NPU04139 P—Cortisol; subst.c.(120 min) = ? nmol/l P—Cortisol; subst.c.(0 min) = ? nmol/l Plasma— Plasma— Cortisol; Cortisol; substance concentration(135 minutes after challenge) substance concentration(1 minute after challenge) nanomol/litre nanomol/litre NPU10645 NPU10409 P—Cortisol; subst.c.(135 min) = ? nmol/l P—Cortisol; subst.c.(1 min) = ? nmol/l Plasma— Plasma— Cortisol; Cortisol; substance concentration(150 minutes after challenge) substance concentration(5 minutes after challenge) nanomol/litre nanomol/litre NPU10224 NPU10410 P—Cortisol; subst.c.(150 min) = ? nmol/l P—Cortisol; subst.c.(5 min) = ? nmol/l Plasma— Plasma— Cortisol; Cortisol; substance concentration(180 minutes after challenge) substance concentration(10 minutes after challenge) nanomol/litre nanomol/litre NPU10222 NPU10628 P—Cortisol; subst.c.(180 min) = ? nmol/l P—Cortisol; subst.c.(10 min) = ? nmol/l Plasma— Plasma— Cortisol; Cortisol; substance concentration(240 minutes after challenge) substance concentration(15 minutes after challenge) nanomol/litre nanomol/litre NPU10408 NPU04966 P—Cortisol; subst.c.(240 min) = ? nmol/l P—Cortisol; subst.c.(15 min) = ? nmol/l Plasma— Plasma— Cortisol; Cortisol; substance concentration(300 minutes after challenge) substance concentration(20 minutes after challenge) nanomol/litre nanomol/litre NPU10223 NPU10630 P—Cortisol; subst.c.(300 min) = ? nmol/l P—Cortisol; subst.c.(20 min) = ? nmol/l Plasma— Plasma— Cortisol; Cortisol; substance concentration(480 minutes after challenge) substance concentration(30 minutes after challenge) nanomol/litre nanomol/litre NPU04972 NPU04140 P—Cortisol; subst.c.(480 min) = ? nmol/l P—Cortisol; subst.c.(30 min) = ? nmol/l Plasma— Plasma— Cortisol; Cortisol; substance concentration(540 minutes after challenge) substance concentration(40 minutes after challenge) nanomol/litre nanomol/litre NPU10589 NPU10631 P—Cortisol; subst.c.(540 min) = ? nmol/l P—Cortisol; subst.c.(40 min) = ? nmol/l Plasma— Plasma— Cortisol; Cortisol; substance concentration(570 minutes after challenge) substance concentration(45 minutes challenge) nanomol/litre nanomol/litre NPU10590 NPU04967 P—Cortisol; subst.c.(570 min) = ? nmol/l P—Cortisol; subst.c.(45 min) = ? nmol/l Plasma— Plasma— Cortisol; Cortisol; substance concentration(1 day after challenge) substance concentration(60 minutes after challenge) nanomol/litre nanomol/litre NPU10533 NPU04968 P—Cortisol; subst.c.(1 d) = ? nmol/l P—Cortisol; subst.c.(60 min) = ? nmol/l Plasma— Cortisol; substance concentration(1,5 days after challenge) nanomol/litre NPU10593 P—Cortisol; subst.c.(1,5 d) = ? nmol/l
50 Urine— Plasma— Cortisone; Cortisol; substance concentration substance concentration(2 days after challenge) mol/litre nanomol/litre M = 360,46 g/mol NPU10588 Authority: IFCC/C-LDA; INN P—Cortisol; subst.c.(2 d) = ? nmol/l NPU04362 U—Cortisone; subst.c.= ? prefix ? mol/l Plasma— Cortisol; Plasma— substance concentration(3 days after challenge) Cortodoxone; nanomol/litre substance concentration(0 minutes after challenge) NPU10587 nanomol/litre P—Cortisol; subst.c.(3 d) = ? nmol/l NPU10526 P—Cortodoxone; subst.c.(0 min) = ? nmol/l Plasma— Cortisol; Plasma— substance concentration(maximum; procedure) Cortodoxone; nanomol/litre substance concentration(240 minutes after challenge) NPU08711 nanomol/litre P—Cortisol; subst.c.(max.; proc.) = ? nmol/l NPU10527 P—Cortodoxone; subst.c.(240 min) = ? nmol/l Plasma— Cortisol; Plasma— substance concentration(minimum; procedure) Cortodoxone; nanomol/litre substance concentration(480 minutes after challenge) NPU08733 nanomol/litre P—Cortisol; subst.c.(min.; proc.) = ? nmol/l NPU10528 P—Cortodoxone; subst.c.(480 min) = ? nmol/l Plasma— Cortisol; Plasma— substance concentration increment(maximum concentration minus 0 Cortodoxone; minutes concentration; procedure) substance concentration(540 minutes after challenge) nanomol/litre nanomol/litre NPU10673 NPU10529 P—Cortisol; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? nmol/l P—Cortodoxone; subst.c.(540 min) = ? nmol/l
Plasma— Plasma— Cortisol; Cortodoxone; substance concentration substance concentration(1 day after challenge) nanomol/litre nanomol/litre M = 362,47 g/mol NPU10632 Other term(s): Compound F P—Cortodoxone; subst.c.(1 d) = ? nmol/l Authority: IUPAC-IUB 89 NPU01787 Plasma— P—Cortisol; subst.c. = ? nmol/l Cortodoxone; substance concentration Saliva— nanomol/litre Cortisol; M = 346,47 g/mol substance concentration Other term(s): Compound S; Cortexolone nanomol/litre NPU01856 M = 362,47 g/mol P—Cortodoxone; subst.c. = ? nmol/l Other term(s): Compound F Authority: IUPAC-IUB 89 Plasma— NPU01788 C-reactive protein; Saliva—Cortisol; subst.c. = ? nmol/l arbitrary substance concentration(IS 85/506; procedure) international unit/litre Urine— M = 105 000 g/mol Cortisol; Recommended calibrator: WHO 1st IS 85/506 substance concentration NPU01422 nanomol/litre P—C-reactive protein; arb.subst.c.(IS 85/506; proc.) = ? int. unit/l M = 362,47 g/mol Other term(s): Compound F; Hydrocortisone Plasma— Authority: IFCC/C-LDA; INN C-reactive protein; NPU04360 substance concentration U—Cortisol; subst.c. = ? nmol/l nanomol/litre M = 105 000 g/mol Patient(Urine)— NPU01423 Cortisol; P—C-reactive protein; subst.c. = ? nmol/l substance rate(procedure) nanomol/day Plasma— Authority: IUPAC-IUB 89 Creatine kinase BB; NPU01786 catalytic-activity concentration(37 °C; procedure) Pt(U)—Cortisol; subst.rate(proc.) = ? nmol/d microkatal/litre Other term(s): Creatin kinase 3 (IUPAC-IUB76) Plasma— Note: M(uscle); B(rain) Cortisone; NPU01799 substance concentration P—Creatine kinase BB; cat.c.(37 °C; proc.) = ? µkat/l mol/litre M = 360,46 g/mol Creatine kinase(Plasma)— Authority: IFCC/C-LDA; INN Creatine kinase BB; NPU04363 catalytic-activity fraction(37 °C; procedure) P—Cortisone; subst.c.= ? prefix ? mol/l Other term(s): Creatin kinase 3 (IUPAC-IUB76) Note: M(uscle); B(rain) NPU01146 CK(P)—Creatine kinase BB; cat.fr.(37 °C; proc.) = ?
51 Plasma— Creatine kinase(Plasma)— Creatine kinase BB; Creatine kinase type; substance concentration catalytic-activity fraction(list; 37 °C; procedure) mol/litre Other term(s): Creatine kinase isoenzymes Other term(s): Creatin kinase 3 (IUPAC-IUB76) Note: M(uscle); B(rain) Note: M(uscle); B(rain) NPU01805 NPU01800 CK(P)—Creatine kinase type; cat.fr.(list; 37 °C; proc.) P—Creatine kinase BB; subst.c.= ? prefix ? mol/l NPU01146 CK(P)—Creatine kinase BB; cat.fr.(37 °C; proc.) = ? NPU03996 CK(P)—Creatine kinase MB; cat.fr.(37 °C; proc.) = ? Plasma— NPU17127 CK(P)—Creatine kinase MB+BB; cat.fr.(37 °C; proc.) = ? Creatine kinase MB; NPU01977 CK(P)—Creatine kinase MM; cat.fr.(37 °C; proc.) = ? catalytic-activity concentration(37 °C; procedure) microkatal/litre Amniotic fluid— Other term(s): Creatin kinase 2 (IUPAC-IUB76) Creatine kinase; Note: M(uscle); B(rain) catalytic-activity concentration(37 °C; procedure) NPU01801 microkatal/litre P—Creatine kinase MB; cat.c.(37 °C; proc.) = ? µkat/l NPU03912 Amf—Creatine kinase; cat.c.(37 °C; proc.) = ? µkat/l Creatine kinase(Plasma)— Creatine kinase MB; Plasma— catalytic-activity fraction(37 °C; procedure) Creatine kinase; Other term(s): Creatin kinase 2 (IUPAC-IUB76) catalytic-activity concentration(37 °C; procedure) Note: M(uscle); B(rain) microkatal/litre NPU03996 Other term(s): Creatine phosphokinase CK(P)—Creatine kinase MB; cat.fr.(37 °C; proc.) = ? NPU01796 P—Creatine kinase; cat.c.(37 °C; proc.) = ? µkat/l Plasma— Creatine kinase MB; Patient(Urine)— substance concentration Creatine; mol/litre substance rate(procedure) Other term(s): Creatin kinase 2 (IUPAC-IUB76) millimol/day Note: M(uscle); B(rain) M = 131,1 g/mol NPU01802 NPU01795 P—Creatine kinase MB; subst.c.= ? prefix ? mol/l Pt(U)—Creatine; subst.rate(proc.) = ? mmol/d
Plasma— Kidney— Creatine kinase MB+BB; Creatininium clearance; catalytic-activity concentration(37 °C; procedure) volume rate(list; procedure) microkatal/litre NPU17160 Note: M(uscle); B(rain) Kidn.—Creatininium clearance; vol.rate(list; proc.) NPU01798 NPU14048 Kidn.—Creatininium clearance; vol.rate(proc.) = ? ml/min P—Creatine kinase MB+BB; cat.c.(37 °C; proc.) = ? µkat/l NPU01809 Kidn.—Creatininium clearance; vol.rate(proc.) = ? ml/s NPU01808 U—Creatininium; subst.c. = ? µmol/l Creatine kinase(Plasma)— NPU09102 U—Creatininium; subst.c. = ? mmol/l Creatine kinase MB+BB; NPU04998 P—Creatininium; subst.c.(enz.) = ? µmol/l catalytic-activity fraction(37 °C; procedure) NPU01807 P—Creatininium; subst.c.(Jaffé) = ? µmol/l Note: M(uscle); B(rain) NPU09101 P—Creatininium; subst.c.(Jaffé) = ? mmol/l NPU17127 NPU03794 Pt—Body; height = ? m CK(P)—Creatine kinase MB+BB; cat.fr.(37 °C; proc.) = ? NPU03804 Pt—Body; mass = ? kg NPU03695 Pt—Urine; vol.(proc.) = ? ml Plasma— NPU10380 Pt—Urine sampling; duration = ? d Creatine kinase MM; NPU10379 Pt—Urine sampling; duration = ? h catalytic-activity concentration(37 °C; procedure) NPU10323 Pt—Urine sampling; duration = ? h:min microkatal/litre NPU10324 Pt—Urine sampling; duration = ? min Other term(s): Creatin kinase 1 (IUPAC-IUB76) Note: M(uscle); B(rain) Kidney— NPU01803 Creatininium clearance; P—Creatine kinase MM; cat.c.(37 °C; proc.) = ? µkat/l volume rate(procedure) millilitre/minute Creatine kinase(Plasma)— Note: calculated from (b × c)/(a × d) Creatine kinase MM; a: [NPU01807] P—Creatininium; subst.c. = ? mmol/l catalytic-activity fraction(37 °C; procedure) b: [NPU01808] U—Creatininium; subst.c. = ? mmol/l Other term(s): Creatin kinase 1 (IUPAC-IUB76) c: [NPU03695] Pt—Urine; vol.(proc.) = ? ml Note: M(uscle); B(rain) d: [NPU10380] U—Sampling period; time = ? d NPU01977 NPU14048 CK(P)—Creatine kinase MM; cat.fr.(37 °C; proc.) = ? Kidn.—Creatininium clearance; vol.rate(proc.) = ? ml/min
Plasma— Kidney— Creatine kinase MM; Creatininium clearance; substance concentration volume rate(procedure) mol/litre millilitre/second Other term(s): Creatin kinase 1 (IUPAC-IUB 76) Note: calculated from (b × c)/(a × d) Note: M(uscle); B(rain) a: [NPU01807] P—Creatininium; subst.c. = ? mmol/l NPU01804 b: [NPU01808] U—Creatininium; subst.c. = ? mmol/l P—Creatine kinase MM; subst.c.= ? prefix ? mol/l c: [NPU03695] Pt—Urine; vol.(proc.) = ? ml d: [NPU10380] U—Sampling period; time = ? d Plasma— NPU01809 Creatine kinase type; Kidn.—Creatininium clearance; vol.rate(proc.) = ? ml/s catalytic-activity concentration(list; 37 °C; procedure) Note: M(uscle); B(rain) Urine— NPU01978 Creatininium; P—Creatine kinase type; cat.c.(list; 37 °C; proc.) amount-of-substance(2 days to 1 day before challenge) NPU01799 P—Creatine kinase BB; cat.c.(37 °C; proc.) = ? µkat/l millimol NPU01801 P—Creatine kinase MB; cat.c.(37 °C; proc.) = ? µkat/l NPU10672 NPU01798 P—Creatine kinase MB+BB; cat.c.(37 °C; proc.) = ? µkat/l U—Creatininium; am.s.(-2 d - -1d) = ? mmol NPU01803 P—Creatine kinase MM; cat.c.(37 °C; proc.) = ? µkat/l
52 Urine— Creatininium; Urine— amount-of-substance(1 day to 0 day before challenge) Creatininium; millimol substance concentration NPU10557 micromol/litre U—Creatininium; am.s.(-1d - 0 d) = ? mmol M = 113,12 g/mol NPU01808 Urine— U—Creatininium; subst.c. = ? µmol/l Creatininium; amount-of-substance(0-1 day after challenge) Amniotic fluid— millimol Creatininium; NPU10558 substance concentration U—Creatininium; am.s.(0-1 d) = ? mmol millimol/litre M = 113,12 g/mol Urine— NPU09100 Creatininium; Amf—Creatininium; subst.c. = ? mmol/l amount-of-substance(1-2 days after challenge) millimol Ascites— NPU10559 Creatininium; U—Creatininium; am.s.(1-2 d) = ? mmol substance concentration millimol/litre Urine— M = 113,12 g/mol Creatininium; NPU08614 amount-of-substance(2-3 days after challenge) Asc—Creatininium; subst.c. = ? mmol/l millimol NPU10560 Cerebrospinal fluid— U—Creatininium; am.s.(2-3 d) = ? mmol Creatininium; substance concentration Ascites— millimol/litre Creatininium; M = 113,12 g/mol amount-of-substance(procedure) NPU09348 millimol Csf—Creatininium; subst.c. = ? mmol/l M = 113,12 g/mol NPU08616 Drain fluid(specification)— Asc—Creatininium; am.s.(proc.) = ? mmol Creatininium; substance concentration System(specification)— millimol/litre Creatininium; NPU17048 amount-of-substance(procedure) Drain fluid(spec.)—Creatininium; subst.c. = ? mmol/l millimol M = 113,12 g/mol Plasma— NPU08617 Creatininium; Syst(spec.)—Creatininium; am.s.(proc.) = ? mmol substance concentration millimol/litre Urine— NPU17559 Creatininium; P—Creatininium; subst.c. = ? mmol/l amount-of-substance(procedure) millimol Secretion(Conjunctiva; specification)— NPU17540 Creatininium; U—Creatininium; am.s.(proc.) = ? mmol substance concentration millimol/litre Plasma— M = 113,12 g/mol Creatininium; NPU09352 substance concentration(enzymatic) Secr(Conj; spec.)—Creatininium; subst.c. = ? mmol/l micromol/litre M = 113,12 g/mol System(specification)— NPU04998 Creatininium; P—Creatininium; subst.c.(enz.) = ? µmol/l substance concentration millimol/litre Plasma— M = 113,12 g/mol Creatininium; NPU08615 substance concentration(Jaffé) Syst(spec.)—Creatininium; subst.c. = ? mmol/l micromol/litre M = 113,12 g/mol Urine— NPU01807 Creatininium; P—Creatininium; subst.c.(Jaffé) = ? µmol/l substance concentration millimol/litre Plasma— M = 113,12 g/mol Creatininium; NPU09102 substance concentration(Jaffé) U—Creatininium; subst.c. = ? mmol/l millimol/litre M = 113,12 g/mol Patient(Urine)— NPU09101 Creatininium; P—Creatininium; subst.c.(Jaffé) = ? mmol/l substance rate(procedure) micromol/hour Amniotic fluid— NPU03801 Creatininium; Pt(U)—Creatininium; subst.rate(proc.) = ? µmol/h substance concentration micromol/litre Patient(Urine)— M = 113,12 g/mol Creatininium; NPU01806 substance rate(procedure) Amf—Creatininium; subst.c. = ? µmol/l millimol/day NPU03800 Dialysis solution— Pt(U)—Creatininium; subst.rate(proc.) = ? mmol/d Creatininium; substance concentration Plasma— micromol/litre Cryoglobulins; M = 113,12 g/mol arbitrary concentration(procedure) NPU10043 NPU01816 Dialysis solution—Creatininium; subst.c. = ? µmol/l P—Cryoglobulins; arb.c.(proc.) = ?
53 Urine— Urine— Cylinder, erythrocyte type; Crystals; number concentration(procedure) arbitrary concentration(procedure) 106/litre NPU08761 NPU10508 U—Crystals; arb.c.(proc.) = ? U—Cylinder, erythrocyte type; num.c.(proc.) = ? × 106/l
Urine— Urine— Crystals; Cylinder, granular type; number concentration(procedure) arbitrary concentration(procedure) 106/litre Other term(s): Cylinders, leukocyte type NPU10511 NPU01818 U—Crystals; num.c.(proc.) = ? × 106/l U—Cylinder, granular type; arb.c.(proc.) = ?
Synovial fluid(specification)— Urine— Crystals; Cylinder, granular type; taxon(procedure) number concentration(procedure) Note: Example of values: urate; pyrophosphate 106/litre NPU04127 Other term(s): Cylinders, leukocyte type Synf(spec.)—Crystals; taxon(proc.) = ? NPU10509 U—Cylinder, granular type; num.c.(proc.) = ? × 106/l Blood— Cyanide; Urine— substance concentration Cylinder, hyaline type; micromol/litre arbitrary concentration(procedure) NPU04780 Other term(s): Cylinders, cereous type B—Cyanide; subst.c.= ? µmol/l NPU01819 U—Cylinder, hyaline type; arb.c.(proc.) = ? Cobalamin(Plasma)— Cyanocobalamin; Urine— substance fraction Cylinder, hyaline type; NPU04954 number concentration(procedure) Cobalamin(P)—Cyanocobalamin; subst.fr. = ? 106/litre Other term(s): Cylinders, cereous type Urine— NPU10510 Cyclic AMP/Creatininium; U—Cylinder, hyaline type; num.c.(proc.) = ? × 106/l substance ratio 10-6 Urine— NPU10260 Cystathionine/Creatininium; U—Cyclic AMP/Creatininium; subst.ratio = ? × 10-6 substance ratio 10-3 Plasma— NPU14205 Cyclic AMP; U—Cystathionine/Creatininium; subst.ratio = ? × 10-3 substance concentration nanomol/litre Plasma— NPU10258 Cystathionine; P—Cyclic AMP; subst.c. = ? nmol/l substance concentration micromol/litre Urine— M = 222,28 g/mol Cyclic AMP; NPU01820 substance concentration P—Cystathionine; subst.c. = ? µmol/l nanomol/litre NPU10259 Urine— U—Cyclic AMP; subst.c. = ? nmol/l Cystathionine; substance concentration Patient(Urine)— micromol/litre Cyclic AMP; M = 222,28 g/mol substance rate NPU01821 millimol/day U—Cystathionine; subst.c. = ? µmol/l NPU14341 Pt(U)—Cyclic AMP; subst.rate = ? mmol/d Plasma— Cystatin C; Urine— substance concentration Cylinder type; mol/litre arbitrary concentration(list; procedure) NPU10302 NPU03856 P—Cystatin C; subst.c.= ? prefix ? mol/l U—Cylinder type; arb.c.(list; proc.) NPU01817 U—Cylinder, erythrocyte type; arb.c.(proc.) = ? Urine— NPU01818 U—Cylinder, granular type; arb.c.(proc.) = ? Cysteine+Cystine; NPU01819 U—Cylinder, hyaline type; arb.c.(proc.) = ? substance concentration micromol/litre Urine— NPU14319 Cylinder type; U—Cysteine+Cystine; subst.c. = ? µmol/l number concentration(list; procedure) NPU09257 Urine— U—Cylinder type; num.c.(list; proc.) Cysteine-L-homocysteine disulfide/Creatininium; NPU10508 U—Cylinder, erythrocyte type; num.c.(proc.) = ? × 106/l substance ratio NPU10509 U—Cylinder, granular type; num.c.(proc.) = ? × 106/l 10-3 NPU10510 U—Cylinder, hyaline type; num.c.(proc.) = ? × 106/l NPU14206 U—Cysteine-L-homocysteine disulfide/Creatininium; subst.ratio = ? × 10-3 Urine— Cylinder, erythrocyte type; Plasma— arbitrary concentration(procedure) Cysteine-L-homocysteine disulfide; NPU01817 substance concentration U—Cylinder, erythrocyte type; arb.c.(proc.) = ? micromol/litre NPU01823 P—Cysteine-L-homocysteine disulfide; subst.c. = ? µmol/l
54 Urine— Patient(Urine)— Cysteine-L-homocysteine disulfide; Cystine; substance concentration substance rate(procedure) micromol/litre micromol/day NPU01824 NPU04161 U—Cysteine-L-homocysteine disulfide; subst.c. = ? µmol/l Pt(U)—Cystine; subst.rate(proc.) = ? µmol/d
Urine— Plasma— Cysteinyldopa/Creatininium; Cytoplasma antibody(Immunoglobulin G); substance ratio arbitrary concentration(procedure) 10-6 NPU16391 Note: Cysteinyldopa = 5-S-Cysteinyldopa P—Cytoplasma antibody(IgG); arb.c.(proc.) = ? NPU09007 U—Cysteinyldopa/Creatininium; subst.ratio = ? × 10-6 Plasma— Cytoplasma antibody(Immunoglobulin G); Urine— arbitrary substance concentration(procedure) Cysteinyldopa; 10³ arbitrary unit/litre substance concentration NPU16392 nanomol/litre P—Cytoplasma antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Other term(s): 5-S-Cysteinyldopa NPU09107 Plasma— U—Cysteinyldopa; subst.c. = ? nmol/l Cytosol aminopeptidase; catalytic-activity concentration(37 °C; procedure) Patient(Urine)— microkatal/litre Cysteinyldopa; Other term(s): Leucine aminopeptidase substance rate NPU01847 nanomol/day P—Cytosol aminopeptidase; cat.c.(37 °C; proc.) = ? µkat/l Other term(s): 5-S-Cysteinyldopa NPU09108 Urine— Pt(U)—Cysteinyldopa; subst.rate = ? nmol/d Dehydrochloromethyl testosterone; arbitrary concentration(procedure) Urine— M = 334,87 g/mol Cystine/Creatininium; NPU04449 substance ratio U—Dehydrochloromethyl testosterone; arb.c.(proc.) = ? 10-3 NPU14207 Urine— U—Cystine/Creatininium; subst.ratio = ? × 10-3 Dehydrochloromethyl testosterone; substance concentration Urine— nanomol/litre Cystine; M = 334,87 g/mol arbitrary concentration(procedure) NPU01851 NPU04782 U—Dehydrochloromethyl testosterone; subst.c. = ? nmol/l U—Cystine; arb.c.(proc.)= ? Plasma— Calculus(Urine)— Dehydroepiandrosterone sulfate; Cystine; substance concentration arbitrary content(procedure) micromol/litre NPU10367 NPU04121 Calculus(U)—Cystine; arb.cont.(proc.) = ? P—Dehydroepiandrosterone sulfate; subst.c. = ? µmol/l
Cerebrospinal fluid— Urine— Cystine; Dehydroepiandrosterone sulfate; substance concentration substance concentration micromol/litre micromol/litre NPU09021 NPU04124 Csf—Cystine; subst.c. = ? µmol/l U—Dehydroepiandrosterone sulfate; subst.c. = ? µmol/l
Plasma— Plasma— Cystine; Dehydroepiandrosterone sulfate; substance concentration substance concentration micromol/litre nanomol/litre NPU01826 NPU14568 P—Cystine; subst.c. = ? µmol/l P—Dehydroepiandrosterone sulfate; subst.c. = ? nmol/l
Urine— Cobalamin(Plasma)— Cystine; Deoxycobalamin; substance concentration substance fraction micromol/litre NPU04959 NPU01828 Cobalamin(P)—Deoxycobalamin; subst.fr.= ? U—Cystine; subst.c. = ? µmol/l Haemoglobin(deoxy+oxy; arterial Blood)— Leukocyte protein— Deoxyhaemoglobin; Cystine; substance fraction substance content Authority: IFCC/C-BGE micromol/kilogram NPU08754 NPU01825 Hb(deoxy+oxy; aB)—Deoxyhaemoglobin; subst.fr. = ? Lkc prot.—Cystine; subst.cont. = ? µmol/kg Haemoglobin(total; arterial Blood)— Calculus(Urine)— Deoxyhaemoglobin; Cystine; substance fraction substance content Authority: IFCC/C-BGE mol/kilogram Note: "total" includes dyshaemoglobin, carboxihaemoglobin, methaemoglobin, NPU01827 sulfhaemoglobin Calculus(U)—Cystine; subst.cont. = ? mol/kg NPU08753 Hb(tot.; aB)—Deoxyhaemoglobin; subst.fr. = ?
55 Urine— Patient— Deoxypyridinoline/Creatininium; Dialysis solution; substance ratio property(list; procedure) 10-6 NPU14913 Note: _M_ (deoxypyridinoline) = ? g/mol; _M_ (creatininium) = 113,12 Pt—Dialysis solution; prop.(list; proc.) NPU09098 NPU10018 Dialysis solution—Albumin; subst.c. = ? µmol/l U—Deoxypyridinoline/Creatininium; subst.ratio = ? × 10-6 NPU10026 Dialysis solution—Carbamide; subst.c. = ? mmol/l NPU17172 Dialysis solution—Calcium(II; total); subst.c. = ? mmol/l Urine— NPU10043 Dialysis solution—Creatininium; subst.c. = ? µmol/l Dermatan sulfate; NPU10112 Dialysis solution—Glucose; subst.c. = ? mmol/l substance concentration NPU10165 Dialysis solution—Hydrogen carbonate; subst.c.(actual) = ? mmol/l micromol/litre NPU14922 Dialysis solution—Hydrogen ion; subst.c. = ? nmol/l M = 50 000 g/mol NPU14355 Dialysis solution—Hydrogen ion; pH = ? Authority: IUPAC-IUB85 NPU10168 Dialysis solution—Potassium ion; subst.c. = ? mmol/l NPU01857 NPU10182 Dialysis solution—Lithium ion; subst.c.(therapy) = ? mmol/l U—Dermatan sulfate; subst.c. = ? µmol/l NPU10192 Dialysis solution—Sodium ion; subst.c. = ? mmol/l
Patient— Patient(Blood)— Desmopressin(administered); Dialysis solution; amount-of-substance(intranasal administration) property(list; procedure) micromol NPU17054 M = 1069,23 g/mol Pt(B)—Dialysis solution; prop.(list; proc.) NPU12875 NPU10018 Dialysis solution—Albumin; subst.c. = ? µmol/l Pt—Desmopressin(administered); am.s.(i.n.) = ? µmol NPU10026 Dialysis solution—Carbamide; subst.c. = ? mmol/l NPU17172 Dialysis solution—Calcium(II; total); subst.c. = ? mmol/l Patient— NPU10043 Dialysis solution—Creatininium; subst.c. = ? µmol/l Desmopressin(administered); NPU10112 Dialysis solution—Glucose; subst.c. = ? mmol/l amount-of-substance(intranasal administration) NPU10165 Dialysis solution—Hydrogen carbonate; subst.c.(actual) = ? mmol/l nanomol NPU14922 Dialysis solution—Hydrogen ion; subst.c. = ? nmol/l M = 1069,23 g/mol NPU14355 Dialysis solution—Hydrogen ion; pH = ? NPU09117 NPU10168 Dialysis solution—Potassium ion; subst.c. = ? mmol/l Pt—Desmopressin(administered); am.s.(i.n.) = ? nmol NPU10182 Dialysis solution—Lithium ion; subst.c.(therapy) = ? mmol/l NPU10192 Dialysis solution—Sodium ion; subst.c. = ? mmol/l Patient— Desmopressin(administered); Patient(Peritoneum)— substance content(intranasal administration; amount-of-substance/body Dialysis solution; mass) property(list; procedure) nanomol/kilogram NPU17070 M = 1069,23 g/mol Pt(Peritoneum)—Dialysis solution; prop.(list; proc.) NPU09118 NPU10018 Dialysis solution—Albumin; subst.c. = ? µmol/l Pt—Desmopressin(administered); subst.cont.(i.n.; am.s./body mass) = ? NPU17172 Dialysis solution—Calcium(II; total); subst.c. = ? mmol/l nmol/kg NPU10026 Dialysis solution—Carbamide; subst.c. = ? mmol/l NPU10043 Dialysis solution—Creatininium; subst.c. = ? µmol/l Plasma— NPU10112 Dialysis solution—Glucose; subst.c. = ? mmol/l Desoxycortone; NPU10165 Dialysis solution—Hydrogen carbonate; subst.c.(actual) = ? mmol/l substance concentration NPU14355 Dialysis solution—Hydrogen ion; pH = ? mol/litre NPU14922 Dialysis solution—Hydrogen ion; subst.c. = ? nmol/l M = 330,45 g/mol NPU10168 Dialysis solution—Potassium ion; subst.c. = ? mmol/l Other term(s): Deoxycorticosterone; 11-Hydroxyprogesterone NPU10182 Dialysis solution—Lithium ion; subst.c.(therapy) = ? mmol/l Authority: INN NPU10192 Dialysis solution—Sodium ion; subst.c. = ? mmol/l NPU04369 P—Desoxycortone; subst.c.= ? prefix ? mol/l Plasma— Dicarboxylic acid C6C8C10; Urine— substance concentration Desoxycortone; micromol/litre substance concentration NPU01881 mol/litre P—Dicarboxylic acid C6C8C10; subst.c. = ? µmol/l M = 330,45 g/mol Other term(s): Deoxycorticosterone; 11-Hydroxyprogesterone Urine— Authority: INN Dicarboxylic acid C6C8C10; NPU04368 substance concentration U—Desoxycortone; subst.c.= ? prefix ? mol/l micromol/litre NPU01882 Patient— U—Dicarboxylic acid C6C8C10; subst.c. = ? µmol/l Dexamethasone(administered); amount-of-substance(single dose oral administration) Erythrocytes(Blood)— micromol 2,3- M = 392,45 g/mol Diphosphoglycerate; NPU10532 substance concentration Pt—Dexamethasone(administered); am.s.(single dose p.o.) = ? µmol millimol/litre Other term(s): Glycerate 2,3-biphosphate Patient— NPU01907 Dexamethasone(administered); Ercs(B)—2,3-Diphosphoglycerate; subst.c. = ? mmol/l number of doses NPU09115 Plasma— Pt—Dexamethasone(administered); number of doses = ? DNA(double coil) antibody(Immunoglobulin G); arbitrary concentration(procedure) Patient— Other term(s): DNA(double coil) antibody Dexamethasone(administered); NPU04172 time interval(between doses) P—DNA(double coil) antibody(IgG); arb.c.(proc.) = ? minute NPU09116 Plasma— Pt—Dexamethasone(administered); time int.(between doses) = ? min DNA(double coil) antibody(Immunoglobulin G); arbitrary substance concentration(procedure) arbitrary unit/litre NPU12038 P—DNA(double coil) antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l
56 Plasma— Plasma— DNA(double coil) antibody(Immunoglobulin G); Endomysium antibody(Immunoglobulin G); arbitrary substance concentration(WHO calibrator; procedure) arbitrary substance concentration(procedure) 10³ international unit/litre arbitrary unit NPU16393 NPU14342 P—DNA(double coil) antibody(IgG); arb.subst.c.(WHO calib.; proc.) = ? × 10³ P—Endomysium antibody(IgG); arb.subst.c.(proc.) = ? arb.unit int.unit/l Plasma— Plasma— beta- DNA(double coil) antibody; Endorphin; arbitrary concentration(procedure) substance concentration Other term(s): DNA(double coil) antibody(IgG) picomol/litre NPU01913 NPU10606 P—DNA(double coil) antibody; arb.c.(proc.) = ? P—beta-Endorphin; subst.c. = ? pmol/l
Plasma— Plasma— DNA(double coil) antibody; Entactin antibody(Immunoglobulin G); mass concentration arbitrary concentration(procedure) milligram/litre NPU12549 Other term(s): DNA(double coil) antibody(IgG) P—Entactin antibody(IgG); arb.c.(proc.) = ? NPU10751 P—DNA(double coil) antibody; mass c. = ? mg/l Plasma— Entactin antibody(Immunoglobulin G); Plasma— arbitrary substance concentration(procedure) DNA-ase B antibody; 10³ arbitrary unit/litre arbitrary substance concentration(procedure) NPU12550 arbitrary unit/litre P—Entactin antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Other term(s): ASH NPU13794 Plasma— P—DNA-ase B antibody; arb.subst.c.(proc.) = ? arb.unit/l Entactin antibody(Immunoglobulin M); arbitrary concentration(procedure) Plasma— NPU12547 DNP antibody; P—Entactin antibody(IgM); arb.c.(proc.) = ? arbitrary concentration(procedure) NPU01914 Plasma— P—DNP antibody; arb.c.(proc.) = ? Entactin antibody(Immunoglobulin M); arbitrary substance concentration(procedure) Urine— 10³ arbitrary unit/litre Dopamine; NPU12551 amount-of-substance(procedure) P—Entactin antibody(IgM); arb.subst.c.(proc.) = ? × 10³ arb.unit/l micromol M = 153,18 g/mol Plasma— NPU08619 Entactin antibody; U—Dopamine; am.s.(proc.) = ? µmol arbitrary concentration(list; procedure) NPU17102 Urine— P—Entactin antibody; arb.c.(list; proc.) Dopamine; NPU12549 P—Entactin antibody(IgG); arb.c.(proc.) = ? substance concentration NPU12547 P—Entactin antibody(IgM); arb.c.(proc.) = ? micromol/litre M = 153,18 g/mol Plasma— NPU01915 Entactin antibody; U—Dopamine; subst.c. = ? µmol/l arbitrary substance concentration(list; procedure) NPU17103 Drain fluid(specification)— P—Entactin antibody; arb.subst.c.(list; proc.) Drain fluid; NPU12550 P—Entactin antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l property(list; procedure) NPU12551 P—Entactin antibody(IgM); arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU17126 Drain fluid(spec.)—Drain fluid; prop.(list; proc.) Plasma— NPU17046 Drain fluid(spec.)—Albumin; subst.c. = ? µmol/l Entactin; NPU08590 Drain fluid(spec.)—Amylase, pancreatic type 3+4+5; cat.c.(37 °C; arbitrary substance concentration(procedure) proc.) = ? µkat/l arbitrary unit/litre NPU17195 Drain fluid(spec.)—Amylase; cat.c.(37 °C; proc.) = ? µkat/l NPU12119 NPU17043 Drain fluid(spec.)—Bilirubins(tot.); subst.c. = ? µmol/l P—Entactin; arb.subst.c.(proc.) = ? arb.unit/l NPU17047 Drain fluid(spec.)—Carbamide; subst.c. = ? mmol/l NPU17050 Drain fluid(spec.)—Glucose; subst.c. = ? mmol/l Expectorate— NPU17048 Drain fluid(spec.)—Creatininium; subst.c. = ? mmol/l Eosinophilocytes; NPU17051 Drain fluid(spec.)—Haemoglobin(Fe); arb.c.(proc.) = ? arbitrary concentration(procedure) NPU17052 Drain fluid(spec.)—Haemoglobin(Fe); subst.c. = ? µmol/l NPU01934 NPU17049 Drain fluid(spec.)—Potassium ion; subst.c. = ? mmol/l Ex—Eosinophilocytes; arb.c.(proc.) = ? NPU17178 Drain fluid(spec.)—Leukocytes; num.c. = ? × 106/l NPU17045 Drain fluid(spec.)—Sodium ion; subst.c. = ? mmol/l Secretion(Nasopharynx)— NPU17042 Drain fluid(spec.)—Protein; mass c. = ? g/l Eosinophilocytes; arbitrary concentration(procedure) Blood— NPU10142 Echinocytes; Secr(Nasoph)—Eosinophilocytes; arb.c.(proc.) = ? arbitrary concentration(procedure) NPU17083 Secretion(specification)— B—Echinocytes; arb.c.(proc.) = ? Eosinophilocytes; arbitrary concentration(procedure) Plasma— NPU01935 Endomysium antibody(Immunoglobulin A); Secr(spec.)—Eosinophilocytes; arb.c.(proc.) = ? arbitrary concentration(procedure) NPU12538 Blood— P—Endomysium antibody(IgA); arb.c.(proc.) = ? Eosinophilocytes; number concentration(mechanical) 109/litre NPU01933 B—Eosinophilocytes; num.c.(mech.) = ? × 109/l
57 Blood— Blood fraction(specification)— Eosinophilocytes; Erythroblasts(basophil); number concentration(microscopic) number concentration 109/litre 109/litre NPU17562 NPU17598 B—Eosinophilocytes; num.c.(micr.) = ? × 109/l B fract.(spec.)—Erythroblasts(basophil); num.c. = ? × 109/l
Secretion(Nasopharynx)— Bone marrow— Eosinophilocytes; Erythroblasts(basophil); number concentration number concentration 106/litre 109/litre NPU10220 NPU03798 Secr(Nasoph)—Eosinophilocytes; num.c. = ? × 106/l Marrow—Erythroblasts(basophil); num.c. = ? × 109/l
Blood fraction(specification)— Leukocytes(Blood)— Eosinophilocytes; Erythroblasts(basophil); number concentration number fraction 109/litre NPU04691 NPU17561 Lkcs(B)—Erythroblasts(basophil); num.fr. = ? B fract.(spec.)—Eosinophilocytes; num.c. = ? × 109/l Leukocytes(Bone marrow)— Bone marrow— Erythroblasts(basophil); Eosinophilocytes; number fraction number concentration NPU04991 109/litre Lkcs(Marrow)—Erythroblasts(basophil); num.fr. = ? NPU04671 Marrow—Eosinophilocytes; num.c. = ? × 109/l Blood— Erythroblasts(orthochrome); Leukocytes(Blood)— number concentration Eosinophilocytes; 109/litre number fraction NPU04692 NPU03967 B—Erythroblasts(orthochrome); num.c. = ? × 109/l Lkcs(B)—Eosinophilocytes; num.fr. = ? Blood fraction(specification)— Leukocytes(Bone marrow)— Erythroblasts(orthochrome); Eosinophilocytes; number concentration number fraction 109/litre NPU04672 NPU17599 Lkcs(Marrow)—Eosinophilocytes; num.fr. = ? B fract.(spec.)—Erythroblasts(orthochrome); num.c. = ? × 109/l
Urine— Bone marrow— Epitestosterone; Erythroblasts(orthochrome); substance concentration number concentration nanomol/litre 109/litre M = 288,43 g/mol NPU03799 NPU01941 Marrow—Erythroblasts(orthochrome); num.c. = ? × 109/l U—Epitestosterone; subst.c. = ? nmol/l Leukocytes(Blood)— Pleural fluid(specification)— Erythroblasts(orthochrome); Epithelial cells; number fraction arbitrary concentration(procedure) NPU04694 NPU10307 Lkcs(B)—Erythroblasts(orthochrome); num.fr. = ? Plf(spec.)—Epithelial cells; arb.c.(proc.) = ? Leukocytes(Bone marrow)— Synovial fluid(specification)— Erythroblasts(orthochrome); Epithelial cells; number fraction arbitrary concentration(procedure) NPU04993 NPU10308 Lkcs(Marrow)—Erythroblasts(orthochrome); num.fr. = ? Synf(spec.)—Epithelial cells; arb.c.(proc.) = ? Blood— System(specification)— Erythroblasts(polychrome); Epithelial cells; number concentration arbitrary concentration(procedure) 109/litre NPU10306 NPU04695 Syst(spec.)—Epithelial cells; arb.c.(proc.) = ? B—Erythroblasts(polychrome); num.c. = ? × 109/l
Urine— Blood fraction(specification)— Epithelial cells; Erythroblasts(polychrome); arbitrary concentration(procedure) number concentration NPU03986 109/litre U—Epithelial cells; arb.c.(proc.) = ? NPU17600 B fract.(spec.)—Erythroblasts(polychrome); num.c. = ? × 109/l Urine— Epithelial cells; Bone marrow— number concentration(procedure) Erythroblasts(polychrome); 106/litre number concentration NPU10507 109/litre U—Epithelial cells; num.c.(proc.) = ? × 106/l NPU03806 Marrow—Erythroblasts(polychrome); num.c. = ? × 109/l Blood— Erythroblasts(basophil); Leukocytes(Blood)— number concentration Erythroblasts(polychrome); 109/litre number fraction NPU04690 NPU04696 B—Erythroblasts(basophil); num.c. = ? × 109/l Lkcs(B)—Erythroblasts(polychrome); num.fr. = ?
58 Leukocytes(Bone marrow)— Blood— Erythroblasts(polychrome); Erythrocytes(hyperchrome); number fraction arbitrary concentration(procedure) NPU04992 NPU17091 Lkcs(Marrow)—Erythroblasts(polychrome); num.fr. = ? B—Erythrocytes(hyperchrome); arb.c.(proc.) = ?
Blood— Erythrocytes(Blood)— Erythroblasts; Erythrocytes(hyperchrome); arbitrary concentration(procedure) number fraction NPU17086 NPU14350 B—Erythroblasts; arb.c.(proc.) = ? Ercs(B)—Erythrocytes(hyperchrome); num.fr. = ?
Blood— Blood— Erythroblasts; Erythrocytes(hypochromic); number concentration arbitrary concentration(procedure) 109/litre NPU17092 NPU01943 B—Erythrocytes(hypochromic); arb.c.(proc.) = ? B—Erythroblasts; num.c. = ? × 109/l Erythrocytes(Blood)— Blood fraction(specification)— Erythrocytes(hypochromic); Erythroblasts; number fraction number concentration NPU14111 109/litre Ercs(B)—Erythrocytes(hypochromic); num.fr. = ? NPU17601 B fract.(spec.)—Erythroblasts; num.c. = ? × 109/l Blood— Erythrocytes(polychrome); Leukocytes(Blood)— arbitrary concentration(procedure) Erythroblasts; NPU14275 number concentration B—Erythrocytes(polychrome); arb.c.(proc.) = ? 109/litre NPU09110 Erythrocytes(Amniotic fluid)— Lkcs(B)—Erythroblasts; num.c. = ? × 109/l Erythrocytes, haemoglobin F containing; number fraction Erythrocytes(Blood)— NPU01963 Erythroblasts; Ercs(Amf)—Erythrocytes, haemoglobin F containing; num.fr. = ? number fraction NPU14347 Erythrocytes(Blood)— Ercs(B)—Erythroblasts; num.fr. = ? Erythrocytes, haemoglobin F containing; number fraction Leukocytes(Blood)— NPU01964 Erythroblasts; Ercs(B)—Erythrocytes, haemoglobin F containing; num.fr. = ? number fraction NPU10143 Erythrocytes(vaginal Blood)— Lkcs(B)—Erythroblasts; num.fr. = ? Erythrocytes, haemoglobin F containing; number fraction Patient(Blood)— NPU01965 Erythrocyte elimination; Ercs(vagB)—Erythrocytes, haemoglobin F containing; num.fr. = ? half-life(procedure) day Urine— NPU04150 Erythrocytes; Pt(B)—Erythrocyte elimination; half-life(proc.) = ? d arbitrary concentration(procedure) NPU03963 Blood— U—Erythrocytes; arb.c.(proc.) = ? Erythrocyte surface; entitic area Blood— micro(metre)² Erythrocytes; NPU04074 entitic diameter B—Erythrocyte surface; entitic area = ? µm² micrometre NPU04060 Blood— B—Erythrocytes; entitic diameter = ? µm Erythrocytes(Anisocytosis); arbitrary concentration(procedure) Blood— NPU14259 Erythrocytes; B—Erythrocytes(Anisoc.); arb.c.(proc.) = ? entitic volume difference(maximum-minimum; erythrocyte distribution width; procedure) Blood— femtolitre Erythrocytes(basophilic punctured); Other term(s): MCV arbitrary concentration(procedure) NPU14143 NPU17081 B—Erythrocytes; entitic vol.diff.?(max.-min.; RDW; proc.) = ? fl B—Erythrocytes(baso punct.); arb.c.(proc.) = ? Blood— Erythrocytes(Blood)— Erythrocytes; Erythrocytes(basophilic punctured); entitic volume number fraction femtolitre NPU14349 Other term(s): MCV Ercs(B)—Erythrocytes(baso punct.); num.fr. = ? NPU01944 B—Erythrocytes; entitic vol. = ? fl Blood— Erythrocytes(Howell-Jolly bodies); arbitrary concentration(procedure) NPU17090 B—Erythrocytes(Howell-Jolly); arb.c.(proc.) = ?
Erythrocytes(Blood)— Erythrocytes(Howell-Jolly bodies); number fraction NPU14269 Ercs(B)—Erythrocytes(Howell-Jolly); num.fr. = ?
59 Blood— Amniotic fluid— Erythrocytes; Erythrocytes; morphology(list; procedure) number concentration NPU14139 106/litre B—Erythrocytes; morphology(list; proc.) NPU08967 NPU14348 Ercs(B)—Acanthocytes; num.fr. = ? Amf—Erythrocytes; num.c. = ? × 106/l NPU17074 B—Acanthocytes; arb.c.(proc.) = ? NPU17078 B—Annulocytes; arb.c.(proc.) = ? Ascites— NPU17083 B—Echinocytes; arb.c.(proc.) = ? Erythrocytes; NPU14347 Ercs(B)—Erythroblasts; num.fr. = ? number concentration NPU17086 B—Erythroblasts; arb.c.(proc.) = ? 106/litre NPU14259 B—Erythrocytes(Anisoc.); arb.c.(proc.) = ? NPU08934 NPU14349 Ercs(B)—Erythrocytes(baso punct.); num.fr. = ? Asc—Erythrocytes; num.c. = ? × 106/l NPU17081 B—Erythrocytes(baso punct.); arb.c.(proc.) = ? NPU14269 Ercs(B)—Erythrocytes(Howell-Jolly); num.fr. = ? Cerebrospinal fluid— NPU17090 B—Erythrocytes(Howell-Jolly); arb.c.(proc.) = ? Erythrocytes; NPU14350 Ercs(B)—Erythrocytes(hyperchrome); num.fr. = ? number concentration NPU17091 B—Erythrocytes(hyperchrome); arb.c.(proc.) = ? 106/litre NPU14111 Ercs(B)—Erythrocytes(hypochromic); num.fr. = ? NPU01962 NPU17092 B—Erythrocytes(hypochromic); arb.c.(proc.) = ? Csf—Erythrocytes; num.c. = ? × 106/l NPU14275 B—Erythrocytes(polychrome); arb.c.(proc.) = ? NPU17088 B—Helmet cells; arb.c.(proc.) = ? Pleural fluid(specification)— NPU14270 Ercs(B)—Megalocytes; num.fr. = ? Erythrocytes; NPU17094 B—Megalocytes; arb.c.(proc.) = ? number concentration NPU14371 Ercs(B)—Megaloblasts; num.fr. = ? 106/litre NPU17093 B—Megaloblasts; arb.c.(proc.) = ? NPU10145 NPU14271 Ercs(B)—Microcytes; num.fr. = ? Plf(spec.)—Erythrocytes; num.c. = ? × 106/l NPU17095 B—Microcytes; arb.c.(proc.) = ? NPU17096 B—Rouleau formation; arb.c.(proc.) = ? Semen— NPU14274 B—Poikilocytosis; arb.c.(proc.) = ? Erythrocytes; NPU17097 B—Schistocytes; arb.c.(proc.) = ? number concentration NPU14272 Ercs(B)—Sickle cells; num.fr. = ? 106/litre NPU17098 B—Sickle cells; arb.c.(proc.) = ? NPU10146 NPU14110 Ercs(B)—spherocytic; num.fr. = ? Sem—Erythrocytes; num.c. = ? × 106/l NPU17099 B—spherocytic; arb.c.(proc.) = ? NPU17130 B—Smudge cells; arb.c.(proc.) = ? Synovial fluid(specification)— NPU17100 B—Stomatocytes; arb.c.(proc.) = ? Erythrocytes; NPU14273 Ercs(B)—Target cells; num.fr. = ? number concentration NPU17101 B—Target cells; arb.c.(proc.) = ? 106/litre NPU08933 Blood— Synf(spec.)—Erythrocytes; num.c. = ? × 106/l Erythrocytes; morphology(procedure) System(specification)— NPU04221 Erythrocytes; B—Erythrocytes; morphology(proc.) = ? number concentration 106/litre Urine— NPU10144 Erythrocytes; Syst(spec.)—Erythrocytes; num.c. = ? × 106/l number of entities(procedure) 106 System(specification)— Note: f.ex. Addis 1949; 3 d Erythrocytes; NPU03843 number concentration U—Erythrocytes; num.(proc.) = ? × 106 109/litre NPU10129 Blood— Syst(spec.)—Erythrocytes; num.c. = ? × 109/l Erythrocytes; number concentration(microscopic) Patient(Blood)— 1012/litre Erythrocytes; NPU17564 volume(procedure) B—Erythrocytes; num.c.(micr.) = ? × 1012/l litre NPU04168 Urine— Pt(B)—Erythrocytes; vol.(proc.)=? l Erythrocytes; number concentration(procedure) Blood— 106/litre Erythrocytes; NPU03842 volume fraction U—Erythrocytes; num.c.(proc.) = ? × 106/l NPU01961 B—Erythrocytes; vol.fr. = ? Blood— Erythrocytes; Blood fraction(specification)— number concentration Erythrocytes; 1012/litre volume fraction NPU01960 NPU17565 B—Erythrocytes; num.c. = ? × 1012/l B fract.(spec.)—Erythrocytes; vol.fr. = ?
Blood fraction(specification)— Plasma— Erythrocytes; Erythrolysine, biphasical(Immunoglobulin G); number concentration arbitrary substance concentration(procedure) 1012/litre arbitrary unit/litre NPU17563 Other term(s): Biphasic hemolysine; Donath-Landsteiner antibody B fract.(spec.)—Erythrocytes; num.c. = ? × 1012/l NPU17110 P—Erythrolysine, biphasical(IgG); arb.subst.c.(proc.) = ? arb.unit/l Synovial fluid(specification)— Erythrocytes; Plasma— number concentration Erythrolysine, biphasical; 1012/litre arbitrary concentration(procedure) NPU14080 Other term(s): Biphasic hemolysine; Donath-Landsteiner antibody Synf(spec.)—Erythrocytes; num.c. = ? × 1012/l NPU01966 P—Erythrolysine, biphasical; arb.c.(proc.) = ?
60 Plasma— Plasma— Erythrolysine, cold(Immunoglobulin M); Erythropoietin; arbitrary substance concentration(procedure) arbitrary substance concentration(two-site immunoassay; IRP 67/343; arbitrary unit/litre procedure) Other term(s): Cold hemolysine international unit/litre NPU17107 M = 30 000 g/mol P—Erythrolysine, cold(IgM); arb.subst.c.(proc.) = ? arb.unit/l Recommended calibrator: WHO 2nd IRP 67/343 Authority: IUPAC-IUB 74 Plasma— NPU04013 Erythrolysine, cold; P—Erythropoietin; arb.subst.c.(two-site immunoassay; IRP 67/343; proc.) = ? arbitrary concentration(procedure) int. unit/l Other term(s): Cold hemolysine NPU01967 Plasma— P—Erythrolysine, cold; arb.c.(proc.) = ? Erythropoietin; arbitrary substance concentration(two-site immunoassay; IS 87/684; procedure) Plasma— international unit/litre Erythrolysine, heat; M = 30 000 g/mol arbitrary concentration(procedure) Recommended calibrator: 1st IS 87/684 Other term(s): Heat hemolysine Calibrator(s): 1st IRP; 2nd IRP 67/343 NPU01968 Authority: IUPAC-IUB 74 P—Erythrolysine, heat; arb.c.(proc.) = ? NPU03830 P—Erythropoietin; arb.subst.c.(two-site immunoassay; IS 87/684; proc.) = ? int. Plasma— unit/l Erythropoietin; arbitrary substance concentration(in-vitro bioassay; IRP 67/343; procedure) Plasma— international unit/litre Erythropoietin; M = 30 000 g/mol substance concentration Recommended calibrator: WHO 2nd IRP 67/343 mol/litre Authority: IUPAC-IUB 74 M = 30 000 g/mol NPU04011 Authority: IUPAC-IUB 74 P—Erythropoietin; arb.subst.c.(in-vitro bioassay; IRP 67/343; proc.) = ? int. NPU01970 unit/l P—Erythropoietin; subst.c.= ? prefix ? mol/l
Plasma— Plasma— Erythropoietin; Estradiol(free); arbitrary substance concentration(in-vitro bioassay; IS 87/684; procedure) substance concentration international unit/litre nanomol/litre M = 30 000 g/mol M = 272,37 g/mol Recommended calibrator: 1st IS 87/684 Other term(s): Free E2 Calibrator(s): 1st IRP; 2nd IRP 67/343 Authority: IUPAC-IUB 89 Authority: IUPAC-IUB 74 NPU01974 NPU03828 P—Estradiol(free); subst.c. = ? nmol/l P—Erythropoietin; arb.subst.c.(in-vitro bioassay; IS 87/684; proc.) = ? int. unit/l Plasma— Plasma— Estradiol(free); Erythropoietin; substance concentration arbitrary substance concentration(in-vivo bioassay; IRP 67/343; procedure) picomol/litre international unit/litre M = 272,37 g/mol M = 30 000 g/mol Other term(s): Free E2 Recommended calibrator: 2nd IRP 67/343 Authority: IUPAC-IUB 89 Authority: IUPAC-IUB 74 NPU14569 NPU04010 P—Estradiol(free); subst.c. = ? pmol/l P—Erythropoietin; arb.subst.c.(in-vivo bioassay; IRP 67/343; proc.) = ? int. unit/l Plasma— Plasma— Estradiol(non sexual-hormone-binding-globulin bound); Erythropoietin; substance concentration arbitrary substance concentration(in-vivo bioassay; IS 87/684; procedure) nanomol/litre international unit/litre NPU12124 M = 30 000 g/mol P—Estradiol(non SHBG bound); subst.c. = ? nmol/l Recommended calibrator: WHO 1st IS 87/684 Calibrator(s): WHO 1st IRP; 2nd IRP 67/343 Plasma— Authority: IUPAC-IUB 74 Estradiol(non sexual-hormone-binding-globulin bound); NPU01969 substance concentration P—Erythropoietin; arb.subst.c.(in-vivo bioassay; IS 87/684; proc.) = ? int. unit/l picomol/litre NPU14570 Plasma— P—Estradiol(non SHBG bound); subst.c. = ? pmol/l Erythropoietin; arbitrary substance concentration(one-site immunoassay; IRP 67/343; Cystic fluid(specification)— procedure) Estradiol(total); international unit/litre substance concentration M = 30 000 g/mol nanomol/litre Recommended calibrator: WHO 2nd IRP 67/343 NPU08760 Authority: IUPAC-IUB 74 Cystf(spec.)—Estradiol(tot.); subst.c. = ? nmol/l NPU04012 P—Erythropoietin; arb.subst.c.(one-site immunoassay; IRP 67/343; proc.) = ? Plasma— int. unit/l Estradiol(total); substance concentration Plasma— nanomol/litre Erythropoietin; M = 272,37 g/mol arbitrary substance concentration(one-site immunoassay; IS 87/684; Authority: IUPAC-IUB 89 which is Estradiol-17-beta. Here 17-beta is omitted as procedure) 17-alpha does not occur in human plasma; CAS50-28-2 international unit/litre NPU01972 M = 30 000 g/mol P—Estradiol(tot.); subst.c. = ? nmol/l Recommended calibrator: 1st IS 87/684 Calibrator(s): 1st IRP; 2nd IRP 67/343 Authority: IUPAC-IUB 74 NPU03829 P—Erythropoietin; arb.subst.c.(one-site immunoassay; IS 87/684; proc.) = ? int. unit/l
61 Saliva— Plasma— Estradiol(total); Estrogen; substance concentration substance concentration(list; procedure) nanomol/litre NPU12122 M = 272,37 g/mol P—Estrogen; subst.c.(list; proc.) Authority: IUPAC-IUB 89 which is Estradiol-17-beta. Here 17-beta is omitted as NPU01974 P—Estradiol(free); subst.c. = ? nmol/l 17-alpha does not occur in human plasma; CAS50-28-2 NPU14569 P—Estradiol(free); subst.c. = ? pmol/l NPU01973 NPU12124 P—Estradiol(non SHBG bound); subst.c. = ? nmol/l Saliva—Estradiol(tot.); subst.c. = ? nmol/l NPU14570 P—Estradiol(non SHBG bound); subst.c. = ? pmol/l NPU01972 P—Estradiol(tot.); subst.c. = ? nmol/l Plasma— NPU09357 P—Estradiol(tot.); subst.c. = ? pmol/l Estradiol(total); NPU01980 P—Estriol(tot.); subst.c. = ? nmol/l substance concentration NPU01982 P—Estrone; subst.c. = ? pmol/l picomol/litre NPU12123 P—Estrone sulphate; subst.c. = ? pmol/l M = 272,37 g/mol NPU03419 P—Sexual-hormone-binding-globulin; subst.c. = ? nmol/l Authority: IUPAC-IUB 89 which is Estradiol-17-beta. Here 17-beta is omitted as 17-alpha does not occur in human plasma; CAS50-28-2 Plasma— NPU09357 Estrone sulphate; P—Estradiol(tot.); subst.c. = ? pmol/l substance concentration picomol/litre Mammary cytosol protein— NPU12123 Estradiol-receptor(free); P—Estrone sulphate; subst.c. = ? pmol/l substance content nanomol/kilogram Plasma— NPU01976 Estrone; Mammary cytosol prot.—Estradiol-receptor(free); subst.cont. = ? nmol/kg substance concentration picomol/litre Mammary cytosol protein— M = 270,36 g/mol Estradiol-receptor(total); Authority: IUPAC-IUB 89 substance content NPU01982 nanomol/kilogram P—Estrone; subst.c. = ? pmol/l NPU01975 Mammary cytosol prot.—Estradiol-receptor(tot.); subst.cont. = ? nmol/kg Urine— Ethanolamine/Creatininium; Plasma— substance ratio Estriol(total); 10-3 substance concentration NPU14208 nanomol/litre U—Ethanolamine/Creatininium; subst.ratio = ? × 10-3 Other term(s): Estriol+estriolglucuronate+estriol sulphate; Total estriols; Unconjugated+conjugated estriol Plasma— NPU01980 Ethyleneglycol; P—Estriol(tot.); subst.c. = ? nmol/l substance concentration millimol/litre Urine— M = 62,07 g/mol Estriol(total); NPU09008 substance concentration P—Ethyleneglycol; subst.c. = ? mmol/l nanomol/litre Other term(s): Estriol+estriolglucuronate+estriol sulphate; Total estriols; Urine— Unconjugated+conjugated estriol Etiocholanolone; NPU01981 substance concentration U—Estriol(tot.); subst.c. = ? nmol/l micromol/litre M = 290,4 g/mol Plasma— NPU02013 Estriol(total); U—Etiocholanolone; subst.c. = ? µmol/l substance concentration picomol/litre Patient(Urine)— Other term(s): Estriol+estriolglucuronate+estriol sulphate; Total estriols; Etiocholanolone; Unconjugated+conjugated estriol substance rate NPU14571 micromol/day P—Estriol(tot.); subst.c. = ? pmol/l NPU10134 Pt(U)—Etiocholanolone; subst.rate = ? µmol/d Plasma— Estriol; Plasma— substance concentration Extractable nuclear-antigen antibody; nanomol/litre arbitrary substance concentration(list; procedure) M = 288,37 g/mol NPU12022 Other term(s): Unconjugated estriol P—Extractable nuclear-antigen antibody; arb.subst.c.(list; proc.) Authority: IUPAC-IUB 89 NPU14504 P—Ribonucleoprotein antibody(IgG); arb.subst.c.(proc.) = ? NPU01979 arb.unit/l P—Estriol; subst.c. = ? nmol/l NPU14505 P—Ribonucleoprotein(U1) antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Plasma— NPU12024 P—Smith's antibody; arb.subst.c.(proc.) = ? arb.unit/l Estriol; substance concentration Patient— picomol/litre Faeces; M = 288,37 g/mol mass rate(procedure) Other term(s): Unconjugated estriol gram/day Authority: IUPAC-IUB 89 NPU03813 NPU14572 Pt—Faeces; mass rate(proc.) = ? g/d P—Estriol; subst.c. = ? pmol/l Patient— Faeces; mass(procedure) gram NPU10221 Pt—Faeces; mass(proc.) = ? g
62 Plasma— Patient(Urine)— Ferritin; Fluoride; substance concentration substance rate(procedure) picomol/litre micromol/day M = 450 000 g/mol NPU02063 NPU03899 Pt(U)—Fluoride; subst.rate(proc.) = ? µmol/d P—Ferritin; subst.c. = ? pmol/l Plasma— Plasma— Folate; Ferroxidase; substance concentration substance concentration nanomol/litre micromol/litre M = 441,40 g/mol M = 134 000 g/mol NPU02070 Other term(s): Ceruloplasmin; Coeruloplasmin P—Folate; subst.c. = ? nmol/l Authority: IUB 84; E.C. 1.16.3.1 NPU02041 Erythrocytes(Blood)— P—Ferroxidase; subst.c. = ? µmol/l Folates(total); substance concentration alpha-1-Fetoprotein— micromol/litre alpha-1- Other term(s): Pteroylpolyglutamic Acids for Folates Fetoprotein(non con-A reactive); NPU17169 substance fraction(IS 72/225; procedure) Ercs(B)—Folates(tot.); subst.c. = ? µmol/l NPU17674 alpha-1-Fetoprotein—alpha-1-Fetoprotein(non con-A reactive); subst.fr.(IS Blood— 72/225; proc.) = ? Folates(total); substance concentration Amniotic fluid— nanomol/litre alpha-1- Other term(s): Pteroylpolyglutamic Acids for Folates Fetoprotein; NPU14326 arbitrary substance concentration(IS 72/225) B—Folates(tot.); subst.c. = ? nmol/l 10³ international unit/litre NPU17685 Erythrocytes(Blood)— Amf—alpha-1-Fetoprotein; arb.subst.c.(IS 72/225) = ? × 10³ int.unit/l Folates(total); substance concentration Plasma— nanomol/litre alpha-1- Other term(s): Pteroylpolyglutamic Acids for Folates Fetoprotein; NPU02071 arbitrary substance concentration(IS 72/225; procedure) Ercs(B)—Folates(tot.); subst.c. = ? nmol/l 10³ international unit/litre M = 69 000 g/mol Plasma— Recommended calibrator: WHO 1st IS 72/225 Follitropin alpha-chain; NPU02043 substance concentration P—alpha-1-Fetoprotein; arb.subst.c.(IS 72/225; proc.) = ? × 10³ int.unit/l picomol/litre M = 14 000 g/mol Amniotic fluid— NPU02074 alpha-1- P—Follitropin alpha-chain; subst.c. = ? pmol/l Fetoprotein; arbitrary substance concentration(IS 72/225; procedure) Plasma— international unit/litre Follitropin beta-chain; M = 69 000 g/mol substance concentration Recommended calibrator: WHO 1st IS 72/225 picomol/litre NPU02042 M = 19 000 g/mol Amf—alpha-1-Fetoprotein; arb.subst.c.(IS 72/225; proc.) = ? int. unit/l NPU02075 P—Follitropin beta-chain; subst.c. = ? pmol/l Amniotic fluid— alpha-1- Pituitary gland— Fetoprotein; Follitropin secretion; substance concentration substance rate(gonadorelin, intravenous administration; list; procedure) nanomol/litre Other term(s): Gonadorelin test; Gonadoliberin test; Luliberin test; M = 69 000 g/mol Gonadotropin-releasing hormone test; GRH test NPU03925 Note: _M_(gonadorelin) = 1 182,3 g/mol Amf—alpha-1-Fetoprotein; subst.c. = ? nmol/l NPU10570 PitGl—Follitropin secretion; subst.rate(gonadorelin i.v.; list; proc.) Plasma— NPU10561 Pt—Gonadorelin(administered); am.s.(i.v.) = ? nmol alpha-1- NPU10674 P—Follitropin; arb.subst.c.(IRP 78/549; -60 min; proc.) = ? int. unit/l Fetoprotein; NPU10675 P—Follitropin; arb.subst.c.(IRP 78/549; -15 min; proc.) = ? int. unit/l substance concentration NPU10562 P—Follitropin; arb.subst.c.(IRP 78/549; 0 min; proc.) = ? int. unit/l nanomol/litre NPU10563 P—Follitropin; arb.subst.c.(IRP 78/549; 15 min; proc.) = ? int. unit/l M = 69 000 g/mol NPU10564 P—Follitropin; arb.subst.c.(IRP 78/549; 30 min; proc.) = ? int. unit/l NPU03924 NPU10565 P—Follitropin; arb.subst.c.(IRP 78/549; 60 min; proc.) = ? int. unit/l P—alpha-1-Fetoprotein; subst.c. = ? nmol/l NPU10566 P—Follitropin; arb.subst.c.(IRP 78/549; 75 min; proc.) = ? int. unit/l NPU10567 P—Follitropin; arb.subst.c.(IRP 78/549; 90 min; proc.) = ? int. unit/l Plasma— NPU10568 P—Follitropin; arb.subst.c.(IRP 78/549; 105 min; proc.) = ? int. unit/l Fluoride; NPU10569 P—Follitropin; arb.subst.c.(IRP 78/549; 120 min; proc.) = ? int. unit/l substance concentration micromol/litre Plasma— M = 19,00 g/mol Follitropin; Authority: IUPAC/VII-C-TOX arbitrary substance concentration(IRP 78/549; 0 minutes after challenge; NPU04882 procedure) P—Fluoride; subst.c. = ? µmol/l international unit/litre NPU10562 Urine— P—Follitropin; arb.subst.c.(IRP 78/549; 0 min; proc.) = ? int. unit/l Fluoride; substance concentration Plasma— micromol/litre Follitropin; M = 19,00 g/mol arbitrary substance concentration(IRP 78/549; 105 minutes after Authority: IUPAC/VII-C-TOX challenge; procedure) NPU10152 international unit/litre U—Fluoride; subst.c. = ? µmol/l NPU10568 P—Follitropin; arb.subst.c.(IRP 78/549; 105 min; proc.) = ? int. unit/l
63 Plasma— Plasma— Follitropin; Follitropin; substance concentration arbitrary substance concentration(IRP 78/549; 120 minutes after mol/litre challenge; procedure) M = 33 000 g/mol international unit/litre Other term(s): Follicle-stimulating hormone; FSH NPU10569 Authority: IUPAC-IUB 74 P—Follitropin; arb.subst.c.(IRP 78/549; 120 min; proc.) = ? int. unit/l NPU02073 P—Follitropin; subst.c.= ? prefix ? mol/l Plasma— Follitropin; Plasma— arbitrary substance concentration(IRP 78/549; 15 minutes after challenge; Follitropin+Lutropin; procedure) arbitrary substance concentration(list; procedure) international unit/litre NPU17672 NPU10563 P—Follitropin+Lutropin; arb.subst.c.(list; proc.) P—Follitropin; arb.subst.c.(IRP 78/549; 15 min; proc.) = ? int. unit/l NPU04014 P—Follitropin; arb.subst.c.(IRP 78/549; proc.) = ? int. unit/l NPU02618 P—Lutropin; arb.subst.c.(IS 80/552; proc.) = ? int. unit/l Plasma— Follitropin; Patient— arbitrary substance concentration(IRP 78/549; 15 minutes before Food ingestion; challenge; procedure) mass rate(procedure) international unit/litre gram/day NPU10675 NPU04077 P—Follitropin; arb.subst.c.(IRP 78/549; -15 min; proc.) = ? int. unit/l Pt—Food ingestion; mass rate(proc.) = ? g/d
Plasma— Urine— Follitropin; Formiminoglutamate; arbitrary substance concentration(IRP 78/549; 30 minutes after challenge; amount-of-substance(0-540 minutes after histidine, oral administration; procedure) procedure) international unit/litre micromol NPU10564 Other term(s): FIGLU test P—Follitropin; arb.subst.c.(IRP 78/549; 30 min; proc.) = ? int. unit/l NPU02086 U—Formiminoglutamate; am.s.(0-540 min after histidine p.o.; proc.)= ? µmol Plasma— Follitropin; Plasma— arbitrary substance concentration(IRP 78/549; 60 minutes after challenge; Freezing point; procedure) Celsius temperature increment(Water-Plasma) international unit/litre degree Celsius NPU10565 NPU04035 P—Follitropin; arb.subst.c.(IRP 78/549; 60 min; proc.) = ? int. unit/l P—Freezing point; temp.incr.(Water-Plasma) = ? °C
Plasma— Plasma— Follitropin; Fructosamine; arbitrary substance concentration(IRP 78/549; 60 minutes before substance concentration challenge; procedure) micromol/litre international unit/litre NPU02096 NPU10674 P—Fructosamine; subst.c. = ? µmol/l P—Follitropin; arb.subst.c.(IRP 78/549; -60 min; proc.) = ? int. unit/l Patient— Plasma— Fructose(administered); Follitropin; amount-of-substance(oral administration) arbitrary substance concentration(IRP 78/549; 75 minutes after challenge; millimol procedure) M = 180,16 g/mol international unit/litre Other term(s): D-Fructose; D-Levulose NPU10566 NPU10498 P—Follitropin; arb.subst.c.(IRP 78/549; 75 min; proc.) = ? int. unit/l Pt—Fructose(administered); am.s.(p.o.) = ? mmol
Plasma— Patient— Follitropin; Fructose(administered); arbitrary substance concentration(IRP 78/549; 90 minutes after challenge; substance content(oral administration; amount-of-substance/body mass) procedure) millimol/kilogram international unit/litre M = 180,16 g/mol NPU10567 Other term(s): D-Fructose; D-Levulose P—Follitropin; arb.subst.c.(IRP 78/549; 90 min; proc.) = ? int. unit/l NPU10499 Pt—Fructose(administered); subst.cont.(p.o.; am.s./body mass) = ? mmol/kg Plasma— Follitropin; Urine— arbitrary substance concentration(IRP 78/549; procedure) Fructose; international unit/litre substance concentration M = 33 000 g/mol mol/litre Recommended calibrator: WHO 2nd IRP 78/549 M = 180,16 g/mol Other term(s): Follicle-stimulating hormone; FSH Other term(s): Levulose Authority: IUPAC-IUB 74 NPU02098 NPU04014 U—Fructose; subst.c.= ? prefix ? mol/l P—Follitropin; arb.subst.c.(IRP 78/549; proc.) = ? int. unit/l
Plasma— Follitropin; arbitrary substance concentration(IS 83/575; procedure) international unit/litre M = 33 000 g/mol Recommended calibrator: WHO 1st IS 83/575 Calibrator(s): WHO 2nd IRP 78/549 Other term(s): Follicle-stimulating hormone; FSH Authority: IUPAC-IUB 74 NPU02072 P—Follitropin; arb.subst.c.(IS 83/575; proc.) = ? int. unit/l
64 Patient— Patient— Fructose+glucose tolerance; Galactose tolerance; property(fructose+glucose, oral administration; list; procedure) property(galactose, intravenous administration; list; procedure) Note: _M_ (fructose) = 180,16 g/mol; _M_ (glucose) = 180,16 g/mol Other term(s): Galactose elimination capacity test NPU02099 Note: _M_(galactose) = 180,16 g/mol Pt—Fructose+glucose tolerance; prop.(fructose+glucose p.o.; list; proc.) NPU10336 NPU10498 Pt—Fructose(administered); am.s.(p.o.) = ? mmol Pt—Galactose tolerance; prop.(galactose i.v.; list; proc.) NPU10499 Pt—Fructose(administered); subst.cont.(p.o.; am.s./body mass) = ? NPU10344 Pt—Galactose(administered); am.s.(i.v.) = ? mmol mmol/kg NPU10345 Pt—Galactose(administered); subst.cont.(i.v.; am.s./body mass) = ? NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol mmol/kg NPU10575 Pt—Glucose(administered); subst.cont.(p.o.; am.s./body mass) = ? NPU14914 Pt—Galactose elimination; subst.rate(proc.) = ? mmol/s mmol/kg NPU17700 Pt(P)—Galactose elimination; subst.rate ratio(galactose i.v.; NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l actual/norm; proc.) = ? NPU08516 B—Glucose; subst.c.(15 min) = ? mmol/l NPU10337 B—Galactose; subst.c.(0 min) = ? mmol/l NPU08504 B—Glucose; subst.c.(30 min) = ? mmol/l NPU10338 B—Galactose; subst.c.(10 min) = ? mmol/l NPU08517 B—Glucose; subst.c.(45 min) = ? mmol/l NPU09241 B—Galactose; subst.c.(25 min) = ? mmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l NPU10340 B—Galactose; subst.c.(30 min) = ? mmol/l NPU08518 B—Glucose; subst.c.(75 min) = ? mmol/l NPU09242 B—Galactose; subst.c.(35 min) = ? mmol/l NPU08506 B—Glucose; subst.c.(90 min) = ? mmol/l NPU09243 B—Galactose; subst.c.(45 min) = ? mmol/l NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l NPU10343 B—Galactose; subst.c.(60 min) = ? mmol/l NPU08500 B—Glucose; subst.c.(180 min) = ? mmol/l NPU10495 B—Galactose; subst.c.(90 min) = ? mmol/l NPU08515 B—Glucose; subst.c.(360 min) = ? mmol/l NPU10496 B—Galactose; subst.c.(120 min) = ? mmol/l NPU08502 B—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l NPU14128 B(cB)—Galactose; subst.c.(0 min) = ? mmol/l NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU14130 B(cB)—Galactose; subst.c.(25 min) = ? mmol/l NPU04186 P—Glucose; subst.c.(15 min) = ? mmol/l NPU14131 B(cB)—Galactose; subst.c.(30 min) = ? mmol/l NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l NPU14132 B(cB)—Galactose; subst.c.(35 min) = ? mmol/l NPU04187 P—Glucose; subst.c.(45 min) = ? mmol/l NPU14133 B(cB)—Galactose; subst.c.(45 min) = ? mmol/l NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l NPU14134 B(cB)—Galactose; subst.c.(60 min) = ? mmol/l NPU04965 P—Glucose; subst.c.(75 min) = ? mmol/l NPU14135 B(cB)—Galactose; subst.c.(90 min) = ? mmol/l NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l NPU14129 B(cB)—Galactose; subst.c.(120 min) = ? mmol/l NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l Patient— NPU04185 P—Glucose; subst.c.(360 min) = ? mmol/l Galactose tolerance; NPU03841 P—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l property(galactose, oral administration; list; procedure) Note: _M_(galactose) = 180,16 g/mol Urine— NPU10573 Fumarate; Pt—Galactose tolerance; prop.(galactose p.o.; list; proc.) substance concentration NPU10572 Pt—Galactose(administered); am.s.(p.o.) = ? mmol mol/litre NPU10497 Pt—Galactose(administered); subst.cont.(p.o.; am.s./body mass) M = 116,07 g/mol = ? mmol/kg NPU02118 NPU10337 B—Galactose; subst.c.(0 min) = ? mmol/l U—Fumarate; subst.c.= ? prefix ? mol/l NPU10338 B—Galactose; subst.c.(10 min) = ? mmol/l NPU09241 B—Galactose; subst.c.(25 min) = ? mmol/l Patient— NPU10340 B—Galactose; subst.c.(30 min) = ? mmol/l Furosemide(administered); NPU09242 B—Galactose; subst.c.(35 min) = ? mmol/l amount-of-substance(oral administration) NPU09243 B—Galactose; subst.c.(45 min) = ? mmol/l micromol NPU10343 B—Galactose; subst.c.(60 min) = ? mmol/l M = 330,75 g/mol NPU10495 B—Galactose; subst.c.(90 min) = ? mmol/l NPU10419 NPU10496 B—Galactose; subst.c.(120 min) = ? mmol/l Pt—Furosemide(administered); am.s.(p.o.) = ? µmol NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l NPU08504 B—Glucose; subst.c.(30 min) = ? mmol/l Patient(Plasma)— NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l Galactose elimination; NPU08506 B—Glucose; subst.c.(90 min) = ? mmol/l substance rate ratio(galactose, intravenous administration; actual/norm; NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l procedure) NPU14128 B(cB)—Galactose; subst.c.(0 min) = ? mmol/l NPU17700 NPU14130 B(cB)—Galactose; subst.c.(25 min) = ? mmol/l Pt(P)—Galactose elimination; subst.rate ratio(galactose i.v.; actual/norm; proc.) NPU14131 B(cB)—Galactose; subst.c.(30 min) = ? mmol/l = ? NPU14132 B(cB)—Galactose; subst.c.(35 min) = ? mmol/l NPU14133 B(cB)—Galactose; subst.c.(45 min) = ? mmol/l Patient— NPU14134 B(cB)—Galactose; subst.c.(60 min) = ? mmol/l Galactose elimination; NPU14135 B(cB)—Galactose; subst.c.(90 min) = ? mmol/l substance rate(procedure) NPU14129 B(cB)—Galactose; subst.c.(120 min) = ? mmol/l millimol/second NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l NPU14914 NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? mmol/l Pt—Galactose elimination; subst.rate(proc.) = ? mmol/s NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? mmol/l NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l NPU02152 U—Galactose; rel.ams.(U 300 min/intake; proc.) = ?
Patient— Galactose(administered); amount-of-substance(intravenous administration) millimol M = 180,16 g/mol NPU10344 Pt—Galactose(administered); am.s.(i.v.) = ? mmol
Patient— Galactose(administered); amount-of-substance(oral administration) millimol M = 180,16 g/mol NPU10572 Pt—Galactose(administered); am.s.(p.o.) = ? mmol
65 Patient— Blood(capillary Blood)— Galactose(administered); Galactose; substance content(intravenous administration; amount-of- substance concentration(35 minutes after challenge) substance/body mass) millimol/litre millimol/kilogram NPU14132 M = 180,16 g/mol B(cB)—Galactose; subst.c.(35 min) = ? mmol/l NPU10345 Pt—Galactose(administered); subst.cont.(i.v.; am.s./body mass) = ? mmol/kg Blood— Galactose; Patient— substance concentration(40 minutes after challenge) Galactose(administered); millimol/litre substance content(oral administration; amount-of-substance/body mass) NPU10341 millimol/kilogram B—Galactose; subst.c.(40 min) = ? mmol/l M = 180,16 g/mol NPU10497 Blood— Pt—Galactose(administered); subst.cont.(p.o.; am.s./body mass) = ? mmol/kg Galactose; substance concentration(45 minutes challenge) Urine— millimol/litre Galactose; NPU09243 relative amount-of-substance(urine 300 minutes/intake; procedure) B—Galactose; subst.c.(45 min) = ? mmol/l NPU02152 U—Galactose; rel.ams.(U 300 min/intake; proc.) = ? Blood(capillary Blood)— Galactose; Blood— substance concentration(45 minutes challenge) Galactose; millimol/litre substance concentration(0 minutes after challenge) NPU14133 millimol/litre B(cB)—Galactose; subst.c.(45 min) = ? mmol/l NPU10337 B—Galactose; subst.c.(0 min) = ? mmol/l Blood— Galactose; Blood(capillary Blood)— substance concentration(50 minutes after challenge) Galactose; millimol/litre substance concentration(0 minutes after challenge) NPU10342 millimol/litre B—Galactose; subst.c.(50 min) = ? mmol/l NPU14128 B(cB)—Galactose; subst.c.(0 min) = ? mmol/l Blood— Galactose; Blood— substance concentration(60 minutes after challenge) Galactose; millimol/litre substance concentration(10 minutes after challenge) NPU10343 millimol/litre B—Galactose; subst.c.(60 min) = ? mmol/l NPU10338 B—Galactose; subst.c.(10 min) = ? mmol/l Blood(capillary Blood)— Galactose; Blood— substance concentration(60 minutes after challenge) Galactose; millimol/litre substance concentration(20 minutes after challenge) NPU14134 millimol/litre B(cB)—Galactose; subst.c.(60 min) = ? mmol/l NPU10339 B—Galactose; subst.c.(20 min) = ? mmol/l Blood— Galactose; Blood— substance concentration(90 minutes after challenge) Galactose; millimol/litre substance concentration(25 minutes after challenge) NPU10495 millimol/litre B—Galactose; subst.c.(90 min) = ? mmol/l NPU09241 B—Galactose; subst.c.(25 min) = ? mmol/l Blood(capillary Blood)— Galactose; Blood(capillary Blood)— substance concentration(90 minutes after challenge) Galactose; millimol/litre substance concentration(25 minutes after challenge) NPU14135 millimol/litre B(cB)—Galactose; subst.c.(90 min) = ? mmol/l NPU14130 B(cB)—Galactose; subst.c.(25 min) = ? mmol/l Blood— Galactose; Blood— substance concentration(120 minutes after challenge) Galactose; millimol/litre substance concentration(30 minutes after challenge) NPU10496 millimol/litre B—Galactose; subst.c.(120 min) = ? mmol/l NPU10340 B—Galactose; subst.c.(30 min) = ? mmol/l Blood(capillary Blood)— Galactose; Blood(capillary Blood)— substance concentration(120 minutes after challenge) Galactose; millimol/litre substance concentration(30 minutes after challenge) NPU14129 millimol/litre B(cB)—Galactose; subst.c.(120 min) = ? mmol/l NPU14131 B(cB)—Galactose; subst.c.(30 min) = ? mmol/l Blood— Galactose; Blood— substance concentration(55 minutes after challenge) Galactose; millimol/litre substance concentration(35 minutes after challenge) NPU09244 millimol/litre B—Galactose; subst.c.(550 min) = ? mmol/l NPU09242 B—Galactose; subst.c.(35 min) = ? mmol/l
66 Blood(capillary Blood)— Galactose; Cerebrospinal fluid— substance concentration Gamma-globulin; millimol/litre mass concentration M = 180,16 g/mol milligram/litre NPU10611 NPU04661 B(cB)—Galactose; subst.c. = ? mmol/l Csf—Gamma-globulin; mass c. = ? mg/l
Plasma— Urine— Galactose; Gamma-globulin; substance concentration mass concentration millimol/litre milligram/litre M = 180,16 g/mol NPU04657 NPU02150 U—Gamma-globulin; mass c. = ? mg/l P—Galactose; subst.c. = ? mmol/l Protein(Cerebrospinal fluid)— Urine— Gamma-globulin; Galactose; mass fraction substance concentration NPU04953 millimol/litre Prot.(Csf)—Gamma-globulin; mass fr. = ? M = 180,16 g/mol NPU02151 Protein(Plasma)— U—Galactose; subst.c. = ? mmol/l Gamma-globulin; mass fraction Patient— NPU04943 Galactose+glucose tolerance; Prot.(P)—Gamma-globulin; mass fr. = ? property(galactose+glucose, oral administration; list; procedure) Note: _M_ (galactose) = 180,16 g/mol; _M_ (glucose) = 180,16 g/mol Protein(Urine)— NPU08697 Gamma-globulin; Pt—Galactose+glucose tolerance; prop.(galactose+glucose p.o.; list; proc.) mass fraction NPU10572 Pt—Galactose(administered); am.s.(p.o.) = ? mmol NPU04948 NPU10497 Pt—Galactose(administered); subst.cont.(p.o.; am.s./body mass) Prot.(U)—Gamma-globulin; mass fr. = ? = ? mmol/kg NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol Plasma— NPU10575 Pt—Glucose(administered); subst.cont.(p.o.; am.s./body mass) = ? Gangliosid(GM1) antibody(Immunoglobulin G); mmol/kg arbitrary substance concentration(procedure) NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l 10³ arbitrary unit/litre NPU08516 B—Glucose; subst.c.(15 min) = ? mmol/l NPU14506 NPU08504 B—Glucose; subst.c.(30 min) = ? mmol/l P—Gangliosid(GM1) antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU08517 B—Glucose; subst.c.(45 min) = ? mmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l Plasma— NPU08506 B—Glucose; subst.c.(90 min) = ? mmol/l Gangliosid(GM1) antibody(Immunoglobulin M); NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l arbitrary substance concentration(procedure) NPU08502 B—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l 10³ arbitrary unit/litre NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l NPU12895 NPU10059 B(cB)—Glucose; subst.c.(15 min) = ? mmol/l P—Gangliosid(GM1) antibody(IgM); arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? mmol/l NPU10060 B(cB)—Glucose; subst.c.(45 min) = ? mmol/l Plasma— NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l Gangliosid(GM1) antibody; NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? mmol/l arbitrary substance concentration(list; procedure) NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l NPU17004 NPU10046 B(cB)—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? P—Gangliosid(GM1) antibody; arb.subst.c.(list; proc.) mmol/l NPU14506 P—Gangliosid(GM1) antibody(IgG); arb.subst.c.(proc.) = ? × 10³ NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l arb.unit/l NPU04186 P—Glucose; subst.c.(15 min) = ? mmol/l NPU12895 P—Gangliosid(GM1) antibody(IgM); arb.subst.c.(proc.) = ? × 10³ NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l arb.unit/l NPU04187 P—Glucose; subst.c.(45 min) = ? mmol/l NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l Alveolar gas— NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l Gas; NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l pressure NPU03841 P—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l kilopascal NPU04033 Erythrocytes(Blood)— Alveolar gas—Gas; pr. = ? kPa Galactose-1-phosphate; entitic amount-of-substance Plasma— attomol Gastric parietal cell antibody; M = 260,14 g/mol arbitrary concentration(procedure) NPU02153 NPU02160 Ercs(B)—Galactose-1-phosphate; entitic am.s. = ? amol P—Gastric parietal cell antibody; arb.c.(proc.) = ?
Plasma— Patient— Gall canaliculus antibody; Gastrin secretion; arbitrary concentration(procedure) substance rate(secretin, intravenous administration; list; procedure) NPU02158 Note: _M_ (secretin) = 3 056 g/mol. P—Gall canaliculus antibody; arb.c.(proc.) = ? NPU10522 Pt—Gastrin secretion; subst.rate(secretin i.v.; list; proc.) Urine— NPU10512 Pt—Secretin(administered); am.s.(i.v.) = ? nmol Gallium; NPU10513 Pt—Secretin(administered); subst.cont.(i.v.; am.s./body mass) = ? substance concentration pmol/kg picomol/litre NPU10514 P—Gastrin; subst.c.(0 min) = ? pmol/l M = 69,72 g/mol NPU10515 P—Gastrin; subst.c.(5 min) = ? pmol/l NPU02159 NPU10516 P—Gastrin; subst.c.(10 min) = ? pmol/l U—Gallium; subst.c. = ? pmol/l NPU10517 P—Gastrin; subst.c.(15 min) = ? pmol/l NPU10518 P—Gastrin; subst.c.(20 min) = ? pmol/l Plasma— NPU10519 P—Gastrin; subst.c.(25 min) = ? pmol/l Gamma-globulin; NPU10520 P—Gastrin; subst.c.(30 min) = ? pmol/l mass concentration NPU10521 P—Gastrin; subst.c.(max.; proc.) = ? pmol/l gram/litre NPU04653 P—Gamma-globulin; mass c. = ? g/l
67 Plasma— Patient(Urine)— Gastrin; Gastrin; substance concentration(0 minutes after challenge) substance rate picomol/litre picomol/day NPU10514 M = 2 080 g/mol P—Gastrin; subst.c.(0 min) = ? pmol/l NPU14004 Pt(U)—Gastrin; subst.rate = ? pmol/d Plasma— Gastrin; Urine— substance concentration(5 minutes after challenge) Germanium; picomol/litre substance concentration NPU10515 picomol/litre P—Gastrin; subst.c.(5 min) = ? pmol/l M = 72,61 g/mol NPU02165 Plasma— U—Germanium; subst.c. = ? pmol/l Gastrin; substance concentration(10 minutes after challenge) Patient— picomol/litre Gestation period; NPU10516 duration P—Gastrin; subst.c.(10 min) = ? pmol/l Week(s) NPU09355 Plasma— Pt—Gestation period; duration= ? Week(s) Gastrin; substance concentration(15 minutes after challenge) Plasma— picomol/litre Gliadin antibody(Immunoglobulin A); NPU10517 arbitrary concentration(procedure) P—Gastrin; subst.c.(15 min) = ? pmol/l NPU12539 P—Gliadin antibody(IgA); arb.c.(proc.) = ? Plasma— Gastrin; Plasma— substance concentration(20 minutes after challenge) Gliadin antibody(Immunoglobulin A); picomol/litre arbitrary substance concentration(procedure) NPU10518 10³ arbitrary unit/litre P—Gastrin; subst.c.(20 min) = ? pmol/l NPU08945 P—Gliadin antibody(IgA); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Plasma— Gastrin; Plasma— substance concentration(25 minutes after challenge) Gliadin antibody(Immunoglobulin G); picomol/litre arbitrary concentration(procedure) NPU10519 NPU12537 P—Gastrin; subst.c.(25 min) = ? pmol/l P—Gliadin antibody(IgG); arb.c.(proc.) = ?
Plasma— Plasma— Gastrin; Gliadin antibody(Immunoglobulin G); substance concentration(30 minutes after challenge) arbitrary substance concentration(procedure) picomol/litre 10³ arbitrary unit/litre NPU10520 NPU08944 P—Gastrin; subst.c.(30 min) = ? pmol/l P—Gliadin antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l
Plasma— Plasma— Gastrin; Gliadin antibody; substance concentration(maximum; procedure) arbitrary concentration(list; procedure) picomol/litre NPU14050 NPU10521 P—Gliadin antibody; arb.c.(list; proc.) P—Gastrin; subst.c.(max.; proc.) = ? pmol/l NPU12539 P—Gliadin antibody(IgA); arb.c.(proc.) = ? NPU12537 P—Gliadin antibody(IgG); arb.c.(proc.) = ? Plasma— Gastrin; Plasma— substance concentration Gliadin antibody; picomol/litre arbitrary substance concentration(list; procedure) M = 2 080 g/mol NPU14051 Recommended calibrator: Non sulphated gastrin-17 P—Gliadin antibody; arb.subst.c.(list; proc.) Authority: IUPAC-IUB74 NPU08945 P—Gliadin antibody(IgA); arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU02161 NPU08944 P—Gliadin antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l P—Gastrin; subst.c. = ? pmol/l Plasma— Plasma(fasting Patient)— Glomerulus membrane antibody(Immunoglobulin G); Gastrin; arbitrary concentration(procedure) substance concentration NPU12542 picomol/litre P—Glomerulus membrane antibody(IgG); arb.c.(proc.) = ? M = 2 080 g/mol NPU04152 Plasma— P(fPt)—Gastrin; subst.c. = ? pmol/l Glomerulus membrane antibody(Immunoglobulin G); arbitrary substance concentration(procedure) Urine— 10³ arbitrary unit/litre Gastrin; NPU12552 substance concentration P—Glomerulus membrane antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l picomol/litre M = 2 080 g/mol Plasma— Recommended calibrator: Non sulphated gastrin-17 Glomerulus membrane antibody; Authority: IUPAC-IUB74 arbitrary concentration(procedure) NPU14003 NPU02167 U—Gastrin; subst.c. = ? pmol/l P—Glomerulus membrane antibody; arb.c.(proc.) = ?
68 Patient— Patient— Glucagon(administered); Glucose tolerance; amount-of-substance(intramuscular administration) property(glucose, intravenous administration; list; procedure) nanomol Note: _M_ (glucose) = 180,16 g/mol M = 3 482,8 g/mol NPU08505 Other term(s): Hyperglycaemic factor Pt—Glucose tolerance; prop.(glucose i.v.; list; proc.) Authority: IUPAC-IUB 74 NPU10406 Pt—Glucose(administered); am.s.(i.v.) = ? mmol NPU10662 NPU10407 Pt—Glucose(administered); subst.cont.(i.v.; am.s./body mass) = ? Pt—Glucagon(administered); am.s.(i.m.) = ? nmol mmol/kg NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l Patient— NPU08657 P—Glucose; subst.c.(1 min) = ? mmol/l Glucagon(administered); NPU08658 P—Glucose; subst.c.(3 min) = ? mmol/l amount-of-substance(intravenous administration) NPU08659 P—Glucose; subst.c.(5 min) = ? mmol/l nanomol NPU08660 P—Glucose; subst.c.(10 min) = ? mmol/l M = 3 482,8 g/mol NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l Other term(s): Hyperglycaemic factor NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l Authority: IUPAC-IUB 74 NPU10389 Patient— Pt—Glucagon(administered); am.s.(i.v.) = ? nmol Glucose tolerance; property(glucose, oral administration; list; (0 120) minutes after challenge) Patient— NPU14383 Glucagon(administered); Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 120) min) substance content(intramuscular administration; amount-of-substance/body NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol mass) NPU10575 Pt—Glucose(administered); subst.cont.(p.o.; am.s./body mass) = ? nanomol/kilogram mmol/kg M = 3 482,8 g/mol NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l Other term(s): Hyperglycaemic factor NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l Authority: IUPAC-IUB 74 NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l NPU10690 NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l Pt—Glucagon(administered); subst.cont.(i.m.; am.s./body mass) = ? nmol/kg NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l Patient— NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l Glucagon(administered); NPU08770 U—Glucose; subst.c.(120 min) = ? mmol/l substance content(intravenous administration; amount-of-substance/body mass) Patient— nanomol/kilogram Glucose tolerance; M = 3 482,8 g/mol property(glucose, oral administration; list; (0 30 45 60 90 120 150 180 210 Other term(s): Hyperglycaemic factor 240) minutes after challenge) Authority: IUPAC-IUB 74 NPU17071 NPU10691 Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 30 45 60 90 120 150 180 210 Pt—Glucagon(administered); subst.cont.(i.v.; am.s./body mass) = ? nmol/kg 240) min) NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol Plasma— NPU10575 Pt—Glucose(administered); subst.cont.(p.o.; am.s./body mass) = ? Glucagon(total); mmol/kg substance concentration NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l picomol/litre NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? mmol/l M = 3 482,8 g/mol NPU10060 B(cB)—Glucose; subst.c.(45 min) = ? mmol/l Other term(s): Hyperglycaemic factor NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l Authority: IUPAC-IUB 74 NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? mmol/l NPU02169 NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l P—Glucagon(tot.); subst.c. = ? pmol/l NPU10052 B(cB)—Glucose; subst.c.(150 min) = ? mmol/l NPU10044 B(cB)—Glucose; subst.c.(180 min) = ? mmol/l Plasma— NPU10053 B(cB)—Glucose; subst.c.(210 min) = ? mmol/l Glucagon, pancreatic type; NPU10054 B(cB)—Glucose; subst.c.(240 min) = ? mmol/l substance concentration picomol/litre M = 3 482,8 g/mol NPU08656 P—Glucagon, pancreatic type; subst.c. = ? pmol/l
Plasma— Glucagon; arbitrary substance concentration(IS 69/194; procedure) international unit/litre M = 3 482,8 g/mol Recommended calibrator: WHO 1st IS 69/194 (porcine) Other term(s): Hyperglycaemic factor Authority: IUPAC-IUB 74 NPU02168 P—Glucagon; arb.subst.c.(IS 69/194; proc.) = ? int. unit/l
Plasma— Glucagon+proglucagon(1-61); substance concentration picomol/litre Recommended calibrator: Glucagon NPU02170 P—Glucagon+proglucagon(1-61); subst.c. = ? pmol/l
69 Patient— Patient— Glucose tolerance; Glucose tolerance; property(glucose, oral administration; list; (0 30 60 90 120 150 180) property(glucose, oral administration; list; (0 60 120 150 180 210 240) minutes after challenge) minutes after challenge) NPU14387 NPU14916 Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 30 60 90 120 150 180) min) Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 60 120 150 180 210 240) NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol min) NPU10575 Pt—Glucose(administered); subst.cont.(p.o.; am.s./body mass) = ? NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol mmol/kg NPU10575 Pt—Glucose(administered); subst.cont.(p.o.; am.s./body mass) = ? NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l mmol/kg NPU08504 B—Glucose; subst.c.(30 min) = ? mmol/l NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l NPU08506 B—Glucose; subst.c.(90 min) = ? mmol/l NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l NPU10052 B(cB)—Glucose; subst.c.(150 min) = ? mmol/l NPU08508 B—Glucose; subst.c.(150 min) = ? mmol/l NPU10044 B(cB)—Glucose; subst.c.(180 min) = ? mmol/l NPU08500 B—Glucose; subst.c.(180 min) = ? mmol/l NPU10053 B(cB)—Glucose; subst.c.(210 min) = ? mmol/l NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l NPU10054 B(cB)—Glucose; subst.c.(240 min) = ? mmol/l NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? mmol/l NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l Patient— NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? mmol/l Glucose tolerance; NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l property(glucose, oral administration; list; (0 60 120 180 240) minutes after NPU10052 B(cB)—Glucose; subst.c.(150 min) = ? mmol/l challenge) NPU10044 B(cB)—Glucose; subst.c.(180 min) = ? mmol/l NPU14388 NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 60 120 180 240) min) NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l NPU10575 Pt—Glucose(administered); subst.cont.(p.o.; am.s./body mass) = ? NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l mmol/kg NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l NPU04178 P—Glucose; subst.c.(150 min) = ? mmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l NPU08500 B—Glucose; subst.c.(180 min) = ? mmol/l NPU10581 U—Glucose; subst.c.(30 min) = ? mmol/l NPU08511 B—Glucose; subst.c.(240 min) = ? mmol/l NPU08769 U—Glucose; subst.c.(60 min) = ? mmol/l NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l NPU10582 U—Glucose; subst.c.(90 min) = ? mmol/l NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l NPU08770 U—Glucose; subst.c.(120 min) = ? mmol/l NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l NPU08771 U—Glucose; subst.c.(180 min) = ? mmol/l NPU10044 B(cB)—Glucose; subst.c.(180 min) = ? mmol/l NPU10054 B(cB)—Glucose; subst.c.(240 min) = ? mmol/l Patient— NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l Glucose tolerance; NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l property(glucose, oral administration; list; (0 30 60 90 120 150) minutes NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l after challenge) NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l NPU14386 NPU04181 P—Glucose; subst.c.(240 min) = ? mmol/l Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 30 60 90 120 150) min) NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol NPU08769 U—Glucose; subst.c.(60 min) = ? mmol/l NPU10575 Pt—Glucose(administered); subst.cont.(p.o.; am.s./body mass) = ? NPU08770 U—Glucose; subst.c.(120 min) = ? mmol/l mmol/kg NPU08771 U—Glucose; subst.c.(180 min) = ? mmol/l NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l NPU10583 U—Glucose; subst.c.(240 min) = ? mmol/l NPU08504 B—Glucose; subst.c.(30 min) = ? mmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l Patient— NPU08506 B—Glucose; subst.c.(90 min) = ? mmol/l Glucose tolerance; NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l property(glucose, oral administration; list; (0 60 120) minutes after NPU08508 B—Glucose; subst.c.(150 min) = ? mmol/l challenge) NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l NPU14385 NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? mmol/l Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 60 120) min) NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? mmol/l NPU10575 Pt—Glucose(administered); subst.cont.(p.o.; am.s./body mass) = ? NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l mmol/kg NPU10052 B(cB)—Glucose; subst.c.(150 min) = ? mmol/l NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l NPU04178 P—Glucose; subst.c.(150 min) = ? mmol/l NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l NPU10581 U—Glucose; subst.c.(30 min) = ? mmol/l NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l NPU08769 U—Glucose; subst.c.(60 min) = ? mmol/l NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l NPU10582 U—Glucose; subst.c.(90 min) = ? mmol/l NPU08769 U—Glucose; subst.c.(60 min) = ? mmol/l NPU08770 U—Glucose; subst.c.(120 min) = ? mmol/l NPU08770 U—Glucose; subst.c.(120 min) = ? mmol/l
Patient— Patient— Glucose tolerance; Glucose tolerance; property(glucose, oral administration; list; (0 30 60 90 120) minutes after property(glucose, oral administration; list; (0 60) minutes after challenge) challenge) NPU14384 NPU14915 Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 60) min) Pt—Glucose tolerance; prop.(glucose p.o.; list; (0 30 60 90 120) min) NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol NPU10575 Pt—Glucose(administered); subst.cont.(p.o.; am.s./body mass) = ? NPU10575 Pt—Glucose(administered); subst.cont.(p.o.; am.s./body mass) = ? mmol/kg mmol/kg NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? mmol/l NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? mmol/l NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l NPU08769 U—Glucose; subst.c.(60 min) = ? mmol/l
70 Patient— Patient— Glucose tolerance; Glucose(administered); property(glucose, oral administration; list; procedure) substance content(intravenous administration; amount-of- Note: _M_ (glucose) = 180,16 g/mol substance/body mass) NPU02196 millimol/kilogram Pt—Glucose tolerance; prop.(glucose p.o.; list; proc.) M = 180,16 g/mol NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol NPU10407 NPU10575 Pt—Glucose(administered); subst.cont.(p.o.; am.s./body mass) = ? Pt—Glucose(administered); subst.cont.(i.v.; am.s./body mass) = ? mmol/kg mmol/kg NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l Patient— NPU08516 B—Glucose; subst.c.(15 min) = ? mmol/l Glucose(administered); NPU08504 B—Glucose; subst.c.(30 min) = ? mmol/l substance content(oral administration; amount-of-substance/body mass) NPU08517 B—Glucose; subst.c.(45 min) = ? mmol/l millimol/kilogram NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l M = 180,16 g/mol NPU08518 B—Glucose; subst.c.(75 min) = ? mmol/l NPU10575 NPU08506 B—Glucose; subst.c.(90 min) = ? mmol/l Pt—Glucose(administered); subst.cont.(p.o.; am.s./body mass) = ? mmol/kg NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l NPU08508 B—Glucose; subst.c.(150 min) = ? mmol/l Ascites— NPU08500 B—Glucose; subst.c.(180 min) = ? mmol/l Glucose; NPU08510 B—Glucose; subst.c.(210 min) = ? mmol/l amount-of-substance(procedure) NPU08511 B—Glucose; subst.c.(240 min) = ? mmol/l millimol NPU08512 B—Glucose; subst.c.(270 min) = ? mmol/l M = 180,16 g/mol NPU08513 B—Glucose; subst.c.(300 min) = ? mmol/l NPU08624 NPU08514 B—Glucose; subst.c.(330 min) = ? mmol/l Asc—Glucose; am.s.(proc.) = ? mmol NPU08515 B—Glucose; subst.c.(360 min) = ? mmol/l NPU08735 B—Glucose; subst.c.(max.; proc.) = ? mmol/l Urine— NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l Glucose; NPU10059 B(cB)—Glucose; subst.c.(15 min) = ? mmol/l amount-of-substance NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? mmol/l millimol NPU10060 B(cB)—Glucose; subst.c.(45 min) = ? mmol/l NPU17566 NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l U—Glucose; am.s. = ? mmol NPU10061 B(cB)—Glucose; subst.c.(75 min) = ? mmol/l NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? mmol/l Urine— NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l Glucose; NPU10052 B(cB)—Glucose; subst.c.(150 min) = ? mmol/l arbitrary concentration(procedure) NPU10044 B(cB)—Glucose; subst.c.(180 min) = ? mmol/l M = 180,16 g/mol NPU10053 B(cB)—Glucose; subst.c.(210 min) = ? mmol/l NPU04207 NPU10054 B(cB)—Glucose; subst.c.(240 min) = ? mmol/l U—Glucose; arb.c.(proc.)= ? NPU10055 B(cB)—Glucose; subst.c.(270 min) = ? mmol/l NPU10056 B(cB)—Glucose; subst.c.(300 min) = ? mmol/l Urine— NPU10057 B(cB)—Glucose; subst.c.(330 min) = ? mmol/l Glucose; NPU10058 B(cB)—Glucose; subst.c.(360 min) = ? mmol/l relative amount-of-substance(urine 300 minutes/intake; procedure) NPU10111 B(cB)—Glucose; subst.c.(max.; proc.) = ? mmol/l NPU10491 NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l U—Glucose; rel.ams.(U 300 min/intake; proc.) = ? NPU04186 P—Glucose; subst.c.(15 min) = ? mmol/l NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l Cerebrospinal fluid— NPU04187 P—Glucose; subst.c.(45 min) = ? mmol/l Glucose; NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l relative substance concentration(Cerebrospinal fluid/Plasma) NPU04965 P—Glucose; subst.c.(75 min) = ? mmol/l M = 180,16 g/mol NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l NPU01523 NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l Csf—Glucose; rel.subst.c.(Csf/P) = ? NPU04178 P—Glucose; subst.c.(150 min) = ? mmol/l NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l Synovial fluid(specification)— NPU04180 P—Glucose; subst.c.(210 min) = ? mmol/l Glucose; NPU04181 P—Glucose; subst.c.(240 min) = ? mmol/l relative substance concentration(Synovial fluid/Plasma) NPU04182 P—Glucose; subst.c.(270 min) = ? mmol/l M = 180,16 g/mol NPU04183 P—Glucose; subst.c.(300 min) = ? mmol/l NPU04232 NPU04184 P—Glucose; subst.c.(330 min) = ? mmol/l Synf(spec.)—Glucose; rel.subst.c.(Synf/P)= ? NPU04185 P—Glucose; subst.c.(360 min) = ? mmol/l NPU08734 P—Glucose; subst.c.(max.; proc.) = ? mmol/l Plasma— NPU08768 U—Glucose; subst.c.(0 min) = ? mmol/l Glucose; NPU10581 U—Glucose; subst.c.(30 min) = ? mmol/l substance concentration(10 minutes before challenge) NPU08769 U—Glucose; subst.c.(60 min) = ? mmol/l millimol/litre NPU10582 U—Glucose; subst.c.(90 min) = ? mmol/l NPU08666 NPU08770 U—Glucose; subst.c.(120 min) = ? mmol/l P—Glucose; subst.c.(-10 min) = ? mmol/l NPU08771 U—Glucose; subst.c.(180 min) = ? mmol/l NPU10583 U—Glucose; subst.c.(240 min) = ? mmol/l Plasma— NPU10571 U—Glucose; subst.c.(300 min) = ? mmol/l Glucose; NPU10584 U—Glucose; subst.c.(360 min) = ? mmol/l substance concentration(5 minutes before challenge) millimol/litre Patient— NPU08665 Glucose(administered); P—Glucose; subst.c.(-5 min) = ? mmol/l amount-of-substance(intravenous administration) millimol Blood— M = 180,16 g/mol Glucose; NPU10406 substance concentration(0 minutes after challenge) Pt—Glucose(administered); am.s.(i.v.) = ? mmol millimol/litre NPU08503 Patient— B—Glucose; subst.c.(0 min) = ? mmol/l Glucose(administered); amount-of-substance(oral administration) Blood(capillary Blood)— millimol Glucose; M = 180,16 g/mol substance concentration(0 minutes after challenge) NPU10574 millimol/litre Pt—Glucose(administered); am.s.(p.o.) = ? mmol NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l
71 Plasma— Glucose; Plasma— substance concentration(0 minutes after challenge) Glucose; millimol/litre substance concentration(20 minutes after challenge) NPU04173 millimol/litre P—Glucose; subst.c.(0 min) = ? mmol/l NPU08661 P—Glucose; subst.c.(20 min) = ? mmol/l Urine— Glucose; Blood— substance concentration(0 minutes after challenge) Glucose; millimol/litre substance concentration(30 minutes after challenge) NPU08768 millimol/litre U—Glucose; subst.c.(0 min) = ? mmol/l NPU08504 B—Glucose; subst.c.(30 min) = ? mmol/l Plasma— Glucose; Blood(capillary Blood)— substance concentration(1 minute after challenge) Glucose; millimol/litre substance concentration(30 minutes after challenge) NPU08657 millimol/litre P—Glucose; subst.c.(1 min) = ? mmol/l NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? mmol/l Plasma— Glucose; Plasma— substance concentration(3 minutes after challenge) Glucose; millimol/litre substance concentration(30 minutes after challenge) NPU08658 millimol/litre P—Glucose; subst.c.(3 min) = ? mmol/l NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l Blood— Glucose; Urine— substance concentration(5 minutes after challenge) Glucose; millimol/litre substance concentration(30 minutes after challenge) NPU14352 millimol/litre B—Glucose; subst.c.(5 min) = ? mmol/l NPU10581 U—Glucose; subst.c.(30 min) = ? mmol/l Blood(capillary Blood)— Glucose; Plasma— substance concentration(5 minutes after challenge) Glucose; millimol/litre substance concentration(40 minutes after challenge) NPU14353 millimol/litre B(cB)—Glucose; subst.c.(5 min) = ? mmol/l NPU08662 P—Glucose; subst.c.(40 min) = ? mmol/l Plasma— Glucose; Blood— substance concentration(5 minutes after challenge) Glucose; millimol/litre substance concentration(45 minutes challenge) NPU08659 millimol/litre P—Glucose; subst.c.(5 min) = ? mmol/l NPU08517 B—Glucose; subst.c.(45 min) = ? mmol/l Blood— Glucose; Blood(capillary Blood)— substance concentration(6 minutes after challenge) Glucose; millimol/litre substance concentration(45 minutes challenge) NPU10655 millimol/litre B—Glucose; subst.c.(6 min) = ? mmol/l NPU10060 B(cB)—Glucose; subst.c.(45 min) = ? mmol/l Blood— Glucose; Plasma— substance concentration(10 minutes after challenge) Glucose; millimol/litre substance concentration(45 minutes challenge) NPU10117 millimol/litre B—Glucose; subst.c.(10 min) = ? mmol/l NPU04187 P—Glucose; subst.c.(45 min) = ? mmol/l Plasma— Glucose; Plasma— substance concentration(10 minutes after challenge) Glucose; millimol/litre substance concentration(50 minutes after challenge) NPU08660 millimol/litre P—Glucose; subst.c.(10 min) = ? mmol/l NPU08663 P—Glucose; subst.c.(50 min) = ? mmol/l Blood— Glucose; Blood— substance concentration(15 minutes after challenge) Glucose; millimol/litre substance concentration(60 minutes after challenge) NPU08516 millimol/litre B—Glucose; subst.c.(15 min) = ? mmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l Blood(capillary Blood)— Glucose; Blood(capillary Blood)— substance concentration(15 minutes after challenge) Glucose; millimol/litre substance concentration(60 minutes after challenge) NPU10059 millimol/litre B(cB)—Glucose; subst.c.(15 min) = ? mmol/l NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l Plasma— Glucose; substance concentration(15 minutes after challenge) millimol/litre NPU04186 P—Glucose; subst.c.(15 min) = ? mmol/l
72 Plasma— Glucose; Blood— substance concentration(60 minutes after challenge) Glucose; millimol/litre substance concentration(120 minutes after challenge) NPU04175 millimol/litre P—Glucose; subst.c.(60 min) = ? mmol/l NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l Urine— Glucose; Blood(capillary Blood)— substance concentration(60 minutes after challenge) Glucose; millimol/litre substance concentration(120 minutes after challenge) NPU08769 millimol/litre U—Glucose; subst.c.(60 min) = ? mmol/l NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l Blood— Glucose; Plasma— substance concentration(75 minutes after challenge) Glucose; millimol/litre substance concentration(120 minutes after challenge) NPU08518 millimol/litre B—Glucose; subst.c.(75 min) = ? mmol/l NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l Blood(capillary Blood)— Glucose; Urine— substance concentration(75 minutes after challenge) Glucose; millimol/litre substance concentration(120 minutes after challenge) NPU10061 millimol/litre B(cB)—Glucose; subst.c.(75 min) = ? mmol/l NPU08770 U—Glucose; subst.c.(120 min) = ? mmol/l Plasma— Glucose; Blood— substance concentration(75 minutes after challenge) Glucose; millimol/litre substance concentration(135 minutes after challenge) NPU04965 millimol/litre P—Glucose; subst.c.(75 min) = ? mmol/l NPU10697 B—Glucose; subst.c.(135 min) = ? mmol/l Blood— Glucose; Plasma— substance concentration(90 minutes after challenge) Glucose; millimol/litre substance concentration(135 minutes after challenge) NPU08506 millimol/litre B—Glucose; subst.c.(90 min) = ? mmol/l NPU10653 P—Glucose; subst.c.(135 min) = ? mmol/l Blood(capillary Blood)— Glucose; Blood— substance concentration(90 minutes after challenge) Glucose; millimol/litre substance concentration(150 minutes after challenge) NPU10050 millimol/litre B(cB)—Glucose; subst.c.(90 min) = ? mmol/l NPU08508 B—Glucose; subst.c.(150 min) = ? mmol/l Plasma— Glucose; Blood(capillary Blood)— substance concentration(90 minutes after challenge) Glucose; millimol/litre substance concentration(150 minutes after challenge) NPU04176 millimol/litre P—Glucose; subst.c.(90 min) = ? mmol/l NPU10052 B(cB)—Glucose; subst.c.(150 min) = ? mmol/l Urine— Glucose; Plasma— substance concentration(90 minutes after challenge) Glucose; millimol/litre substance concentration(150 minutes after challenge) NPU10582 millimol/litre U—Glucose; subst.c.(90 min) = ? mmol/l NPU04178 P—Glucose; subst.c.(150 min) = ? mmol/l Blood— Glucose; Urine— substance concentration(105 minutes after challenge) Glucose; millimol/litre substance concentration(150 minutes after challenge) NPU10764 millimol/litre B—Glucose; subst.c.(105 min) = ? mmol/l NPU14165 U—Glucose; subst.c.(150 min) = ? mmol/l Plasma— Glucose; Blood— substance concentration(105 minutes after challenge) Glucose; millimol/litre substance concentration(180 minutes after challenge) NPU08664 millimol/litre P—Glucose; subst.c.(105 min) = ? mmol/l NPU08500 B—Glucose; subst.c.(180 min) = ? mmol/l Blood— Glucose; Blood(capillary Blood)— substance concentration(110 minutes after challenge) Glucose; millimol/litre substance concentration(180 minutes after challenge) NPU10696 millimol/litre B—Glucose; subst.c.(110 min) = ? mmol/l NPU10044 B(cB)—Glucose; subst.c.(180 min) = ? mmol/l Plasma— Glucose; substance concentration(110 minutes after challenge) millimol/litre NPU10652 P—Glucose; subst.c.(110 min) = ? mmol/l
73 Plasma— Glucose; Urine— substance concentration(180 minutes after challenge) Glucose; millimol/litre substance concentration(270 minutes after challenge) NPU04179 millimol/litre P—Glucose; subst.c.(180 min) = ? mmol/l NPU14167 U—Glucose; subst.c.(270 min) = ? mmol/l Urine— Glucose; Blood— substance concentration(180 minutes after challenge) Glucose; millimol/litre substance concentration(300 minutes after challenge) NPU08771 millimol/litre U—Glucose; subst.c.(180 min) = ? mmol/l NPU08513 B—Glucose; subst.c.(300 min) = ? mmol/l Blood— Glucose; Blood(capillary Blood)— substance concentration(210 minutes after challenge) Glucose; millimol/litre substance concentration(300 minutes after challenge) NPU08510 millimol/litre B—Glucose; subst.c.(210 min) = ? mmol/l NPU10056 B(cB)—Glucose; subst.c.(300 min) = ? mmol/l Blood(capillary Blood)— Glucose; Plasma— substance concentration(210 minutes after challenge) Glucose; millimol/litre substance concentration(300 minutes after challenge) NPU10053 millimol/litre B(cB)—Glucose; subst.c.(210 min) = ? mmol/l NPU04183 P—Glucose; subst.c.(300 min) = ? mmol/l Plasma— Glucose; Urine— substance concentration(210 minutes after challenge) Glucose; millimol/litre substance concentration(300 minutes after challenge) NPU04180 millimol/litre P—Glucose; subst.c.(210 min) = ? mmol/l NPU10571 U—Glucose; subst.c.(300 min) = ? mmol/l Urine— Glucose; Blood— substance concentration(210 minutes after challenge) Glucose; millimol/litre substance concentration(330 minutes after challenge) NPU14166 millimol/litre U—Glucose; subst.c.(210 min) = ? mmol/l NPU08514 B—Glucose; subst.c.(330 min) = ? mmol/l Blood— Glucose; Blood(capillary Blood)— substance concentration(240 minutes after challenge) Glucose; millimol/litre substance concentration(330 minutes after challenge) NPU08511 millimol/litre B—Glucose; subst.c.(240 min) = ? mmol/l NPU10057 B(cB)—Glucose; subst.c.(330 min) = ? mmol/l Blood(capillary Blood)— Glucose; Plasma— substance concentration(240 minutes after challenge) Glucose; millimol/litre substance concentration(330 minutes after challenge) NPU10054 millimol/litre B(cB)—Glucose; subst.c.(240 min) = ? mmol/l NPU04184 P—Glucose; subst.c.(330 min) = ? mmol/l Plasma— Glucose; Urine— substance concentration(240 minutes after challenge) Glucose; millimol/litre substance concentration(330 minutes after challenge) NPU04181 millimol/litre P—Glucose; subst.c.(240 min) = ? mmol/l NPU14168 U—Glucose; subst.c.(330 min) = ? mmol/l Urine— Glucose; Blood— substance concentration(240 minutes after challenge) Glucose; millimol/litre substance concentration(360 minutes after challenge) NPU10583 millimol/litre U—Glucose; subst.c.(240 min) = ? mmol/l NPU08515 B—Glucose; subst.c.(360 min) = ? mmol/l Blood— Glucose; Blood(capillary Blood)— substance concentration(270 minutes after challenge) Glucose; millimol/litre substance concentration(360 minutes after challenge) NPU08512 millimol/litre B—Glucose; subst.c.(270 min) = ? mmol/l NPU10058 B(cB)—Glucose; subst.c.(360 min) = ? mmol/l Blood(capillary Blood)— Glucose; Plasma— substance concentration(270 minutes after challenge) Glucose; millimol/litre substance concentration(360 minutes after challenge) NPU10055 millimol/litre B(cB)—Glucose; subst.c.(270 min) = ? mmol/l NPU04185 P—Glucose; subst.c.(360 min) = ? mmol/l Plasma— Glucose; substance concentration(270 minutes after challenge) millimol/litre NPU04182 P—Glucose; subst.c.(270 min) = ? mmol/l
74 Urine— Plasma— Glucose; Glucose; substance concentration(360 minutes after challenge) substance concentration(list; time; procedure) millimol/litre M = 180,16 g/mol NPU10584 NPU08571 U—Glucose; subst.c.(360 min) = ? mmol/l P—Glucose; subst.c.(list; time; proc.) NPU08544 P—Glucose; subst.c.(T00) = ? mmol/l Blood— NPU08893 P—Glucose; subst.c.(T00:30) = ? mmol/l Glucose; NPU08545 P—Glucose; subst.c.(T01) = ? mmol/l substance concentration(420 minutes after challenge) NPU08894 P—Glucose; subst.c.(T01:30) = ? mmol/l millimol/litre NPU08546 P—Glucose; subst.c.(T02) = ? mmol/l NPU10118 NPU08895 P—Glucose; subst.c.(T02:30) = ? mmol/l B—Glucose; subst.c.(420 min) = ? mmol/l NPU08547 P—Glucose; subst.c.(T03) = ? mmol/l NPU08896 P—Glucose; subst.c.(T03:30) = ? mmol/l Blood— NPU08548 P—Glucose; subst.c.(T04) = ? mmol/l Glucose; NPU08897 P—Glucose; subst.c.(T04:30) = ? mmol/l substance concentration(480 minutes after challenge) NPU08549 P—Glucose; subst.c.(T05) = ? mmol/l millimol/litre NPU08898 P—Glucose; subst.c.(T05:30) = ? mmol/l NPU10119 NPU08550 P—Glucose; subst.c.(T06) = ? mmol/l B—Glucose; subst.c.(480 min) = ? mmol/l NPU08899 P—Glucose; subst.c.(T06:30) = ? mmol/l NPU08551 P—Glucose; subst.c.(T07) = ? mmol/l Blood— NPU08900 P—Glucose; subst.c.(T07:30) = ? mmol/l Glucose; NPU08552 P—Glucose; subst.c.(T08) = ? mmol/l substance concentration(540 minutes after challenge) NPU08901 P—Glucose; subst.c.(T08:30) = ? mmol/l millimol/litre NPU08553 P—Glucose; subst.c.(T09) = ? mmol/l NPU10120 NPU08902 P—Glucose; subst.c.(T09:30) = ? mmol/l B—Glucose; subst.c.(540 min) = ? mmol/l NPU08554 P—Glucose; subst.c.(T10) = ? mmol/l NPU08903 P—Glucose; subst.c.(T10:30) = ? mmol/l Blood— NPU08555 P—Glucose; subst.c.(T11) = ? mmol/l Glucose; NPU08904 P—Glucose; subst.c.(T11:30) = ? mmol/l substance concentration(600 minutes after challenge) NPU08556 P—Glucose; subst.c.(T12) = ? mmol/l millimol/litre NPU08905 P—Glucose; subst.c.(T12:30) = ? mmol/l NPU10121 NPU08557 P—Glucose; subst.c.(T13) = ? mmol/l B—Glucose; subst.c.(600 min) = ? mmol/l NPU08906 P—Glucose; subst.c.(T13:30) = ? mmol/l NPU08558 P—Glucose; subst.c.(T14) = ? mmol/l Blood— NPU08907 P—Glucose; subst.c.(T14:30) = ? mmol/l Glucose; NPU08559 P—Glucose; subst.c.(T15) = ? mmol/l substance concentration(list; time; procedure) NPU08908 P—Glucose; subst.c.(T15:30) = ? mmol/l M = 180,16 g/mol NPU08560 P—Glucose; subst.c.(T16) = ? mmol/l NPU08572 NPU08909 P—Glucose; subst.c.(T16:30) = ? mmol/l B—Glucose; subst.c.(list; time; proc.) NPU08561 P—Glucose; subst.c.(T17) = ? mmol/l NPU08520 B—Glucose; subst.c.(T00) = ? mmol/l NPU08910 P—Glucose; subst.c.(T17:30) = ? mmol/l NPU08869 B—Glucose; subst.c.(T00:30) = ? mmol/l NPU08562 P—Glucose; subst.c.(T18) = ? mmol/l NPU08521 B—Glucose; subst.c.(T01) = ? mmol/l NPU08911 P—Glucose; subst.c.(T18:30) = ? mmol/l NPU08870 B—Glucose; subst.c.(T01:30) = ? mmol/l NPU08563 P—Glucose; subst.c.(T19) = ? mmol/l NPU08522 B—Glucose; subst.c.(T02) = ? mmol/l NPU08912 P—Glucose; subst.c.(T19:30) = ? mmol/l NPU08871 B—Glucose; subst.c.(T02:30) = ? mmol/l NPU08564 P—Glucose; subst.c.(T20) = ? mmol/l NPU08523 B—Glucose; subst.c.(T03) = ? mmol/l NPU08913 P—Glucose; subst.c.(T20:30) = ? mmol/l NPU08872 B—Glucose; subst.c.(T03:30) = ? mmol/l NPU08565 P—Glucose; subst.c.(T21) = ? mmol/l NPU08524 B—Glucose; subst.c.(T04) = ? mmol/l NPU08914 P—Glucose; subst.c.(T21:30) = ? mmol/l NPU08873 B—Glucose; subst.c.(T04:30) = ? mmol/l NPU08566 P—Glucose; subst.c.(T22) = ? mmol/l NPU08525 B—Glucose; subst.c.(T05) = ? mmol/l NPU08915 P—Glucose; subst.c.(T22:30) = ? mmol/l NPU08874 B—Glucose; subst.c.(T05:30) = ? mmol/l NPU08567 P—Glucose; subst.c.(T23) = ? mmol/l NPU08526 B—Glucose; subst.c.(T06) = ? mmol/l NPU08916 P—Glucose; subst.c.(T23:30) = ? mmol/l NPU08875 B—Glucose; subst.c.(T06:30) = ? mmol/l NPU08527 B—Glucose; subst.c.(T07) = ? mmol/l Blood— NPU08876 B—Glucose; subst.c.(T07:30) = ? mmol/l Glucose; NPU08528 B—Glucose; subst.c.(T08) = ? mmol/l substance concentration(maximum; procedure) NPU08877 B—Glucose; subst.c.(T08:30) = ? mmol/l millimol/litre NPU08529 B—Glucose; subst.c.(T09) = ? mmol/l NPU08735 NPU08878 B—Glucose; subst.c.(T09:30) = ? mmol/l B—Glucose; subst.c.(max.; proc.) = ? mmol/l NPU08530 B—Glucose; subst.c.(T10) = ? mmol/l NPU08879 B—Glucose; subst.c.(T10:30) = ? mmol/l Blood(capillary Blood)— NPU08531 B—Glucose; subst.c.(T11) = ? mmol/l Glucose; NPU08880 B—Glucose; subst.c.(T11:30) = ? mmol/l substance concentration(maximum; procedure) NPU08532 B—Glucose; subst.c.(T12) = ? mmol/l millimol/litre NPU08881 B—Glucose; subst.c.(T12:30) = ? mmol/l NPU10111 NPU08533 B—Glucose; subst.c.(T13) = ? mmol/l B(cB)—Glucose; subst.c.(max.; proc.) = ? mmol/l NPU08882 B—Glucose; subst.c.(T13:30) = ? mmol/l NPU08534 B—Glucose; subst.c.(T14) = ? mmol/l Plasma— NPU08883 B—Glucose; subst.c.(T14:30) = ? mmol/l Glucose; NPU08535 B—Glucose; subst.c.(T15) = ? mmol/l substance concentration(maximum; procedure) NPU08884 B—Glucose; subst.c.(T15:30) = ? mmol/l millimol/litre NPU08536 B—Glucose; subst.c.(T16) = ? mmol/l NPU08734 NPU08885 B—Glucose; subst.c.(T16:30) = ? mmol/l P—Glucose; subst.c.(max.; proc.) = ? mmol/l NPU08537 B—Glucose; subst.c.(T17) = ? mmol/l NPU08886 B—Glucose; subst.c.(T17:30) = ? mmol/l Blood— NPU08538 B—Glucose; subst.c.(T18) = ? mmol/l Glucose; NPU08887 B—Glucose; subst.c.(T18:30) = ? mmol/l substance concentration(minimum; procedure) NPU08539 B—Glucose; subst.c.(T19) = ? mmol/l millimol/litre NPU08888 B—Glucose; subst.c.(T19:30) = ? mmol/l NPU08519 NPU08540 B—Glucose; subst.c.(T20) = ? mmol/l B—Glucose; subst.c.(min.; proc.) = ? mmol/l NPU08889 B—Glucose; subst.c.(T20:30) = ? mmol/l NPU08541 B—Glucose; subst.c.(T21) = ? mmol/l Blood(capillary Blood)— NPU08890 B—Glucose; subst.c.(T21:30) = ? mmol/l Glucose; NPU08542 B—Glucose; subst.c.(T22) = ? mmol/l substance concentration(minimum; procedure) NPU08891 B—Glucose; subst.c.(T22:30) = ? mmol/l millimol/litre NPU08543 B—Glucose; subst.c.(T23) = ? mmol/l NPU10062 NPU08892 B—Glucose; subst.c.(T23:30) = ? mmol/l B(cB)—Glucose; subst.c.(min.; proc.) = ? mmol/l
75 Plasma— Blood— Glucose; Glucose; substance concentration(minimum; procedure) substance concentration(T01:30) millimol/litre millimol/litre NPU04981 NPU08870 P—Glucose; subst.c.(min.; proc.) = ? mmol/l B—Glucose; subst.c.(T01:30) = ? mmol/l
Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(procedure) substance concentration(T01:30) millimol/litre millimol/litre M = 180,16 g/mol NPU10088 NPU10114 B(cB)—Glucose; subst.c.(T01:30) = ? mmol/l B(cB)—Glucose; subst.c.(proc.) = ? mmol/l Plasma— Urine— Glucose; Glucose; substance concentration(T01:30) substance concentration(procedure) millimol/litre millimol/litre NPU08894 M = 180,16 g/mol P—Glucose; subst.c.(T01:30) = ? mmol/l NPU02194 U—Glucose; subst.c.(proc.) = ? mmol/l Blood— Glucose; Blood— substance concentration(T02) Glucose; millimol/litre substance concentration(T00) NPU08522 millimol/litre B—Glucose; subst.c.(T02) = ? mmol/l NPU08520 B—Glucose; subst.c.(T00) = ? mmol/l Blood(capillary Blood)— Glucose; Blood(capillary Blood)— substance concentration(T02) Glucose; millimol/litre substance concentration(T00) NPU10065 millimol/litre B(cB)—Glucose; subst.c.(T02) = ? mmol/l NPU10063 B(cB)—Glucose; subst.c.(T00) = ? mmol/l Plasma— Glucose; Plasma— substance concentration(T02) Glucose; millimol/litre substance concentration(T00) NPU08546 millimol/litre P—Glucose; subst.c.(T02) = ? mmol/l NPU08544 P—Glucose; subst.c.(T00) = ? mmol/l Blood— Glucose; Blood— substance concentration(T02:30) Glucose; millimol/litre substance concentration(T00:30) NPU08871 millimol/litre B—Glucose; subst.c.(T02:30) = ? mmol/l NPU08869 B—Glucose; subst.c.(T00:30) = ? mmol/l Blood(capillary Blood)— Glucose; Blood(capillary Blood)— substance concentration(T02:30) Glucose; millimol/litre substance concentration(T00:30) NPU10089 millimol/litre B(cB)—Glucose; subst.c.(T02:30) = ? mmol/l NPU10087 B(cB)—Glucose; subst.c.(T00:30) = ? mmol/l Plasma— Glucose; Plasma— substance concentration(T02:30) Glucose; millimol/litre substance concentration(T00:30) NPU08895 millimol/litre P—Glucose; subst.c.(T02:30) = ? mmol/l NPU08893 P—Glucose; subst.c.(T00:30) = ? mmol/l Blood— Glucose; Blood— substance concentration(T03) Glucose; millimol/litre substance concentration(T01) NPU08523 millimol/litre B—Glucose; subst.c.(T03) = ? mmol/l NPU08521 B—Glucose; subst.c.(T01) = ? mmol/l Blood(capillary Blood)— Glucose; Blood(capillary Blood)— substance concentration(T03) Glucose; millimol/litre substance concentration(T01) NPU10066 millimol/litre B(cB)—Glucose; subst.c.(T03) = ? mmol/l NPU10064 B(cB)—Glucose; subst.c.(T01) = ? mmol/l Plasma— Glucose; Plasma— substance concentration(T03) Glucose; millimol/litre substance concentration(T01) NPU08547 millimol/litre P—Glucose; subst.c.(T03) = ? mmol/l NPU08545 P—Glucose; subst.c.(T01) = ? mmol/l Blood— Glucose; substance concentration(T03:30) millimol/litre NPU08872 B—Glucose; subst.c.(T03:30) = ? mmol/l
76 Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T05:30) substance concentration(T03:30) millimol/litre millimol/litre NPU10092 NPU10090 B(cB)—Glucose; subst.c.(T05:30) = ? mmol/l B(cB)—Glucose; subst.c.(T03:30) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T05:30) substance concentration(T03:30) millimol/litre millimol/litre NPU08898 NPU08896 P—Glucose; subst.c.(T05:30) = ? mmol/l P—Glucose; subst.c.(T03:30) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T06) substance concentration(T04) millimol/litre millimol/litre NPU08526 NPU08524 B—Glucose; subst.c.(T06) = ? mmol/l B—Glucose; subst.c.(T04) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T06) substance concentration(T04) millimol/litre millimol/litre NPU10069 NPU10067 B(cB)—Glucose; subst.c.(T06) = ? mmol/l B(cB)—Glucose; subst.c.(T04) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T06) substance concentration(T04) millimol/litre millimol/litre NPU08550 NPU08548 P—Glucose; subst.c.(T06) = ? mmol/l P—Glucose; subst.c.(T04) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T06:30) substance concentration(T04:30) millimol/litre millimol/litre NPU08875 NPU08873 B—Glucose; subst.c.(T06:30) = ? mmol/l B—Glucose; subst.c.(T04:30) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T06:30) substance concentration(T04:30) millimol/litre millimol/litre NPU10093 NPU10091 B(cB)—Glucose; subst.c.(T06:30) = ? mmol/l B(cB)—Glucose; subst.c.(T04:30) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T06:30) substance concentration(T04:30) millimol/litre millimol/litre NPU08899 NPU08897 P—Glucose; subst.c.(T06:30) = ? mmol/l P—Glucose; subst.c.(T04:30) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T07) substance concentration(T05) millimol/litre millimol/litre NPU08527 NPU08525 B—Glucose; subst.c.(T07) = ? mmol/l B—Glucose; subst.c.(T05) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T07) substance concentration(T05) millimol/litre millimol/litre NPU10070 NPU10068 B(cB)—Glucose; subst.c.(T07) = ? mmol/l B(cB)—Glucose; subst.c.(T05) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T07) substance concentration(T05) millimol/litre millimol/litre NPU08551 NPU08549 P—Glucose; subst.c.(T07) = ? mmol/l P—Glucose; subst.c.(T05) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T07:30) substance concentration(T05:30) millimol/litre millimol/litre NPU08876 NPU08874 B—Glucose; subst.c.(T07:30) = ? mmol/l B—Glucose; subst.c.(T05:30) = ? mmol/l Blood(capillary Blood)— Glucose; substance concentration(T07:30) millimol/litre NPU10094 B(cB)—Glucose; subst.c.(T07:30) = ? mmol/l
77 Blood(capillary Blood)— Blood(fasting Patient)— Glucose; Glucose; substance concentration(T09:30) substance concentration(T07:30) millimol/litre millimol/litre NPU10096 NPU08509 B(cB)—Glucose; subst.c.(T09:30) = ? mmol/l B(fPt)—Glucose; subst.c.(T07:30) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T09:30) substance concentration(T07:30) millimol/litre millimol/litre NPU08902 NPU08900 P—Glucose; subst.c.(T09:30) = ? mmol/l P—Glucose; subst.c.(T07:30) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T10) substance concentration(T08) millimol/litre millimol/litre NPU08530 NPU08528 B—Glucose; subst.c.(T10) = ? mmol/l B—Glucose; subst.c.(T08) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T10) substance concentration(T08) millimol/litre millimol/litre NPU10073 NPU10071 B(cB)—Glucose; subst.c.(T10) = ? mmol/l B(cB)—Glucose; subst.c.(T08) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T10) substance concentration(T08) millimol/litre millimol/litre NPU08554 NPU08552 P—Glucose; subst.c.(T10) = ? mmol/l P—Glucose; subst.c.(T08) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T10:30) substance concentration(T08:30) millimol/litre millimol/litre NPU08879 NPU08877 B—Glucose; subst.c.(T10:30) = ? mmol/l B—Glucose; subst.c.(T08:30) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T10:30) substance concentration(T08:30) millimol/litre millimol/litre NPU10097 NPU10095 B(cB)—Glucose; subst.c.(T10:30) = ? mmol/l B(cB)—Glucose; subst.c.(T08:30) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T10:30) substance concentration(T08:30) millimol/litre millimol/litre NPU08903 NPU08901 P—Glucose; subst.c.(T10:30) = ? mmol/l P—Glucose; subst.c.(T08:30) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T11) substance concentration(T09) millimol/litre millimol/litre NPU08531 NPU08529 B—Glucose; subst.c.(T11) = ? mmol/l B—Glucose; subst.c.(T09) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T11) substance concentration(T09) millimol/litre millimol/litre NPU10074 NPU10072 B(cB)—Glucose; subst.c.(T11) = ? mmol/l B(cB)—Glucose; subst.c.(T09) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T11) substance concentration(T09) millimol/litre millimol/litre NPU08555 NPU08553 P—Glucose; subst.c.(T11) = ? mmol/l P—Glucose; subst.c.(T09) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T11:30) substance concentration(T09:30) millimol/litre millimol/litre NPU08880 NPU08878 B—Glucose; subst.c.(T11:30) = ? mmol/l B—Glucose; subst.c.(T09:30) = ? mmol/l Blood(capillary Blood)— Glucose; substance concentration(T11:30) millimol/litre NPU10098 B(cB)—Glucose; subst.c.(T11:30) = ? mmol/l
78 Plasma— Plasma— Glucose; Glucose; substance concentration(T13:30) substance concentration(T11:30) millimol/litre millimol/litre NPU08906 NPU08904 P—Glucose; subst.c.(T13:30) = ? mmol/l P—Glucose; subst.c.(T11:30) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T14) substance concentration(T12) millimol/litre millimol/litre NPU08534 NPU08532 B—Glucose; subst.c.(T14) = ? mmol/l B—Glucose; subst.c.(T12) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T14) substance concentration(T12) millimol/litre millimol/litre NPU10077 NPU10075 B(cB)—Glucose; subst.c.(T14) = ? mmol/l B(cB)—Glucose; subst.c.(T12) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T14) substance concentration(T12) millimol/litre millimol/litre NPU08558 NPU08556 P—Glucose; subst.c.(T14) = ? mmol/l P—Glucose; subst.c.(T12) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T14:30) substance concentration(T12:30) millimol/litre millimol/litre NPU08883 NPU08881 B—Glucose; subst.c.(T14:30) = ? mmol/l B—Glucose; subst.c.(T12:30) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T14:30) substance concentration(T12:30) millimol/litre millimol/litre NPU10101 NPU10099 B(cB)—Glucose; subst.c.(T14:30) = ? mmol/l B(cB)—Glucose; subst.c.(T12:30) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T14:30) substance concentration(T12:30) millimol/litre millimol/litre NPU08907 NPU08905 P—Glucose; subst.c.(T14:30) = ? mmol/l P—Glucose; subst.c.(T12:30) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T15) substance concentration(T13) millimol/litre millimol/litre NPU08535 NPU08533 B—Glucose; subst.c.(T15) = ? mmol/l B—Glucose; subst.c.(T13) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T15) substance concentration(T13) millimol/litre millimol/litre NPU10078 NPU10076 B(cB)—Glucose; subst.c.(T15) = ? mmol/l B(cB)—Glucose; subst.c.(T13) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T15) substance concentration(T13) millimol/litre millimol/litre NPU08559 NPU08557 P—Glucose; subst.c.(T15) = ? mmol/l P—Glucose; subst.c.(T13) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T15:30) substance concentration(T13:30) millimol/litre millimol/litre NPU08884 NPU08882 B—Glucose; subst.c.(T15:30) = ? mmol/l B—Glucose; subst.c.(T13:30) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T15:30) substance concentration(T13:30) millimol/litre millimol/litre NPU10102 NPU10100 B(cB)—Glucose; subst.c.(T15:30) = ? mmol/l B(cB)—Glucose; subst.c.(T13:30) = ? mmol/l Plasma— Glucose; substance concentration(T15:30) millimol/litre NPU08908 P—Glucose; subst.c.(T15:30) = ? mmol/l
79 Blood— Blood— Glucose; Glucose; substance concentration(T18) substance concentration(T16) millimol/litre millimol/litre NPU08538 NPU08536 B—Glucose; subst.c.(T18) = ? mmol/l B—Glucose; subst.c.(T16) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T18) substance concentration(T16) millimol/litre millimol/litre NPU10081 NPU10079 B(cB)—Glucose; subst.c.(T18) = ? mmol/l B(cB)—Glucose; subst.c.(T16) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T18) substance concentration(T16) millimol/litre millimol/litre NPU08562 NPU08560 P—Glucose; subst.c.(T18) = ? mmol/l P—Glucose; subst.c.(T16) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T18:30) substance concentration(T16:30) millimol/litre millimol/litre NPU08887 NPU08885 B—Glucose; subst.c.(T18:30) = ? mmol/l B—Glucose; subst.c.(T16:30) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T18:30) substance concentration(T16:30) millimol/litre millimol/litre NPU10105 NPU10103 B(cB)—Glucose; subst.c.(T18:30) = ? mmol/l B(cB)—Glucose; subst.c.(T16:30) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T18:30) substance concentration(T16:30) millimol/litre millimol/litre NPU08911 NPU08909 P—Glucose; subst.c.(T18:30) = ? mmol/l P—Glucose; subst.c.(T16:30) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T19) substance concentration(T17) millimol/litre millimol/litre NPU08539 NPU08537 B—Glucose; subst.c.(T19) = ? mmol/l B—Glucose; subst.c.(T17) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T19) substance concentration(T17) millimol/litre millimol/litre NPU10082 NPU10080 B(cB)—Glucose; subst.c.(T19) = ? mmol/l B(cB)—Glucose; subst.c.(T17) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T19) substance concentration(T17) millimol/litre millimol/litre NPU08563 NPU08561 P—Glucose; subst.c.(T19) = ? mmol/l P—Glucose; subst.c.(T17) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T19:30) substance concentration(T17:30) millimol/litre millimol/litre NPU08888 NPU08886 B—Glucose; subst.c.(T19:30) = ? mmol/l B—Glucose; subst.c.(T17:30) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T19:30) substance concentration(T17:30) millimol/litre millimol/litre NPU10106 NPU10104 B(cB)—Glucose; subst.c.(T19:30) = ? mmol/l B(cB)—Glucose; subst.c.(T17:30) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T19:30) substance concentration(T17:30) millimol/litre millimol/litre NPU08912 NPU08910 P—Glucose; subst.c.(T19:30) = ? mmol/l P—Glucose; subst.c.(T17:30) = ? mmol/l Blood— Glucose; substance concentration(T20) millimol/litre NPU08540 B—Glucose; subst.c.(T20) = ? mmol/l
80 Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T22) substance concentration(T20) millimol/litre millimol/litre NPU10085 NPU10083 B(cB)—Glucose; subst.c.(T22) = ? mmol/l B(cB)—Glucose; subst.c.(T20) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T22) substance concentration(T20) millimol/litre millimol/litre NPU08566 NPU08564 P—Glucose; subst.c.(T22) = ? mmol/l P—Glucose; subst.c.(T20) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T22:30) substance concentration(T20:30) millimol/litre millimol/litre NPU08891 NPU08889 B—Glucose; subst.c.(T22:30) = ? mmol/l B—Glucose; subst.c.(T20:30) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T22:30) substance concentration(T20:30) millimol/litre millimol/litre NPU10109 NPU10107 B(cB)—Glucose; subst.c.(T22:30) = ? mmol/l B(cB)—Glucose; subst.c.(T20:30) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T22:30) substance concentration(T20:30) millimol/litre millimol/litre NPU08915 NPU08913 P—Glucose; subst.c.(T22:30) = ? mmol/l P—Glucose; subst.c.(T20:30) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T23) substance concentration(T21) millimol/litre millimol/litre NPU08543 NPU08541 B—Glucose; subst.c.(T23) = ? mmol/l B—Glucose; subst.c.(T21) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T23) substance concentration(T21) millimol/litre millimol/litre NPU10086 NPU10084 B(cB)—Glucose; subst.c.(T23) = ? mmol/l B(cB)—Glucose; subst.c.(T21) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T23) substance concentration(T21) millimol/litre millimol/litre NPU08567 NPU08565 P—Glucose; subst.c.(T23) = ? mmol/l P—Glucose; subst.c.(T21) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration(T23:30) substance concentration(T21:30) millimol/litre millimol/litre NPU08892 NPU08890 B—Glucose; subst.c.(T23:30) = ? mmol/l B—Glucose; subst.c.(T21:30) = ? mmol/l Blood(capillary Blood)— Blood(capillary Blood)— Glucose; Glucose; substance concentration(T23:30) substance concentration(T21:30) millimol/litre millimol/litre NPU10110 NPU10108 B(cB)—Glucose; subst.c.(T23:30) = ? mmol/l B(cB)—Glucose; subst.c.(T21:30) = ? mmol/l Plasma— Plasma— Glucose; Glucose; substance concentration(T23:30) substance concentration(T21:30) millimol/litre millimol/litre NPU08916 NPU08914 P—Glucose; subst.c.(T23:30) = ? mmol/l P—Glucose; subst.c.(T21:30) = ? mmol/l Blood— Blood— Glucose; Glucose; substance concentration increment(maximum concentration minus 0 substance concentration(T22) minutes concentration; procedure) millimol/litre millimol/litre NPU08542 NPU08502 B—Glucose; subst.c.(T22) = ? mmol/l B—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l
81 Blood(capillary Blood)— Cerebrospinal fluid— Glucose; Glucose; substance concentration increment(maximum concentration minus 0 substance concentration minutes concentration; procedure) millimol/litre millimol/litre M = 180,16 g/mol NPU10046 NPU02190 B(cB)—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l Csf—Glucose; subst.c. = ? mmol/l
Plasma— Dialysis solution— Glucose; Glucose; substance concentration increment(maximum concentration minus 0 substance concentration minutes concentration; procedure) millimol/litre millimol/litre M = 180,16 g/mol NPU03841 NPU10112 P—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l Dialysis solution—Glucose; subst.c. = ? mmol/l
Amniotic fluid— Drain fluid(specification)— Glucose; Glucose; substance concentration substance concentration millimol/litre millimol/litre M = 180,16 g/mol NPU17050 NPU08623 Drain fluid(spec.)—Glucose; subst.c. = ? mmol/l Amf—Glucose; subst.c. = ? mmol/l Plasma— Ascites— Glucose; Glucose; substance concentration substance concentration millimol/litre millimol/litre M = 180,16 g/mol M = 180,16 g/mol NPU02192 NPU04072 P—Glucose; subst.c. = ? mmol/l Asc—Glucose; subst.c. = ? mmol/l Plasma(capillary Blood; fasting Patient)— Blood— Glucose; Glucose; substance concentration substance concentration millimol/litre millimol/litre M = 180,16 g/mol M = 180,16 g/mol NPU02193 NPU02187 P(cB; fPt)—Glucose; subst.c. = ? mmol/l B—Glucose; subst.c. = ? mmol/l Pleural fluid(specification)— Blood(arterial Blood)— Glucose; Glucose; substance concentration substance concentration millimol/litre millimol/litre M = 180,16 g/mol M = 180,16 g/mol NPU10115 NPU04092 Plf(spec.)—Glucose; subst.c. = ? mmol/l B(aB)—Glucose; subst.c.=? mmol/l Plasma(venous Blood; fasting Patient)— Blood(capillary Blood)— Glucose; Glucose; substance concentration substance concentration millimol/litre millimol/litre M = 180,16 g/mol M = 180,16 g/mol NPU02195 NPU10113 P(vB; fPt)—Glucose; subst.c. = ? mmol/l B(cB)—Glucose; subst.c. = ? mmol/l Secretion(Conjunctiva; specification)— Blood(capillary Blood; fasting Patient)— Glucose; Glucose; substance concentration substance concentration millimol/litre millimol/litre M = 180,16 g/mol M = 180,16 g/mol NPU09350 NPU02188 Secr(Conj; spec.)—Glucose; subst.c. = ? mmol/l B(cB; fPt)—Glucose; subst.c. = ? mmol/l Synovial fluid(specification)— Blood(fasting Patient)— Glucose; Glucose; substance concentration substance concentration millimol/litre millimol/litre M = 180,16 g/mol M = 180,16 g/mol NPU08622 NPU08972 Synf(spec.)—Glucose; subst.c. = ? mmol/l B(fPt)—Glucose; subst.c. = ? mmol/l System(specification)— Blood(venous Blood)— Glucose; Glucose; substance concentration substance concentration millimol/litre millimol/litre M = 180,16 g/mol M = 180,16 g/mol NPU10127 NPU04093 Syst(spec.)—Glucose; subst.c. = ? mmol/l B(vB)—Glucose; subst.c.=? mmol/l Urine— Blood(venous Blood; fasting Patient)— Glucose; Glucose; substance concentration substance concentration millimol/litre millimol/litre M = 180,16 g/mol M = 180,16 g/mol NPU03936 NPU02189 U—Glucose; subst.c. = ? mmol/l B(vB; fPt)—Glucose; subst.c. = ? mmol/l
82 Patient(Urine)— Plasma— Glucose; Glutamate; substance rate(procedure) substance concentration millimol/day micromol/litre NPU02191 NPU02229 Pt(U)—Glucose; subst.rate(proc.) = ? mmol/d P—Glutamate; subst.c. = ? µmol/l
Biopsy(specification)— Urine— alpha- Glutamate; Glucosidase; substance concentration catalytic-activity content(37 °C; procedure) micromol/litre katal/kilogram NPU02230 NPU10183 U—Glutamate; subst.c. = ? µmol/l Biopsy(spec.)—alpha-Glucosidase; cat.cont.(37 °C; proc.)= ? prefix ? kat/kg Urine— Urine— Glutamine/Creatininium; beta- substance ratio Glucuronidase; 10-3 catalytic-activity concentration(37 °C; procedure) NPU14210 microkatal/litre U—Glutamine/Creatininium; subst.ratio = ? × 10-3 NPU02227 U—beta-Glucuronidase; cat.c.(37 °C; proc.) = ? µkat/l Cerebrospinal fluid— Glutamine; Plasma— substance concentration Glutamate decarboxylase(gad65) antibody(Immunoglobulin G); micromol/litre arbitrary concentration(procedure) M = 146,15 g/mol NPU12544 NPU09022 P—Glutamate decarboxylase(gad65) antibody(IgG); arb.c.(proc.) = ? Csf—Glutamine; subst.c. = ? µmol/l
Plasma— Plasma— Glutamate decarboxylase(gad65) antibody(Immunoglobulin G); Glutamine; arbitrary substance concentration(ELISA; procedure) substance concentration 10³ arbitrary unit/litre micromol/litre NPU12546 M = 146,15 g/mol P—Glutamate decarboxylase(gad65) antibody(IgG); arb.subst.c.(ELISA; proc.) NPU02249 = ? × 10³ arb.unit/l P—Glutamine; subst.c. = ? µmol/l
Plasma— Urine— Glutamate decarboxylase(gad65) antibody(Immunoglobulin G); Glutamine; arbitrary substance concentration(Radioimmunoassay; procedure) substance concentration 10³ arbitrary unit/litre micromol/litre NPU16484 M = 146,15 g/mol P—Glutamate decarboxylase(gad65) antibody(IgG); arb.subst.c.(RIA; proc.) = ? NPU02250 × 10³ arb.unit/l U—Glutamine; subst.c. = ? µmol/l
Amniotic fluid— Amniotic fluid— Glutamate dehydrogenase(NAD(P)+); gamma- catalytic-activity concentration(37 °C; procedure) Glutamyltransferase; microkatal/litre catalytic-activity concentration(37 °C; procedure) NPU03904 microkatal/litre Amf—Glutamate dehydrogenase(NAD(P)+); cat.c.(37 °C; proc.) = ? µkat/l Other term(s): Glutamyl transpeptidase NPU03907 Plasma— Amf—gamma-Glutamyltransferase; cat.c.(37 °C; proc.) = ? µkat/l Glutamate dehydrogenase(NAD(P)+); catalytic-activity concentration(37 °C; procedure) Plasma— microkatal/litre gamma- NPU02247 Glutamyltransferase; P—Glutamate dehydrogenase(NAD(P)+); cat.c.(37 °C; proc.) = ? µkat/l catalytic-activity concentration(37 °C; procedure) microkatal/litre Plasma— Other term(s): Glutamyl transpeptidase Glutamate dehydrogenase(NADP+); NPU02251 catalytic-activity concentration(37 °C; procedure) P—gamma-Glutamyltransferase; cat.c.(37 °C; proc.) = ? µkat/l katal/litre NPU02248 Urine— P—Glutamate dehydrogenase(NADP+); cat.c.(37 °C; proc.)= ? prefix ? kat/l gamma- Glutamyltransferase; Amniotic fluid— catalytic-activity concentration(37 °C; procedure) Glutamate dehydrogenase(NADP+); microkatal/litre catalytic-activity concentration(37 °C; procedure) Other term(s): Glutamyl transpeptidase microkatal/litre NPU10312 NPU03905 U—gamma-Glutamyltransferase; cat.c.(37 °C; proc.) = ? µkat/l Amf—Glutamate dehydrogenase(NADP+); cat.c.(37 °C; proc.) = ? µkat/l Urine— Urine— Glutarate; Glutamate/Creatininium; substance concentration substance ratio micromol/litre 10-3 NPU02252 NPU14209 U—Glutarate; subst.c. = ? µmol/l U—Glutamate/Creatininium; subst.ratio = ? × 10-3 Erythrocytes(Blood)— Cerebrospinal fluid— Glutathione peroxidase; Glutamate; entitic catalytic activity(37 °C; procedure) substance concentration attokatal micromol/litre NPU04801 NPU02228 Ercs(B)—Glutathione peroxidase; entitic cat.act.(37 °C; proc.)= ? akat Csf—Glutamate; subst.c. = ? µmol/l
83 Erythrocytes(Blood)— Plasma— Glutathione reductase (NAD(P)H); beta-2- arbitrary catalytic activity(procedure) Glycoprotein I antibody(Immunoglobulin G); NPU17109 arbitrary concentration(procedure) Ercs(B)—Glutathione reductase (NAD(P)H); arb.cat.act.(proc.) = ? NPU14508 P—beta-2-Glycoprotein I antibody(IgG); arb.c.(proc.) = ? Plasma— Glutathione reductase (NAD(P)H); Plasma— arbitrary catalytic activity(procedure) beta-2- NPU14354 Glycoprotein I antibody(Immunoglobulin G); P—Glutathione reductase (NAD(P)H); arb.cat.act.(proc.) = ? arbitrary substance concentration(procedure) 10³ arbitrary unit/litre Urine— NPU16397 Glycerate; P—beta-2-Glycoprotein I antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l substance concentration mol/litre Plasma— NPU02279 beta-2- U—Glycerate; subst.c.= ? prefix ? mol/l Glycoprotein I antibody(Immunoglobulin M); arbitrary concentration(procedure) Plasma— NPU14509 Glycerol; P—beta-2-Glycoprotein I antibody(IgM); arb.c.(proc.) = ? substance concentration millimol/litre Plasma— NPU08973 beta-2- P—Glycerol; subst.c. = ? mmol/l Glycoprotein I antibody(Immunoglobulin M); arbitrary substance concentration(procedure) Urine— 10³ arbitrary unit/litre Glycine/Creatininium; NPU16398 substance ratio P—beta-2-Glycoprotein I antibody(IgM); arb.subst.c.(proc.) = ? × 10³ arb.unit/l 10-3 NPU14211 Plasma— U—Glycine/Creatininium; subst.ratio = ? × 10-3 beta-2- Glycoprotein I antibody; Cerebrospinal fluid— arbitrary substance concentration(list; procedure) Glycine; NPU17671 substance concentration P—beta-2-Glycoprotein I antibody; arb.subst.c.(list; proc.) micromol/litre NPU16397 P—beta-2-Glycoprotein I antibody(IgG); arb.subst.c.(proc.) = ? × 10³ M = 75,07 g/mol arb.unit/l NPU02288 NPU16398 P—beta-2-Glycoprotein I antibody(IgM); arb.subst.c.(proc.) = ? × Csf—Glycine; subst.c. = ? µmol/l 10³ arb.unit/l
Plasma— Plasma— Glycine; alpha-2-HS- substance concentration Glycoprotein; micromol/litre substance concentration NPU02289 micromol/litre P—Glycine; subst.c. = ? µmol/l NPU10274 P—alpha-2-HS-Glycoprotein; subst.c. = ? µmol/l Urine— Glycine; Synovial fluid(specification)— substance concentration Gold; micromol/litre substance concentration(therapy) NPU02290 micromol/litre U—Glycine; subst.c. = ? µmol/l M = 196,97 g/mol NPU10769 Haemoglobin(Fe; Blood)— Synf(spec.)—Gold; subst.c.(therapy) = ? µmol/l Glycohaemoglobin(Fe); substance fraction Blood— M = 16 700 g/mol Gold; Other term(s): glycosylated haemoglobin substance concentration Authority: IUPAC-IUB85 picomol/litre NPU02307 M = 196,97 g/mol Hb(Fe; B)—Glycohaemoglobin(Fe); subst.fr. = ? Authority: IUPAC/VII-C-TOX NPU02310 Urine— B—Gold; subst.c. = ? pmol/l Glycolate/Creatininium; substance ratio Plasma— 10-3 Gold; NPU14212 substance concentration U—Glycolate/Creatininium; subst.ratio = ? × 10-3 picomol/litre M = 196,97 g/mol Plasma— Authority: IUPAC/VII-C-TOX Glycolate; NPU02312 substance concentration P—Gold; subst.c. = ? pmol/l mol/litre NPU02308 Urine— P—Glycolate; subst.c.= ? prefix ? mol/l Gold; substance concentration Urine— picomol/litre Glycolate; M = 196,97 g/mol substance concentration Authority: IUPAC/VII-C-TOX mol/litre NPU02313 NPU02309 U—Gold; subst.c. = ? pmol/l U—Glycolate; subst.c.= ? prefix ? mol/l
84 Hair— Gold; Haemoglobin(Fe; Blood)— substance content Haemoglobin F+Haemoglobin F1; nanomol/kilogram substance fraction M = 196,97 g/mol NPU10160 Authority: IUPAC/VII-C-TOX Hb(Fe; B)—Haemoglobin F+Haemoglobin F1; subst.fr.= ? NPU02311 Hair—Gold; subst.cont. = ? nmol/kg Haemoglobin(Fe; Blood)— Haemoglobin F1(Fe); Patient(Urine)— substance fraction Gold; M = 16 500 g/mol substance rate(therapy) NPU04614 micromol/day Hb(Fe; B)—Haemoglobin F1(Fe); subst.fr.= ? M = 196,97 g/mol NPU10313 Haemoglobin(Fe; Blood)— Pt(U)—Gold; subst.rate(therapy) = ? µmol/d Haemoglobin S(Fe); substance fraction Patient— NPU10158 Gonadorelin(administered); Hb(Fe; B)—Haemoglobin S(Fe); subst.fr.= ? amount-of-substance(intravenous administration) nanomol Haemoglobin(Blood)— NPU10561 Haemoglobin type; Pt—Gonadorelin(administered); am.s.(i.v.) = ? nmol property(list; procedure) NPU17703 Haemoglobin(Fe; Blood)— Hb(B)—Haemoglobin type; prop.(list; proc.) Haemoglobin A(Fe); NPU04610 Hb(Fe; B)—Haemoglobin A(Fe); subst.fr.= ? substance fraction NPU04994 Hb(Fe; B)—Haemoglobin A1(Fe); subst.fr.= ? M = 16 500 g/mol NPU04611 Hb(Fe; B)—Haemoglobin A2(Fe); subst.fr.= ? NPU04610 NPU04612 Hb(Fe; B)—Haemoglobin A3(Fe); subst.fr.= ? Hb(Fe; B)—Haemoglobin A(Fe); subst.fr.= ? NPU04613 Hb(Fe; B)—Haemoglobin F(Fe); subst.fr.= ? NPU04614 Hb(Fe; B)—Haemoglobin F1(Fe); subst.fr.= ? Haemoglobin(Fe; Blood)— NPU04984 Hb(Fe; B)—Haemoglobin, other(Fe; spec.); subst.fr.= ? Haemoglobin A1(Fe); NPU09034 Hb(Fe; B)—Haemoglobin, heat unstable(Fe); arb.c.(proc.) = ? substance fraction NPU02327 Hb(Fe; B)—Haemoglobin, heat unstable(Fe); subst.fr.(proc.) = ? M = 16 500 g/mol NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); subst.fr. = ? NPU04994 Hb(Fe; B)—Haemoglobin A1(Fe); subst.fr.= ? Haemoglobin(Blood)— Haemoglobin type; Haemoglobin(Fe; Blood)— substance fraction(list; procedure) Haemoglobin A1c(Fe); NPU02326 substance fraction Hb(B)—Haemoglobin type; subst.fr.(list; proc.) M = 16 500 g/mol NPU04610 Hb(Fe; B)—Haemoglobin A(Fe); subst.fr.= ? NPU03835 NPU04994 Hb(Fe; B)—Haemoglobin A1(Fe); subst.fr.= ? Hb(Fe; B)—Haemoglobin A1c(Fe); subst.fr. = ? NPU04611 Hb(Fe; B)—Haemoglobin A2(Fe); subst.fr.= ? NPU04612 Hb(Fe; B)—Haemoglobin A3(Fe); subst.fr.= ? Haemoglobin(Fe; Blood)— NPU04613 Hb(Fe; B)—Haemoglobin F(Fe); subst.fr.= ? Haemoglobin A2(Fe); NPU04614 Hb(Fe; B)—Haemoglobin F1(Fe); subst.fr.= ? substance fraction NPU04984 Hb(Fe; B)—Haemoglobin, other(Fe; spec.); subst.fr.= ? M = 16 500 g/mol NPU02725 Hb(Fe; B)—Methaemoglobin(Fe); subst.fr. = ? NPU04611 Hb(Fe; B)—Haemoglobin A2(Fe); subst.fr.= ? Drain fluid(specification)— Haemoglobin(Fe); Haemoglobin(Fe; Blood)— arbitrary concentration(procedure) Haemoglobin A3(Fe); NPU17051 substance fraction Drain fluid(spec.)—Haemoglobin(Fe); arb.c.(proc.) = ? M = 16 500 g/mol NPU04612 System(specification)— Hb(Fe; B)—Haemoglobin A3(Fe); subst.fr.= ? Haemoglobin(Fe); arbitrary concentration(procedure) Haemoglobin(Fe; Blood)— M = 16 500 g/mol Haemoglobin C(Fe); NPU10314 substance fraction Syst(spec.)—Haemoglobin(Fe); arb.c.(proc.) = ? NPU10161 Hb(Fe; B)—Haemoglobin C(Fe); subst.fr.= ? Erythrocytes(Blood)— Haemoglobin(Fe); Haemoglobin(Fe; Blood)— entitic amount-of-substance Haemoglobin D(Fe); femtomol substance fraction M = 16 500 g/mol NPU10163 Other term(s): MCH Hb(Fe; B)—Haemoglobin D(Fe); subst.fr.= ? NPU02320 Ercs(B)—Haemoglobin(Fe); entitic am.s. = ? fmol Haemoglobin(Fe; Blood)— Haemoglobin E(Fe); Reticulocytes(Blood)— substance fraction Haemoglobin(Fe); NPU10159 entitic amount-of-substance Hb(Fe; B)—Haemoglobin E(Fe); subst.fr.= ? femtomol M = 16 500 g/mol Haemoglobin(Fe; Amniotic fluid)— Other term(s): MCH Haemoglobin F(Fe); NPU17007 substance fraction Rtcs(B)—Haemoglobin(Fe); entitic am.s. = ? fmol M = 16 500 g/mol NPU02325 System(specification)— Hb(Fe; Amf)—Haemoglobin F(Fe); subst.fr. = ? Haemoglobin(Fe); substance concentration(procedure) Haemoglobin(Fe; Blood)— nanomol/litre Haemoglobin F(Fe); M = 16 500 g/mol substance fraction NPU10287 M = 16 500 g/mol Syst(spec.)—Haemoglobin(Fe); subst.c.(proc.) = ? nmol/l NPU04613 Hb(Fe; B)—Haemoglobin F(Fe); subst.fr.= ?
85 Urine— Pleural fluid— Haemoglobin(Fe); Haemoglobin(Fe); substance concentration(procedure) substance concentration nanomol/litre millimol/litre M = 16 500 g/mol M = 16 500 g/mol NPU02323 NPU17022 U—Haemoglobin(Fe); subst.c.(proc.) = ? nmol/l Plf—Haemoglobin(Fe); subst.c. = ? mmol/l
Urine(cell free)— Reticulocytes(Blood)— Haemoglobin(Fe); Haemoglobin(Fe); substance concentration(procedure) substance concentration nanomol/litre millimol/litre M = 16 500 g/mol NPU17008 NPU02324 Rtcs(B)—Haemoglobin(Fe); subst.c. = ? mmol/l U(cell free)—Haemoglobin(Fe); subst.c.(proc.) = ? nmol/l Haemoglobin(Fe; Blood)— Blood fraction(specification)— Haemoglobin, heat unstable(Fe); Haemoglobin(Fe); arbitrary concentration(procedure) substance concentration M = 16 500 g/mol micromol/litre NPU09034 NPU17569 Hb(Fe; B)—Haemoglobin, heat unstable(Fe); arb.c.(proc.) = ? B fract.(spec.)—Haemoglobin(Fe); subst.c. = ? µmol/l Haemoglobin(Fe; Blood)— Cerebrospinal fluid— Haemoglobin, heat unstable(Fe); Haemoglobin(Fe); substance fraction(procedure) substance concentration M = 16 500 g/mol micromol/litre NPU02327 M = 16 500 g/mol Hb(Fe; B)—Haemoglobin, heat unstable(Fe); subst.fr.(proc.) = ? NPU17030 Csf—Haemoglobin(Fe); subst.c. = ? µmol/l Haemoglobin(Fe; Blood)— Haemoglobin, other(Fe; specification); Drain fluid(specification)— substance fraction Haemoglobin(Fe); M = 16 500 g/mol substance concentration NPU04984 micromol/litre Hb(Fe; B)—Haemoglobin, other(Fe; spec.); subst.fr.= ? NPU17052 Drain fluid(spec.)—Haemoglobin(Fe); subst.c. = ? µmol/l Haemoglobin(Blood)— Haemoglobin, unusual; Plasma— taxon(procedure) Haemoglobin(Fe); NPU03988 substance concentration Hb(B)—Haemoglobin, unusual; taxon(proc.)= ? micromol/litre M = 16 500 g/mol Urine— NPU02322 Haemoglobin; P—Haemoglobin(Fe); subst.c. = ? µmol/l arbitrary concentration(procedure) NPU04208 Blood— U—Haemoglobin; arb.c.(proc.)= ? Haemoglobin(Fe); substance concentration Faeces— millimol/litre Haemoglobin; M = 16 500 g/mol arbitrary content(procedure) NPU02319 NPU01393 B—Haemoglobin(Fe); subst.c. = ? mmol/l F—Haemoglobin; arb.cont.(proc.) = ?
Blood fraction(specification)— Cerebrospinal fluid(cell free)— Haemoglobin(Fe); Haemoglobin+derivative; substance concentration arbitrary concentration(procedure) millimol/litre NPU08626 NPU17570 Csf(cell free)—Haemoglobin+derivative; arb.c.(proc.) = ? B fract.(spec.)—Haemoglobin(Fe); subst.c. = ? mmol/l Plasma— Blood(cord Blood)— Haemopexin; Haemoglobin(Fe); substance concentration substance concentration micromol/litre millimol/litre M = 57 000 g/mol NPU10162 NPU02328 B(cordB)—Haemoglobin(Fe); subst.c. = ? mmol/l P—Haemopexin; subst.c. = ? µmol/l
Erythrocytes(Blood)— Urine— Haemoglobin(Fe); Haemosiderin; substance concentration arbitrary concentration(procedure) millimol/litre NPU04209 M = 16 500 g/mol U—Haemosiderin; arb.c.(proc.)= ? Other term(s): MCHC NPU02321 Plasma— Ercs(B)—Haemoglobin(Fe); subst.c. = ? mmol/l Haptocorrin(free); substance concentration Lavage fluid(specification)— picomol/litre Haemoglobin(Fe); M = 70 000 g/mol substance concentration Other term(s): Transcobalamin I(free) millimol/litre NPU08569 NPU14358 P—Haptocorrin(free); subst.c. = ? pmol/l Lavagef(spec.)—Haemoglobin(Fe); subst.c. = ? mmol/l
86 Plasma— Urine— Haptocorrin(total); Histidine; substance concentration substance concentration picomol/litre micromol/litre M = 70 000 g/mol M = 155,16 g/mol Other term(s): Transcobalamin I(total) NPU02374 NPU02317 U—Histidine; subst.c. = ? µmol/l P—Haptocorrin(tot.); subst.c. = ? pmol/l Plasma— Plasma— Histidine-tRNA ligase antibody(Immunoglobulin G); Haptoglobin; arbitrary concentration(procedure) substance concentration Other term(s): Jo-1 antibody micromol/litre NPU12568 M = 100 000 g/mol P—Histidine-tRNA ligase antibody(IgG); arb.c.(proc.) = ? NPU02318 P—Haptoglobin; subst.c. = ? µmol/l Plasma— Histidine-tRNA ligase antibody; Blood— arbitrary concentration(procedure) Helmet cells; Other term(s): Jo-1 antibody; histidyl tRNA syntetase antibody arbitrary concentration(procedure) NPU12040 NPU17088 P—Histidine-tRNA ligase antibody; arb.c.(proc.) = ? B—Helmet cells; arb.c.(proc.) = ? Plasma— Urine— Histidine--tRNA-synthetase(Jo 1) antibody(Immunoglobulin G); Heparan sulfate; arbitrary concentration(procedure) substance concentration NPU14511 mol/litre P—Histidine--tRNA-synthetase(Jo 1) antibody(IgG); arb.c.(proc.) = ? Authority: IUPAC-IUB85 NPU02329 Plasma— U—Heparan sulfate; subst.c.= ? prefix ? mol/l Histon; arbitrary substance concentration(procedure) Erythrocytes(Ascites)— arbitrary unit/litre Hexokinase; NPU12904 entitic catalytic-activity content P—Histon; arb.subst.c.(proc.) = ? arb.unit/l attokatal NPU17567 Plasma— Ercs(Asc)—Hexokinase; entitic cat.cont. = ? akat Histone antibody(Immunoglobulin G); arbitrary concentration(procedure) Urine— NPU12560 Hexose(reducing); P—Histone antibody(IgG); arb.c.(proc.) = ? arbitrary concentration(procedure) NPU14142 Plasma— U—Hexose(reducing); arb.c.(proc.) = ? Histone antibody(Immunoglobulin G); arbitrary substance concentration(procedure) Patient(Urine)— 10³ arbitrary unit/litre Hippurate; NPU12559 substance rate(procedure) P—Histone antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l micromol/day NPU02371 Plasma— Pt(U)—Hippurate; subst.rate(proc.) = ? µmol/d Histone antibody; arbitrary concentration(procedure) Blood— NPU02385 Histamine; P—Histone antibody; arb.c.(proc.) = ? substance concentration micromol/litre Plasma— NPU04805 Histone antibody; B—Histamine; subst.c.= ? µmol/l arbitrary substance concentration(procedure) arbitrary unit/litre Patient(Urine)— NPU12034 Histamine; P—Histone antibody; arb.subst.c.(proc.) = ? arb.unit/l substance rate(procedure) micromol/day Urine— NPU04812 Homoarginine/Creatininium; Pt(U)—Histamine; subst.rate(proc.)= ? µmol/d substance ratio 10-3 Urine— NPU14214 Histidine/Creatininium; U—Homoarginine/Creatininium; subst.ratio = ? × 10-3 substance ratio 10-3 Urine— NPU14213 Homoarginine; U—Histidine/Creatininium; subst.ratio = ? × 10-3 substance concentration micromol/litre Cerebrospinal fluid— M = 189,2 g/mol Histidine; NPU02386 substance concentration U—Homoarginine; subst.c. = ? µmol/l micromol/litre M = 195,16 g/mol Urine— NPU09023 Homocarnosine/Creatininium; Csf—Histidine; subst.c. = ? µmol/l substance ratio 10-3 Plasma— NPU14215 Histidine; U—Homocarnosine/Creatininium; subst.ratio = ? × 10-3 substance concentration micromol/litre Cerebrospinal fluid— M = 155,16 g/mol Homocarnosine; NPU02373 substance concentration P—Histidine; subst.c. = ? µmol/l micromol/litre M = 240,26 g/mol NPU02387 Csf—Homocarnosine; subst.c. = ? µmol/l
87 Urine— Urine— Homovanillate; Homocitrulline/Creatininium; substance concentration substance ratio micromol/litre 10-3 NPU02402 NPU14216 U—Homovanillate; subst.c. = ? µmol/l U—Homocitrulline/Creatininium; subst.ratio = ? × 10-3 Patient(Urine)— Urine— Homovanillate; Homocitrulline; substance rate(procedure) substance concentration micromol/day micromol/litre NPU04814 NPU02388 Pt(U)—Homovanillate; subst.rate(proc.)= ? µmol/d U—Homocitrulline; subst.c. = ? µmol/l Dialysis solution— Plasma— Hydrogen carbonate; Homocysteine(total); substance concentration(actual) substance concentration millimol/litre micromol/litre Authority: IFCC/C-BGE NPU04073 NPU10165 P—Homocysteine(tot.); subst.c. = ? µmol/l Dialysis solution—Hydrogen carbonate; subst.c.(actual) = ? mmol/l
Urine— Plasma(arterial Blood)— Homocystine/Creatininium; Hydrogen carbonate; substance ratio substance concentration(actual) 10-3 millimol/litre NPU14217 Authority: IFCC/C-BGE U—Homocystine/Creatininium; subst.ratio = ? × 10-3 NPU02409 P(aB)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l Plasma— Homocystine; Plasma(capillary Blood)— substance concentration Hydrogen carbonate; micromol/litre substance concentration(actual) M = 268,36 g/mol millimol/litre NPU02397 Authority: IFCC/C-BGE P—Homocystine; subst.c. = ? µmol/l NPU14264 P(cB)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l Urine— Homocystine; Plasma(cord Blood)— substance concentration Hydrogen carbonate; micromol/litre substance concentration(actual) M = 268,36 g/mol millimol/litre NPU02398 Authority: IFCC/C-BGE U—Homocystine; subst.c. = ? µmol/l NPU14265 P(cordB)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l Urine— Homogentisate; Plasma(cord Blood; arterial Blood)— substance concentration Hydrogen carbonate; micromol/litre substance concentration(actual) NPU02399 millimol/litre U—Homogentisate; subst.c. = ? µmol/l Authority: IFCC/C-BGE NPU17145 Urine— P(cordB; aB)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l Homoserine/Creatininium; substance ratio Plasma(cord Blood; venous Blood)— 10-3 Hydrogen carbonate; NPU14218 substance concentration(actual) U—Homoserine/Creatininium; subst.ratio = ? × 10-3 millimol/litre Authority: IFCC/C-BGE Urine— NPU17146 Homoserine; P(cordB; vB)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l substance concentration micromol/litre Plasma(mixed Blood)— M = 119,1 g/mol Hydrogen carbonate; NPU02400 substance concentration(actual) U—Homoserine; subst.c. = ? µmol/l millimol/litre Authority: IFCC/C-BGE Urine— NPU09209 Homovanillate/Creatininium; P(mixB)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l substance ratio 10-3 Plasma(venous Blood)— NPU10164 Hydrogen carbonate; U—Homovanillate/Creatininium; subst.ratio = ? × 10-3 substance concentration(actual) millimol/litre Urine— Authority: IFCC/C-BGE Homovanillate; NPU14266 amount-of-substance P(vB)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l micromol NPU17568 System(specification)— U—Homovanillate; am.s. = ? µmol Hydrogen carbonate; substance concentration(actual) Cerebrospinal fluid— millimol/litre Homovanillate; Authority: IFCC/C-BGE substance concentration NPU10286 micromol/litre Syst(spec.)—Hydrogen carbonate; subst.c.(actual) = ? mmol/l NPU02401 Csf—Homovanillate; subst.c. = ? µmol/l
88 Plasma— Plasma(cord Blood; arterial Blood)— Hydrogen carbonate; Hydrogen ion; substance concentration(pCO2 = 5,3 kPa; 37 ºC) pH(patient body temperature) millimol/litre NPU17149 Other term(s): Standard bicarbonate P(cordB; aB)—Hydrogen ion; pH(body temp.) = ? Authority: IFCC/C-BGE Note: standard: blood; pCO2 = 5,3 kPa; 37 øC Plasma(cord Blood; venous Blood)— NPU02410 Hydrogen ion; P—Hydrogen carbonate; subst.c.(pCO2 = 5,3 kPa; 37 ºC) = ? mmol/l pH(patient body temperature) NPU17150 Plasma(arterial Blood)— P(cordB; vB)—Hydrogen ion; pH(body temp.) = ? Hydrogen carbonate; substance concentration(pCO2 = 5,3 kPa; 37 ºC) Plasma(mixed Blood)— millimol/litre Hydrogen ion; Authority: IFCC/C-BGE pH(patient body temperature) Note: standard: blod; pCO2 = 5,3 kPa; 37 ºC Authority: IFCC/C-BGE NPU14176 Note: See also P--Hydrogen ion; subst.c. P(aB)—Hydrogen carbonate; subst.c.(pCO2 = 5,3 kPa; 37 ºC) = ? mmol/l NPU09211 P(mixB)—Hydrogen ion; pH(body temp.) = ? Plasma(capillary Blood)— Hydrogen carbonate; Plasma(venous Blood)— substance concentration(pCO2 = 5,3 kPa; 37 ºC) Hydrogen ion; millimol/litre pH(patient body temperature) Authority: IFCC/C-BGE NPU12492 Note: standard: blod; pCO2 = 5,3 kPa; 37 ºC P(vB)—Hydrogen ion; pH(body temp.) = ? NPU14279 P(cB)—Hydrogen carbonate; subst.c.(pCO2 = 5,3 kPa; 37 ºC) = ? mmol/l Faeces— Hydrogen ion; Plasma(cord Blood)— pH(procedure) Hydrogen carbonate; Authority: IFCC/C-BGE substance concentration(pCO2 = 5,3 kPa; 37 ºC) NPU10318 millimol/litre F—Hydrogen ion; pH(proc.) = ? Authority: IFCC/C-BGE Note: standard: blod; pCO2 = 5,3 kPa; 37 ºC Urine— NPU10166 Hydrogen ion; P(cordB)—Hydrogen carbonate; subst.c.(pCO2 = 5,3 kPa; 37 ºC) = ? mmol/l pH(procedure) Authority: IFCC/C-BGE Plasma(venous Blood)— NPU02415 Hydrogen carbonate; U—Hydrogen ion; pH(proc.) = ? substance concentration(pCO2 = 5,3 kPa; 37 ºC) millimol/litre Amniotic fluid— Authority: IFCC/C-BGE Hydrogen ion; Note: standard: blod; pCO2 = 5,3 kPa; 37 ºC pH NPU09360 Authority: IFCC/C-BGE P(vB)—Hydrogen carbonate; subst.c.(pCO2 = 5,3 kPa; 37 ºC) = ? mmol/l NPU10209 Amf—Hydrogen ion; pH = ? Plasma(arterial Blood)— Hydrogen ion; Dialysis solution— pH(37 °C) Hydrogen ion; NPU12474 pH P(aB)—Hydrogen ion; pH(37 °C) = ? NPU14355 Dialysis solution—Hydrogen ion; pH = ? Plasma(capillary Blood)— Hydrogen ion; Duodenal fluid— pH(37 °C) Hydrogen ion; NPU12490 pH P(cB)—Hydrogen ion; pH(37 °C) = ? NPU14356 Duodf—Hydrogen ion; pH = ? Plasma(mixed Blood)— Hydrogen ion; Plasma(capillary Blood)— pH(37 °C) Hydrogen ion; NPU09210 pH P(mixB)—Hydrogen ion; pH(37 °C) = ? NPU10212 P(cB)—Hydrogen ion; pH = ? Plasma(venous Blood)— Hydrogen ion; Plasma(cord Blood)— pH(37 °C) Hydrogen ion; NPU12489 pH P(vB)—Hydrogen ion; pH(37 °C) = ? NPU10016 P(cordB)—Hydrogen ion; pH = ? Plasma(arterial Blood)— Hydrogen ion; Plasma(cord Blood; arterial Blood)— pH(patient body temperature) Hydrogen ion; Authority: IFCC/C-BGE pH Note: See also P--Hydrogen ion; subst.c. NPU17147 NPU02412 P(cordB; aB)—Hydrogen ion; pH = ? P(aB)—Hydrogen ion; pH(body temp.) = ? Plasma(cord Blood; venous Blood)— Plasma(capillary Blood)— Hydrogen ion; Hydrogen ion; pH pH(patient body temperature) NPU17148 NPU12491 P(cordB; vB)—Hydrogen ion; pH = ? P(cB)—Hydrogen ion; pH(body temp.) = ? Plasma(venous Blood)— Plasma(cord Blood)— Hydrogen ion; Hydrogen ion; pH pH(patient body temperature) Authority: IFCC/C-BGE NPU12493 NPU03995 P(cordB)—Hydrogen ion; pH(body temp.) = ? P(vB)—Hydrogen ion; pH = ?
89 System(specification)— Hydrogen ion; Plasma(mixed Blood)— pH Hydrogen ion; NPU10126 substance concentration(patient body temperature) Syst(spec.)—Hydrogen ion; pH = ? nanomol/litre Authority: IFCC/C-BGE Plasma(arterial Blood)— NPU09213 Hydrogen ion; P(mixB)—Hydrogen ion; subst.c.(body temp.) = ? nmol/l substance concentration(37 °C) nanomol/litre Plasma(venous Blood)— NPU12475 Hydrogen ion; P(aB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l substance concentration(patient body temperature) nanomol/litre Plasma(capillary Blood)— NPU12498 Hydrogen ion; P(vB)—Hydrogen ion; subst.c.(body temp.) = ? nmol/l substance concentration(37 °C) nanomol/litre Dialysis solution— NPU12494 Hydrogen ion; P(cB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l substance concentration nanomol/litre Plasma(cord Blood)— Authority: IFCC/C-BGE Hydrogen ion; NPU14922 substance concentration(37 °C) Dialysis solution—Hydrogen ion; subst.c. = ? nmol/l nanomol/litre NPU12496 Urine— P(cordB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l Hydrogen ion; substance concentration Plasma(cord Blood; arterial Blood)— nanomol/litre Hydrogen ion; Authority: IFCC/C-BGE substance concentration(37 °C) NPU03848 nanomol/litre U—Hydrogen ion; subst.c. = ? nmol/l NPU17151 P(cordB; aB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l Stomach fluid— Hydrogen ion; Plasma(cord Blood; venous Blood)— substance rate(procedure) Hydrogen ion; millimol/day substance concentration(37 °C) NPU14357 nanomol/litre Stomf—Hydrogen ion; subst.rate(proc.) = ? mmol/d NPU17152 P(cordB; vB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l Cobalamin(Plasma)— Hydroxocobalamin; Plasma(mixed Blood)— substance fraction Hydrogen ion; NPU04955 substance concentration(37 °C) Cobalamin(P)—Hydroxocobalamin; subst.fr. = ? nanomol/litre NPU09212 Urine— P(mixB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l 3- Hydroxy-3-carboxy-n-propylthio-cystine/Creatininium; Plasma(venous Blood)— substance ratio Hydrogen ion; 10-3 substance concentration(37 °C) NPU14220 nanomol/litre U—3-Hydroxy-3-carboxy-n-propylthio-cystine/Creatininium; subst.ratio = ? × 10- NPU12495 3 P(vB)—Hydrogen ion; subst.c.(37 °C) = ? nmol/l Urine— Plasma(arterial Blood)— 3- Hydrogen ion; Hydroxy-3-carboxy-n-propylthio-cystine; substance concentration(patient body temperature) substance concentration nanomol/litre mol/litre Authority: IFCC/C-BGE NPU02416 NPU02413 U—3-Hydroxy-3-carboxy-n-propylthio-cystine; subst.c.= ? prefix ? mol/l P(aB)—Hydrogen ion; subst.c.(body temp.) = ? nmol/l Urine— Plasma(capillary Blood)— 3- Hydrogen ion; Hydroxy-3-methylglutarate; substance concentration(patient body temperature) substance concentration nanomol/litre mol/litre NPU12497 NPU02417 P(cB)—Hydrogen ion; subst.c.(body temp.) = ? nmol/l U—3-Hydroxy-3-methylglutarate; subst.c.= ? prefix ? mol/l
Plasma(cord Blood)— Urine— Hydrogen ion; 11-beta- substance concentration(patient body temperature) Hydroxyandrosterone; nanomol/litre substance concentration NPU12499 micromol/litre P(cordB)—Hydrogen ion; subst.c.(body temp.) = ? nmol/l M = 306,43 g/mol NPU02422 Plasma(cord Blood; arterial Blood)— U—11-beta-Hydroxyandrosterone; subst.c. = ? µmol/l Hydrogen ion; substance concentration(patient body temperature) Urine— nanomol/litre 3- NPU17153 Hydroxyasparagine/Creatininium; P(cordB; aB)—Hydrogen ion; subst.c.(body temp.) = ? nmol/l substance ratio 10-3 Plasma(cord Blood; venous Blood)— NPU14222 Hydrogen ion; U—3-Hydroxyasparagine/Creatininium; subst.ratio = ? × 10-3 substance concentration(patient body temperature) nanomol/litre NPU17154 P(cordB; vB)—Hydrogen ion; subst.c.(body temp.) = ? nmol/l
90 Urine— Adrenal cortex— 3- 17- Hydroxyasparagine; Hydroxycorticosteroid secretion; substance concentration substance rate(tetracosactide, intramuscular administration; list; mol/litre procedure) NPU02423 Note: _M_ (tetracosactide) = 2 933,57 g/mol; _M_ (17-hydroxycorticosteroid) U—3-Hydroxyasparagine; subst.c.= ? prefix ? mol/l = ? g/mol NPU10447 Urine— Adrenal cortex—17-Hydroxycorticosteroid secretion; subst.rate(tetracosactide alpha- i.m.; list; proc.) Hydroxy-beta-chito-gamma-aminobutyrate/Creatininium; NPU10534 Pt—Tetracosactide(administered); am.s.(i.m.) = ? nmol substance ratio NPU10443 U—17-Hydroxycorticosteroid; am.s.(-1d - 0 d) = ? µmol 10-3 NPU10444 U—17-Hydroxycorticosteroid; am.s.(0-1 d) = ? µmol NPU14221 NPU10445 U—17-Hydroxycorticosteroid; am.s.(1-2 d) = ? µmol U—alpha-Hydroxy-beta-chito-gamma-aminobutyrate/Creatininium; subst.ratio = NPU10446 U—17-Hydroxycorticosteroid; am.s.(2-3 d) = ? µmol ? × 10-3 Urine— Urine— 17- alpha- Hydroxycorticosteroid; Hydroxy-beta-chito-gamma-aminobutyrate; amount-of-substance(1 day to 0 day before challenge) substance concentration micromol mol/litre NPU10443 NPU02418 U—17-Hydroxycorticosteroid; am.s.(-1d - 0 d) = ? µmol U—alpha-Hydroxy-beta-chito-gamma-aminobutyrate; subst.c.= ? prefix ? mol/l Urine— Plasma— 17- 3- Hydroxycorticosteroid; Hydroxybutyrate; amount-of-substance(0-1 day after challenge) substance concentration micromol millimol/litre NPU10444 NPU02424 U—17-Hydroxycorticosteroid; am.s.(0-1 d) = ? µmol P—3-Hydroxybutyrate; subst.c. = ? mmol/l Urine— Urine— 17- 4- Hydroxycorticosteroid; Hydroxybutyrate; amount-of-substance(1-2 days after challenge) substance concentration micromol millimol/litre NPU10445 NPU02425 U—17-Hydroxycorticosteroid; am.s.(1-2 d) = ? µmol U—4-Hydroxybutyrate; subst.c. = ? mmol/l Urine— Cerebrospinal fluid— 17- beta- Hydroxycorticosteroid; Hydroxybutyrate; amount-of-substance(2-3 days after challenge) substance concentration micromol millimol/litre NPU10446 NPU02426 U—17-Hydroxycorticosteroid; am.s.(2-3 d) = ? µmol Csf—beta-Hydroxybutyrate; subst.c. = ? mmol/l Patient(Urine)— Plasma— 17- beta- Hydroxycorticosteroid; Hydroxybutyrate; substance rate(procedure) substance concentration micromol/day millimol/litre NPU09094 NPU02427 Pt(U)—17-Hydroxycorticosteroid; subst.rate(proc.) = ? µmol/d P—beta-Hydroxybutyrate; subst.c. = ? mmol/l Urine— Plasma— 5- (24R)- Hydroxyindolylacetate; Hydroxycalcidiol; amount-of-substance(procedure) substance concentration micromol nanomol/litre NPU17541 M = 416,3 g/mol U—5-Hydroxyindolylacetate; am.s.(proc.) = ? µmol Authority: IUPAC-IUB81 NPU02428 Urine— P—(24R)-Hydroxycalcidiol; subst.c. = ? nmol/l 5- Hydroxyindolylacetate; Adrenal cortex— arbitrary concentration(procedure) 17- NPU10014 Hydroxycorticosteroid secretion; U—5-Hydroxyindolylacetate; arb.c.(proc.) = ? substance rate(dexamethasone, oral administration; list; procedure) Note: _M_ (dexamethasone) = 392,5 g/mol Urine— NPU10442 5- Adrenal cortex—17-Hydroxycorticosteroid secretion; subst.rate(dexamethasone Hydroxyindolylacetate; p.o.; list; proc.) substance concentration NPU09115 Pt—Dexamethasone(administered); number of doses = ? micromol/litre NPU09116 Pt—Dexamethasone(administered); time int.(between doses) = ? Other term(s): 5-HIAA min NPU02430 NPU10532 Pt—Dexamethasone(administered); am.s.(single dose p.o.) = ? U—5-Hydroxyindolylacetate; subst.c. = ? µmol/l µmol NPU10443 U—17-Hydroxycorticosteroid; am.s.(-1d - 0 d) = ? µmol Cerebrospinal fluid— NPU10444 U—17-Hydroxycorticosteroid; am.s.(0-1 d) = ? µmol 5- NPU10445 U—17-Hydroxycorticosteroid; am.s.(1-2 d) = ? µmol Hydroxyindolylacetate; NPU10446 U—17-Hydroxycorticosteroid; am.s.(2-3 d) = ? µmol substance concentration nanomol/litre Other term(s): 5-HIAA NPU02429 Csf—5-Hydroxyindolylacetate; subst.c. = ? nmol/l
91 Patient(Urine)— Plasma— 5- 17- Hydroxyindolylacetate; Hydroxyprogesterone; substance rate(procedure) substance concentration(0 minutes after challenge) micromol/day nanomol/litre Other term(s): 5-HIAA-excretion NPU04977 NPU03939 P—17-Hydroxyprogesterone; subst.c.(0 min) = ? nmol/l Pt(U)—5-Hydroxyindolylacetate; subst.rate(proc.) = ? µmol/d Plasma— Urine— 17- 3- Hydroxyprogesterone; Hydroxyisovalerate/Creatininium; substance concentration(30 minutes after challenge) substance ratio nanomol/litre 10-3 NPU04978 NPU14223 P—17-Hydroxyprogesterone; subst.c.(30 min) = ? nmol/l U—3-Hydroxyisovalerate/Creatininium; subst.ratio = ? × 10-3 Plasma— Urine— 17- 3- Hydroxyprogesterone; Hydroxyisovalerate; substance concentration substance concentration nanomol/litre mol/litre M = 330,47 g/mol NPU02431 Authority: IUPAC-IUB U—3-Hydroxyisovalerate; subst.c.= ? prefix ? mol/l NPU02460 P—17-Hydroxyprogesterone; subst.c. = ? nmol/l Urine— 3- Patient(Urine)— Hydroxykynurenine/Creatininium; Hydroxyproline(free); substance ratio substance rate(procedure) 10-3 micromol/day NPU14224 NPU02462 U—3-Hydroxykynurenine/Creatininium; subst.ratio = ? × 10-3 Pt(U)—Hydroxyproline(free); subst.rate(proc.) = ? µmol/d
Urine— Patient(Urine)— 3- Hydroxyproline(total); Hydroxykynurenine; substance rate(procedure) substance concentration micromol/day mol/litre NPU02466 M = 224,2 g/mol Pt(U)—Hydroxyproline(tot.); subst.rate(proc.) = ? µmol/d NPU02432 U—3-Hydroxykynurenine; subst.c.= ? prefix ? mol/l Urine— 3- Urine— Hydroxyproline/Creatininium; 5- substance ratio Hydroxylysine/Creatininium; 10-3 substance ratio NPU14228 10-3 U—3-Hydroxyproline/Creatininium; subst.ratio = ? × 10-3 NPU14225 U—5-Hydroxylysine/Creatininium; subst.ratio = ? × 10-3 Urine— 4- Plasma— Hydroxyproline/Creatininium; 5- substance ratio Hydroxylysine; 10-3 substance concentration NPU14226 micromol/litre U—4-Hydroxyproline/Creatininium; subst.ratio = ? × 10-3 M = 162,1 g/mol NPU02433 Urine— P—5-Hydroxylysine; subst.c. = ? µmol/l Hydroxyproline/Creatininium; substance ratio Urine— 10-3 5- NPU04210 Hydroxylysine; U—Hydroxyproline/Creatininium; subst.ratio= ? × 10-3 substance concentration micromol/litre Cerebrospinal fluid— M = 162,1 g/mol 3- NPU02434 Hydroxyproline; U—5-Hydroxylysine; subst.c. = ? µmol/l substance concentration micromol/litre Adrenal cortex— M = 131,13 g/mol 17- NPU09025 Hydroxyprogesterone secretion; Csf—3-Hydroxyproline; subst.c. = ? µmol/l substance rate(tetracosactide, intravenous administration; list; procedure) Plasma— Note: _M_ (tetracosactide) = 2 933,57 g/mol; _M_ (hydroxyprogesterone) = 3- 330,47 g/mol Hydroxyproline; NPU02461 substance concentration Adrenal cortex—17-Hydroxyprogesterone secretion; subst.rate(tetracosactide micromol/litre i.v.; list; proc.) M = 131,13 g/mol NPU10688 Pt—Tetracosactide(administered); am.s.(i.v.) = ? nmol NPU02463 NPU10689 Pt—Tetracosactide(administered); subst.cont.(i.v.; am.s./body P—3-Hydroxyproline; subst.c. = ? µmol/l mass) = ? nmol/kg NPU04977 P—17-Hydroxyprogesterone; subst.c.(0 min) = ? nmol/l Urine— NPU04978 P—17-Hydroxyprogesterone; subst.c.(30 min) = ? nmol/l 3- Hydroxyproline; substance concentration micromol/litre M = 131,13 g/mol NPU09024 U—3-Hydroxyproline; subst.c. = ? µmol/l
92 Cerebrospinal fluid— Cerebrospinal fluid— 4- Immunoglobulin A; Hydroxyproline; relative substance concentration(Cerebrospinal fluid/Plasma) substance concentration M = 160 000 g/mol micromol/litre Note: Calculated from: NPU09336 and NPU02476 M = 131,13 g/mol NPU09337 NPU09026 Csf—Immunoglobulin A; rel.subst.c.(Csf/P) = ? Csf—4-Hydroxyproline; subst.c. = ? µmol/l Cerebrospinal fluid— Plasma— Immunoglobulin A; 4- substance concentration Hydroxyproline; micromol/litre substance concentration M = 160 000 g/mol micromol/litre NPU09336 M = 131,13 g/mol Csf—Immunoglobulin A; subst.c. = ? µmol/l NPU02464 P—4-Hydroxyproline; subst.c. = ? µmol/l Plasma— Immunoglobulin A; Urine— substance concentration 4- micromol/litre Hydroxyproline; M = 160 000 g/mol substance concentration NPU02476 micromol/litre P—Immunoglobulin A; subst.c. = ? µmol/l M = 131,13 g/mol NPU02465 Saliva— U—4-Hydroxyproline; subst.c. = ? µmol/l Immunoglobulin A; substance concentration Plasma— micromol/litre L- M = 160 000 g/mol Iditol dehydrogenase; NPU02477 catalytic-activity concentration(37 °C; procedure) Saliva—Immunoglobulin A; subst.c. = ? µmol/l katal/litre Other term(s): Polyol dehydrogenase; Sorbitol dehydrogenase Plasma— NPU02469 Immunoglobulin D; P—L-Iditol dehydrogenase; cat.c.(37 °C; proc.)= ? prefix ? kat/l arbitrary substance concentration arbitrary unit/litre Amniotic fluid— M = 170 000 g/mol L- NPU14663 Iditol dehydrogenase; P—Immunoglobulin D; arb.subst.c. = ? arb.unit/l catalytic-activity concentration(37 °C; procedure) microkatal/litre Plasma— NPU03909 Immunoglobulin D; Amf—L-Iditol dehydrogenase; cat.c.(37 °C; proc.) = ? µkat/l substance concentration micromol/litre Plasma— M = 170 000 g/mol Immune complexes(C1q binding); NPU02479 arbitrary concentration(procedure) P—Immunoglobulin D; subst.c. = ? µmol/l Authority: ICW91 NPU02474 Central nervous system— P—Immune complexes(C1q bind.); arb.c.(proc.) = ? Immunoglobulin G production; arbitrary rate(procedure) Plasma— Other term(s): IgG Index Immunoglobulin A antibody(Immunoglobulin G); Note1: _M_(albumin) = 66 000 g/mol; _M_(immunglobulin G) = 160 000 g/mol arbitrary substance concentration(procedure) Note2: calculated from (a × d)/(b × c) 10³ arbitrary unit/litre a: [NPU01132] P—Albumin; subst.c. = ? µmol/l NPU14512 b: [NPU01130] Csf—Albumin; subst.c. = ? µmol/l P—Immunoglobulin A antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l c: [NPU02481] P—Immunoglobulin G; subst.c. = ? µmol/l d: [NPU04099] Csf—Immunoglobulin G; subst.c.= ? µmol/l Plasma— NPU02485 Immunoglobulin A antibody(Immunoglobulin M); Cns—Immunoglobulin G production; arb.rate(proc.) = ? arbitrary substance concentration(procedure) 10³ arbitrary unit/litre Central nervous system— NPU14513 Immunoglobulin G production; P—Immunoglobulin A antibody(IgM); arb.subst.c.(proc.) = ? × 10³ arb.unit/l property(list; procedure) NPU17072 Plasma— Cns—Immunoglobulin G production; prop.(list; proc.) Immunoglobulin A antibody; NPU02485 Cns—Immunoglobulin G production; arb.rate(proc.) = ? arbitrary substance concentration(list; procedure) NPU17076 Csf—Immunoglobulin oligocloni; arb.c.(proc.) = ? NPU17669 P—Immunoglobulin A antibody; arb.subst.c.(list; proc.) Plasma— NPU14512 P—Immunoglobulin A antibody(IgG); arb.subst.c.(proc.) = ? × 10³ Immunoglobulin G subclasses; arb.unit/l substance concentration(list; procedure) NPU14513 P—Immunoglobulin A antibody(IgM); arb.subst.c.(proc.) = ? × 10³ Note: _M _(IgG1) = 146 000; _M_(IgG2) =146 000; _M_(IgG3) = 170 000; arb.unit/l _M_(IgG4) = 146 000 g/mol NPU02486 Central nervous system— P—Immunoglobulin G subclasses; subst.c.(list; proc.) Immunoglobulin A production; NPU10500 P—Immunoglobulin G1; subst.c. = ? µmol/l arbitrary rate(procedure) NPU10501 P—Immunoglobulin G2; subst.c. = ? µmol/l NPU17680 NPU10502 P—Immunoglobulin G3; subst.c. = ? µmol/l Cns—Immunoglobulin A production; arb.rate(proc.) = ? NPU10503 P—Immunoglobulin G4; subst.c. = ? µmol/l
Plasma— Plasma— Immunoglobulin A; Immunoglobulin G subclasses; arbitrary concentration(procedure) taxon(procedure) NPU02478 NPU10608 P—Immunoglobulin A; arb.c.(proc.) = ? P—Immunoglobulin G subclasses; taxon(proc.) = ?
93 Cerebrospinal fluid— Central nervous system— Immunoglobulin G/Albumin; Immunoglobulin M production; relative substance ratio(Cerebrospinal fluid/Plasma) arbitrary rate(procedure) NPU04029 NPU17681 Csf—Immunoglobulin G/Albumin; rel.subst.ratio(Csf/P) = ? Cns—Immunoglobulin M production; arb.rate(proc.) = ?
Erythrocytes(Blood)— Cerebrospinal fluid— Immunoglobulin G; Immunoglobulin M; arbitrary entitic number(procedure) relative substance concentration(Cerebrospinal fluid/Plasma) M = 160 000 g/mol M = 950 000 g/mol Other term(s): IgG Note: Calculated from: NPU09338 and NPU02488 NPU04070 NPU09339 Ercs(B)—Immunoglobulin G; arb.entitic num.(proc.) = ? Csf—Immunoglobulin M; rel.subst.c.(Csf/P) = ?
Erythrocytes(Blood)— Cerebrospinal fluid— Immunoglobulin G; Immunoglobulin M; entitic number(procedure) substance concentration M = 160 000 g/mol micromol/litre Other term(s): IgG M = 950 000 g/mol NPU01948 NPU09338 Ercs(B)—Immunoglobulin G; entitic num.(proc.) = ? Csf—Immunoglobulin M; subst.c. = ? µmol/l
Cerebrospinal fluid— Plasma— Immunoglobulin G; Immunoglobulin M; relative substance concentration(Cerebrospinal fluid/Plasma) substance concentration M = 160 000 g/mol micromol/litre Note: Calculated from: NPU04099 and NPU2481 M = 950 000 g/mol NPU09335 NPU02488 Csf—Immunoglobulin G; rel.subst.c.(Csf/P) = ? P—Immunoglobulin M; subst.c. = ? µmol/l
Cerebrospinal fluid— Urine— Immunoglobulin G; Immunoglobulin M; substance concentration substance concentration micromol/litre micromol/litre M = 160 000 g/mol M = 950 000 g/mol NPU04099 NPU08573 Csf—Immunoglobulin G; subst.c.= ? µmol/l U—Immunoglobulin M; subst.c. = ? µmol/l
Plasma— Cerebrospinal fluid— Immunoglobulin G; Immunoglobulin oligocloni; substance concentration arbitrary concentration(procedure) micromol/litre NPU17076 M = 160 000 g/mol Csf—Immunoglobulin oligocloni; arb.c.(proc.) = ? NPU02481 P—Immunoglobulin G; subst.c. = ? µmol/l Plasma— Inhibin; Urine— substance concentration Immunoglobulin G; picomol/litre substance concentration M = 32 000 g/mol micromol/litre NPU02492 M = 160 000 g/mol P—Inhibin; subst.c. = ? pmol/l NPU04101 U—Immunoglobulin G; subst.c.= ? µmol/l Plasma— Insulin antibody(Immunoglobulin G); Plasma— arbitrary substance concentration(procedure) Immunoglobulin G1; arbitrary unit/litre substance concentration NPU12039 micromol/litre P—Insulin antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l M = 146 000 g/mol NPU10500 Plasma— P—Immunoglobulin G1; subst.c. = ? µmol/l Insulin antibody; arbitrary substance concentration(procedure) Plasma— 10³ arbitrary unit/litre Immunoglobulin G2; NPU14359 substance concentration P—Insulin antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l micromol/litre M = 146 000 g/mol NPU10501 P—Immunoglobulin G2; subst.c. = ? µmol/l
Plasma— Immunoglobulin G3; substance concentration micromol/litre M = 170 000 g/mol NPU10502 P—Immunoglobulin G3; subst.c. = ? µmol/l
Plasma— Immunoglobulin G4; substance concentration micromol/litre M = 146 000 g/mol NPU10503 P—Immunoglobulin G4; subst.c. = ? µmol/l
94 Pancreatic beta-cell— Pancreatic beta-cell— Insulin secretion; Insulin secretion; substance rate(glucagon, intramuscular administration; list; procedure) substance rate(tolbutamide, intravenous administration; list; procedure) Note: _M_ (glucagon) = 3 482,8 g/mol; _M_ (insulin) = 5 807,65 g/mol Note: _M_ (tolbutamide) = 270,34 g/mol; _M_ (insulin) = 5 807,65 g/mol NPU10663 NPU10468 Pancreatic beta-cell—Insulin secretion; subst.rate(glucagon i.m.; list; proc.) Pancreatic beta-cell—Insulin secretion; subst.rate(tolbutamide i.v.; list; proc.) NPU10662 Pt—Glucagon(administered); am.s.(i.m.) = ? nmol NPU10467 Pt—Tolbutamide(administered); am.s.(i.v.) = ? mmol NPU10690 Pt—Glucagon(administered); subst.cont.(i.m.; am.s./body mass) = ? NPU13487 Pt—Tolbutamide(administered); subst.cont.(i.v.; am.s./body mass) = nmol/kg ? µmol/kg NPU08715 P—Insulin; subst.c.(0 min) = ? pmol/l NPU08715 P—Insulin; subst.c.(0 min) = ? pmol/l NPU10656 P—Insulin; subst.c.(6 min) = ? pmol/l NPU08703 P—Insulin; subst.c.(30 min) = ? pmol/l NPU08702 P—Insulin; subst.c.(15 min) = ? pmol/l NPU08705 P—Insulin; subst.c.(60 min) = ? pmol/l NPU08705 P—Insulin; subst.c.(60 min) = ? pmol/l NPU08707 P—Insulin; subst.c.(90 min) = ? pmol/l NPU08707 P—Insulin; subst.c.(90 min) = ? pmol/l NPU08708 P—Insulin; subst.c.(120 min) = ? pmol/l NPU08708 P—Insulin; subst.c.(120 min) = ? pmol/l NPU10235 P—Insulin; subst.c.(150 min) = ? pmol/l NPU10657 P—Insulin; arb.subst.c.(IRP 66/304; 0 min; proc.) = ? × 10-3 int.unit/l NPU08709 P—Insulin; subst.c.(180 min) = ? pmol/l NPU10658 P—Insulin; arb.subst.c.(IRP 66/304; 6 min; proc.) = ? × 10-3 int.unit/l NPU10659 P—Insulin; arb.subst.c.(IRP 66/304; 15 min; proc.) = ? × 10-3 Patient— int.unit/l Insulin(administered); NPU10660 P—Insulin; arb.subst.c.(IRP 66/304; 60 min; proc.) = ? × 10-3 arbitrary substance content(intravenous administration; arbitrary amount- int.unit/l of-substance/body m; procedure) NPU10692 P—Insulin; arb.subst.c.(IRP 66/304; 90 min; proc.) = ? × 10-3 international unit/kilogram int.unit/l M = 5 807,65 g/mol NPU10661 P—Insulin; arb.subst.c.(IRP 66/304; 120 min; proc.) = ? × 10-3 NPU10548 int.unit/l Pt—Insulin(administered); arb.subst.cont.(i.v.; arb.am.s./body mass; proc.) = ? NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l int. unit/kg NPU10655 B—Glucose; subst.c.(6 min) = ? mmol/l NPU08516 B—Glucose; subst.c.(15 min) = ? mmol/l Patient— NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l Insulin(administered); NPU08506 B—Glucose; subst.c.(90 min) = ? mmol/l substance content(intravenous administration; amount-of- NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l substance/body mass) micromol/kilogram Pancreatic beta-cell— M = 5 807,65 g/mol Insulin secretion; NPU10547 substance rate(glucose, oral administration; list; procedure) Pt—Insulin(administered); subst.cont.(i.v.; am.s./body mass) = ? µmol/kg Note: _M_ (glucose) = 180,16 g/mol; _M_ (insulin) = 5 807,65 g/mol NPU10471 Plasma— Pancreatic beta-cell—Insulin secretion; subst.rate(glucose p.o.; list; proc.) Insulin; NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol arbitrary substance concentration(IRP 66/304; 0 minutes after challenge; NPU08715 P—Insulin; subst.c.(0 min) = ? pmol/l procedure) NPU08703 P—Insulin; subst.c.(30 min) = ? pmol/l 10-3 international unit/litre NPU08705 P—Insulin; subst.c.(60 min) = ? pmol/l NPU10657 NPU08708 P—Insulin; subst.c.(120 min) = ? pmol/l P—Insulin; arb.subst.c.(IRP 66/304; 0 min; proc.) = ? × 10-3 int.unit/l NPU08709 P—Insulin; subst.c.(180 min) = ? pmol/l NPU10469 P—Insulin; subst.c.(240 min) = ? pmol/l Plasma— NPU10470 P—Insulin; subst.c.(300 min) = ? pmol/l Insulin; NPU08710 P—Insulin; subst.c.(360 min) = ? pmol/l arbitrary substance concentration(IRP 66/304; 120 minutes after NPU08756 P—Insulin; subst.c.(max.; proc.) = ? pmol/l challenge; procedure) 10-3 international unit/litre Pancreatic beta-cell— NPU10661 Insulin secretion; P—Insulin; arb.subst.c.(IRP 66/304; 120 min; proc.) = ? × 10-3 int.unit/l substance rate(leucine, oral administration; list; procedure) Note: _M_ (leucine) = 131,17 g/mol; _M_ (insulin) = 5 807,65 g/mol Plasma— NPU02591 Insulin; Pancreatic beta-cell—Insulin secretion; subst.rate(leucine p.o.; list; proc.) arbitrary substance concentration(IRP 66/304; 15 minutes after challenge; NPU10598 Pt—Leucine(administered); am.s.(p.o.) = ? mmol procedure) NPU10599 Pt—Leucine(administered); subst.cont.(p.o.; am.s./body mass) = ? 10-3 international unit/litre mmol/kg NPU10659 NPU08715 P—Insulin; subst.c.(0 min) = ? pmol/l P—Insulin; arb.subst.c.(IRP 66/304; 15 min; proc.) = ? × 10-3 int.unit/l NPU08702 P—Insulin; subst.c.(15 min) = ? pmol/l NPU08703 P—Insulin; subst.c.(30 min) = ? pmol/l Plasma— NPU08704 P—Insulin; subst.c.(45 min) = ? pmol/l Insulin; NPU08705 P—Insulin; subst.c.(60 min) = ? pmol/l arbitrary substance concentration(IRP 66/304; 6 minutes after challenge; NPU08706 P—Insulin; subst.c.(75 min) = ? pmol/l procedure) NPU08707 P—Insulin; subst.c.(90 min) = ? pmol/l 10-3 international unit/litre NPU08708 P—Insulin; subst.c.(120 min) = ? pmol/l NPU10658 NPU08709 P—Insulin; subst.c.(180 min) = ? pmol/l P—Insulin; arb.subst.c.(IRP 66/304; 6 min; proc.) = ? × 10-3 int.unit/l NPU08710 P—Insulin; subst.c.(360 min) = ? pmol/l NPU08756 P—Insulin; subst.c.(max.; proc.) = ? pmol/l Plasma— NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l Insulin; NPU04186 P—Glucose; subst.c.(15 min) = ? mmol/l arbitrary substance concentration(IRP 66/304; 60 minutes after challenge; NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l procedure) NPU04187 P—Glucose; subst.c.(45 min) = ? mmol/l 10-3 international unit/litre NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l NPU10660 NPU04965 P—Glucose; subst.c.(75 min) = ? mmol/l P—Insulin; arb.subst.c.(IRP 66/304; 60 min; proc.) = ? × 10-3 int.unit/l NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l Plasma— NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l Insulin; NPU04185 P—Glucose; subst.c.(360 min) = ? mmol/l arbitrary substance concentration(IRP 66/304; 90 minutes after challenge; NPU04981 P—Glucose; subst.c.(min.; proc.) = ? mmol/l procedure) 10-3 international unit/litre NPU10692 P—Insulin; arb.subst.c.(IRP 66/304; 90 min; proc.) = ? × 10-3 int.unit/l
Plasma— Insulin; arbitrary substance concentration(IRP 66/304; procedure) 10-3 international unit/litre NPU02496 P—Insulin; arb.subst.c.(IRP 66/304; proc.) = ? × 10-3 int.unit/l
95 Plasma— Plasma— Insulin; Insulin; substance concentration(300 minutes after challenge) substance concentration(0 minutes after challenge) picomol/litre picomol/litre NPU10470 NPU08715 P—Insulin; subst.c.(300 min) = ? pmol/l P—Insulin; subst.c.(0 min) = ? pmol/l Plasma— Plasma— Insulin; Insulin; substance concentration(360 minutes after challenge) substance concentration(6 minutes after challenge) picomol/litre picomol/litre NPU08710 NPU10656 P—Insulin; subst.c.(360 min) = ? pmol/l P—Insulin; subst.c.(6 min) = ? pmol/l Plasma— Plasma— Insulin; Insulin; substance concentration(maximum; procedure) substance concentration(15 minutes after challenge) picomol/litre picomol/litre NPU08756 NPU08702 P—Insulin; subst.c.(max.; proc.) = ? pmol/l P—Insulin; subst.c.(15 min) = ? pmol/l Plasma— Plasma— Insulin; Insulin; substance concentration increment(maximum concentration minus 0 substance concentration(30 minutes after challenge) minutes concentration) picomol/litre picomol/litre NPU08703 NPU04979 P—Insulin; subst.c.(30 min) = ? pmol/l P—Insulin; subst.c.incr.(max. c. minus 0 min c.) = ? pmol/l
Plasma— Plasma(fasting Patient)— Insulin; Insulin; substance concentration(45 minutes challenge) substance concentration picomol/litre picomol/litre NPU08704 M = 5 807,65 g/mol P—Insulin; subst.c.(45 min) = ? pmol/l Authority: IUPAC-IUB 74 NPU02497 Plasma— P(fPt)—Insulin; subst.c. = ? pmol/l Insulin; substance concentration(60 minutes after challenge) Plasma— picomol/litre Insulin-like growth factor I; NPU08705 arbitrary substance concentration(IRR 87/518; procedure) P—Insulin; subst.c.(60 min) = ? pmol/l international unit/litre M = 7 649 g/mol Plasma— Recommended calibrator: WHO 1st IRR 87/518 Insulin; Other term(s): Somatomedin C substance concentration(75 minutes after challenge) NPU02498 picomol/litre P—Insulin-like growth factor I; arb.subst.c.(IRR 87/518; proc.) = ? int. unit/l NPU08706 P—Insulin; subst.c.(75 min) = ? pmol/l Plasma— Insulin-like growth factor I; Plasma— substance concentration Insulin; nanomol/litre substance concentration(90 minutes after challenge) M = 7 649 g/mol picomol/litre Other term(s): Somatomedin C NPU08707 NPU02499 P—Insulin; subst.c.(90 min) = ? pmol/l P—Insulin-like growth factor I; subst.c. = ? nmol/l
Plasma— Plasma— Insulin; Insulin-like growth factor II; substance concentration(120 minutes after challenge) substance concentration picomol/litre nanomol/litre NPU08708 M = 7 471 g/mol P—Insulin; subst.c.(120 min) = ? pmol/l Other term(s): Somatomedin MSA NPU02500 Plasma— P—Insulin-like growth factor II; subst.c. = ? nmol/l Insulin; substance concentration(150 minutes after challenge) Plasma— picomol/litre Insulinlike growthfactor-binding protein 3; NPU10235 substance concentration P—Insulin; subst.c.(150 min) = ? pmol/l nanomol/litre NPU10381 Plasma— P—Insulinlike growthfactor-binding protein 3; subst.c. = ? nmol/l Insulin; substance concentration(180 minutes after challenge) Plasma— picomol/litre Inter alpha inhibitor; NPU08709 substance concentration P—Insulin; subst.c.(180 min) = ? pmol/l mol/litre NPU02501 Plasma— P—Inter alpha inhibitor; subst.c.= ? prefix ? mol/l Insulin; substance concentration(240 minutes after challenge) Plasma— picomol/litre Interferon beta antibody; NPU10469 arbitrary substance concentration(procedure) P—Insulin; subst.c.(240 min) = ? pmol/l arbitrary unit/litre NPU12890 P—Interferon beta antibody; arb.subst.c.(proc.) = ? arb.unit/l
96 Plasma— Plasma— Interferon; Iron binding capacity(Fe; free); arbitrary substance concentration(procedure) substance concentration arbitrary unit/litre micromol/litre M = 20 000 g/mol NPU04132 NPU09121 P—Iron binding capacity(Fe; free); subst.c.= ? µmol/l P—Interferon; arb.subst.c.(proc.) = ? arb.unit/l Plasma— Plasma— Iron binding capacity(total); Interferon; substance concentration substance concentration micromol/litre mol/litre Other term(s): TIBC M = 20 000 g/mol NPU04133 NPU09120 P—Iron binding capacity(tot.); subst.c.= ? µmol/l P—Interferon; subst.c.= ? prefix ? mol/l Patient(Plasma)— Plasma— Iron elimination; Intrinsic factor antibody; half-life(procedure) arbitrary concentration(procedure) minute NPU02503 NPU04192 P—Intrinsic factor antibody; arb.c.(proc.) = ? Pt(P)—Iron elimination; half-life(proc.)= ? min
Patient— Patient(Plasma)— Intrinsic factor secretion; Iron turnover; substance rate(pentagastrin, subcutaneous administration; list; substance rate procedure) micromol/day Note: _M_ (intrinsic factor) = 50 000 g/mol; _M_ (pentagastrin) = 767,9 g/mol NPU04193 NPU14031 Pt(P)—Iron turnover; subst.rate= ? µmol/d Pt—Intrinsic factor secretion; subst.rate(pentagastrin s.c.; list; proc.) NPU10477 Pt—Pentagastrin(administered); subst.cont.(i.v.; am.s./body mass) = Plasma— ? nmol/kg Iron; NPU14032 Stomf—Intrinsic factor; am.s.(0-60 min) = ? nmol substance concentration NPU14033 Stomf—Intrinsic factor; am.s.(60-120 min) = ? nmol micromol/litre NPU14034 Stomf—Intrinsic factor; am.s.(120-180 min) = ? nmol M = 55,85 g/mol Authority: IUPAC/VII-C-TOX Stomach fluid— NPU02508 Intrinsic factor; P—Iron; subst.c. = ? µmol/l amount-of-substance(0-60 minutes after challenge) nanomol Plasma(fasting Patient)— NPU14032 Iron; Stomf—Intrinsic factor; am.s.(0-60 min) = ? nmol substance concentration micromol/litre Stomach fluid— M = 55,85 g/mol Intrinsic factor; Authority: IUPAC/VII-C-TOX amount-of-substance(60-120 minutes after challenge) NPU10153 nanomol P(fPt)—Iron; subst.c. = ? µmol/l NPU14033 Stomf—Intrinsic factor; am.s.(60-120 min) = ? nmol Urine— Iron; Stomach fluid— substance concentration Intrinsic factor; micromol/litre amount-of-substance(120-180 minutes after challenge) M = 55,85 g/mol nanomol Authority: IUPAC/VII-C-TOX NPU14034 NPU03940 Stomf—Intrinsic factor; am.s.(120-180 min) = ? nmol U—Iron; subst.c. = ? µmol/l
Stomach fluid— Hair— Intrinsic factor; Iron; amount-of-substance(procedure) substance content nanomol micromol/kilogram Note: _M_ (intrinsic factor) = 50 000 g/mol; _M_ (pentagastrin) = ? g/mol M = 55,85 g/mol NPU02504 Authority: IUPAC/VII-C-TOX Stomf—Intrinsic factor; am.s.(proc.) = ? nmol NPU02506 Hair—Iron; subst.cont. = ? µmol/kg Stomach fluid— Intrinsic factor; Transferrin(Fe-binding sites; Plasma)— substance concentration Iron; nanomol/litre substance fraction M = 50 000 g/mol NPU04191 NPU02502 Transferrin(Fe-binding sites; P)—Iron; subst.fr.= ? Stomf—Intrinsic factor; subst.c. = ? nmol/l Patient(Urine)— Urine— Iron; Iodine; substance rate(procedure) substance concentration micromol/day micromol/litre M = 55,85 g/mol M = 126,90 g/mol Authority: IUPAC/VII-C-TOX Authority: IUPAC/VII-C-TOX NPU02507 NPU04884 Pt(U)—Iron; subst.rate(proc.) = ? µmol/d U—Iodine; subst.c. = ? µmol/l Urine— Patient(Urine)— Isoleucine/Creatininium; Iodine; substance ratio substance rate(procedure) 10-3 micromol/day NPU14229 M = 126,90 g/mol U—Isoleucine/Creatininium; subst.ratio = ? × 10-3 Authority: IUPAC/VII-C-TOX NPU02505 Pt(U)—Iodine; subst.rate(proc.) = ? µmol/d
97 Cerebrospinal fluid— Urine— Isoleucine; Kynurenine; substance concentration substance concentration micromol/litre mol/litre M = 131,17 g/mol M = 208,2 g/mol NPU09027 NPU02537 Csf—Isoleucine; subst.c. = ? µmol/l U—Kynurenine; subst.c.= ? prefix ? mol/l
Plasma— Plasma— Isoleucine; Lactate dehydrogenase H2M2; substance concentration catalytic-activity concentration(37 °C; procedure) micromol/litre microkatal/litre M = 131,17 g/mol Other term(s): LDH-3 NPU02510 Note: H(eart); M(uscle) P—Isoleucine; subst.c. = ? µmol/l NPU04104 P—Lactate dehydrogenase H2M2; cat.c.(37 °C; proc.)= ? µkat/l Urine— Isoleucine; Lactate dehydrogenase(Plasma)— substance concentration Lactate dehydrogenase H2M2; micromol/litre catalytic-activity fraction(37 °C; procedure) M = 131,17 g/mol Other term(s): LDH-3 NPU02511 Note: H(eart); M(uscle) U—Isoleucine; subst.c. = ? µmol/l NPU04109 LDH(P)—Lactate dehydrogenase H2M2; cat.fr.(37 °C; proc.)= ? Urine— Kappa chain(Ig); Plasma— arbitrary concentration(procedure) Lactate dehydrogenase H3M; NPU04095 catalytic-activity concentration(37 °C; procedure) U—Kappa chain(Ig); arb.c.(proc.)= ? microkatal/litre Other term(s): LDH-2 Plasma— Note: H(eart); M(uscle) Kappa chain(Ig); NPU04103 substance concentration P—Lactate dehydrogenase H3M; cat.c.(37 °C; proc.)= ? µkat/l micromol/litre NPU08634 Lactate dehydrogenase(Plasma)— P—Kappa chain(Ig); subst.c.=? µmol/l Lactate dehydrogenase H3M; catalytic-activity fraction(37 °C; procedure) Urine— Other term(s): LDH-2 Kappa chain(Ig); Note: H(eart); M(uscle) substance concentration NPU04108 micromol/litre LDH(P)—Lactate dehydrogenase H3M; cat.fr.(37 °C; proc.)= ? NPU04096 U—Kappa chain(Ig); subst.c.=? µmol/l Plasma— Lactate dehydrogenase H4; Urine— catalytic-activity concentration(37 °C; procedure) Keratan sulfate; microkatal/litre substance concentration Other term(s): LDH-1 mol/litre Note: H(eart); M(uscle) Authority: IUPAC-IUB85 NPU04102 NPU02521 P—Lactate dehydrogenase H4; cat.c.(37 °C; proc.)= ? µkat/l U—Keratan sulfate; subst.c.= ? prefix ? mol/l Lactate dehydrogenase(Plasma)— Plasma— Lactate dehydrogenase H4; Keratine antibody(Immunoglobulin G); catalytic-activity fraction(37 °C; procedure) arbitrary concentration(procedure) Other term(s): LDH-1 NPU12540 NPU04107 P—Keratine antibody(IgG); arb.c.(proc.) = ? LDH(P)—Lactate dehydrogenase H4; cat.fr.(37 °C; proc.)= ?
Plasma— Plasma— Keratine antibody(Immunoglobulin G); Lactate dehydrogenase HM3; arbitrary substance concentration(procedure) catalytic-activity concentration(37 °C; procedure) 10³ arbitrary unit/litre microkatal/litre NPU16399 Other term(s): LDH-4 P—Keratine antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Note: H(eart); M(uscle) NPU04105 Plasma— P—Lactate dehydrogenase HM3; cat.c.(37 °C; proc.)= ? µkat/l Keratine antibody; arbitrary concentration(procedure) Lactate dehydrogenase(Plasma)— NPU02522 Lactate dehydrogenase HM3; P—Keratine antibody; arb.c.(proc.) = ? catalytic-activity fraction(37 °C; procedure) Other term(s): LDH-4 Plasma— Note: H(eart); M(uscle) Kidney+liver microsom antibody(Immunoglobulin G); NPU04110 arbitrary concentration(procedure) LDH(P)—Lactate dehydrogenase HM3; cat.fr.(37 °C; proc.)= ? NPU12997 P—Kidney+liver microsom antibody(IgG); arb.c.(proc.) = ? Plasma— Lactate dehydrogenase M4; Urine— catalytic-activity concentration(37 °C; procedure) Kynurenine/Creatininium; microkatal/litre substance ratio Other term(s): LDH-5 10-3 Note: H(eart); M(uscle) NPU14230 NPU04106 U—Kynurenine/Creatininium; subst.ratio = ? × 10-3 P—Lactate dehydrogenase M4; cat.c.(37 °C; proc.)= ? µkat/l
98 Lactate dehydrogenase(Plasma)— Plasma(arterial Blood)— Lactate dehydrogenase M4; Lactate; catalytic-activity fraction(37 °C; procedure) substance concentration Other term(s): LDH-5 millimol/litre Note: H(eart); M(uscle) NPU03943 NPU04111 P(aB)—Lactate; subst.c. = ? mmol/l LDH(P)—Lactate dehydrogenase M4; cat.fr.(37 °C; proc.)= ? Plasma(venous Blood)— Plasma— Lactate; Lactate dehydrogenase type; substance concentration catalytic-activity concentration(list; 37 °C; procedure) millimol/litre Other term(s): H4 formerly coded LD1 (from anode) or LD5 (from side of NPU03944 application) P(vB)—Lactate; subst.c. = ? mmol/l Note: H(eart); M(uscle) NPU02547 Urine— P—Lactate dehydrogenase type; cat.c.(list; 37 °C; proc.) Lactate; NPU02546 P—Lactate dehydrogenase; cat.c.(37 °C; proc.) = ? µkat/l substance concentration NPU04102 P—Lactate dehydrogenase H4; cat.c.(37 °C; proc.)= ? µkat/l millimol/litre NPU04103 P—Lactate dehydrogenase H3M; cat.c.(37 °C; proc.)= ? µkat/l NPU10757 NPU04104 P—Lactate dehydrogenase H2M2; cat.c.(37 °C; proc.)= ? µkat/l U—Lactate; subst.c. = ? mmol/l NPU04105 P—Lactate dehydrogenase HM3; cat.c.(37 °C; proc.)= ? µkat/l NPU04106 P—Lactate dehydrogenase M4; cat.c.(37 °C; proc.)= ? µkat/l Patient(Urine)— Lactate; Lactate dehydrogenase(Plasma)— substance rate(procedure) Lactate dehydrogenase type; micromol/day catalytic-activity fraction(list; 37 °C; procedure) NPU17793 Other term(s): H4 formerly coded LD1 (from anode) or LD5 (from side of Pt(U)—Lactate; subst.rate(proc.) = ? µmol/d application) Note: H(eart); M(uscle) Plasma— NPU02822 Lactescence; LDH(P)—Lactate dehydrogenase type; cat.fr.(list; 37 °C; proc.) arbitrary concentration(procedure) NPU04107 LDH(P)—Lactate dehydrogenase H4; cat.fr.(37 °C; proc.)= ? NPU17021 NPU04108 LDH(P)—Lactate dehydrogenase H3M; cat.fr.(37 °C; proc.)= ? P—Lactescence; arb.c.(proc.)= ? NPU04109 LDH(P)—Lactate dehydrogenase H2M2; cat.fr.(37 °C; proc.)= ? NPU04110 LDH(P)—Lactate dehydrogenase HM3; cat.fr.(37 °C; proc.)= ? Plasma(fasting Patient)— NPU04111 LDH(P)—Lactate dehydrogenase M4; cat.fr.(37 °C; proc.)= ? Lactescence; arbitrary concentration(procedure) Amniotic fluid— NPU04194 Lactate dehydrogenase; P(fPt)—Lactescence; arb.c.(proc.)= ? catalytic-activity concentration(37 °C; procedure) microkatal/litre Plasma— NPU03910 Lactoferrin antibody(Immunoglobulin G); Amf—Lactate dehydrogenase; cat.c.(37 °C; proc.) = ? µkat/l arbitrary concentration(procedure) NPU12577 Plasma— P—Lactoferrin antibody(IgG); arb.c.(proc.) = ? Lactate dehydrogenase; catalytic-activity concentration(37 °C; procedure) microkatal/litre Other term(s): Lactic acid dehydrogenase NPU02546 P—Lactate dehydrogenase; cat.c.(37 °C; proc.) = ? µkat/l
System(specification)— Lactate dehydrogenase; catalytic-activity concentration(37 °C; procedure) microkatal/litre NPU10124 Syst(spec.)—Lactate dehydrogenase; cat.c.(37 °C; proc.) = ? µkat/l
Plasma(fasting Patient)— Lactate; substance concentration micromol/litre NPU17791 P(fPt)—Lactate; subst.c. = ? µmol/l
Blood(arterial Blood)— Lactate; substance concentration millimol/litre NPU02544 B(aB)—Lactate; subst.c. = ? mmol/l
Blood(venous Blood)— Lactate; substance concentration millimol/litre NPU03942 B(vB)—Lactate; subst.c. = ? mmol/l
Cerebrospinal fluid— Lactate; substance concentration millimol/litre NPU02545 Csf—Lactate; subst.c. = ? mmol/l
99 Intestine, small— Blood— Lactose tolerance; Lactose; property(lactose, oral administration; list; procedure) substance concentration(120 minutes after challenge) Note: _M_ (lactose) = 342,30 g/mol millimol/litre NPU02542 NPU10466 Intest., small—Lactose tolerance; prop.(lactose p.o.; list; proc.) B—Lactose; subst.c.(120 min) = ? mmol/l NPU10576 Pt—Lactose(administered); am.s.(p.o.) = ? mmol NPU10577 Pt—Lactose(administered); subst.cont.(p.o.; am.s./body mass) = ? Urine— mmol/kg Lambda chain(Ig); NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l arbitrary concentration(procedure) NPU08516 B—Glucose; subst.c.(15 min) = ? mmol/l NPU04097 NPU08504 B—Glucose; subst.c.(30 min) = ? mmol/l U—Lambda chain(Ig); arb.c.(proc.) = ? NPU08517 B—Glucose; subst.c.(45 min) = ? mmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l Plasma— NPU08518 B—Glucose; subst.c.(75 min) = ? mmol/l Lambda chain(Ig); NPU08506 B—Glucose; subst.c.(90 min) = ? mmol/l substance concentration NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l micromol/litre NPU08500 B—Glucose; subst.c.(180 min) = ? mmol/l NPU08636 NPU08515 B—Glucose; subst.c.(360 min) = ? mmol/l P—Lambda chain(Ig); subst.c.=? µmol/l NPU08502 B—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l NPU10463 B—Lactose; subst.c.(0 min) = ? mmol/l Urine— NPU10464 B—Lactose; subst.c.(30 min) = ? mmol/l Lambda chain(Ig); NPU10465 B—Lactose; subst.c.(60 min) = ? mmol/l substance concentration NPU10466 B—Lactose; subst.c.(120 min) = ? mmol/l micromol/litre NPU10047 B(cB)—Glucose; subst.c.(0 min) = ? mmol/l NPU04098 NPU10059 B(cB)—Glucose; subst.c.(15 min) = ? mmol/l U—Lambda chain(Ig); subst.c.=? µmol/l NPU10048 B(cB)—Glucose; subst.c.(30 min) = ? mmol/l NPU10060 B(cB)—Glucose; subst.c.(45 min) = ? mmol/l Blood— NPU10045 B(cB)—Glucose; subst.c.(60 min) = ? mmol/l Large unstained cells; NPU10050 B(cB)—Glucose; subst.c.(90 min) = ? mmol/l number concentration NPU10051 B(cB)—Glucose; subst.c.(120 min) = ? mmol/l 109/litre NPU10044 B(cB)—Glucose; subst.c.(180 min) = ? mmol/l NPU14267 NPU10058 B(cB)—Glucose; subst.c.(360 min) = ? mmol/l B—Large unstained cells; num.c. = ? × 109/l NPU10046 B(cB)—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l Blood fraction(specification)— NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l Large unstained cells; NPU04186 P—Glucose; subst.c.(15 min) = ? mmol/l number concentration NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l 109/litre NPU04187 P—Glucose; subst.c.(45 min) = ? mmol/l NPU17617 NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l B fract.(spec.)—Large unstained cells; num.c. = ? × 109/l NPU04965 P—Glucose; subst.c.(75 min) = ? mmol/l NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l Leukocytes(Blood)— NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l Large unstained cells; NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l number fraction NPU04185 P—Glucose; subst.c.(360 min) = ? mmol/l NPU04153 NPU03841 P—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l Lkcs(B)—Large unstained cells; num.fr. = ? NPU10581 U—Glucose; subst.c.(30 min) = ? mmol/l NPU08769 U—Glucose; subst.c.(60 min) = ? mmol/l Blood— NPU08770 U—Glucose; subst.c.(120 min) = ? mmol/l Lead; NPU14908 Pt—Stomach pain; prop.(proc.) = ? substance concentration micromol/litre Patient— M = 207,2 g/mol Lactose(administered); Authority: IUPAC VII/C-TOX amount-of-substance(oral administration) NPU02572 millimol B—Lead; subst.c. = ? µmol/l M = 342,30 g/mol NPU10576 Plasma— Pt—Lactose(administered); am.s.(p.o.) = ? mmol Lead; substance concentration Patient— micromol/litre Lactose(administered); M = 207,2 g/mol substance content(oral administration; amount-of-substance/body mass) Authority: IUPAC/VII-C-TOX millimol/kilogram NPU04887 M = 342,30 g/mol P—Lead; subst.c. = ? µmol/l NPU10577 Pt—Lactose(administered); subst.cont.(p.o.; am.s./body mass) = ? mmol/kg Urine— Lead; Blood— substance concentration Lactose; micromol/litre substance concentration(0 minutes after challenge) M = 207,2 g/mol millimol/litre Authority: IUPAC/VII-C-TOX NPU10463 NPU02575 B—Lactose; subst.c.(0 min) = ? mmol/l U—Lead; subst.c. = ? µmol/l
Blood— Cells(Blood)— Lactose; Lead; substance concentration(30 minutes after challenge) substance content millimol/litre micromol/kilogram NPU10464 M = 207,2 g/mol B—Lactose; subst.c.(30 min) = ? mmol/l Authority: IUPAC/VII-C-TOX NPU02573 Blood— Cells(B)—Lead; subst.cont. = ? µmol/kg Lactose; substance concentration(60 minutes after challenge) millimol/litre NPU10465 B—Lactose; subst.c.(60 min) = ? mmol/l
100 Hair— Blood— Lead; Leukocyte type; substance content number concentration(list; microscopic; procedure) micromol/kilogram NPU17580 M = 207,2 g/mol B—Leukocyte type; num.c.(list; micr.; proc.) Authority: IUPAC VII/C-TOX NPU01349 B—Basophilocytes; num.c. = ? × 109/l NPU02574 NPU17562 B—Eosinophilocytes; num.c.(micr.) = ? × 109/l Hair—Lead; subst.cont. = ? µmol/kg NPU04690 B—Erythroblasts(basophil); num.c. = ? × 109/l NPU04692 B—Erythroblasts(orthochrome); num.c. = ? × 109/l Patient(Urine)— NPU04695 B—Erythroblasts(polychrome); num.c. = ? × 109/l Lead; NPU01943 B—Erythroblasts; num.c. = ? × 109/l substance rate NPU14360 B—Leukocytes(Auer bodies); num.c. = ? × 109/l micromol/day NPU14367 B—Leukocytes(Pelger-Huët); num.c. = ? × 109/l M = 207,2 g/mol NPU17053 B—Leukocytes(unspecified); num.c. = ? × 109/l Authority: IUPAC/VII-C-TOX NPU02593 B—Leukocytes; num.c. = ? × 109/l NPU10288 NPU04996 B—Lymphoblasts; num.c. = ? × 109/l Pt(U)—Lead; subst.rate = ? µmol/d NPU02636 B—Lymphocytes; num.c. = ? × 109/l NPU14345 B—Megaloblasts; num.c. = ? × 109/l Patient— NPU03978 B—Metamyelocytes; num.c. = ? × 109/l Leucine(administered); NPU02840 B—Monocytes; num.c. = ? × 109/l amount-of-substance(oral administration) NPU03970 B—Myeloblasts; num.c. = ? × 109/l millimol NPU04704 B—Myelocytes(eosinophil); num.c. = ? × 109/l M = 131,17 g/mol NPU04706 B—Myelocytes(neutrophil); num.c. = ? × 109/l Other term(s): L-Leucine NPU03976 B—Myelocytes; num.c. = ? × 109/l NPU10598 NPU03982 B—Neutrophilocytes(segmented); num.c. = ? × 109/l Pt—Leucine(administered); am.s.(p.o.) = ? mmol NPU03980 B—Neutrophilocytes(band); num.c. = ? × 109/l NPU02902 B—Neutrophilocytes; num.c. = ? × 109/l Patient— NPU17597 B—Naked nuclei; num.c. = ? × 109/l Leucine(administered); NPU04708 B—Plasmocytes; num.c. = ? × 109/l substance content(oral administration; amount-of-substance/body mass) NPU03974 B—Promyelocytes; num.c. = ? × 109/l millimol/kilogram NPU03972 B—Blast cells; num.c. = ? × 109/l M = 131,17 g/mol NPU14267 B—Large unstained cells; num.c. = ? × 109/l Other term(s): L-Leucine NPU08686 B—Virocytes; num.c. = ? × 109/l NPU10599 Pt—Leucine(administered); subst.cont.(p.o.; am.s./body mass) = ? mmol/kg Blood fraction(specification)— Leukocyte type; Urine— number concentration(list; procedure) Leucine/Creatininium; NPU17596 substance ratio B fract.(spec.)—Leukocyte type; num.c.(list; proc.) 10-3 NPU17547 B fract.(spec.)—Basophilocytes; num.c. = ? × 109/l NPU14231 NPU17561 B fract.(spec.)—Eosinophilocytes; num.c. = ? × 109/l U—Leucine/Creatininium; subst.ratio = ? × 10-3 NPU17598 B fract.(spec.)—Erythroblasts(basophil); num.c. = ? × 109/l NPU17599 B fract.(spec.)—Erythroblasts(orthochrome); num.c. = ? × 109/l Cerebrospinal fluid— NPU17600 B fract.(spec.)—Erythroblasts(polychrome); num.c. = ? × 109/l Leucine; NPU17601 B fract.(spec.)—Erythroblasts; num.c. = ? × 109/l substance concentration NPU17602 B fract.(spec.)—Leukocytes(Auer bodies); num.c. = ? × 109/l micromol/litre NPU17603 B fract.(spec.)—Leukocytes(Pelger-Huët); num.c. = ? × 109/l M = 131,17 g/mol NPU17604 B fract.(spec.)—Leukocytes(unspecified); num.c. = ? × 109/l NPU09028 NPU17578 B fract.(spec.)—Leukocytes; num.c. = ? × 109/l Csf—Leucine; subst.c. = ? µmol/l NPU17605 B fract.(spec.)—Lymphoblasts; num.c. = ? × 109/l NPU17581 B fract.(spec.)—Lymphocytes; num.c. = ? × 109/l Plasma— NPU17606 B fract.(spec.)—Megaloblasts; num.c. = ? × 109/l Leucine; NPU17607 B fract.(spec.)—Metamyelocytes; num.c. = ? × 109/l substance concentration NPU17582 B fract.(spec.)—Monocytes; num.c. = ? × 109/l micromol/litre NPU17608 B fract.(spec.)—Myeloblasts; num.c. = ? × 109/l M = 131,17 g/mol NPU17609 B fract.(spec.)—Myelocytes(eosinophil); num.c. = ? × 109/l NPU02589 NPU17610 B fract.(spec.)—Myelocytes(neutrophil); num.c. = ? × 109/l P—Leucine; subst.c. = ? µmol/l NPU17611 B fract.(spec.)—Myelocytes; num.c. = ? × 109/l NPU17612 B fract.(spec.)—Neutrophilocytes(segmented); num.c. = ? × 109/l Urine— NPU17613 B fract.(spec.)—Neutrophilocytes(band); num.c. = ? × 109/l Leucine; NPU17584 B fract.(spec.)—Neutrophilocytes; num.c. = ? × 109/l substance concentration NPU17630 B fract.(spec.)—Naked nuclei; num.c. = ? × 109/l micromol/litre NPU17614 B fract.(spec.)—Plasmocytes; num.c. = ? × 109/l M = 131,17 g/mol NPU17615 B fract.(spec.)—Promyelocytes; num.c. = ? × 109/l NPU02590 NPU17616 B fract.(spec.)—Blast cells; num.c. = ? × 109/l U—Leucine; subst.c. = ? µmol/l NPU17617 B fract.(spec.)—Large unstained cells; num.c. = ? × 109/l NPU17618 B fract.(spec.)—Virocytes; num.c. = ? × 109/l Plasma— Leukocyte antibody; arbitrary concentration(procedure) NPU04130 P—Leukocyte antibody; arb.c.(proc.)= ?
Plasma— Leukocyte elastase; catalytic-activity concentration(37 °C; procedure) katal/litre Other term(s): Lysosomal elastase; Neutrophil elastase NPU02592 P—Leukocyte elastase; cat.c.(37 °C; proc.)= ? prefix ? kat/l
101 Bone marrow— Leukocytes(Blood)— Leukocyte type; Leukocyte type; number concentration(list; procedure) number fraction(list; mechanical; procedure) Note: The concept Leukocyte in this case also comprises erythrocyte Note: The concept Leukocyte in this case also comprises erythrocyte precursors precursors NPU04997 NPU02596 Marrow—Leukocyte type; num.c.(list; proc.) Lkcs(B)—Leukocyte type; num.fr.(list; mech.; proc.) NPU03619 Marrow—Leukocytes; num.c. = ? × 109/l NPU03968 Lkcs(B)—Basophilocytes; num.fr. = ? NPU04664 Marrow—Basophilocytes; num.c. = ? × 109/l NPU03967 Lkcs(B)—Eosinophilocytes; num.fr. = ? NPU04671 Marrow—Eosinophilocytes; num.c. = ? × 109/l NPU04691 Lkcs(B)—Erythroblasts(basophil); num.fr. = ? NPU03798 Marrow—Erythroblasts(basophil); num.c. = ? × 109/l NPU04694 Lkcs(B)—Erythroblasts(orthochrome); num.fr. = ? NPU14346 Marrow—Megaloblasts; num.c. = ? × 109/l NPU04696 Lkcs(B)—Erythroblasts(polychrome); num.fr. = ? NPU03799 Marrow—Erythroblasts(orthochrome); num.c. = ? × 109/l NPU10143 Lkcs(B)—Erythroblasts; num.fr. = ? NPU03806 Marrow—Erythroblasts(polychrome); num.c. = ? × 109/l NPU14362 Lkcs(B)—Leukocytes(Auer bodies); num.fr. = ? NPU14361 Marrow—Leukocytes(Auer bodies); num.c. = ? × 109/l NPU14365 Lkcs(B)—Leukocytes(Pelger-Huët); num.fr. = ? NPU14368 Marrow—Leukocytes(Pelger-Huët); num.c. = ? × 109/l NPU03984 Lkcs(B)—Leukocytes(unspecified); num.fr. = ? NPU04688 Marrow—Lymphoblasts; num.c. = ? × 109/l NPU04995 Lkcs(B)—Lymphoblasts; num.fr. = ? NPU04673 Marrow—Lymphocytes; num.c. = ? × 109/l NPU03965 Lkcs(B)—Lymphocytes; num.fr. = ? NPU04675 Marrow—Metamyelocytes; num.c. = ? × 109/l NPU14343 Lkcs(B)—Megaloblasts; num.fr. = ? NPU04677 Marrow—Monocytes; num.c. = ? × 109/l NPU03977 Lkcs(B)—Metamyelocytes; num.fr. = ? NPU04679 Marrow—Myeloblasts; num.c. = ? × 109/l NPU03966 Lkcs(B)—Monocytes; num.fr. = ? NPU14381 Marrow—Myelocytes; num.c. = ? × 109/l NPU03969 Lkcs(B)—Myeloblasts; num.fr. = ? NPU03994 Marrow—Myelocytes(eosinophil); num.c. = ? × 109/l NPU04705 Lkcs(B)—Myelocytes(eosinophil); num.fr. = ? NPU04089 Marrow—Myelocytes(neutrophil); num.c. = ? × 109/l NPU04707 Lkcs(B)—Myelocytes(neutrophil); num.fr. = ? NPU04681 Marrow—Neutrophilocytes(segmented); num.c. = ? × 109/l NPU03975 Lkcs(B)—Myelocytes; num.fr. = ? NPU04683 Marrow—Neutrophilocytes(band); num.c. = ? × 109/l NPU03981 Lkcs(B)—Neutrophilocytes(segmented); num.fr. = ? NPU04090 Marrow—Plasmocytes; num.c. = ? × 109/l NPU03979 Lkcs(B)—Neutrophilocytes(band); num.fr. = ? NPU04091 Marrow—Promyelocytes; num.c. = ? × 109/l NPU03983 Lkcs(B)—Neutrophilocytes; num.fr. = ? NPU04134 Marrow—Reticulum cells; num.c. = ? × 109/l NPU17619 Lkcs(B)—Naked nuclei; num.fr. = ? NPU04667 Marrow—Blast cells; num.c. = ? × 109/l NPU04709 Lkcs(B)—Plasmocytes; num.fr. = ? NPU03973 Lkcs(B)—Promyelocytes; num.fr. = ? Blood— NPU03971 Lkcs(B)—Blast cells; num.fr. = ? Leukocyte type; NPU04153 Lkcs(B)—Large unstained cells; num.fr. = ? number concentration(list; mechanical; procedure) NPU17620 Lkcs(B)—Virocytes; num.fr. = ? Note: The concept Leukocyte in this case also comprises erythrocyte precursors Leukocytes(Blood)— NPU04100 Leukocyte type; B—Leukocyte type; num.c.(list; mech.; proc.) number fraction(list; microscopic; procedure) NPU01349 B—Basophilocytes; num.c. = ? × 109/l Note: The concept Leukocyte in this case also comprises erythrocyte NPU01933 B—Eosinophilocytes; num.c.(mech.) = ? × 109/l precursors NPU04690 B—Erythroblasts(basophil); num.c. = ? × 109/l NPU17027 NPU04692 B—Erythroblasts(orthochrome); num.c. = ? × 109/l Lkcs(B)—Leukocyte type; num.fr.(list; micr.; proc.) NPU04695 B—Erythroblasts(polychrome); num.c. = ? × 109/l NPU03968 Lkcs(B)—Basophilocytes; num.fr. = ? NPU01943 B—Erythroblasts; num.c. = ? × 109/l NPU03967 Lkcs(B)—Eosinophilocytes; num.fr. = ? NPU14360 B—Leukocytes(Auer bodies); num.c. = ? × 109/l NPU04691 Lkcs(B)—Erythroblasts(basophil); num.fr. = ? NPU14367 B—Leukocytes(Pelger-Huët); num.c. = ? × 109/l NPU04694 Lkcs(B)—Erythroblasts(orthochrome); num.fr. = ? NPU17053 B—Leukocytes(unspecified); num.c. = ? × 109/l NPU04696 Lkcs(B)—Erythroblasts(polychrome); num.fr. = ? NPU02593 B—Leukocytes; num.c. = ? × 109/l NPU10143 Lkcs(B)—Erythroblasts; num.fr. = ? NPU04996 B—Lymphoblasts; num.c. = ? × 109/l NPU14362 Lkcs(B)—Leukocytes(Auer bodies); num.fr. = ? NPU02636 B—Lymphocytes; num.c. = ? × 109/l NPU14365 Lkcs(B)—Leukocytes(Pelger-Huët); num.fr. = ? NPU14345 B—Megaloblasts; num.c. = ? × 109/l NPU03984 Lkcs(B)—Leukocytes(unspecified); num.fr. = ? NPU03978 B—Metamyelocytes; num.c. = ? × 109/l NPU04995 Lkcs(B)—Lymphoblasts; num.fr. = ? NPU02840 B—Monocytes; num.c. = ? × 109/l NPU03965 Lkcs(B)—Lymphocytes; num.fr. = ? NPU03970 B—Myeloblasts; num.c. = ? × 109/l NPU14343 Lkcs(B)—Megaloblasts; num.fr. = ? NPU04704 B—Myelocytes(eosinophil); num.c. = ? × 109/l NPU03977 Lkcs(B)—Metamyelocytes; num.fr. = ? NPU04706 B—Myelocytes(neutrophil); num.c. = ? × 109/l NPU03966 Lkcs(B)—Monocytes; num.fr. = ? NPU03976 B—Myelocytes; num.c. = ? × 109/l NPU03969 Lkcs(B)—Myeloblasts; num.fr. = ? NPU03982 B—Neutrophilocytes(segmented); num.c. = ? × 109/l NPU04705 Lkcs(B)—Myelocytes(eosinophil); num.fr. = ? NPU03980 B—Neutrophilocytes(band); num.c. = ? × 109/l NPU04707 Lkcs(B)—Myelocytes(neutrophil); num.fr. = ? NPU02902 B—Neutrophilocytes; num.c. = ? × 109/l NPU03975 Lkcs(B)—Myelocytes; num.fr. = ? NPU17597 B—Naked nuclei; num.c. = ? × 109/l NPU03981 Lkcs(B)—Neutrophilocytes(segmented); num.fr. = ? NPU04708 B—Plasmocytes; num.c. = ? × 109/l NPU03979 Lkcs(B)—Neutrophilocytes(band); num.fr. = ? NPU03974 B—Promyelocytes; num.c. = ? × 109/l NPU03983 Lkcs(B)—Neutrophilocytes; num.fr. = ? NPU03972 B—Blast cells; num.c. = ? × 109/l NPU17619 Lkcs(B)—Naked nuclei; num.fr. = ? NPU14267 B—Large unstained cells; num.c. = ? × 109/l NPU04709 Lkcs(B)—Plasmocytes; num.fr. = ? NPU08686 B—Virocytes; num.c. = ? × 109/l NPU03973 Lkcs(B)—Promyelocytes; num.fr. = ? NPU03971 Lkcs(B)—Blast cells; num.fr. = ? NPU04153 Lkcs(B)—Large unstained cells; num.fr. = ? NPU17620 Lkcs(B)—Virocytes; num.fr. = ?
Leukocytes(Ascites)— Leukocyte type; number fraction(list; procedure) Note: The concept Leukocyte in this case also comprises erythrocyte precursors NPU14113 Lkcs(Asc)—Leukocyte type; num.fr.(list; proc.) NPU10176 Lkcs(Asc)—Leukocytes(mononucl.); num.fr. = ? NPU10756 Lkcs(Asc)—Neutrophilocytes; num.fr.= ? NPU10178 Lkcs(Asc)—Leukocytes(polynucl.); num.fr. = ?
Leukocytes(Cerebrospinal fluid)— Leukocyte type; number fraction(list; procedure) NPU02597 Lkcs(Csf)—Leukocyte type; num.fr.(list; proc.) NPU04227 Lkcs(Csf)—Leukocytes(mononucl.); num.fr.= ? NPU10213 Lkcs(Csf)—Leukocytes(polynucl.); num.fr. = ? NPU04226 Lkcs(Csf)—Neutrophilocytes; num.fr.= ? NPU17035 Lkcs(Csf)—Leukocytes(unspecified); num.fr. = ?
102 Blood fraction(specification)— Leukocytes(Drain fluid; specification)— Leukocytes(Auer bodies); Leukocyte type; number concentration number fraction(list; procedure) 109/litre NPU17038 NPU17602 Lkcs(Drain fluid; spec.)—Leukocyte type; num.fr.(list; proc.) B fract.(spec.)—Leukocytes(Auer bodies); num.c. = ? × 109/l NPU17039 Lkcs(Drain fluid; spec.)—Leukocytes(mononucl.); num.fr. = ? NPU17040 Lkcs(Drain fluid; spec.)—Leukocytes(polynucl.); num.fr. = ? Bone marrow— NPU17041 Lkcs(Drain fluid; spec.)—Leukocytes(unspecified); num.fr. = ? Leukocytes(Auer bodies); number concentration Leukocytes(Bone marrow)— 109/litre Leukocyte type; NPU14361 number fraction(list; procedure) Marrow—Leukocytes(Auer bodies); num.c. = ? × 109/l Note: The concept Leukocyte in this case also comprises erythrocyte precursors Leukocytes(Blood)— NPU04720 Leukocytes(Auer bodies); Lkcs(Marrow)—Leukocyte type; num.fr.(list; proc.) number fraction NPU04666 Lkcs(Marrow)—Basophilocytes; num.fr. = ? NPU14362 NPU04672 Lkcs(Marrow)—Eosinophilocytes; num.fr. = ? Lkcs(B)—Leukocytes(Auer bodies); num.fr. = ? NPU04991 Lkcs(Marrow)—Erythroblasts(basophil); num.fr. = ? NPU14344 Lkcs(Marrow)—Megaloblasts; num.fr. = ? Leukocytes(Bone marrow)— NPU04993 Lkcs(Marrow)—Erythroblasts(orthochrome); num.fr. = ? Leukocytes(Auer bodies); NPU04992 Lkcs(Marrow)—Erythroblasts(polychrome); num.fr. = ? number fraction NPU14363 Lkcs(Marrow)—Leukocytes(Auer bodies); num.fr. = ? NPU14363 NPU14366 Lkcs(Marrow)—Leukocytes(Pelger-Huët); num.fr. = ? Lkcs(Marrow)—Leukocytes(Auer bodies); num.fr. = ? NPU04663 Lkcs(Marrow)—Leukocytes(unspecified); num.fr. = ? NPU04689 Lkcs(Marrow)—Lymphoblasts; num.fr. = ? Cerebrospinal fluid— NPU04674 Lkcs(Marrow)—Lymphocytes; num.fr. = ? Leukocytes(mononuclear); NPU04676 Lkcs(Marrow)—Metamyelocytes; num.fr. = ? number concentration NPU04678 Lkcs(Marrow)—Monocytes; num.fr. = ? 106/litre NPU04680 Lkcs(Marrow)—Myeloblasts; num.fr. = ? NPU10763 NPU14380 Lkcs(Marrow)—Myelocytes; num.fr. = ? Csf—Leukocytes(mononucl.); num.c. = ? × 106/l NPU04987 Lkcs(Marrow)—Myelocytes(eosinophil); num.fr. = ? NPU04986 Lkcs(Marrow)—Myelocytes(neutrophil); num.fr. = ? Blood— NPU04682 Lkcs(Marrow)—Neutrophilocytes(segmented); num.fr. = ? Leukocytes(mononuclear); NPU04684 Lkcs(Marrow)—Neutrophilocytes(band); num.fr. = ? number concentration NPU04989 Lkcs(Marrow)—Plasmocytes; num.fr. = ? 109/litre NPU04985 Lkcs(Marrow)—Promyelocytes; num.fr. = ? NPU04851 NPU14382 Lkcs(Marrow)—Reticulum cells; num.fr. = ? B—Leukocytes(mononucl.); num.c. = ? × 109/l NPU04668 Lkcs(Marrow)—Blast cells; num.fr. = ? Leukocytes(Ascites)— Leukocytes(Pleural fluid; specification)— Leukocytes(mononuclear); Leukocyte type; number fraction number fraction(list; procedure) NPU10176 Note: The concept Leukocyte in this case also comprises erythrocyte Lkcs(Asc)—Leukocytes(mononucl.); num.fr. = ? precursors NPU14115 Leukocytes(Cerebrospinal fluid)— Lkcs(Plf; spec.)—Leukocyte type; num.fr.(list; proc.) Leukocytes(mononuclear); NPU10175 Lkcs(Plf; spec.)—Leukocytes(mononucl.); num.fr. = ? number fraction NPU10177 Lkcs(Plf; spec.)—Leukocytes(polynucl.); num.fr. = ? NPU04227 NPU17037 Lkcs(Plf; spec.)—Leukocytes(unspecified); num.fr. = ? Lkcs(Csf)—Leukocytes(mononucl.); num.fr.= ?
Leukocytes(Synovial fluid; specification)— Leukocytes(Drain fluid; specification)— Leukocyte type; Leukocytes(mononuclear); number fraction(list; procedure) number fraction Note: The concept Leukocyte in this case also comprises erythrocyte NPU17039 precursors Lkcs(Drain fluid; spec.)—Leukocytes(mononucl.); num.fr. = ? NPU14114 Lkcs(Synf; spec.)—Leukocyte type; num.fr.(list; proc.) Leukocytes(Pericardial fluid)— NPU10173 Lkcs(Synf; spec.)—Leukocytes(mononucl.); num.fr. = ? Leukocytes(mononuclear); NPU10174 Lkcs(Synf; spec.)—Leukocytes(polynucl.); num.fr. = ? number fraction NPU17036 Lkcs(Synf; spec.)—Leukocytes(unspecified); num.fr. = ? NPU10758 Lkcs(Pericardialf.)—Leukocytes(mononucl.); num.fr.= ? Leukocytes(System; specification)— Leukocyte type; Leukocytes(Pleural fluid; specification)— number fraction(list; procedure) Leukocytes(mononuclear); NPU14370 number fraction Lkcs(Syst; spec.)—Leukocyte type; num.fr.(list; proc.) NPU10175 NPU14364 Syst(spec.)—Leukocytes(mononucl.); num.fr. = ? Lkcs(Plf; spec.)—Leukocytes(mononucl.); num.fr. = ? NPU14369 Syst(spec.)—Leukocytes(polynucl.); num.fr. = ? Leukocytes(Synovial fluid; specification)— Plasma— Leukocytes(mononuclear); Leukocytelastase antibody(Immunoglobulin G); number fraction arbitrary concentration(procedure) NPU10173 Other term(s): EC3.4.21.37 antibody Lkcs(Synf; spec.)—Leukocytes(mononucl.); num.fr. = ? NPU12576 P—Leukocytelastase antibody(IgG); arb.c.(proc.) = ? System(specification)— Leukocytes(mononuclear); Blood— number fraction Leukocytes(Auer bodies); NPU14364 number concentration Syst(spec.)—Leukocytes(mononucl.); num.fr. = ? 109/litre NPU14360 Blood— B—Leukocytes(Auer bodies); num.c. = ? × 109/l Leukocytes(Pelger-Huët); number concentration 109/litre NPU14367 B—Leukocytes(Pelger-Huët); num.c. = ? × 109/l
103 Blood fraction(specification)— Leukocytes(Pelger-Huët); System(specification)— number concentration Leukocytes(polynuclear); 109/litre number fraction NPU17603 NPU14369 B fract.(spec.)—Leukocytes(Pelger-Huët); num.c. = ? × 109/l Syst(spec.)—Leukocytes(polynucl.); num.fr. = ?
Bone marrow— Ascites— Leukocytes(Pelger-Huët); Leukocytes(unspecified); number concentration number concentration 109/litre 106/litre NPU14368 NPU17574 Marrow—Leukocytes(Pelger-Huët); num.c. = ? × 109/l Asc—Leukocytes(unspecified); num.c. = ? × 106/l
Leukocytes(Blood)— Cerebrospinal fluid— Leukocytes(Pelger-Huët); Leukocytes(unspecified); number fraction number concentration NPU14365 106/litre Lkcs(B)—Leukocytes(Pelger-Huët); num.fr. = ? NPU17575 Csf—Leukocytes(unspecified); num.c. = ? × 106/l Leukocytes(Bone marrow)— Leukocytes(Pelger-Huët); Pleural fluid(specification)— number fraction Leukocytes(unspecified); NPU14366 number concentration Lkcs(Marrow)—Leukocytes(Pelger-Huët); num.fr. = ? 106/litre NPU17577 Ascites— Plf(spec.)—Leukocytes(unspecified); num.c. = ? × 106/l Leukocytes(polynuclear); number concentration Synovial fluid(specification)— 106/litre Leukocytes(unspecified); NPU10215 number concentration Asc—Leukocytes(polynucl.); num.c. = ? × 106/l 106/litre NPU17576 Cerebrospinal fluid— Synf(spec.)—Leukocytes(unspecified); num.c. = ? × 106/l Leukocytes(polynuclear); number concentration Blood— 106/litre Leukocytes(unspecified); NPU10774 number concentration Csf—Leukocytes(polynucl.); num.c. = ? × 106/l 109/litre NPU17053 Pleural fluid(specification)— B—Leukocytes(unspecified); num.c. = ? × 109/l Leukocytes(polynuclear); number concentration Blood fraction(specification)— 106/litre Leukocytes(unspecified); NPU10216 number concentration Plf(spec.)—Leukocytes(polynucl.); num.c. = ? × 106/l 109/litre NPU17604 Synovial fluid(specification)— B fract.(spec.)—Leukocytes(unspecified); num.c. = ? × 109/l Leukocytes(polynuclear); number concentration Leukocytes(Blood)— 106/litre Leukocytes(unspecified); NPU10214 number fraction Synf(spec.)—Leukocytes(polynucl.); num.c. = ? × 106/l NPU03984 Lkcs(B)—Leukocytes(unspecified); num.fr. = ? Blood— Leukocytes(polynuclear); Leukocytes(Cerebrospinal fluid)— number concentration Leukocytes(unspecified); 109/litre number fraction NPU04852 NPU17035 B—Leukocytes(polynucl.); num.c. = ? × 109/l Lkcs(Csf)—Leukocytes(unspecified); num.fr. = ?
Leukocytes(Ascites)— Leukocytes(Drain fluid; specification)— Leukocytes(polynuclear); Leukocytes(unspecified); number fraction number fraction NPU10178 NPU17041 Lkcs(Asc)—Leukocytes(polynucl.); num.fr. = ? Lkcs(Drain fluid; spec.)—Leukocytes(unspecified); num.fr. = ?
Leukocytes(Cerebrospinal fluid)— Leukocytes(Bone marrow)— Leukocytes(polynuclear); Leukocytes(unspecified); number fraction number fraction NPU10213 NPU04663 Lkcs(Csf)—Leukocytes(polynucl.); num.fr. = ? Lkcs(Marrow)—Leukocytes(unspecified); num.fr. = ?
Leukocytes(Drain fluid; specification)— Leukocytes(Pleural fluid; specification)— Leukocytes(polynuclear); Leukocytes(unspecified); number fraction number fraction NPU17040 NPU17037 Lkcs(Drain fluid; spec.)—Leukocytes(polynucl.); num.fr. = ? Lkcs(Plf; spec.)—Leukocytes(unspecified); num.fr. = ?
Leukocytes(Pleural fluid; specification)— Leukocytes(Synovial fluid; specification)— Leukocytes(polynuclear); Leukocytes(unspecified); number fraction number fraction NPU10177 NPU17036 Lkcs(Plf; spec.)—Leukocytes(polynucl.); num.fr. = ? Lkcs(Synf; spec.)—Leukocytes(unspecified); num.fr. = ?
Leukocytes(Synovial fluid; specification)— Dialysis solution— Leukocytes(polynuclear); Leukocytes; number fraction arbitrary concentration(procedure) NPU10174 NPU10760 Lkcs(Synf; spec.)—Leukocytes(polynucl.); num.fr. = ? Dialysis solution—Leukocytes; arb.c.(proc.) = ?
104 Synovial fluid(specification)— Urine— Leukocytes; Leukocytes; number concentration arbitrary concentration(procedure) 109/litre NPU03987 NPU14082 U—Leukocytes; arb.c.(proc.) = ? Synf(spec.)—Leukocytes; num.c. = ? × 109/l
Vaginal fluid— Patient— Leukocytes; Levodopa(administered); arbitrary concentration(procedure) amount-of-substance(oral administration) NPU14317 millimol Vagf—Leukocytes; arb.c.(proc.) = ? M = 197,2 g/mol Other term(s): L-Dopa Blood— NPU10457 Leukocytes; Pt—Levodopa(administered); am.s.(p.o.) = ? mmol number concentration(microscopic) 109/litre Urine— NPU17579 Levodopa/Creatininium; B—Leukocytes; num.c.(micr.) = ? × 109/l substance ratio 10-3 Urine— NPU14232 Leukocytes; U—Levodopa/Creatininium; subst.ratio = ? × 10-3 number concentration(procedure) 106/litre Plasma— NPU10505 Lipid(total); U—Leukocytes; num.c.(proc.) = ? × 106/l mass concentration gram/litre Ascites— NPU03807 Leukocytes; P—Lipid(tot.); mass c. = ? g/l number concentration 106/litre Faeces(dry)— NPU08638 Lipid(total); Asc—Leukocytes; num.c. = ? × 106/l mass fraction NPU03844 Cerebrospinal fluid— F(dry)—Lipid(tot.); mass fr. = ? Leukocytes; number concentration Kidney— 106/litre Lithium clearance; NPU02594 volume rate(procedure) Csf—Leukocytes; num.c. = ? × 106/l millilitre/second Authority: IUPAC/VII/C-TOX Drain fluid(specification)— NPU10181 Leukocytes; Kidn.—Lithium clearance; vol.rate(proc.) = ? ml/s number concentration 106/litre Patient— NPU17178 Lithium ion(administered); Drain fluid(spec.)—Leukocytes; num.c. = ? × 106/l amount-of-substance(oral administration) millimol Pleural fluid(specification)— NPU14800 Leukocytes; Pt—Lithium ion(administered); am.s.(p.o.) = ? mmol number concentration 106/litre Urine— NPU08637 Lithium ion; Plf(spec.)—Leukocytes; num.c. = ? × 106/l amount-of-substance(procedure) millimol Synovial fluid(specification)— M = 6,94 g/mol Leukocytes; NPU10180 number concentration U—Lithium ion; am.s.(proc.) = ? mmol 106/litre NPU08639 Dialysis solution— Synf(spec.)—Leukocytes; num.c. = ? × 106/l Lithium ion; substance concentration(therapy) System(specification)— millimol/litre Leukocytes; NPU10182 number concentration Dialysis solution—Lithium ion; subst.c.(therapy) = ? mmol/l 106/litre NPU10130 Plasma— Syst(spec.)—Leukocytes; num.c. = ? × 106/l Lithium ion; substance concentration(therapy) Blood— millimol/litre Leukocytes; M = 6,94 g/mol number concentration Authority: IUPAC/VII/C-TOX 109/litre NPU02613 NPU02593 P—Lithium ion; subst.c.(therapy) = ? mmol/l B—Leukocytes; num.c. = ? × 109/l Urine— Blood fraction(specification)— Lithium ion; Leukocytes; substance concentration(therapy) number concentration millimol/litre 109/litre M = 6,94 g/mol NPU17578 NPU13479 B fract.(spec.)—Leukocytes; num.c. = ? × 109/l U—Lithium ion; subst.c.(therapy) = ? mmol/l
Bone marrow— Leukocytes; number concentration 109/litre NPU03619 Marrow—Leukocytes; num.c. = ? × 109/l
105 Urine— Pituitary gland— Lithium ion; Lutropin secretion; substance concentration substance rate(gonadorelin, intravenous administration; list; procedure) millimol/litre Note: _M_(gonadorelin) = 1 182,3 g/mol M = 6,94 g/mol NPU10441 Authority: IUPAC/VII/C-TOX PitGl—Lutropin secretion; subst.rate(gonadorelin i.v.; list; proc.) NPU04888 NPU10561 Pt—Gonadorelin(administered); am.s.(i.v.) = ? nmol U—Lithium ion; subst.c. = ? mmol/l NPU10676 P—Lutropin; arb.subst.c.(IS 80/552; -60 min; proc.) = ? int. unit/l NPU10677 P—Lutropin; arb.subst.c.(IS 80/552; -30 min; proc.) = ? int. unit/l Hair— NPU10436 P—Lutropin; arb.subst.c.(IS 80/552; 0 min; proc.) = ? int. unit/l Lithium ion; NPU10437 P—Lutropin; arb.subst.c.(IS 80/552; 30 min; proc.) = ? int. unit/l substance content NPU10438 P—Lutropin; arb.subst.c.(IS 80/552; 60 min; proc.) = ? int. unit/l micromol/kilogram NPU10439 P—Lutropin; arb.subst.c.(IS 80/552; 90 min; proc.) = ? int. unit/l M = 6,94 g/mol NPU10440 P—Lutropin; arb.subst.c.(IS 80/552; 120 min; proc.) = ? int. unit/l Authority: IUPAC/VII/C-TOX NPU10678 P—Lutropin; arb.subst.c.(IRP 68/40; -60 min; proc.) = ? int. unit/l NPU02612 NPU10679 P—Lutropin; arb.subst.c.(IRP 68/40; -30 min; proc.) = ? int. unit/l Hair—Lithium ion; subst.cont. = ? µmol/kg NPU10430 P—Lutropin; arb.subst.c.(IRP 68/40; 0 min; proc.) = ? int. unit/l NPU10431 P—Lutropin; arb.subst.c.(IRP 68/40; 30 min; proc.) = ? int. unit/l Patient— NPU10432 P—Lutropin; arb.subst.c.(IRP 68/40; 60 min; proc.) = ? int. unit/l Lithiumcarbonate(administered); NPU10433 P—Lutropin; arb.subst.c.(IRP 68/40; 90 min; proc.) = ? int. unit/l mass(oral administration) NPU10434 P—Lutropin; arb.subst.c.(IRP 68/40; 120 min; proc.) = ? int. unit/l milligram NPU14801 Plasma— Pt—Lithiumcarbonate(administered); mass(p.o.) = ? mg Lutropin; arbitrary substance concentration(IRP 68/40; 0 minutes after challenge; Patient— procedure) Liver; international unit/litre mass Other term(s): Luteinizing hormone; LH; Lutenin kilogram NPU10430 NPU03803 P—Lutropin; arb.subst.c.(IRP 68/40; 0 min; proc.) = ? int. unit/l Pt—Liver; mass = ? kg Plasma— Plasma— Lutropin; Livercytosol antibody(Immunoglobulin G); arbitrary substance concentration(IRP 68/40; 120 minutes after challenge; arbitrary concentration(procedure) procedure) NPU14515 international unit/litre P—Livercytosol antibody(IgG); arb.c.(proc.) = ? Other term(s): Luteinizing hormone; LH; Lutenin NPU10434 Plasma— P—Lutropin; arb.subst.c.(IRP 68/40; 120 min; proc.) = ? int. unit/l Liver-kidney-microsome antibody(Immunoglobulin G); arbitrary concentration(procedure) Plasma— NPU14516 Lutropin; P—Liver-kidney-microsome antibody(IgG); arb.c.(proc.) = ? arbitrary substance concentration(IRP 68/40; 30 minutes after challenge; procedure) Blood— international unit/litre Long QT syndrome DNA; Other term(s): Luteinizing hormone; LH; Lutenin arbitrary concentration(procedure) NPU10431 NPU17684 P—Lutropin; arb.subst.c.(IRP 68/40; 30 min; proc.) = ? int. unit/l B—Long QT syndrome DNA; arb.c.(proc.) = ? Plasma— Blood— Lutropin; Lupus erythematosus particles; arbitrary substance concentration(IRP 68/40; 30 minutes before challenge; arbitrary concentration(procedure) procedure) NPU02617 international unit/litre B—Lupus erythematosus particles; arb.c.(proc.) = ? Other term(s): Luteinizing hormone; LH; Lutenin NPU10679 Plasma— P—Lutropin; arb.subst.c.(IRP 68/40; -30 min; proc.) = ? int. unit/l Lutropin alpha-chain; arbitrary substance concentration(IS 78/554; procedure) Plasma— international unit/litre Lutropin; M = 14 000 g/mol arbitrary substance concentration(IRP 68/40; 60 minutes after challenge; Recommended calibrator: WHO 1st IS 78/554 procedure) NPU02620 international unit/litre P—Lutropin alpha-chain; arb.subst.c.(IS 78/554; proc.) = ? int. unit/l Other term(s): Luteinizing hormone; LH; Lutenin NPU10432 Plasma— P—Lutropin; arb.subst.c.(IRP 68/40; 60 min; proc.) = ? int. unit/l Lutropin alpha-chain; substance concentration Plasma— picomol/litre Lutropin; M = 14 000 g/mol arbitrary substance concentration(IRP 68/40; 60 minutes before challenge; NPU02621 procedure) P—Lutropin alpha-chain; subst.c. = ? pmol/l international unit/litre Other term(s): Luteinizing hormone; LH; Lutenin Plasma— NPU10678 Lutropin beta-chain; P—Lutropin; arb.subst.c.(IRP 68/40; -60 min; proc.) = ? int. unit/l arbitrary substance concentration(IS 78/556; procedure) international unit/litre Plasma— M = 15 000 g/mol Lutropin; Recommended calibrator: WHO 1st IS 78/556 arbitrary substance concentration(IRP 68/40; 90 minutes after challenge; NPU02622 procedure) P—Lutropin beta-chain; arb.subst.c.(IS 78/556; proc.) = ? int. unit/l international unit/litre Other term(s): Luteinizing hormone; LH; Lutenin Plasma— NPU10433 Lutropin beta-chain; P—Lutropin; arb.subst.c.(IRP 68/40; 90 min; proc.) = ? int. unit/l substance concentration picomol/litre M = 15 000 g/mol NPU02623 P—Lutropin beta-chain; subst.c. = ? pmol/l
106 Plasma— Plasma— Lutropin; Lutropin; arbitrary substance concentration(IRP 68/40; procedure) arbitrary substance concentration(IS 80/552; procedure) international unit/litre international unit/litre M = 29 000 g/mol M = 29 000 g/mol Recommended calibrator: WHO 1st IRP 68/40 (for immunoassay) Recommended calibrator: WHO 2nd IS 80/552 Other term(s): Luteinizing hormone; LH Calibrator(s): WHO 1st IRP 68/40 (for immunoassay) Authority: IUPAC-IUB 74 Other term(s): Luteinizing hormone; LH NPU04015 Authority: IUPAC-IUB 74 P—Lutropin; arb.subst.c.(IRP 68/40; proc.) = ? int. unit/l NPU02618 P—Lutropin; arb.subst.c.(IS 80/552; proc.) = ? int. unit/l Urine— Lutropin; Urine— arbitrary substance concentration(IRP 68/40; procedure) Lutropin; international unit/litre arbitrary substance concentration(IS 80/552; procedure) M = 29 000 g/mol international unit/litre Recommended calibrator: WHO 1st IRP 68/40 (for immunoassay) M = 29 000 g/mol Other term(s): Luteinizing hormone; LH Recommended calibrator: WHO 2nd IS 80/552 Authority: IUPAC-IUB 74 Calibrator(s): WHO 1st IRP 68/40 (for immunoassay) NPU04016 Other term(s): Luteinizing hormonr; LH U—Lutropin; arb.subst.c.(IRP 68/40; proc.) = ? int. unit/l Authority: IUPAC-IUB 74 NPU03836 Plasma— U—Lutropin; arb.subst.c.(IS 80/552; proc.) = ? int. unit/l Lutropin; arbitrary substance concentration(IS 80/552; 0 minutes after challenge; Plasma— procedure) Lutropin; international unit/litre substance concentration Other term(s): Luteinizing hormone; LH; Lutenin mol/litre NPU10436 M = 29 000 g/mol P—Lutropin; arb.subst.c.(IS 80/552; 0 min; proc.) = ? int. unit/l Other term(s): Luteinizing hormone; LH Authority: IUPAC-IUB 74 Plasma— NPU02619 Lutropin; P—Lutropin; subst.c.= ? prefix ? mol/l arbitrary substance concentration(IS 80/552; 120 minutes after challenge; procedure) Blood— international unit/litre Lymphoblasts; Other term(s): Luteinizing hormone; LH; Lutenin number concentration NPU10440 109/litre P—Lutropin; arb.subst.c.(IS 80/552; 120 min; proc.) = ? int. unit/l NPU04996 B—Lymphoblasts; num.c. = ? × 109/l Plasma— Lutropin; Blood fraction(specification)— arbitrary substance concentration(IS 80/552; 30 minutes after challenge; Lymphoblasts; procedure) number concentration international unit/litre 109/litre Other term(s): Luteinizing hormone; LH; Lutenin NPU17605 NPU10437 B fract.(spec.)—Lymphoblasts; num.c. = ? × 109/l P—Lutropin; arb.subst.c.(IS 80/552; 30 min; proc.) = ? int. unit/l Bone marrow— Plasma— Lymphoblasts; Lutropin; number concentration arbitrary substance concentration(IS 80/552; 30 minutes before challenge; 109/litre procedure) NPU04688 international unit/litre Marrow—Lymphoblasts; num.c. = ? × 109/l Other term(s): Luteinizing hormone; LH; Lutenin NPU10677 Leukocytes(Blood)— P—Lutropin; arb.subst.c.(IS 80/552; -30 min; proc.) = ? int. unit/l Lymphoblasts; number fraction Plasma— NPU04995 Lutropin; Lkcs(B)—Lymphoblasts; num.fr. = ? arbitrary substance concentration(IS 80/552; 60 minutes after challenge; procedure) Leukocytes(Bone marrow)— international unit/litre Lymphoblasts; Other term(s): Luteinizing hormone; LH; Lutenin number fraction NPU10438 NPU04689 P—Lutropin; arb.subst.c.(IS 80/552; 60 min; proc.) = ? int. unit/l Lkcs(Marrow)—Lymphoblasts; num.fr. = ?
Plasma— Blood— Lutropin; Lymphocytes(immature); arbitrary substance concentration(IS 80/552; 60 minutes before challenge; number concentration procedure) 109/litre international unit/litre NPU14260 Other term(s): Luteinizing hormone; LH; Lutenin B—Lymphocytes(immature); num.c. = ? × 109/l NPU10676 P—Lutropin; arb.subst.c.(IS 80/552; -60 min; proc.) = ? int. unit/l Lymphocytes(Blood)— Lymphocytes(vacuolated); Plasma— number fraction Lutropin; NPU17000 arbitrary substance concentration(IS 80/552; 90 minutes after challenge; Lymphocs(B)—Lymphocytes(vacuolated); num.fr. = ? procedure) international unit/litre Blood— Other term(s): Luteinizing hormone; LH; Lutenin Lymphocytes; NPU10439 morphology(procedure) P—Lutropin; arb.subst.c.(IS 80/552; 90 min; proc.) = ? int. unit/l NPU17065 B—Lymphocytes; morphology(proc.) = ?
107 Blood— Urine— Lymphocytes; Lysine; number concentration substance concentration 109/litre micromol/litre NPU02636 M = 146,19 g/mol B—Lymphocytes; num.c. = ? × 109/l NPU02640 U—Lysine; subst.c. = ? µmol/l Blood fraction(specification)— Lymphocytes; Plasma— number concentration Lysozyme; 109/litre catalytic-activity concentration(37 °C; procedure) NPU17581 katal/litre B fract.(spec.)—Lymphocytes; num.c. = ? × 109/l NPU03895 P—Lysozyme; cat.c.(37 °C; proc.)= ? prefix ? kat/l Bone marrow— Lymphocytes; Plasma— number concentration Lysozyme; 109/litre substance concentration NPU04673 nanomol/litre Marrow—Lymphocytes; num.c. = ? × 109/l M = 14 500 g/mol Other term(s): Muramidase Leukocytes(Blood)— NPU02641 Lymphocytes; P—Lysozyme; subst.c. = ? nmol/l number fraction NPU03965 Urine— Lkcs(B)—Lymphocytes; num.fr. = ? Lysozyme; substance concentration Leukocytes(Bone marrow)— nanomol/litre Lymphocytes; M = 14 500 g/mol number fraction NPU04856 NPU04674 U—Lysozyme; subst.c. = ? nmol/l Lkcs(Marrow)—Lymphocytes; num.fr. = ? Plasma— Ascites— alpha-2- Lymphocytes+Monocytes; Macroglobulin; number concentration substance concentration 106/litre micromol/litre NPU08641 M = 725 000 g/mol Asc—Lymphocytes+Monocytes; num.c. = ? × 106/l NPU02646 P—alpha-2-Macroglobulin; subst.c. = ? µmol/l Cerebrospinal fluid— Lymphocytes+Monocytes; Calculus(Urine)— number concentration Magnesium ammonium phosphate; 106/litre arbitrary content(procedure) NPU02637 M = 137,3 g/mol Csf—Lymphocytes+Monocytes; num.c. = ? × 106/l NPU10368 Calculus(U)—Magnesium ammonium phosphate; arb.cont.(proc.) = ? Pleural fluid(specification)— Lymphocytes+Monocytes; Calculus(Urine)— number concentration Magnesium ammonium phosphate; 106/litre substance content NPU08640 mol/kilogram Plf(spec.)—Lymphocytes+Monocytes; num.c. = ? × 106/l M = 137,3 g/mol NPU02649 Synovial fluid(specification)— Calculus(U)—Magnesium ammonium phosphate; subst.cont. = ? mol/kg Lymphocytes+Monocytes; number concentration Plasma— 106/litre Magnesium ion; NPU04231 substance concentration Synf(spec.)—Lymphocytes+Monocytes; num.c.= ? × 106/l millimol/litre M = 24,30 g/mol Urine— NPU02650 Lysine/Creatininium; P—Magnesium ion; subst.c. = ? mmol/l substance ratio 10-3 Secretion(Ileum)— NPU14233 Magnesium(II; total); U—Lysine/Creatininium; subst.ratio = ? × 10-3 amount-of-substance(procedure) millimol Cerebrospinal fluid— M = 24,30 g/mol Lysine; NPU08646 substance concentration Secr(Ileum)—Magnesium(II; total); am.s.(proc.) = ? mmol micromol/litre M = 146,19 g/mol Urine— NPU09029 Magnesium(II; total); Csf—Lysine; subst.c. = ? µmol/l amount-of-substance millimol Plasma— NPU17542 Lysine; U—Magnesium(II; total); am.s. = ? mmol substance concentration micromol/litre Calculus(Urine)— M = 146,19 g/mol Magnesium(II; total); NPU02639 arbitrary content(procedure) P—Lysine; subst.c. = ? µmol/l M = 24,30 g/mol NPU09234 Calculus(U)—Magnesium(II; total); arb.cont.(proc.) = ?
108 Plasma— Urine— Magnesium(II; total); Malate; substance concentration substance concentration millimol/litre mol/litre M = 24,30 g/mol NPU02651 Authority: IFCC/C-BGE; IUPAC/VII/C-TOX U—Malate; subst.c.= ? prefix ? mol/l NPU02647 P—Magnesium(II; total); subst.c. = ? mmol/l Blood— Manganese; Secretion(Ileum)— substance concentration Magnesium(II; total); nanomol/litre substance concentration M = 54,94 g/mol millimol/litre Authority: IUPAC/VII-C-TOX M = 24,30 g/mol NPU02668 NPU08645 B—Manganese; subst.c. = ? nmol/l Secr(Ileum)—Magnesium(II; total); subst.c. = ? mmol/l Plasma— System(specification)— Manganese; Magnesium(II; total); substance concentration substance concentration nanomol/litre millimol/litre M = 54,94 g/mol M = 24,30 g/mol Authority: IUPAC/VII-C-TOX NPU14119 NPU02669 Syst(spec.)—Magnesium(II; total); subst.c. = ? mmol/l P—Manganese; subst.c. = ? nmol/l
Urine— Urine— Magnesium(II; total); Manganese; substance concentration substance concentration millimol/litre nanomol/litre M = 24,30 g/mol M = 54,94 g/mol Authority: IFCC/C-BGE; IUPAC/VII/C-TOX Authority: IUPAC/VII-C-TOX NPU02648 NPU02670 U—Magnesium(II; total); subst.c. = ? mmol/l U—Manganese; subst.c. = ? nmol/l
Faeces— Cells(Blood)— Magnesium(II; total); Manganese; substance content substance content millimol/kilogram nanomol/kilogram M = 24,30 g/mol M = 54,94 g/mol NPU04217 Authority: IUPAC/VII-C-TOX F—Magnesium(II; total); subst.cont. = ? mmol/kg NPU04891 Cells(B)—Manganese; subst.cont. = ? nmol/kg Faeces(specification)— Magnesium(II; total); Plasma— substance content Mannan-binding lectin; millimol/kilogram substance concentration M = 24,30 g/mol nanomol/litre NPU08644 NPU09227 F(spec.)—Magnesium(II; total); subst.cont. = ? mmol/kg P—Mannan-binding lectin; subst.c. = ? nmol/l
Calculus(Urine)— Plasma— Magnesium(II; total); M-component(specification); substance content arbitrary substance concentration(procedure) mol/kilogram arbitrary unit/litre M = 24,30 g/mol NPU08642 NPU09240 P—M-component(spec.); arb.subst.c.(proc.) = ? arb.unit/l Calculus(U)—Magnesium(II; total); subst.cont. = ? mol/kg Urine— Patient(Faeces)— M-component(specification); Magnesium(II; total); arbitrary substance concentration(procedure) substance rate(procedure) arbitrary unit/litre millimol/day NPU08643 M = 24,30 g/mol U—M-component(spec.); arb.subst.c.(proc.) = ? arb.unit/l NPU04216 Pt(F)—Magnesium(II; total); subst.rate(proc.) = ? mmol/d Plasma— M-component(specification); Patient(Urine)— substance concentration Magnesium(II; total); micromol/litre substance rate(procedure) Other term(s): Myeloma protein; Paraprotein millimol/day NPU02644 M = 24,30 g/mol P—M-component(spec.); subst.c. = ? µmol/l Authority: IFCC/BGE; IUPAC/VII/C-TOX NPU03945 Urine— Pt(U)—Magnesium(II; total); subst.rate(proc.) = ? mmol/d M-component(specification); substance concentration Faeces(specification)— micromol/litre Magnesium; Other term(s): Myeloma protein; Paraprotein amount-of-substance NPU02645 millimol U—M-component(spec.); subst.c. = ? µmol/l NPU17621 F(spec.)—Magnesium; am.s. = ? mmol Plasma— M-component; Urine— arbitrary concentration(procedure) Malate/Creatininium; NPU17675 substance ratio P—M-component; arb.c.(proc.) = ? 10-3 NPU14234 U—Malate/Creatininium; subst.ratio = ? × 10-3
109 Urine— M-component; Urine— arbitrary concentration(procedure) Melanin; NPU17676 arbitrary concentration(procedure) U—M-component; arb.c.(proc.) = ? NPU08647 U—Melanin; arb.c.(proc.) = ? Plasma— M-component; Urine— taxon(procedure) Melanin; Other term(s): Myeloma protein; Paraprotein substance concentration NPU02642 millimol/litre P—M-component; taxon(proc.) = ? NPU02695 U—Melanin; subst.c. = ? mmol/l Urine— M-component; Urine— taxon(procedure) Melanin+Melanogen; Other term(s): Myeloma protein; Paraprotein substance concentration NPU02643 millimol/litre U—M-component; taxon(proc.)= ? NPU12902 U—Melanin+Melanogen; subst.c. = ? mmol/l Blood— Megakaryocytes; Plasma— number concentration Melatonin; 109/litre substance concentration NPU04702 picomol/litre B—Megakaryocytes; num.c. = ? × 109/l M = 232,28 g/mol NPU09333 Bone marrow— P—Melatonin; subst.c. = ? pmol/l Megakaryocytes; number concentration Blood— 109/litre Mercury; NPU03993 substance concentration Marrow—Megakaryocytes; num.c. = ? × 109/l nanomol/litre M = 200,59 g/mol Blood— Authority: IUPAC/VII-C-TOX Megaloblasts; NPU02699 arbitrary concentration(procedure) B—Mercury; subst.c. = ? nmol/l NPU17093 B—Megaloblasts; arb.c.(proc.) = ? Plasma— Mercury; Blood— substance concentration Megaloblasts; nanomol/litre number concentration M = 200,59 g/mol 109/litre Authority: IUPAC/VII-C-TOX NPU14345 NPU02701 B—Megaloblasts; num.c. = ? × 109/l P—Mercury; subst.c. = ? nmol/l
Blood fraction(specification)— Urine— Megaloblasts; Mercury; number concentration substance concentration 109/litre nanomol/litre NPU17606 M = 200,59 g/mol B fract.(spec.)—Megaloblasts; num.c. = ? × 109/l Authority: IUPAC/VII-C-TOX NPU02702 Bone marrow— U—Mercury; subst.c. = ? nmol/l Megaloblasts; number concentration Hair— 109/litre Mercury; NPU14346 substance content Marrow—Megaloblasts; num.c. = ? × 109/l micromol/kilogram M = 200,59 g/mol Erythrocytes(Blood)— Authority: IUPAC/VII-C-TOX Megaloblasts; NPU02700 number fraction Hair—Mercury; subst.cont. = ? µmol/kg NPU14371 Ercs(B)—Megaloblasts; num.fr. = ? Cells(Blood)— Mercury; Leukocytes(Blood)— substance content Megaloblasts; nanomol/kilogram number fraction M = 200,59 g/mol NPU14343 Authority: IUPAC/VII-C-TOX Lkcs(B)—Megaloblasts; num.fr. = ? NPU04893 Cells(B)—Mercury; subst.cont. = ? nmol/kg Leukocytes(Bone marrow)— Megaloblasts; Patient(Urine)— number fraction Mercury; NPU14344 substance rate(procedure) Lkcs(Marrow)—Megaloblasts; num.fr. = ? nanomol/day M = 200,59 g/mol Blood— NPU04211 Megalocytes; Pt(U)—Mercury; subst.rate(proc.) = ? nmol/d arbitrary concentration(procedure) NPU17094 Blood— B—Megalocytes; arb.c.(proc.) = ? Metamyelocytes; number concentration Erythrocytes(Blood)— 109/litre Megalocytes; NPU03978 number fraction B—Metamyelocytes; num.c. = ? × 109/l NPU14270 Ercs(B)—Megalocytes; num.fr. = ?
110 Blood fraction(specification)— Plasma— Metamyelocytes; Methionine; number concentration substance concentration 109/litre micromol/litre NPU17607 M = 149,21 g/mol B fract.(spec.)—Metamyelocytes; num.c. = ? × 109/l NPU02726 P—Methionine; subst.c. = ? µmol/l Bone marrow— Metamyelocytes; Urine— number concentration Methionine; 109/litre substance concentration NPU04675 micromol/litre Marrow—Metamyelocytes; num.c. = ? × 109/l M = 149,21 g/mol NPU02727 Leukocytes(Blood)— U—Methionine; subst.c. = ? µmol/l Metamyelocytes; number fraction Cerebrospinal fluid— NPU03977 Methotrexate; Lkcs(B)—Metamyelocytes; num.fr. = ? substance concentration micromol/litre Leukocytes(Bone marrow)— M = 454,44 g/mol Metamyelocytes; NPU02738 number fraction Csf—Methotrexate; subst.c. = ? µmol/l NPU04676 Lkcs(Marrow)—Metamyelocytes; num.fr. = ? Plasma— Methotrexate; Cerebrospinal fluid— substance concentration Methaemoglobin(Fe); micromol/litre arbitrary substance concentration(procedure) M = 454,44 g/mol arbitrary unit/litre NPU02739 NPU14144 P—Methotrexate; subst.c. = ? µmol/l Csf—Methaemoglobin(Fe); arb.subst.c.(proc.) = ? arb.unit/l Patient(Urine)— Haemoglobin(Fe; Blood)— 3- Methaemoglobin(Fe); Methoxyadrenalinium/Creatininium; substance fraction substance rate ratio(procedure) Other term(s): Hemiglobin 10-6 Authority: IFCC/C-BGE Other term(s): 3-Methoxy adrenalinium: Metanephrine NPU02725 NPU10002 Hb(Fe; B)—Methaemoglobin(Fe); subst.fr. = ? Pt(U)—3-Methoxyadrenalinium/Creatininium; subst.rate ratio(proc.) = ? × 10-6
Plasma— Patient(Urine)— Methanol; 3- substance concentration Methoxyadrenalinium; millimol/litre substance rate(procedure) M = 32,04 g/mol micromol/day Other term(s): Methyl alcohol NPU17112 NPU02723 Pt(U)—3-Methoxyadrenalinium; subst.rate(proc.) = ? µmol/d P—Methanol; subst.c. = ? mmol/l Patient(Urine)— Urine— 3- Methionine sulfoxide/Creatininium; Methoxyadrenalinium; substance ratio substance rate(procedure) 10-3 millimol/day NPU14236 M = 197,23 g/mol U—Methionine sulfoxide/Creatininium; subst.ratio = ? × 10-3 Other term(s): Metanephrine NPU10693 Plasma— Pt(U)—3-Methoxyadrenalinium; subst.rate(proc.) = ? mmol/d Methionine sulfoxide; substance concentration Urine— mol/litre 3- M = 165,2 g/mol Methoxyadrenalinium+3-Methoxynoradrenalinium; NPU02736 amount-of-substance(procedure) P—Methionine sulfoxide; subst.c.= ? prefix ? mol/l micromol NPU17626 Urine— U—3-Methoxyadrenalinium+3-Methoxynoradrenalinium; am.s.(proc.) = ? µmol Methionine sulfoxide; substance concentration Urine— mol/litre 3- M = 165,2 g/mol Methoxyadrenalinium+3-Methoxynoradrenalinium; NPU02737 substance concentration U—Methionine sulfoxide; subst.c.= ? prefix ? mol/l micromol/litre Other term(s): Metanephrine+normetanephrine Urine— NPU02740 Methionine/Creatininium; U—3-Methoxyadrenalinium+3-Methoxynoradrenalinium; subst.c. = ? µmol/l substance ratio 10-3 Patient(Urine)— NPU14235 3- U—Methionine/Creatininium; subst.ratio = ? × 10-3 Methoxynoradrenalinium/Creatininium; substance rate ratio(procedure) Cerebrospinal fluid— 10-6 Methionine; Other term(s): 3-Methoxy noradrenalinium: Normetanephrine substance concentration NPU10003 micromol/litre Pt(U)—3-Methoxynoradrenalinium/Creatininium; subst.rate ratio(proc.) = ? × 10- M = 149,21 g/mol 6 NPU09030 Csf—Methionine; subst.c. = ? µmol/l
111 Patient(Urine)— Urine— 3- 1- Methoxynoradrenalinium; Methylhistidine; substance rate(procedure) substance concentration micromol/day micromol/litre NPU17113 M = 169,19 g/mol Pt(U)—3-Methoxynoradrenalinium; subst.rate(proc.) = ? µmol/d NPU02777 U—1-Methylhistidine; subst.c. = ? µmol/l Patient(Urine)— 3- Plasma— Methoxynoradrenalinium; 3- substance rate(procedure) Methylhistidine; millimol/day substance concentration M = 183,21 g/mol micromol/litre Other term(s): Normetanephrine M = 169,19 g/mol NPU10694 NPU02778 Pt(U)—3-Methoxynoradrenalinium; subst.rate(proc.) = ? mmol/d P—3-Methylhistidine; subst.c. = ? µmol/l
Patient(Urine)— Urine— Methoxytyramine/Creatininium; 3- substance rate ratio(procedure) Methylhistidine; 10-6 substance concentration NPU10004 micromol/litre Pt(U)—Methoxytyramine/Creatininium; subst.rate ratio(proc.) = ? × 10-6 M = 169,19 g/mol NPU02779 Patient(Urine)— U—3-Methylhistidine; subst.c. = ? µmol/l Methoxytyramine; substance rate(procedure) Plasma— millimol/day Methylmalonate; NPU10695 substance concentration Pt(U)—Methoxytyramine; subst.rate(proc.) = ? mmol/d micromol/litre Note: _M_ (anion) = 117,09 g/mol Urine— NPU02780 Methylcitrate/Creatininium; P—Methylmalonate; subst.c. = ? µmol/l substance ratio 10-3 Patient(Urine)— NPU14237 Methylmalonate; U—Methylcitrate/Creatininium; subst.ratio = ? × 10-3 substance rate(procedure) micromol/day Urine— NPU10770 Methylcitrate; Pt(U)—Methylmalonate; subst.rate(proc.) = ? µmol/d substance concentration mol/litre Patient— NPU02744 Metyrapone(administered); U—Methylcitrate; subst.c.= ? prefix ? mol/l amount-of-substance(oral administration) millimol Cobalamin(Plasma)— M = 226,27 g/mol Methylcobalamin; NPU10524 substance fraction Pt—Metyrapone(administered); am.s.(p.o.) = ? mmol NPU04958 Cobalamin(P)—Methylcobalamin; subst.fr.= ? Patient— Metyrapone(administered); Patient(Urine)— number of doses Methylhippurate; M = 226,27 g/mol substance rate(procedure) NPU09113 mol/day Pt—Metyrapone(administered); number of doses = ? NPU02775 Pt(U)—Methylhippurate; subst.rate(proc.)= ? prefix ? mol/d Patient— Metyrapone(administered); Urine— substance content(oral administration; amount-of-substance/body mass) 1- millimol/kilogram Methylhistidine/Creatininium; M = 226,27 g/mol substance ratio NPU10525 10-3 Pt—Metyrapone(administered); subst.cont.(p.o.; am.s./body mass) = ? mmol/kg NPU14238 U—1-Methylhistidine/Creatininium; subst.ratio = ? × 10-3 Patient— Metyrapone(administered); Urine— time interval(between doses) 3- minute Methylhistidine/Creatininium; M = 226,27 g/mol substance ratio NPU09114 10-3 Pt—Metyrapone(administered); time int.(between doses) = ? min NPU14239 U—3-Methylhistidine/Creatininium; subst.ratio = ? × 10-3 Blood— Microcytes; Plasma— arbitrary concentration(procedure) 1- NPU17095 Methylhistidine; B—Microcytes; arb.c.(proc.) = ? substance concentration micromol/litre Erythrocytes(Blood)— M = 169,19 g/mol Microcytes; NPU02776 number fraction P—1-Methylhistidine; subst.c. = ? µmol/l NPU14271 Ercs(B)—Microcytes; num.fr. = ?
112 Urine— Plasma— alpha-1- Mitotic spindle apparatus antibody; Microglobulin; arbitrary substance concentration(procedure) substance concentration arbitrary unit/litre micromol/litre NPU14124 NPU04129 P—Mitotic spindle apparatus antibody; arb.subst.c.(proc.) = ? arb.unit/l U—alpha-1-Microglobulin; subst.c.=? µmol/l Blood— Cerebrospinal fluid— Molybdenum; beta-2- substance concentration Microglobulin; nanomol/litre substance concentration M = 95,94 g/mol nanomol/litre Authority: IUPAC/VII-C-TOX M = 11 800 g/mol NPU02836 NPU10284 B—Molybdenum; subst.c. = ? nmol/l Csf—beta-2-Microglobulin; subst.c. = ? nmol/l Plasma— Plasma— Molybdenum; beta-2- substance concentration Microglobulin; nanomol/litre substance concentration M = 95,94 g/mol nanomol/litre Authority: IUPAC/VII-C-TOX M = 11 800 g/mol NPU02838 NPU02817 P—Molybdenum; subst.c. = ? nmol/l P—beta-2-Microglobulin; subst.c. = ? nmol/l Urine— Urine— Molybdenum; beta-2- substance concentration Microglobulin; nanomol/litre substance concentration M = 95,94 g/mol nanomol/litre Authority: IUPAC/VII-C-TOX M = 11 800 g/mol NPU02839 NPU02818 U—Molybdenum; subst.c. = ? nmol/l U—beta-2-Microglobulin; subst.c. = ? nmol/l Hair— Patient(Urine)— Molybdenum; beta-2- substance content Microglobulin; micromol/kilogram substance rate M = 95,94 g/mol nanomol/day Authority: IUPAC/VII-C-TOX M = 11 800 g/mol NPU02837 NPU10285 Hair—Molybdenum; subst.cont. = ? µmol/kg Pt(U)—beta-2-Microglobulin; subst.rate = ? nmol/d Blood— Plasma— Monocytes; Mitochondrial antibody(Immunoglobulin G); number concentration arbitrary concentration(procedure) 109/litre NPU14122 NPU02840 P—Mitochondrial antibody(IgG); arb.c.(proc.) = ? B—Monocytes; num.c. = ? × 109/l
Plasma— Blood fraction(specification)— Mitochondrial antibody(Immunoglobulin G); Monocytes; arbitrary substance concentration(procedure) number concentration 10³ arbitrary unit/litre 109/litre NPU09332 NPU17582 P—Mitochondrial antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l B fract.(spec.)—Monocytes; num.c. = ? × 109/l
Plasma— Bone marrow— Mitochondrial antibody; Monocytes; arbitrary concentration(procedure) number concentration NPU02834 109/litre P—Mitochondrial antibody; arb.c.(proc.) = ? NPU04677 Marrow—Monocytes; num.c. = ? × 109/l Plasma— Mitochondrial antibody; Leukocytes(Blood)— arbitrary substance concentration(procedure) Monocytes; arbitrary unit/litre number fraction NPU14123 NPU03966 P—Mitochondrial antibody; arb.subst.c.(proc.) = ? arb.unit/l Lkcs(B)—Monocytes; num.fr. = ?
Plasma— Leukocytes(Bone marrow)— Mitotic spindle apparatus antibody(Immunoglobulin G); Monocytes; arbitrary concentration(procedure) number fraction NPU12017 NPU04678 P—Mitotic spindle apparatus antibody(IgG); arb.c.(proc.) = ? Lkcs(Marrow)—Monocytes; num.fr. = ?
Plasma— Plasma— Mitotic spindle apparatus antibody(Immunoglobulin G); Motilin; arbitrary substance concentration(procedure) substance concentration(procedure) arbitrary unit/litre picomol/litre NPU12585 M = 2 700 g/mol P—Mitotic spindle apparatus antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l NPU08961 P—Motilin; subst.c.(proc.) = ? pmol/l Plasma— Mitotic spindle apparatus antibody; arbitrary concentration(procedure) NPU02835 P—Mitotic spindle apparatus antibody; arb.c.(proc.) = ?
113 Plasma— Blood fraction(specification)— Motoric neuropathy antibody; Myeloblasts; property(list; procedure) number concentration NPU14517 109/litre P—Motoric neuropathy antibody; prop.(list; proc.) NPU17608 NPU14521 P—Motoric neuropathy(GM1) antibody; arb.subst.c.(proc.) = ? × 10³ B fract.(spec.)—Myeloblasts; num.c. = ? × 109/l arb.unit/l NPU14518 P—Motoric neuropathy(GM1-asialo) antibody; arb.subst.c.(proc.) Bone marrow— = ? × 10³ arb.unit/l Myeloblasts; NPU14519 P—Motoric neuropathy(GD1a) antibody; arb.subst.c.(proc.) = ? × number concentration 10³ arb.unit/l 109/litre NPU14520 P—Motoric neuropathy(GD1b) antibody; arb.subst.c.(proc.) = ? × NPU04679 10³ arb.unit/l Marrow—Myeloblasts; num.c. = ? × 109/l NPU14522 P—Motoric neuropathy(GQ1b) antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l Leukocytes(Blood)— NPU14526 P—Myeline associated glycoprotein antibody(IgM); arb.subst.c. Myeloblasts; (proc.) = ? × 10³ arb.unit/l number fraction NPU14523 P—Neuropathy M-component; arb.c.(IFE; proc.) = ? NPU03969 NPU14525 P—Neuropathy(SGPG)-antibody(IgM); arb.subst.c.(proc.) = ? × 10³ Lkcs(B)—Myeloblasts; num.fr. = ? arb.unit/l Leukocytes(Bone marrow)— Plasma— Myeloblasts; Motoric neuropathy(GD1a) antibody; number fraction arbitrary substance concentration(procedure) NPU04680 10³ arbitrary unit/litre Lkcs(Marrow)—Myeloblasts; num.fr. = ? NPU14519 P—Motoric neuropathy(GD1a) antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l Blood— Myelocytes(eosinophil); Plasma— number concentration Motoric neuropathy(GD1b) antibody; 109/litre arbitrary substance concentration(procedure) NPU04704 10³ arbitrary unit/litre B—Myelocytes(eosinophil); num.c. = ? × 109/l NPU14520 P—Motoric neuropathy(GD1b) antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l Blood fraction(specification)— Myelocytes(eosinophil); Plasma— number concentration Motoric neuropathy(GM1) antibody; 109/litre arbitrary substance concentration(procedure) NPU17609 10³ arbitrary unit/litre B fract.(spec.)—Myelocytes(eosinophil); num.c. = ? × 109/l NPU14521 P—Motoric neuropathy(GM1) antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l Bone marrow— Myelocytes(eosinophil); Plasma— number concentration Motoric neuropathy(GM1-asialo) antibody; 109/litre arbitrary substance concentration(procedure) NPU03994 10³ arbitrary unit/litre Marrow—Myelocytes(eosinophil); num.c. = ? × 109/l NPU14518 P—Motoric neuropathy(GM1-asialo) antibody; arb.subst.c.(proc.) = ? × 10³ Leukocytes(Blood)— arb.unit/l Myelocytes(eosinophil); number fraction Plasma— NPU04705 Motoric neuropathy(GQ1b) antibody; Lkcs(B)—Myelocytes(eosinophil); num.fr. = ? arbitrary substance concentration(procedure) 10³ arbitrary unit/litre Leukocytes(Bone marrow)— NPU14522 Myelocytes(eosinophil); P—Motoric neuropathy(GQ1b) antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l number fraction NPU04987 Plasma— Lkcs(Marrow)—Myelocytes(eosinophil); num.fr. = ? Mycophenolate; substance concentration Blood— micromol/litre Myelocytes(neutrophil); NPU17173 number concentration P—Mycophenolate; subst.c. = ? µmol/l 109/litre NPU04706 Cerebrospinal fluid— B—Myelocytes(neutrophil); num.c. = ? × 109/l Myelin basic protein; mass concentration Blood fraction(specification)— microgram/litre Myelocytes(neutrophil); NPU09340 number concentration Csf—Myelin basic protein; mass c. = ? µg/l 109/litre NPU17610 Plasma— B fract.(spec.)—Myelocytes(neutrophil); num.c. = ? × 109/l Myeline associated glycoprotein antibody(Immunoglobulin M); arbitrary substance concentration(procedure) Bone marrow— 10³ arbitrary unit/litre Myelocytes(neutrophil); NPU14526 number concentration P—Myeline associated glycoprotein antibody(IgM); arb.subst.c.(proc.) = ? × 10³ 109/litre arb.unit/l NPU04089 Marrow—Myelocytes(neutrophil); num.c. = ? × 109/l Blood— Myeloblasts; Leukocytes(Blood)— number concentration Myelocytes(neutrophil); 109/litre number fraction NPU03970 NPU04707 B—Myeloblasts; num.c. = ? × 109/l Lkcs(B)—Myelocytes(neutrophil); num.fr. = ?
114 Leukocytes(Bone marrow)— Urine— Myelocytes(neutrophil); Myoglobin; number fraction substance concentration NPU04986 nanomol/litre Lkcs(Marrow)—Myelocytes(neutrophil); num.fr. = ? M = 17 200 g/mol NPU17416 Blood— U—Myoglobin; subst.c. = ? nmol/l Myelocytes; number concentration Blood— 109/litre Naked nuclei; NPU03976 number concentration B—Myelocytes; num.c. = ? × 109/l 109/litre NPU17597 Blood fraction(specification)— B—Naked nuclei; num.c. = ? × 109/l Myelocytes; number concentration Blood fraction(specification)— 109/litre Naked nuclei; NPU17611 number concentration B fract.(spec.)—Myelocytes; num.c. = ? × 109/l 109/litre NPU17630 Bone marrow— B fract.(spec.)—Naked nuclei; num.c. = ? × 109/l Myelocytes; number concentration Leukocytes(Blood)— 109/litre Naked nuclei; NPU14381 number fraction Marrow—Myelocytes; num.c. = ? × 109/l NPU17619 Lkcs(B)—Naked nuclei; num.fr. = ? Leukocytes(Blood)— Myelocytes; Plasma— number fraction Neuron specific enolase; NPU03975 arbitrary substance concentration(procedure) Lkcs(B)—Myelocytes; num.fr. = ? arbitrary unit/litre NPU12998 Leukocytes(Bone marrow)— P—Neuron specific enolase; arb.subst.c.(proc.) = ? arb.unit/l Myelocytes; number fraction Plasma— NPU14380 Neuron(CNS-lupus) antibody(Immunoglobulin G); Lkcs(Marrow)—Myelocytes; num.fr. = ? arbitrary concentration(procedure) NPU14541 Plasma— P—Neuron(CNS-lupus) antibody(IgG); arb.c.(proc.) = ? Myeloperoxidase antibody(Immunoglobulin G); arbitrary concentration(procedure) Plasma— Other term(s): MPO antibody Neuronal cell nucleus(Hu)-antistof(Immunoglobulin G); NPU12575 arbitrary substance concentration(procedure) P—Myeloperoxidase antibody(IgG); arb.c.(proc.) = ? 10³ arbitrary unit/litre NPU14542 Plasma— P—Neuronal cell nucleus(Hu)-antistof(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Myeloperoxidase antibody(Immunoglobulin G); arbitrary substance concentration(procedure) Plasma— 10³ arbitrary unit/litre Neuropathy antibody; Other term(s): MPO antibody property(list; procedure) NPU12036 NPU14527 P—Myeloperoxidase antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l P—Neuropathy antibody; prop.(list; proc.) NPU14518 P—Motoric neuropathy(GM1-asialo) antibody; arb.subst.c.(proc.) Urine— = ? × 10³ arb.unit/l Myoglobin; NPU14519 P—Motoric neuropathy(GD1a) antibody; arb.subst.c.(proc.) = ? × arbitrary concentration(procedure) 10³ arb.unit/l M = 17 200 g/mol NPU14520 P—Motoric neuropathy(GD1b) antibody; arb.subst.c.(proc.) = ? × NPU09016 10³ arb.unit/l U—Myoglobin; arb.c.(proc.) = ? NPU14521 P—Motoric neuropathy(GM1) antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l Plasma— NPU14522 P—Motoric neuropathy(GQ1b) antibody; arb.subst.c.(proc.) = ? × Myoglobin; 10³ arb.unit/l substance concentration NPU14523 P—Neuropathy M-component; arb.c.(IFE; proc.) = ? micromol/litre NPU14526 P—Myeline associated glycoprotein antibody(IgM); arb.subst.c. M = 17 200 g/mol (proc.) = ? × 10³ arb.unit/l NPU02854 NPU14525 P—Neuropathy(SGPG)-antibody(IgM); arb.subst.c.(proc.) = ? × 10³ P—Myoglobin; subst.c. = ? µmol/l arb.unit/l NPU14528 P—Sensoric neuropathy(Hu) antibody(IgG); arb.subst.c.(proc.) = ? Urine— × 10³ arb.unit/l Myoglobin; NPU14529 P—Sensoric neuropathy(sulfatid) antibody; arb.subst.c.(proc.) = ? × substance concentration 10³ arb.unit/l micromol/litre M = 17 200 g/mol Plasma— NPU03901 Neuropathy M-component; U—Myoglobin; subst.c. = ? µmol/l arbitrary concentration(IFE; procedure) NPU14523 Plasma— P—Neuropathy M-component; arb.c.(IFE; proc.) = ? Myoglobin; substance concentration Plasma— nanomol/litre Neuropathy(SGPG)-antibody(Immunoglobulin M); M = 17 200 g/mol arbitrary substance concentration(procedure) NPU17415 10³ arbitrary unit/litre P—Myoglobin; subst.c. = ? nmol/l NPU14525 P—Neuropathy(SGPG)-antibody(IgM); arb.subst.c.(proc.) = ? × 10³ arb.unit/l
115 Plasma(fasting Patient)— Plasma— Neuropeptide K; Neutrophilocyte cytoplasm antibody(Immunoglobulin G); substance concentration arbitrary substance concentration(list; procedure) picomol/litre NPU16402 NPU14024 P—Neutrophilocyte cytoplasm antibody(IgG); arb.subst.c.(list; proc.) P(fPt)—Neuropeptide K; subst.c. = ? pmol/l NPU12010 P—Neutrophilocyte cytoplasm antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l Urine— NPU14533 P—Neutrophilocyte peripheral cytoplasma antibody(IgG); Neuropeptide K; arb.subst.c.(proc.) = ? arb.unit/l substance concentration picomol/litre Plasma— NPU14025 Neutrophilocyte cytoplasm antibody(Immunoglobulin G); U—Neuropeptide K; subst.c. = ? pmol/l arbitrary substance concentration(procedure) arbitrary unit/litre Patient(Urine)— NPU12010 Neuropeptide K; P—Neutrophilocyte cytoplasm antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l substance rate picomol/day Plasma— NPU14026 Neutrophilocyte cytoplasm antibody; Pt(U)—Neuropeptide K; subst.rate = ? pmol/d arbitrary concentration(procedure) NPU02899 Plasma— P—Neutrophilocyte cytoplasm antibody; arb.c.(proc.) = ? Neuropeptide Y; substance concentration Plasma— picomol/litre Neutrophilocyte cytoplasm antibody; NPU10616 arbitrary substance concentration(procedure) P—Neuropeptide Y; subst.c. = ? pmol/l arbitrary unit/litre NPU12011 Urine— P—Neutrophilocyte cytoplasm antibody; arb.subst.c.(proc.) = ? arb.unit/l Neuropeptide Y; substance concentration Plasma— picomol/litre Neutrophilocyte cytoplasmatic cytoplasma antibody(Immunoglobulin G); NPU14019 arbitrary concentration(procedure) U—Neuropeptide Y; subst.c. = ? pmol/l NPU14531 P—Neutrophilocyte cytoplasmatic cytoplasma antibody(IgG); arb.c.(proc.) = ? Patient(Urine)— Neuropeptide Y; Plasma— substance rate Neutrophilocyte peripheral cytoplasma antibody(Immunoglobulin G); picomol/day arbitrary concentration(procedure) NPU14020 NPU14532 Pt(U)—Neuropeptide Y; subst.rate = ? pmol/d P—Neutrophilocyte peripheral cytoplasma antibody(IgG); arb.c.(proc.) = ?
Plasma(fasting Patient)— Plasma— Neurotensin; Neutrophilocyte peripheral cytoplasma antibody(Immunoglobulin G); substance concentration arbitrary substance concentration(procedure) picomol/litre arbitrary unit/litre NPU14021 NPU14533 P(fPt)—Neurotensin; subst.c. = ? pmol/l P—Neutrophilocyte peripheral cytoplasma antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l Urine— Neurotensin; Plasma— substance concentration Neutrophilocyte proteinase 3(Immunoglobulin G); picomol/litre arbitrary substance concentration(procedure) NPU14022 arbitrary unit/litre U—Neurotensin; subst.c. = ? pmol/l Other term(s): anti-Pr3: Pr3-ANCA NPU12012 Patient(Urine)— P—Neutrophilocyte proteinase 3(IgG); arb.subst.c.(proc.) = ? arb.unit/l Neurotensin; substance rate Blood— picomol/day Neutrophilocytes(band); NPU14023 number concentration Pt(U)—Neurotensin; subst.rate = ? pmol/d 109/litre NPU03980 Plasma— B—Neutrophilocytes(band); num.c. = ? × 109/l Neutrophilocyte antibody; arbitrary concentration(procedure) Blood fraction(specification)— NPU02898 Neutrophilocytes(band); P—Neutrophilocyte antibody; arb.c.(proc.) = ? number concentration 109/litre Plasma— NPU17613 Neutrophilocyte cytoplasm antibody(Immunoglobulin G); B fract.(spec.)—Neutrophilocytes(band); num.c. = ? × 109/l arbitrary concentration(list; procedure) NPU16401 Bone marrow— P—Neutrophilocyte cytoplasm antibody(IgG); arb.c.(list; proc.) Neutrophilocytes(band); NPU14530 P—Neutrophilocyte cytoplasm antibody(IgG); arb.c.(proc.) = ? number concentration NPU14531 P—Neutrophilocyte cytoplasmatic cytoplasma antibody(IgG); arb.c. 109/litre (proc.) = ? NPU04683 NPU14532 P—Neutrophilocyte peripheral cytoplasma antibody(IgG); arb.c. Marrow—Neutrophilocytes(band); num.c. = ? × 109/l (proc.) = ? Leukocytes(Blood)— Plasma— Neutrophilocytes(band); Neutrophilocyte cytoplasm antibody(Immunoglobulin G); number fraction arbitrary concentration(procedure) NPU03979 NPU14530 Lkcs(B)—Neutrophilocytes(band); num.fr. = ? P—Neutrophilocyte cytoplasm antibody(IgG); arb.c.(proc.) = ? Leukocytes(Bone marrow)— Neutrophilocytes(band); number fraction NPU04684 Lkcs(Marrow)—Neutrophilocytes(band); num.fr. = ?
116 Leukocytes(Ascites)— Blood— Neutrophilocytes; Neutrophilocytes(segmented); number fraction morphology(procedure) NPU10756 NPU17069 Lkcs(Asc)—Neutrophilocytes; num.fr.= ? B—Neutrophilocytes(segmented); morphology(proc.) = ? Leukocytes(Blood)— Blood— Neutrophilocytes; Neutrophilocytes(segmented); number fraction number concentration NPU03983 109/litre Lkcs(B)—Neutrophilocytes; num.fr. = ? NPU03982 B—Neutrophilocytes(segmented); num.c. = ? × 109/l Leukocytes(Cerebrospinal fluid)— Neutrophilocytes; Blood fraction(specification)— number fraction Neutrophilocytes(segmented); NPU04226 number concentration Lkcs(Csf)—Neutrophilocytes; num.fr.= ? 109/litre NPU17612 Leukocytes(Pericardial fluid)— B fract.(spec.)—Neutrophilocytes(segmented); num.c. = ? × 109/l Neutrophilocytes; number fraction Bone marrow— NPU10759 Neutrophilocytes(segmented); Lkcs(Pericardialf.)—Neutrophilocytes; num.fr.= ? number concentration 109/litre Leukocytes(Pleural fluid; specification)— NPU04681 Neutrophilocytes; Marrow—Neutrophilocytes(segmented); num.c. = ? × 109/l number fraction NPU10753 Leukocytes(Blood)— Lkcs(Plf; spec.)—Neutrophilocytes; num.fr.= ? Neutrophilocytes(segmented); number fraction Leukocytes(Synovial fluid; specification)— NPU03981 Neutrophilocytes; Lkcs(B)—Neutrophilocytes(segmented); num.fr. = ? number fraction NPU10752 Leukocytes(Bone marrow)— Lkcs(Synf; spec.)—Neutrophilocytes; num.fr.= ? Neutrophilocytes(segmented); number fraction Plasma— NPU04682 Nickel; Lkcs(Marrow)—Neutrophilocytes(segmented); num.fr. = ? substance concentration nanomol/litre Urine— M = 58,71 g/mol Neutrophilocytes; Authority: IUPAC/VII-C-TOX number concentration(procedure) NPU02906 106/litre P—Nickel; subst.c. = ? nmol/l NPU02904 U—Neutrophilocytes; num.c.(proc.) = ? × 106/l Urine— Nickel; Ascites— substance concentration Neutrophilocytes; nanomol/litre number concentration M = 58,71 g/mol 106/litre Authority: IUPAC/VII-C-TOX NPU08655 NPU02907 Asc—Neutrophilocytes; num.c. = ? × 106/l U—Nickel; subst.c. = ? nmol/l
Cerebrospinal fluid— Hair— Neutrophilocytes; Nickel; number concentration substance content 106/litre micromol/kilogram NPU02903 M = 58,71 g/mol Csf—Neutrophilocytes; num.c. = ? × 106/l Authority: IUPAC/VII-C-TOX NPU02905 Pleural fluid(specification)— Hair—Nickel; subst.cont. = ? µmol/kg Neutrophilocytes; number concentration Plasma— 106/litre Nitrate; NPU08654 substance concentration Plf(spec.)—Neutrophilocytes; num.c. = ? × 106/l micromol/litre NPU03851 Synovial fluid(specification)— P—Nitrate; subst.c. = ? µmol/l Neutrophilocytes; number concentration Plasma— 106/litre Nitrite; NPU04230 substance concentration Synf(spec.)—Neutrophilocytes; num.c.= ? × 106/l micromol/litre NPU03852 Blood— P—Nitrite; subst.c. = ? µmol/l Neutrophilocytes; number concentration Urine— 109/litre Nitrogen(N); NPU02902 amount-of-substance(procedure) B—Neutrophilocytes; num.c. = ? × 109/l millimol NPU04083 Blood fraction(specification)— U—Nitrogen(N); am.s.(proc.) = ? mmol Neutrophilocytes; number concentration Patient(Urine)— 109/litre Nitrogen(N); NPU17584 substance rate(procedure) B fract.(spec.)—Neutrophilocytes; num.c. = ? × 109/l millimol/day NPU02917 Pt(U)—Nitrogen(N); subst.rate(proc.) = ? mmol/d
117 Plasma— Urine— Nucleus antibody(Immunoglobulin G); Noradrenalinium; arbitrary concentration(list; procedure) amount-of-substance(procedure) NPU09330 micromol P—Nucleus antibody(IgG); arb.c.(list; proc.) NPU17585 NPU01518 P—Centromer antibody(IgG); arb.c.(proc.) = ? U—Noradrenalinium; am.s.(proc.) = ? µmol NPU12017 P—Mitotic spindle apparatus antibody(IgG); arb.c.(proc.) = ? NPU12013 P—Nucleolus antibody(IgG); arb.c.(proc.) = ? Plasma— NPU14534 P—Nucleus(homogeneous staining)-antibody(IgG); arb.c.(proc.) = ? Noradrenalinium; NPU14535 P—Nucleus(dot staining)-antibody(IgG); arb.c.(proc.) = ? substance concentration NPU12018 P—Nucleus antibody(IgG); arb.c.(proc.) = ? micromol/litre NPU01481 P—Nucleus antibody; arb.c.(proc.) = ? M = 169,18 g/mol NPU12582 P—Nucleolus membrane antibody(IgG); arb.c.(proc.) = ? NPU17115 NPU12016 P—Nucleus dot antibody(IgG); arb.c.(proc.) = ? P—Noradrenalinium; subst.c. = ? µmol/l NPU03254 P—Proliferating cell nucleus antibody(IgG); arb.c.(proc.) = ?
Urine— Plasma— Noradrenalinium; Nucleus antibody(Immunoglobulin G); substance concentration arbitrary concentration(procedure) micromol/litre NPU12018 NPU17116 P—Nucleus antibody(IgG); arb.c.(proc.) = ? U—Noradrenalinium; subst.c. = ? µmol/l Plasma— Patient(Urine)— Nucleus antibody(Immunoglobulin G); Noradrenalinium; arbitrary substance concentration(procedure) substance rate(procedure) arbitrary unit/litre micromol/day Authority: IFCC92 NPU17114 NPU14127 Pt(U)—Noradrenalinium; subst.rate(proc.) = ? µmol/d P—Nucleus antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l
Plasma— Plasma— Nucleolus antibody(Immunoglobulin G); Nucleus antibody; arbitrary concentration(procedure) arbitrary concentration(procedure) Other term(s): ANA: Authority: IFCC92 NPU12013 NPU01481 P—Nucleolus antibody(IgG); arb.c.(proc.) = ? P—Nucleus antibody; arb.c.(proc.) = ?
Plasma— Plasma— Nucleolus antibody(Immunoglobulin G); Nucleus antibody; arbitrary substance concentration(procedure) arbitrary substance concentration(list; procedure) arbitrary unit/litre NPU09331 NPU12583 P—Nucleus antibody; arb.subst.c.(list; proc.) P—Nucleolus antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l NPU12015 P—Centromer antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l NPU12585 P—Mitotic spindle apparatus antibody(IgG); arb.subst.c.(proc.) = ? Plasma— arb.unit/l Nucleolus antibody; NPU12583 P—Nucleolus antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l arbitrary concentration(procedure) NPU14536 P—Nucleus(homogeneous staining)-antibody(IgG); arb.subst.c. NPU02925 (proc.) = ? arb.unit/l P—Nucleolus antibody; arb.c.(proc.) = ? NPU14537 P—Nucleus(dot staining)-antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l Plasma— NPU14127 P—Nucleus antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l Nucleolus antibody; NPU14126 P—Nucleus antibody; arb.subst.c.(proc.) = ? arb.unit/l arbitrary substance concentration(procedure) NPU12587 P—Nucleolus membrane antibody(IgG); arb.subst.c.(proc.) = ? arbitrary unit/litre arb.unit/l NPU14125 NPU12586 P—Nucleus dot antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l P—Nucleolus antibody; arb.subst.c.(proc.) = ? arb.unit/l NPU12584 P—Proliferating cell nucleus antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l Plasma— Nucleolus membrane antibody(Immunoglobulin G); Plasma— arbitrary concentration(procedure) Nucleus antibody; NPU12582 arbitrary substance concentration(procedure) P—Nucleolus membrane antibody(IgG); arb.c.(proc.) = ? arbitrary unit/litre Authority: IFCC92 Plasma— NPU14126 Nucleolus membrane antibody(Immunoglobulin G); P—Nucleus antibody; arb.subst.c.(proc.) = ? arb.unit/l arbitrary substance concentration(procedure) arbitrary unit/litre Plasma— NPU12587 Nucleus dot antibody(Immunoglobulin G); P—Nucleolus membrane antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l arbitrary concentration(procedure) NPU12016 Amniotic fluid— P—Nucleus dot antibody(IgG); arb.c.(proc.) = ? 5'- Nucleotidase; Plasma— catalytic-activity concentration(37 °C; procedure) Nucleus dot antibody(Immunoglobulin G); nanokatal/litre arbitrary substance concentration(procedure) NPU03915 arbitrary unit/litre Amf—5'-Nucleotidase; cat.c.(37 °C; proc.) = ? nkat/l NPU12586 P—Nucleus dot antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l Plasma— 5'- Plasma— Nucleotidase; Nucleus(dot staining)-antibody(Immunoglobulin G); catalytic-activity concentration(37 °C; procedure) arbitrary concentration(procedure) nanokatal/litre NPU14535 NPU02926 P—Nucleus(dot staining)-antibody(IgG); arb.c.(proc.) = ? P—5'-Nucleotidase; cat.c.(37 °C; proc.) = ? nkat/l
118 Plasma— Urine— Nucleus(dot staining)-antibody(Immunoglobulin G); Orotate; arbitrary substance concentration(procedure) substance concentration arbitrary unit/litre mol/litre NPU14537 NPU02949 P—Nucleus(dot staining)-antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l U—Orotate; subst.c.= ? prefix ? mol/l
Plasma— Blood— Nucleus(homogeneous staining)-antibody(Immunoglobulin G); Osmotic pressure reaction; arbitrary concentration(procedure) arbitrary concentration(Free Haemoglobin/all Haemoglobin = 0,5; 37 °C; NPU14534 pH = 7,40; 0 hours; procedure) P—Nucleus(homogeneous staining)-antibody(IgG); arb.c.(proc.) = ? Other term(s): Osmotic resistance NPU02966 Plasma— B—Osmotic pressure reaction; arb.c.(Free Hb/all Hb = 0,5; 37 °C; pH = 7,40; 0 Nucleus(homogeneous staining)-antibody(Immunoglobulin G); h; proc.) = ? arbitrary substance concentration(procedure) arbitrary unit/litre Blood— NPU14536 Osmotic pressure reaction; P—Nucleus(homogeneous staining)-antibody(IgG); arb.subst.c.(proc.) = ? arbitrary concentration(Free Haemoglobin/all Haemoglobin = 0,5; 37 °C; arb.unit/l pH = 7,40; 24 hours; procedure) Other term(s): Osmotic resistance Patient— NPU02967 Octreotide(administered); B—Osmotic pressure reaction; arb.c.(Free Hb/all Hb = 0,5; 37 °C; pH = 7,40; 24 amount-of-substance(subcutanous administration) h; proc.) = ? nanomol M = 1 019,26 g/mol Plasma— Other term(s): Sandostatin; Longastatin Osteocalcin; NPU10638 substance concentration Pt—Octreotide(administered); am.s.(s.c.) = ? nmol nanomol/litre M = 5 845 g/mol Patient— Other term(s): Bone-GLA-protein Octreotide(administered); NPU02968 substance content(subcutanous administration; amount-of- P—Osteocalcin; subst.c. = ? nmol/l substance/body mass) nanomol/kilogram Plasma— M = 1 019,26 g/mol Osteonectin; Other term(s): Sandostatin; Longastatin substance concentration NPU10639 mol/litre Pt—Octreotide(administered); subst.cont.(s.c.; am.s./body mass) = ? nmol/kg NPU02969 P—Osteonectin; subst.c.= ? prefix ? mol/l Urine— Ornithine/Creatininium; Plasma— substance ratio Ovary antibody(Immunoglobulin G); 10-3 arbitrary concentration(procedure) NPU14240 NPU14538 U—Ornithine/Creatininium; subst.ratio = ? × 10-3 P—Ovary antibody(IgG); arb.c.(proc.) = ?
Cerebrospinal fluid— Calculus(Urine)— Ornithine; Oxalate; substance concentration arbitrary content(procedure) micromol/litre NPU09231 M = 132,16 g/mol Calculus(U)—Oxalate; arb.cont.(proc.) = ? NPU09031 Csf—Ornithine; subst.c. = ? µmol/l Plasma— Oxalate; Plasma— substance concentration Ornithine; micromol/litre substance concentration NPU02970 micromol/litre P—Oxalate; subst.c. = ? µmol/l M = 132,16 g/mol NPU02936 Urine— P—Ornithine; subst.c. = ? µmol/l Oxalate; substance concentration Urine— micromol/litre Ornithine; NPU02971 substance concentration U—Oxalate; subst.c. = ? µmol/l micromol/litre M = 132,16 g/mol Calculus(Urine)— NPU02937 Oxalate; U—Ornithine; subst.c. = ? µmol/l substance content mol/kilogram Urine— NPU09237 Orosomucoid/Creatininium; Calculus(U)—Oxalate; subst.cont. = ? mol/kg substance ratio 10-3 Patient(Urine)— NPU10195 Oxalate; U—Orosomucoid/Creatininium; subst.ratio = ? × 10-3 substance rate(procedure) micromol/day Plasma— NPU03951 Orosomucoid; Pt(U)—Oxalate; subst.rate(proc.) = ? µmol/d substance concentration micromol/litre Urine— M = 40 000 g/mol Oxoglutarate; Other term(s): alpha-1 acid glycoprotein substance concentration NPU02948 micromol/litre P—Orosomucoid; subst.c. = ? µmol/l NPU02986 U—Oxoglutarate; subst.c. = ? µmol/l
119 Urine— Gas(cord Blood; arterial Blood)— 2- Oxygen(O2); Oxo-isocaproate; partial pressure substance concentration kilopascal mol/litre NPU17170 M = 130,14 g/mol Gas(cordB; aB)—Oxygen(O2); part.pr. = ? kPa NPU02977 U—2-Oxo-isocaproate; subst.c.= ? prefix ? mol/l Gas(cord Blood; venous Blood)— Oxygen(O2); Urine— partial pressure 17- kilopascal Oxosteroid; NPU17171 substance concentration(list; procedure) Gas(cordB; vB)—Oxygen(O2); part.pr. = ? kPa NPU09096 U—17-Oxosteroid; subst.c.(list; proc.) Gas(mixed Blood)— NPU09097 U—Androsterone; subst.c. = ? nmol/l Oxygen(O2); NPU02013 U—Etiocholanolone; subst.c. = ? µmol/l partial pressure NPU01855 U—Prasterone; subst.c. = ? nmol/l kilopascal Authority: IFCC/C-BGE Urine— NPU09214 17- Gas(mixB)—Oxygen(O2); part.pr. = ? kPa Oxosteroid; substance concentration Gas(specification)— micromol/litre Oxygen(O2); NPU09361 partial pressure U—17-Oxosteroid; subst.c. = ? µmol/l kilopascal Authority: IFCC/C-BGE Patient(Urine)— NPU10203 17- Gas(spec.)—Oxygen(O2); part.pr. = ? kPa Oxosteroid; substance rate(list; procedure) Gas(venous Blood)— NPU10136 Oxygen(O2); Pt(U)—17-Oxosteroid; subst.rate(list; proc.) partial pressure NPU10133 Pt(U)—Androsterone; subst.rate = ? nmol/d kilopascal NPU10134 Pt(U)—Etiocholanolone; subst.rate = ? µmol/d Authority: IFCC/C-BGE NPU09095 Pt(U)—17-Oxosteroid; subst.rate(proc.) = ? µmol/d NPU03847 NPU10135 Pt(U)—Prasterone; subst.rate = ? nmol/d Gas(vB)—Oxygen(O2); part.pr. = ? kPa
Patient(Urine)— Haemoglobin(total; arterial Blood)— 17- Oxygen(O2); Oxosteroid; saturation fraction substance rate(procedure) Authority: IFCC/C-BGE micromol/day NPU03011 NPU09095 Hb(tot.; aB)—Oxygen(O2); sat.fr. = ? Pt(U)—17-Oxosteroid; subst.rate(proc.) = ? µmol/d Haemoglobin(total; capillary Blood)— Patient— Oxygen(O2); Oxygen(administered); saturation fraction volume rate Authority: IFCC/C-BGE litre/minute NPU10197 NPU10167 Hb(tot.; cB)—Oxygen(O2); sat.fr. = ? Pt—Oxygen(administered); vol.rate = ? l/min Haemoglobin(total; cord Blood)— Air(respiratory system)— Oxygen(O2); Oxygen(O2); saturation fraction partial pressure NPU12508 kilopascal Hb(tot.; cordB)—Oxygen(O2); sat.fr. = ? Authority: IFCC/C-BGE NPU03006 Haemoglobin(total; mixed Blood)— Air(resp.syst.)—Oxygen(O2); part.pr. = ? kPa Oxygen(O2); saturation fraction Air(specification)— Authority: IFCC/C-BGE Oxygen(O2); NPU09218 partial pressure Hb(tot.; mixB)—Oxygen(O2); sat.fr. = ? kilopascal NPU03814 Haemoglobin(total; venous Blood)— Air(spec.)—Oxygen(O2); part.pr. = ? kPa Oxygen(O2); saturation fraction Gas(arterial Blood)— Authority: IFCC/C-BGE Oxygen(O2); NPU10199 partial pressure Hb(tot.; vB)—Oxygen(O2); sat.fr. = ? kilopascal Authority: IFCC/C-BGE Plasma(arterial Blood)— NPU03009 Oxygen(O2); Gas(aB)—Oxygen(O2); part.pr. = ? kPa gas tension(patient body temperature) kilopascal Gas(capillary Blood)— Authority: IFCC/C-BGE Oxygen(O2); Note: _M_ = 16,00 x 2 g/mol for O2 partial pressure NPU14104 kilopascal P(aB)—Oxygen(O2); tension(body temp.) = ? kPa NPU12514 Gas(cB)—Oxygen(O2); part.pr. = ? kPa Haemoglobin(Blood)— Oxygen(O2); Gas(cord Blood)— gas tension(at halfsaturation) Oxygen(O2); kilopascal partial pressure Authority: IFCC/C-BGE kilopascal Note: _M_ = 16,00 x 2 g/mol for O2 NPU12513 NPU03010 Gas(cordB)—Oxygen(O2); part.pr. = ? kPa Hb(B)—Oxygen(O2); tension(halfsat.) = ? kPa
120 Plasma(arterial Blood)— Plasma(cord Blood)— Oxygen(O2); Oxygen(O2; free); gas tension substance concentration kilopascal millimol/litre Authority: IFCC/C-BGE NPU12478 Note: _M_ = 16,00 x 2 g/mol for O2 P(cordB)—Oxygen(O2; free); subst.c. = ? mmol/l NPU08977 P(aB)—Oxygen(O2); tension = ? kPa Plasma(cord Blood; arterial Blood)— Oxygen(O2; free); Plasma(capillary Blood)— substance concentration Oxygen(O2); millimol/litre gas tension Authority: IFCC/C-BGE kilopascal Note: _M_ = 16,00 x 2 g/mol for O2 NPU12500 NPU17157 P(cB)—Oxygen(O2); tension = ? kPa P(cordB; aB)—Oxygen(O2; free); subst.c. = ? mmol/l
Plasma(cord Blood)— Plasma(cord Blood; venous Blood)— Oxygen(O2); Oxygen(O2; free); gas tension substance concentration kilopascal millimol/litre NPU12502 Authority: IFCC/C-BGE P(cordB)—Oxygen(O2); tension = ? kPa Note: _M_ = 16,00 x 2 g/mol for O2 NPU17158 Plasma(cord Blood; arterial Blood)— P(cordB; vB)—Oxygen(O2; free); subst.c. = ? mmol/l Oxygen(O2); gas tension Plasma(mixed Blood)— kilopascal Oxygen(O2; free); NPU17155 substance concentration P(cordB; aB)—Oxygen(O2); tension = ? kPa millimol/litre Authority: IFCC/C-BGE Plasma(cord Blood; venous Blood)— Note: _M_ = 16,00 x 2 g/mol for O2 Oxygen(O2); NPU09216 gas tension P(mixB)—Oxygen(O2; free); subst.c. = ? mmol/l kilopascal NPU17156 Plasma(venous Blood)— P(cordB; vB)—Oxygen(O2); tension = ? kPa Oxygen(O2; free); substance concentration Plasma(mixed Blood)— millimol/litre Oxygen(O2); NPU12504 gas tension P(vB)—Oxygen(O2; free); subst.c. = ? mmol/l kilopascal Authority: IFCC/C-BGE Blood(arterial Blood)— Note: _M_ = 16,00 x 2 g/mol for O2 Oxygen(O2; total); NPU09215 substance concentration P(mixB)—Oxygen(O2); tension = ? kPa millimol/litre Authority: IFCC/C-BGE Plasma(venous Blood)— Note: _M_ = 16,00 x 2 g/mol for O2 Oxygen(O2); NPU03849 gas tension B(aB)—Oxygen(O2; total); subst.c. = ? mmol/l kilopascal NPU12501 Blood(capillary Blood)— P(vB)—Oxygen(O2); tension = ? kPa Oxygen(O2; total); substance concentration Air(expired)— millimol/litre Oxygen(O2); NPU12506 volume fraction B(cB)—Oxygen(O2; total); subst.c. = ? mmol/l Authority: IFCC/C-BGE Note: _M_ = 16,00 x 2 g/mol for O2 Blood(cord Blood)— NPU03008 Oxygen(O2; total); Air(expired)—Oxygen(O2); vol.fr. = ? substance concentration millimol/litre Air(specification)— NPU12505 Oxygen(O2); B(cordB)—Oxygen(O2; total); subst.c. = ? mmol/l volume fraction Authority: IFCC/C-BGE Blood(mixed Blood)— Note: _M_ = 16,00 x 2 g/mol for O2 Oxygen(O2; total); NPU03007 substance concentration Air(spec.)—Oxygen(O2); vol.fr. = ? millimol/litre Authority: IFCC/C-BGE Plasma(arterial Blood)— Note: _M_ = 16,00 x 2 g/mol for O2 Oxygen(O2; free); NPU09217 substance concentration B(mixB)—Oxygen(O2; total); subst.c. = ? mmol/l millimol/litre Authority: IFCC/C-BGE Blood(venous Blood)— Note: _M_ = 16,00 x 2 g/mol for O2 Oxygen(O2; total); NPU03012 substance concentration P(aB)—Oxygen(O2; free); subst.c. = ? mmol/l millimol/litre NPU12507 Plasma(capillary Blood)— B(vB)—Oxygen(O2; total); subst.c. = ? mmol/l Oxygen(O2; free); substance concentration Cerebrospinal fluid— millimol/litre Oxyhaemoglobin(Fe); NPU12503 arbitrary substance concentration(procedure) P(cB)—Oxygen(O2; free); subst.c. = ? mmol/l arbitrary unit/litre NPU14145 Csf—Oxyhaemoglobin(Fe); arb.subst.c.(proc.) = ? arb.unit/l
121 Haemoglobin(Fe; deoxy+oxy; arterial Blood)— Plasma— Oxyhaemoglobin(Fe); Pancreatic beta-cell antibody; substance fraction arbitrary concentration(procedure) Authority: IFCC/C-BGE Other term(s): Islet beta-cell antibody NPU03014 NPU02509 Hb(Fe; deoxy+oxy; aB)—Oxyhaemoglobin(Fe); subst.fr. = ? P—Pancreatic beta-cell antibody; arb.c.(proc.) = ?
Haemoglobin(Fe; deoxy+oxy; capillary Blood)— Faeces— Oxyhaemoglobin(Fe); Pancreatic elastase I; substance fraction catalytic-activity content NPU12510 microkatal/kilogram Hb(Fe; deoxy+oxy; cB)—Oxyhaemoglobin(Fe); subst.fr. = ? NPU17186 F—Pancreatic elastase I; cat.cont. = ? µkat/kg Haemoglobin(Fe; deoxy+oxy; cord Blood)— Oxyhaemoglobin(Fe); Plasma— substance fraction Pancreatic polypeptide; NPU12509 substance concentration Hb(Fe; deoxy+oxy; cordB)—Oxyhaemoglobin(Fe); subst.fr. = ? picomol/litre M = 4 184 g/mol Haemoglobin(Fe; deoxy+oxy; mixed Blood)— NPU03021 Oxyhaemoglobin(Fe); P—Pancreatic polypeptide; subst.c. = ? pmol/l substance fraction Authority: IFCC/C-BGE Urine— NPU09219 Pancreatic polypeptide; Hb(Fe; deoxy+oxy; mixB)—Oxyhaemoglobin(Fe); subst.fr. = ? substance concentration picomol/litre Haemoglobin(Fe; deoxy+oxy; venous Blood)— M = 4 184 g/mol Oxyhaemoglobin(Fe); NPU14011 substance fraction U—Pancreatic polypeptide; subst.c. = ? pmol/l NPU12511 Hb(Fe; deoxy+oxy; vB)—Oxyhaemoglobin(Fe); subst.fr. = ? Patient(Urine)— Pancreatic polypeptide; Haemoglobin(Fe; total; arterial Blood)— substance rate Oxyhaemoglobin(Fe); picomol/day substance fraction M = 4 184 g/mol Authority: IFCC/C-BGE NPU14012 Note: "total" includes dyshaemoglobin, carboxihaemoglobin, methaemoglobin, Pt(U)—Pancreatic polypeptide; subst.rate = ? pmol/d sulfhaemoglobin NPU03013 Plasma— Hb(Fe; tot.; aB)—Oxyhaemoglobin(Fe); subst.fr. = ? Pancreatic-isle cell(IA-2) antibody; arbitrary substance concentration(procedure) Haemoglobin(Fe; total; capillary Blood)— 10³ arbitrary unit/litre Oxyhaemoglobin(Fe); NPU16403 substance fraction P—Pancreatic-isle cell(IA-2) antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l Authority: IFCC/C-BGE Note: "total" includes dyshaemoglobin, carboxihaemoglobin, methaemoglobin, Plasma— sulfhaemoglobin Pancreozymin; NPU10754 substance concentration Hb(Fe; tot.; cB)—Oxyhaemoglobin(Fe); subst.fr. = ? picomol/litre M = 1 142 g/mol Haemoglobin(Fe; total; cord Blood)— Other term(s): Cholecystokinin Oxyhaemoglobin(Fe); Authority: IUPAC-IUB 74 substance fraction NPU03022 NPU12512 P—Pancreozymin; subst.c. = ? pmol/l Hb(Fe; tot.; cordB)—Oxyhaemoglobin(Fe); subst.fr. = ? Patient— Haemoglobin(Fe; total; mixed Blood)— Paracetamol; Oxyhaemoglobin(Fe); half-life substance fraction minute Authority: IFCC/C-BGE NPU10317 Note: "total" includes dyshaemoglobin, carboxihaemoglobin, methaemoglobin, Pt—Paracetamol; half-life = ? min sulfhaemoglobin NPU09220 Plasma— Hb(Fe; tot.; mixB)—Oxyhaemoglobin(Fe); subst.fr. = ? Paraneoplastic syndrome antibody; arbitrary concentration(list; procedure) Haemoglobin(Fe; total; venous Blood)— NPU14540 Oxyhaemoglobin(Fe); P—Paraneoplastic syndrome antibody; arb.c.(list; proc.) substance fraction NPU14541 P—Neuron(CNS-lupus) antibody(IgG); arb.c.(proc.) = ? Authority: IFCC/C-BGE NPU14542 P—Neuronal cell nucleus(Hu)-antistof(IgG); arb.subst.c.(proc.) = ? × NPU10265 10³ arb.unit/l Hb(Fe; tot.; vB)—Oxyhaemoglobin(Fe); subst.fr. = ? NPU14543 P—Purkinje cell(Yo) antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Plasma— Pancreas island-celle(ICA)-antibody; Plasma— arbitrary concentration(procedure) Paraneoplastic syndrome antibody; NPU14539 arbitrary substance concentration(list) P—Pancreas island-celle(ICA)-antibody; arb.c.(proc.) = ? NPU17707 P—Paraneoplastic syndrome antibody; arb.subst.c.(list) Plasma(fasting Patient)— Pancreastatin; Plasma— substance concentration Parathyrin; picomol/litre arbitrary substance concentration(IRP 79/500; procedure) NPU14027 international unit/litre P(fPt)—Pancreastatin; subst.c. = ? pmol/l M = 9 425 g/mol Recommended calibrator: WHO 1st IRP 79/500 (human) Calibrator(s): WHO 1st IRP 71/324 (bovine) Other term(s): Parathyroid hormone; Parathormone; PTH Authority: IUPAC-IUB 74 NPU03027 P—Parathyrin; arb.subst.c.(IRP 79/500; proc.) = ? int. unit/l
122 Plasma— Synovial fluid(specification)— Parathyrin; Particle type; substance concentration number concentration(list; procedure) picomol/litre NPU04228 M = 9 425 g/mol Synf(spec.)—Particle type; num.c.(list; proc.) Other term(s): Parathyroid hormone; Parathormone; PTH NPU04229 Synf(spec.)—Cells; num.c. = ? × 106/l Authority: IUPAC-IUB 74 NPU08933 Synf(spec.)—Erythrocytes; num.c. = ? × 106/l NPU03028 NPU08639 Synf(spec.)—Leukocytes; num.c. = ? × 106/l P—Parathyrin; subst.c. = ? pmol/l NPU04231 Synf(spec.)—Lymphocytes+Monocytes; num.c.= ? × 106/l NPU04230 Synf(spec.)—Neutrophilocytes; num.c.= ? × 106/l Plasma— Parietal cell antibody(Immunoglobulin G); Patient— arbitrary concentration(procedure) Pentagastrin(administered); NPU12557 substance content(intravenous administration; amount-of- P—Parietal cell antibody(IgG); arb.c.(proc.) = ? substance/body mass) nanomol/kilogram Plasma— Note: Molar Mass: approx. 600 Parietal cell antibody(Immunoglobulin G); NPU10477 arbitrary substance concentration(procedure) Pt—Pentagastrin(administered); subst.cont.(i.v.; am.s./body mass) = ? nmol/kg 10³ arbitrary unit/litre NPU14544 Plasma— P—Parietal cell antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Pepsinogen A; arbitrary concentration(procedure) Plasma— NPU03043 Parietal cell antibody; P—Pepsinogen A; arb.c.(proc.) = ? arbitrary concentration(procedure) NPU03029 Plasma— P—Parietal cell antibody; arb.c.(proc.) = ? Pepsinogen A; substance concentration Urine— mol/litre Particle type; NPU03044 arbitrary concentration(list; procedure) P—Pepsinogen A; subst.c.= ? prefix ? mol/l Other term(s): Urine microscopy NPU04222 Plasma— U—Particle type; arb.c.(list; proc.) Peptide YY; NPU08592 U—Bacterium; arb.c.(proc.) = ? substance concentration NPU01817 U—Cylinder, erythrocyte type; arb.c.(proc.) = ? picomol/litre NPU01818 U—Cylinder, granular type; arb.c.(proc.) = ? NPU10613 NPU01819 U—Cylinder, hyaline type; arb.c.(proc.) = ? P—Peptide YY; subst.c. = ? pmol/l NPU03986 U—Epithelial cells; arb.c.(proc.) = ? NPU03963 U—Erythrocytes; arb.c.(proc.) = ? Plasma— NPU08763 U—Flagellate; arb.c.(proc.) = ? Peptidyl dipeptidase A; NPU14314 U—Yeast cells; arb.c.(proc.) = ? catalytic-activity concentration(37 °C; procedure) NPU08761 U—Crystals; arb.c.(proc.) = ? microkatal/litre NPU03987 U—Leukocytes; arb.c.(proc.) = ? Other term(s): Carboxycathepsin; Dipeptidylcarboxypeptidase; Kininase II; NPU17179 U—Slime; arb.c.(proc.) = ? Peptidase P; Angiotensin I converting enzyme NPU14169 U—Spermatozoa; arb.c.(proc.) = ? Authority: IUB 84 NPU12286 U—Trichomonas vaginalis; arb.c.(proc.) = ? NPU01905 P—Peptidyl dipeptidase A; cat.c.(37 °C; proc.) = ? µkat/l Vaginal fluid— Particle type; Plasma— arbitrary concentration(list; procedure) Perinuclear antibody(Immunoglobulin G); NPU14318 arbitrary concentration(procedure) Vagf—Particle type; arb.c.(list; proc.) NPU16404 NPU06687 Vagf—Bacterium(spec.); arb.c.(proc.) = ? P—Perinuclear antibody(IgG); arb.c.(proc.) = ? NPU14316 Vagf—Clue cells; arb.c.(proc.) = ? NPU14317 Vagf—Leukocytes; arb.c.(proc.) = ? Plasma— NPU12284 Vagf—Trichomonas vaginalis; arb.c.(proc.) = ? Perinuclear antibody(Immunoglobulin G); arbitrary substance concentration(procedure) Ascites— 10³ arbitrary unit/litre Particle type; NPU16405 number concentration(list; procedure) P—Perinuclear antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU08935 Asc—Particle type; num.c.(list; proc.) Urine— NPU08683 Asc—Cells; num.c. = ? × 106/l Phenolphthalein; NPU08934 Asc—Erythrocytes; num.c. = ? × 106/l substance concentration NPU08638 Asc—Leukocytes; num.c. = ? × 106/l mol/litre NPU08641 Asc—Lymphocytes+Monocytes; num.c. = ? × 106/l M = 318,31 g/mol NPU08655 Asc—Neutrophilocytes; num.c. = ? × 106/l Authority: INN NPU04815 Cerebrospinal fluid— U—Phenolphthalein; subst.c.= ? prefix ? mol/l Particle type; number concentration(list; procedure) Urine— NPU04135 Phenylalanine/Creatininium; Csf—Particle type; num.c.(list; proc.) substance ratio NPU04775 Csf—Cells; num.c.= ? × 106/l 10-3 NPU01962 Csf—Erythrocytes; num.c. = ? × 106/l NPU14241 NPU02594 Csf—Leukocytes; num.c. = ? × 106/l U—Phenylalanine/Creatininium; subst.ratio = ? × 10-3 NPU02637 Csf—Lymphocytes+Monocytes; num.c. = ? × 106/l NPU02903 Csf—Neutrophilocytes; num.c. = ? × 106/l Blood— Phenylalanine; Semen— substance concentration Particle type; micromol/litre number concentration(list; procedure) M = 165,19 g/mol NPU14074 NPU12249 Sem—Particle type; num.c.(list; proc.) B—Phenylalanine; subst.c. = ? µmol/l NPU02595 Sem—Leukocytes; num.c. = ? × 109/l NPU08718 Sem—Round cells; num.c. = ? × 109/l NPU03455 Sem—Spermatozoa; num.c. = ? × 109/l
123 Cerebrospinal fluid— Calculus(Urine)— Phenylalanine; Phosphate(P; inorganic); substance concentration substance content micromol/litre mol/kilogram M = 165,19 g/mol NPU09239 Authority: INN Calculus(U)—Phosphate(P; inorganic); subst.cont. = ? mol/kg NPU03069 Csf—Phenylalanine; subst.c. = ? µmol/l Patient(Faeces)— Phosphate(P; inorganic); Plasma— substance rate(procedure) Phenylalanine; millimol/day substance concentration Authority: IFCC/C-BGE micromol/litre NPU10264 M = 165,19 g/mol Pt(F)—Phosphate(P; inorganic); subst.rate(proc.) = ? mmol/d Authority: INN NPU03070 Patient(Urine)— P—Phenylalanine; subst.c. = ? µmol/l Phosphate(P; inorganic); substance rate(procedure) Urine— millimol/day Phenylalanine; Authority: IFCC/C-BGE substance concentration NPU03095 micromol/litre Pt(U)—Phosphate(P; inorganic); subst.rate(proc.) = ? mmol/d M = 165,19 g/mol Authority: INN Amniotic fluid— NPU03071 Phosphatidylcholine(saturated); U—Phenylalanine; subst.c. = ? µmol/l substance concentration mol/litre Urine— NPU03097 Phenylethanolamine; Amf—Phosphatidylcholine(sat.); subst.c.= ? prefix ? mol/l arbitrary concentration(procedure) M = 137,18 g/mol Amniotic fluid— Other term(s): beta-Hydroxyphenethylamine Phosphatidylcholine/Sphingomyelin; NPU04569 substance ratio(procedure) U—Phenylethanolamine; arb.c.(proc.) = ? Other term(s): Lecithin/Sphingomyelin ratio NPU02576 Urine— Amf—Phosphatidylcholine/Sphingomyelin; subst.ratio(proc.) = ? Phosphate(P; inorganic); amount-of-substance(procedure) Urine— millimol Phosphoethanolamine/Creatininium; NPU17543 substance ratio U—Phosphate(P; inorganic); am.s.(proc.) = ? mmol 10-3 NPU14242 Calculus(Urine)— U—Phosphoethanolamine/Creatininium; subst.ratio = ? × 10-3 Phosphate(P; inorganic); arbitrary content(procedure) Plasma— NPU09233 Phosphoethanolamine; Calculus(U)—Phosphate(P; inorganic); arb.cont.(proc.) = ? substance concentration micromol/litre Amniotic fluid— M = 141,1 g/mol Phosphate(P; inorganic); NPU03114 substance concentration P—Phosphoethanolamine; subst.c. = ? µmol/l millimol/litre NPU08667 Plasma— Amf—Phosphate(P; inorganic); subst.c. = ? mmol/l Phospholipid, in HDL; substance concentration Ascites— millimol/litre Phosphate(P; inorganic); NPU17692 substance concentration P—Phospholipid, in HDL; subst.c. = ? mmol/l millimol/litre NPU08668 Plasma— Asc—Phosphate(P; inorganic); subst.c. = ? mmol/l Phospholipid, in LDL; substance concentration Plasma— millimol/litre Phosphate(P; inorganic); NPU17693 substance concentration P—Phospholipid, in LDL; subst.c. = ? mmol/l millimol/litre Authority: IFCC/C-BGE Plasma— NPU03096 Phospholipid, in VLDL; P—Phosphate(P; inorganic); subst.c. = ? mmol/l substance concentration millimol/litre System(specification)— NPU17694 Phosphate(P; inorganic); P—Phospholipid, in VLDL; subst.c. = ? mmol/l substance concentration millimol/litre Plasma— NPU10125 Phospholipid; Syst(spec.)—Phosphate(P; inorganic); subst.c. = ? mmol/l substance concentration millimol/litre Urine— NPU17695 Phosphate(P; inorganic); P—Phospholipid; subst.c. = ? mmol/l substance concentration millimol/litre Plasma— Authority: IFCC/C-BGE Phosphopyruvate hydratase; NPU03955 catalytic-activity concentration(37 °C; procedure) U—Phosphate(P; inorganic); subst.c. = ? mmol/l katal/litre Other term(s): Enolase; 2-Phosphoglycerate dehydratase NPU01929 P—Phosphopyruvate hydratase; cat.c.(37 °C; proc.)= ? prefix ? kat/l
124 Urine— Bone marrow— Phosphoserine/Creatininium; Plasmocytes; substance ratio number concentration 10-3 109/litre NPU14243 NPU04090 U—Phosphoserine/Creatininium; subst.ratio = ? × 10-3 Marrow—Plasmocytes; num.c. = ? × 109/l
Plasma— Leukocytes(Blood)— Phosphoserine; Plasmocytes; substance concentration number fraction micromol/litre NPU04709 Authority: IUPAC-IUB 84 Lkcs(B)—Plasmocytes; num.fr. = ? NPU10399 P—Phosphoserine; subst.c. = ? µmol/l Leukocytes(Bone marrow)— Plasmocytes; Plasma— number fraction Phytanate; NPU04989 substance concentration Lkcs(Marrow)—Plasmocytes; num.fr. = ? mol/litre NPU03171 Plasma— P—Phytanate; subst.c.= ? prefix ? mol/l Platinum; substance concentration Urine— picomol/litre Pipecolate/Creatininium; M = 195,09 g/mol substance ratio Authority: IUPAC/VII-C-TOX 10-3 NPU03204 NPU14244 P—Platinum; subst.c. = ? pmol/l U—Pipecolate/Creatininium; subst.ratio = ? × 10-3 Urine— Cerebrospinal fluid— Platinum; Pipecolate; substance concentration substance concentration picomol/litre mol/litre M = 195,09 g/mol NPU03172 Authority: IUPAC/VII-C-TOX Csf—Pipecolate; subst.c.= ? prefix ? mol/l NPU03205 U—Platinum; subst.c. = ? pmol/l Plasma— Pipecolate; Hair— substance concentration Platinum; mol/litre substance content NPU03173 micromol/kilogram P—Pipecolate; subst.c.= ? prefix ? mol/l M = 195,09 g/mol Authority: IUPAC/VII-C-TOX Urine— NPU03203 Pipecolate; Hair—Platinum; subst.cont. = ? µmol/kg substance concentration mol/litre Patient— NPU03174 Pleural fluid(specification); U—Pipecolate; subst.c.= ? prefix ? mol/l relative volumic mass(20 °C/water, 20 °C; procedure) NPU10186 Plasma— Pt—Pleural fluid(spec.); rel.volumic mass(20 °C/water, 20 °C; proc.) = ? Plain muscle antibody(Immunoglobulin G); arbitrary concentration(procedure) Blood— NPU12996 Poikilocytosis; P—Plain muscle antibody(IgG); arb.c.(proc.) = ? arbitrary concentration(procedure) NPU14274 Plasma— B—Poikilocytosis; arb.c.(proc.) = ? Plain muscle antibody; arbitrary concentration(procedure) Plasma— NPU02850 Polymyositis antibody; P—Plain muscle antibody; arb.c.(proc.) = ? arbitrary concentration(list; procedure) NPU14545 Patient— P—Polymyositis antibody; arb.c.(list; proc.) Plasma; NPU14550 P—Polymyositis(EJ) antibody; arb.c.(proc.) = ? kinematic viscosity(37 °C) NPU14554 P—Polymyositis(Jo-1) antibody; arb.c.(proc.) = ? (metre)²/second NPU14549 P—Polymyositis(Ku) antibody; arb.c.(proc.) = ? NPU03178 NPU14548 P—Polymyositis(Mi-2) antibody; arb.c.(proc.) = ? Pt—Plasma; kin.visc.(37 °C) = ? m²/s NPU14551 P—Polymyositis(OJ) antibody; arb.c.(proc.) = ? NPU14547 P—Polymyositis(PL-12) antibody; arb.c.(proc.) = ? Patient— NPU14546 P—Polymyositis(PL-7) antibody; arb.c.(proc.) = ? Plasma; NPU14552 P—Polymyositis(SRP) antibody; arb.c.(proc.) = ? relative volumic mass(20 °C/water, 20 °C; procedure) NPU14553 P—Polymyositis(U2SnRNP) antibody; arb.c.(proc.) = ? NPU03845 Pt—Plasma; rel.volumic mass(20 °C/water, 20 °C; proc.) = ? Plasma— Polymyositis(EJ) antibody; Blood— arbitrary concentration(procedure) Plasmocytes; NPU14550 number concentration P—Polymyositis(EJ) antibody; arb.c.(proc.) = ? 109/litre NPU04708 Plasma— B—Plasmocytes; num.c. = ? × 109/l Polymyositis(Jo-1) antibody; arbitrary concentration(procedure) Blood fraction(specification)— NPU14554 Plasmocytes; P—Polymyositis(Jo-1) antibody; arb.c.(proc.) = ? number concentration 109/litre Plasma— NPU17614 Polymyositis(Ku) antibody; B fract.(spec.)—Plasmocytes; num.c. = ? × 109/l arbitrary concentration(procedure) NPU14549 P—Polymyositis(Ku) antibody; arb.c.(proc.) = ?
125 Faeces— Plasma— Porphyrine; Polymyositis(Mi-2) antibody; arbitrary content(procedure) arbitrary concentration(procedure) NPU03227 NPU14548 F—Porphyrine; arb.cont.(proc.) = ? P—Polymyositis(Mi-2) antibody; arb.c.(proc.) = ? Erythrocytes(Blood)— Plasma— Porphyrine; Polymyositis(OJ) antibody; substance concentration arbitrary concentration(procedure) micromol/litre NPU14551 NPU10604 P—Polymyositis(OJ) antibody; arb.c.(proc.) = ? Ercs(B)—Porphyrine; subst.c. = ? µmol/l
Plasma— Urine— Polymyositis(PL-12) antibody; Porphyrine; arbitrary concentration(procedure) substance concentration NPU14547 micromol/litre P—Polymyositis(PL-12) antibody; arb.c.(proc.) = ? NPU03228 U—Porphyrine; subst.c. = ? µmol/l Plasma— Polymyositis(PL-7) antibody; Patient(Urine)— arbitrary concentration(procedure) Porphyrine; NPU14546 substance rate(procedure) P—Polymyositis(PL-7) antibody; arb.c.(proc.) = ? micromol/day NPU10217 Plasma— Pt(U)—Porphyrine; subst.rate(proc.) = ? µmol/d Polymyositis(SRP) antibody; arbitrary concentration(procedure) Secretion(Ileum)— NPU14552 Potassium ion; P—Polymyositis(SRP) antibody; arb.c.(proc.) = ? amount-of-substance(procedure) millimol Plasma— NPU08632 Polymyositis(U2SnRNP) antibody; Secr(Ileum)—Potassium ion; am.s.(proc.) = ? mmol arbitrary concentration(procedure) NPU14553 Stomach fluid— P—Polymyositis(U2SnRNP) antibody; arb.c.(proc.) = ? Potassium ion; amount-of-substance(procedure) Blood— millimol Porphobilinogen deaminase; Authority: IFFC/C-BGE catalytic-activity concentration(37 °C; procedure) NPU10169 nanokatal/litre Stomf—Potassium ion; am.s.(proc.) = ? mmol NPU10201 B—Porphobilinogen deaminase; cat.c.(37 °C; proc.) = ? nkat/l System(specification)— Potassium ion; Erythrocytes(Blood)— amount-of-substance(procedure) Porphobilinogen deaminase; millimol catalytic-activity concentration(37 °C; procedure) NPU08633 nanokatal/litre Syst(spec.)—Potassium ion; am.s.(proc.) = ? mmol NPU10202 Ercs(B)—Porphobilinogen deaminase; cat.c.(37 °C; proc.) = ? nkat/l Faeces— Potassium ion; Urine— amount-of-substance Porphobilinogen; millimol arbitrary concentration(procedure) NPU17572 NPU04864 F—Potassium ion; am.s. = ? mmol U—Porphobilinogen; arb.c.(proc.)= ? Urine— Urine— Potassium ion; Porphobilinogen; amount-of-substance substance concentration millimol micromol/litre NPU17573 NPU03210 U—Potassium ion; am.s. = ? mmol U—Porphobilinogen; subst.c. = ? µmol/l Amniotic fluid— Patient(Urine)— Potassium ion; Porphobilinogen; substance concentration substance rate(procedure) millimol/litre micromol/day NPU08628 NPU08730 Amf—Potassium ion; subst.c. = ? mmol/l Pt(U)—Porphobilinogen; subst.rate(proc.) = ? µmol/d Ascites— Urine— Potassium ion; Porphyrine/Creatininium; substance concentration substance ratio millimol/litre 10-3 NPU17032 NPU09099 Asc—Potassium ion; subst.c. = ? mmol/l U—Porphyrine/Creatininium; subst.ratio = ? × 10-3 Aspirate(specification)— Urine— Potassium ion; Porphyrine; substance concentration arbitrary concentration(procedure) millimol/litre NPU03957 NPU14909 U—Porphyrine; arb.c.(proc.) = ? Aspir(spec.)—Potassium ion; subst.c. = ? mmol/l
Faeces— Blood fraction(specification)— Porphyrine; Potassium ion; arbitrary content(list; procedure) substance concentration NPU14923 millimol/litre F—Porphyrine; arb.cont.(list; proc.) NPU17571 B fract.(spec.)—Potassium ion; subst.c. = ? mmol/l
126 Dialysis solution— Plasma— Potassium ion; Prasterone; substance concentration substance concentration millimol/litre nanomol/litre Authority: IFCC/C-BGE M = 288,41 g/mol NPU10168 Other term(s): Dehydroepiandrosterone; DHEA Dialysis solution—Potassium ion; subst.c. = ? mmol/l Authority: INN NPU01852 Drain fluid(specification)— P—Prasterone; subst.c. = ? nmol/l Potassium ion; substance concentration Urine— millimol/litre Prasterone; NPU17049 substance concentration Drain fluid(spec.)—Potassium ion; subst.c. = ? mmol/l nanomol/litre M = 288,41 g/mol Plasma— Other term(s): Dehydroepiandrosterone; DHEA Potassium ion; Authority: INN substance concentration NPU01855 millimol/litre U—Prasterone; subst.c. = ? nmol/l Authority: IFCC/C-BGE NPU03230 Patient(Urine)— P—Potassium ion; subst.c. = ? mmol/l Prasterone; substance rate Secretion(Ileum)— nanomol/day Potassium ion; NPU10135 substance concentration Pt(U)—Prasterone; subst.rate = ? nmol/d millimol/litre NPU08630 Plasma— Secr(Ileum)—Potassium ion; subst.c. = ? mmol/l Pregnancy protein 1; arbitrary concentration(procedure) Stomach fluid— Other term(s): Pregnancy specific beta-1 glycoprotein Potassium ion; NPU03232 substance concentration P—Pregnancy protein 1; arb.c.(proc.) = ? millimol/litre Authority: IFCC/C-BGE Patient(Urine)— NPU10170 Pregnanediol; Stomf—Potassium ion; subst.c. = ? mmol/l substance rate(procedure) micromol/day Sweat— NPU03233 Potassium ion; Pt(U)—Pregnanediol; subst.rate(proc.) = ? µmol/d substance concentration millimol/litre Patient(Urine)— Authority: IFCC/C-BGE Pregnanetriol; NPU03941 substance rate(procedure) Sweat—Potassium ion; subst.c. = ? mmol/l micromol/day NPU03234 System(specification)— Pt(U)—Pregnanetriol; subst.rate(proc.) = ? µmol/d Potassium ion; substance concentration Plasma— millimol/litre Proangiotensin; NPU08631 arbitrary concentration(procedure) Syst(spec.)—Potassium ion; subst.c. = ? mmol/l M = 1 295 g/mol Other term(s): Angiotensin I Urine— Authority: IUPAC-IUB 74 Potassium ion; NPU03236 substance concentration P—Proangiotensin; arb.c.(proc.) = ? millimol/litre Authority: IFCC/C-BGE Plasma— NPU03787 Proangiotensin; U—Potassium ion; subst.c. = ? mmol/l substance concentration mol/litre Faeces— M = 1 295 g/mol Potassium ion; Other term(s): Angiotensin I substance content Authority: IUPAC-IUB 74 millimol/kilogram NPU03237 NPU04214 P—Proangiotensin; subst.c.= ? prefix ? mol/l F—Potassium ion; subst.cont. = ? mmol/kg Urine— Faeces(specification)— Prochlorperazine; Potassium ion; arbitrary concentration(procedure) substance content M = 373,94 g/mol millimol/kilogram Authority: INN NPU08629 NPU09045 F(spec.)—Potassium ion; subst.cont. = ? mmol/kg U—Prochlorperazine; arb.c.(proc.) = ?
Patient(Faeces)— Plasma— Potassium ion; Prochlorperazine; substance rate(procedure) substance concentration millimol/day mol/litre NPU04213 M = 373,94 g/mol Pt(F)—Potassium ion; subst.rate(proc.) = ? mmol/d Authority: INN NPU09043 Patient(Urine)— P—Prochlorperazine; subst.c.= ? prefix ? mol/l Potassium ion; substance rate(procedure) millimol/day Authority: IFCC/C-BGE NPU03229 Pt(U)—Potassium ion; subst.rate(proc.) = ? mmol/d
127 Urine— Plasma— Prochlorperazine; Proinsulin C-peptide; substance concentration arbitrary substance concentration(IRR 84/510; procedure) mol/litre international unit/litre M = 373,94 g/mol M = 3 019 g/mol Authority: INN Recommended calibrator: WHO 1st International Reference Reagent 84/510 NPU09044 Other term(s): C-peptide; Connecting peptide U—Prochlorperazine; subst.c.= ? prefix ? mol/l NPU03248 P—Proinsulin C-peptide; arb.subst.c.(IRR 84/510; proc.) = ? int. unit/l Plasma— Procollagen-III-peptide; Plasma— mass concentration Proinsulin C-peptide; microgram/litre substance concentration(0 minutes after challenge) NPU10227 nanomol/litre P—Procollagen-III-peptide; mass c. = ? µg/l NPU10390 P—Proinsulin C-peptide; subst.c.(0 min) = ? nmol/l Plasma— Procollagen-I-peptide; Plasma— mass concentration Proinsulin C-peptide; microgram/litre substance concentration(6 minutes after challenge) NPU10226 nanomol/litre P—Procollagen-I-peptide; mass c. = ? µg/l NPU10391 P—Proinsulin C-peptide; subst.c.(6 min) = ? nmol/l Plasma— Progastrin; Plasma— substance concentration Proinsulin C-peptide; picomol/litre substance concentration(120 minutes after challenge) NPU17588 nanomol/litre P—Progastrin; subst.c. = ? pmol/l NPU10392 P—Proinsulin C-peptide; subst.c.(120 min) = ? nmol/l Endometric cytosol protein— Progesterone receptor(free); Plasma— substance content Proinsulin C-peptide; nanomol/kilogram substance concentration NPU03245 nanomol/litre Endometric cytosol prot.—Progesterone receptor(free); subst.cont. = ? nmol/kg M = 3 019 g/mol Other term(s): C-peptide; Connecting peptide Endometric cytosol protein— NPU03247 Progesterone receptor(total); P—Proinsulin C-peptide; subst.c. = ? nmol/l substance content nanomol/kilogram Plasma(fasting Patient)— NPU03244 Proinsulin C-peptide; Endometric cytosol prot.—Progesterone receptor(tot.); subst.cont. = ? nmol/kg substance concentration nanomol/litre Cystic fluid(specification)— M = 3 019 g/mol Progesterone; Other term(s): C-peptide; Connecting peptide substance concentration NPU04149 nanomol/litre P(fPt)—Proinsulin C-peptide; subst.c. = ? nmol/l NPU08764 Cystf(spec.)—Progesterone; subst.c. = ? nmol/l Patient(Urine)— Proinsulin C-peptide; Plasma— substance rate(procedure) Progesterone; nanomol/day substance concentration NPU08978 nanomol/litre Pt(U)—Proinsulin C-peptide; subst.rate(proc.) = ? nmol/d M = 314,45 g/mol Authority: IUPAC-IUB 89 Plasma— NPU03242 Proinsulin; P—Progesterone; subst.c. = ? nmol/l arbitrary substance concentration(IRR 84/611; procedure) international unit/litre Saliva— M = 9 395 g/mol Progesterone; Recommended calibrator: Human pro-insulin International Reference Reagent substance concentration 84/611 nanomol/litre NPU03246 M = 314,45 g/mol P—Proinsulin; arb.subst.c.(IRR 84/611; proc.) = ? int. unit/l Authority: IUPAC-IUB 89 NPU03243 Plasma— Saliva—Progesterone; subst.c. = ? nmol/l Proinsulin; substance concentration Pancreatic beta-cell— picomol/litre Proinsulin C-peptide secretion; M = 9 395 g/mol substance rate(glucagon, intravenous administration; list; procedure) NPU04020 Note: _M_ (glucagon) = 3 483 g/mol; _M_ (proinsulin C-peptide) = 3 019 g/mol; P—Proinsulin; subst.c. = ? pmol/l _M_ (glucose) = 180,16 g/mol NPU10393 Plasma(fasting Patient)— Pancreatic beta-cell—Proinsulin C-peptide secretion; subst.rate(glucagon i.v.; Proinsulin; list; proc.) substance concentration NPU10389 Pt—Glucagon(administered); am.s.(i.v.) = ? nmol picomol/litre NPU10691 Pt—Glucagon(administered); subst.cont.(i.v.; am.s./body mass) = ? M = 9 395 g/mol nmol/kg NPU04154 NPU10390 P—Proinsulin C-peptide; subst.c.(0 min) = ? nmol/l P(fPt)—Proinsulin; subst.c. = ? pmol/l NPU10391 P—Proinsulin C-peptide; subst.c.(6 min) = ? nmol/l NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l NPU10655 B—Glucose; subst.c.(6 min) = ? mmol/l
128 Pituitary gland— Plasma— Prolactin secretion; Prolactin; substance rate(insulin, intravenous administration; list; procedure) substance concentration(0 minutes after challenge) Note: _M_ (insulin) = 5 807,65 g/mol; _M_ (prolactin) = 23 000 g/mol nanomol/litre NPU10453 NPU10458 PitGl—Prolactin secretion; subst.rate(insulin i.v.; list; proc.) P—Prolactin; subst.c.(0 min) = ? nmol/l NPU10547 Pt—Insulin(administered); subst.cont.(i.v.; am.s./body mass) = ? µmol/kg Plasma— NPU10458 P—Prolactin; subst.c.(0 min) = ? nmol/l Prolactin; NPU10455 P—Prolactin; subst.c.(30 min) = ? nmol/l substance concentration(15 minutes after challenge) NPU10451 P—Prolactin; subst.c.(45 min) = ? nmol/l nanomol/litre NPU10459 P—Prolactin; subst.c.(60 min) = ? nmol/l NPU10682 NPU10452 P—Prolactin; subst.c.(90 min) = ? nmol/l P—Prolactin; subst.c.(15 min) = ? nmol/l NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU04186 P—Glucose; subst.c.(15 min) = ? mmol/l Plasma— NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l Prolactin; NPU04187 P—Glucose; subst.c.(45 min) = ? mmol/l substance concentration(30 minutes after challenge) NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l nanomol/litre NPU04965 P—Glucose; subst.c.(75 min) = ? mmol/l NPU10455 NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l P—Prolactin; subst.c.(30 min) = ? nmol/l NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l Plasma— Pituitary gland— Prolactin; Prolactin secretion; substance concentration(45 minutes challenge) substance rate(levodopa, oral administration; list; procedure) nanomol/litre Note: _M_ (levodopa) = 197,2 g/mol; _M_ (prolactin) = 23 000 g/mol NPU10451 NPU10462 P—Prolactin; subst.c.(45 min) = ? nmol/l PitGl—Prolactin secretion; subst.rate(levodopa p.o.; list; proc.) NPU10457 Pt—Levodopa(administered); am.s.(p.o.) = ? mmol Plasma— NPU10458 P—Prolactin; subst.c.(0 min) = ? nmol/l Prolactin; NPU10459 P—Prolactin; subst.c.(60 min) = ? nmol/l substance concentration(60 minutes after challenge) NPU10460 P—Prolactin; subst.c.(120 min) = ? nmol/l nanomol/litre NPU10461 P—Prolactin; subst.c.(180 min) = ? nmol/l NPU10459 P—Prolactin; subst.c.(60 min) = ? nmol/l Pituitary gland— Prolactin secretion; Plasma— substance rate(protirelin, intravenous administration; list; procedure) Prolactin; Other term(s): Protirelin: Thyrotropin-releasing hormone substance concentration(90 minutes after challenge) Note: _M_ (protirelin) = 362,4 g/mol; _M_ (prolactin) = 23 000 g/mol nanomol/litre NPU10456 NPU10452 PitGl—Prolactin secretion; subst.rate(protirelin i.v.; list; proc.) P—Prolactin; subst.c.(90 min) = ? nmol/l NPU10454 Pt—Protirelin(administered); am.s.(i.v.) = ? nmol NPU10458 P—Prolactin; subst.c.(0 min) = ? nmol/l Plasma— NPU10682 P—Prolactin; subst.c.(15 min) = ? nmol/l Prolactin; NPU10455 P—Prolactin; subst.c.(30 min) = ? nmol/l substance concentration(120 minutes after challenge) NPU10459 P—Prolactin; subst.c.(60 min) = ? nmol/l nanomol/litre NPU10460 P—Prolactin; subst.c.(120 min) = ? nmol/l NPU10460 NPU10683 P—Prolactin; subst.c.incr.(max. c. minus 0 min c.) = ? nmol/l P—Prolactin; subst.c.(120 min) = ? nmol/l
Plasma— Plasma— Prolactin; Prolactin; arbitrary substance concentration(IRP 75/504; procedure) substance concentration(180 minutes after challenge) international unit/litre nanomol/litre M = 23 000 g/mol NPU10461 Recommended calibrator: WHO IRP 75/504 P—Prolactin; subst.c.(180 min) = ? nmol/l Other term(s): Lactotropic hormone; Lactotropin; Mammatropic hormone; Mammatropin Plasma— Authority: IUPAC-IUB74 Prolactin; NPU04022 substance concentration increment(maximum concentration minus 0 P—Prolactin; arb.subst.c.(IRP 75/504; proc.) = ? int. unit/l minutes concentration) nanomol/litre Plasma— NPU10683 Prolactin; P—Prolactin; subst.c.incr.(max. c. minus 0 min c.) = ? nmol/l arbitrary substance concentration(IS 83/562; procedure) international unit/litre Plasma— M = 23 000 g/mol Prolactin; Recommended calibrator: WHO 2nd IS 83/562 substance concentration Other term(s): Lactropic hormone; Mammatropic hormone; Mammatropin nanomol/litre Authority: IUPAC-IUB 74 M = 23 000 g/mol NPU04021 Other term(s): Lactotropic hormone; Lactotropin; Mammatropic hormone; P—Prolactin; arb.subst.c.(IS 83/562; proc.) = ? int. unit/l Mammatropin Authority: IUPAC-IUB 74 Plasma— NPU03253 Prolactin; P—Prolactin; subst.c. = ? nmol/l arbitrary substance concentration(IS 84/500; procedure) international unit/litre Plasma— M = 23 000 g/mol Proliferating cell nucleus antibody(Immunoglobulin G); Recommended calibrator: WHO 3rd IS 84/500 arbitrary concentration(procedure) Calibrator(s): WHO 2nd IS 83/562; WHO IRP 75/504 NPU03254 Other term(s): Lactotropic hormone; Lactotropin; Mammatropic hormone; P—Proliferating cell nucleus antibody(IgG); arb.c.(proc.) = ? Mammatropin Authority: IUPAC-IUB 74 Plasma— NPU03252 Proliferating cell nucleus antibody(Immunoglobulin G); P—Prolactin; arb.subst.c.(IS 84/500; proc.) = ? int. unit/l arbitrary substance concentration(procedure) arbitrary unit/litre NPU12584 P—Proliferating cell nucleus antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l
129 Erythrocytes(Blood)— Plasma— Proline dipeptidase; Prostata specific antigen(total); entitic catalytic activity(37 °C; procedure) mass concentration attokatal microgram/litre NPU12898 Other term(s): Prostate-specific antigen; PSA Ercs(B)—Proline dipeptidase; entitic cat.act.(37 °C; proc.) = ? akat NPU08669 P—Prostata specific antigen(tot.); mass c. = ? µg/l Urine— Proline/Creatininium; Plasma— substance ratio Prostata specific antigen; 10-3 arbitrary concentration(procedure) NPU14245 NPU03275 U—Proline/Creatininium; subst.ratio = ? × 10-3 P—Prostata specific antigen; arb.c.(proc.) = ?
Cerebrospinal fluid— Cerebrospinal fluid— Proline; Protein type; substance concentration concentration(list; procedure) micromol/litre NPU04865 M = 115,13 g/mol Csf—Protein type; conc.(list; proc.) NPU03255 NPU01130 Csf—Albumin; subst.c. = ? µmol/l Csf—Proline; subst.c. = ? µmol/l NPU04980 Csf—Albumin; rel.subst.c.(Csf/P) = ? NPU04658 Csf—Alpha-1-globulin; mass c. = ? mg/l Plasma— NPU04659 Csf—Alpha-2-globulin; mass c. = ? mg/l Proline; NPU04660 Csf—Beta-globulin; mass c. = ? mg/l substance concentration NPU04661 Csf—Gamma-globulin; mass c. = ? mg/l micromol/litre NPU04099 Csf—Immunoglobulin G; subst.c.= ? µmol/l M = 115,13 g/mol NPU09335 Csf—Immunoglobulin G; rel.subst.c.(Csf/P) = ? NPU03256 P—Proline; subst.c. = ? µmol/l Plasma— Protein type; Urine— concentration(list; procedure) Proline; NPU03300 substance concentration P—Protein type; conc.(list; proc.) micromol/litre NPU01132 P—Albumin; subst.c. = ? µmol/l M = 115,13 g/mol NPU04650 P—Alpha-1-globulin; mass c. = ? g/l NPU03257 NPU04651 P—Alpha-2-globulin; mass c. = ? g/l U—Proline; subst.c. = ? µmol/l NPU09261 P—Alpha-globulin; mass c. = ? g/l NPU09262 P—Beta-1-globulin; mass c. = ? g/l Blood— NPU09263 P—Beta-2-globulin; mass c. = ? g/l Promyelocytes; NPU04652 P—Beta-globulin; mass c. = ? g/l number concentration NPU04653 P—Gamma-globulin; mass c. = ? g/l 109/litre NPU03974 Urine— B—Promyelocytes; num.c. = ? × 109/l Protein type; concentration(list; procedure) Blood fraction(specification)— NPU03301 Promyelocytes; U—Protein type; conc.(list; proc.) number concentration NPU03903 U—Albumin; subst.c. = ? µmol/l 109/litre NPU04654 U—Alpha-1-globulin; mass c. = ? mg/l NPU17615 NPU04655 U—Alpha-2-globulin; mass c. = ? mg/l B fract.(spec.)—Promyelocytes; num.c. = ? × 109/l NPU14037 U—Alpha-globulin; mass c. = ? mg/l NPU04656 U—Beta-globulin; mass c. = ? mg/l Bone marrow— NPU04657 U—Gamma-globulin; mass c. = ? mg/l Promyelocytes; number concentration Protein(Cerebrospinal fluid)— 109/litre Protein type; NPU04091 mass fraction(list; procedure) Marrow—Promyelocytes; num.c. = ? × 109/l NPU04878 Prot.(Csf)—Protein type; mass fr.(list; proc.) Leukocytes(Blood)— NPU04949 Prot.(Csf)—Albumin; mass fr. = ? Promyelocytes; NPU04950 Prot.(Csf)—Alpha-1-globulin; mass fr. = ? number fraction NPU04951 Prot.(Csf)—Alpha-2-globulin; mass fr. = ? NPU03973 NPU14038 Prot.(Csf)—Alpha-globulin; mass fr. = ? Lkcs(B)—Promyelocytes; num.fr. = ? NPU04952 Prot.(Csf)—Beta-globulin; mass fr. = ? NPU04953 Prot.(Csf)—Gamma-globulin; mass fr. = ? Leukocytes(Bone marrow)— Promyelocytes; Protein(Plasma)— number fraction Protein type; NPU04985 mass fraction(list; procedure) Lkcs(Marrow)—Promyelocytes; num.fr. = ? NPU04196 Prot.(P)—Protein type; mass fr.(list; proc.) Plasma— NPU04939 Prot.(P)—Albumin; mass fr. = ? Prostata specific antigen(free); NPU04940 Prot.(P)—Alpha-1-globulin; mass fr. = ? mass concentration NPU04941 Prot.(P)—Alpha-2-globulin; mass fr. = ? microgram/litre NPU09264 Prot.(P)—Alpha-globulin; mass fr. = ? Other term(s): Prostate-specific antigen; PSA NPU09265 Prot.(P)—Beta-1-globulin; mass fr. = ? NPU12534 NPU09266 Prot.(P)—Beta-2-globulin; mass fr. = ? P—Prostata specific antigen(free); mass c. = ? µg/l NPU04942 Prot.(P)—Beta-globulin; mass fr. = ? NPU04943 Prot.(P)—Gamma-globulin; mass fr. = ? Prostata specific antigen(Plasma)— Prostata specific antigen(free); mass fraction Other term(s): Prostate-specific antigen; PSA NPU09226 Prostata specific antigen(P)—Prostata specific antigen(free); mass fr. = ?
130 Protein(Urine)— Urine— Protein type; Protein; mass fraction(list; procedure) mass concentration NPU04823 gram/litre Prot.(U)—Protein type; mass fr.(list; proc.) NPU03958 NPU04944 Prot.(U)—Albumin; mass fr. = ? U—Protein; mass c. = ? g/l NPU04945 Prot.(U)—Alpha-1-globulin; mass fr. = ? NPU04946 Prot.(U)—Alpha-2-globulin; mass fr. = ? Patient(Urine)— NPU14036 Prot.(U)—Alpha-globulin; mass fr. = ? Protein; NPU04947 Prot.(U)—Beta-globulin; mass fr. = ? mass rate(procedure) NPU04948 Prot.(U)—Gamma-globulin; mass fr. = ? gram/day NPU03277 Urine— Pt(U)—Protein; mass rate(proc.) = ? g/d Protein; arbitrary concentration(procedure) Urine— NPU04206 Protein; U—Protein; arb.c.(proc.)= ? mass(procedure) gram Urine— NPU03812 Protein; U—Protein; mass(proc.) = ? g mass concentration(procedure) gram/litre Plasma— NPU17167 Proteinase 3 antibody(Immunoglobulin G); U—Protein; mass c.(proc.) = ? g/l arbitrary concentration(procedure) Other term(s): PR3-ANCA Amniotic fluid— NPU12572 Protein; P—Proteinase 3 antibody(IgG); arb.c.(proc.) = ? mass concentration gram/litre Plasma— NPU08673 Proteinase 3 antibody(Immunoglobulin G); Amf—Protein; mass c. = ? g/l arbitrary substance concentration(procedure) 10³ arbitrary unit/litre Ascites— Other term(s): MPO antibody Protein; NPU12573 mass concentration P—Proteinase 3 antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l gram/litre NPU08671 Plasma— Asc—Protein; mass c. = ? g/l Proteinase 3 antibody; arbitrary concentration(procedure) Breast-milk— Other term(s): PR3-ANCA Protein; NPU12044 mass concentration P—Proteinase 3 antibody; arb.c.(proc.) = ? gram/litre NPU10320 Patient— Breast-milk—Protein; mass c. = ? g/l Protirelin(administered); amount-of-substance(intravenous administration) Cerebrospinal fluid— nanomol Protein; M = 362,4 g/mol mass concentration Other term(s): Thyrotropin-releasing hormone gram/litre NPU10454 NPU03276 Pt—Protirelin(administered); am.s.(i.v.) = ? nmol Csf—Protein; mass c. = ? g/l Erythrocytes(Blood)— Drain fluid(specification)— Protoporphyrin IX; Protein; entitic amount-of-substance mass concentration attomol gram/litre NPU04155 NPU17042 Ercs(B)—Protoporphyrin IX; entitic am.s. = ? amol Drain fluid(spec.)—Protein; mass c. = ? g/l Blood— Plasma— Protoporphyrin(Zn)/Haemoglobin(Fe); Protein; substance ratio mass concentration 10-6 gram/litre NPU03307 NPU03278 B—Protoporphyrin(Zn)/Haemoglobin(Fe); subst.ratio = ? × 10-6 P—Protein; mass c. = ? g/l Erythrocytes(Blood)— Pleural fluid(specification)— Protoporphyrin; Protein; arbitrary entitic amount-of-substance(procedure) mass concentration arbitrary unit gram/litre NPU04065 NPU08670 Ercs(B)—Protoporphyrin; arb.entitic am.s.(proc.) = ? arb.unit Plf(spec.)—Protein; mass c. = ? g/l Erythrocytes(Blood)— Synovial fluid(specification)— Protoporphyrin; Protein; entitic amount-of-substance mass concentration attomol gram/litre M = 626 g/mol NPU08672 NPU03308 Synf(spec.)—Protein; mass c. = ? g/l Ercs(B)—Protoporphyrin; entitic am.s. = ? amol
System(specification)— Erythrocytes(Blood)— Protein; Protoporphyrin; mass concentration substance concentration gram/litre micromol/litre NPU10131 M = 626 g/mol Syst(spec.)—Protein; mass c. = ? g/l NPU14046 Ercs(B)—Protoporphyrin; subst.c. = ? µmol/l
131 Plasma— Blood(arterial Blood)— Purkinje cell(Yo) antibody(Immunoglobulin G); Pyruvate; arbitrary substance concentration(procedure) substance concentration 10³ arbitrary unit/litre micromol/litre NPU14543 M = 88,06 g/mol P—Purkinje cell(Yo) antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU03328 B(aB)—Pyruvate; subst.c. = ? µmol/l Urine— Pyridinoline cross-linked carboxy-terminal telopeptide, collagen type/Creatininium; Blood(venous Blood)— substance ratio Pyruvate; 10-6 substance concentration NPU14337 micromol/litre U—Pyridinoline cross-linked carboxy-terminal telopeptide, collagen M = 88,06 g/mol type/Creatininium; subst.ratio = ? × 10-6 NPU09228 B(vB)—Pyruvate; subst.c. = ? µmol/l Urine— Pyridinoline cross-linked carboxy-terminal telopeptide, collagen type; Cerebrospinal fluid— substance concentration Pyruvate; nanomol/litre substance concentration NPU14336 micromol/litre U—Pyridinoline cross-linked carboxy-terminal telopeptide, collagen type; M = 88,06 g/mol subst.c. = ? nmol/l NPU03329 Csf—Pyruvate; subst.c. = ? µmol/l Urine— Pyridinoline+Deoxypyridinoline; Plasma(fasting Patient)— substance concentration Pyruvate; millimol/litre substance concentration NPU14372 micromol/litre U—Pyridinoline+Deoxypyridinoline; subst.c. = ? mmol/l NPU17792 P(fPt)—Pyruvate; subst.c. = ? µmol/l Plasma— Pyridoxal 5-phosphate; Patient(Urine)— substance concentration Pyruvate; nanomol/litre substance rate(procedure) NPU10612 micromol/day P—Pyridoxal 5-phosphate; subst.c. = ? nmol/l NPU17794 Pt(U)—Pyruvate; subst.rate(proc.) = ? µmol/d Synovial fluid(specification)— Pyrophosphate crystals; Kidney— arbitrary concentration(procedure) Renin secretion; NPU03322 substance rate(furosemide, oral administration; list; procedure) Synf(spec.)—Pyrophosphate crystals; arb.c.(proc.) = ? Note: _M_ (furosemide) = 330,75 g/mol; _M_ (renin) = 42 270 g/mol NPU10422 Cells(Synovial fluid; specification)— Kidn.—Renin secretion; subst.rate(furosemide p.o.; list; proc.) Pyrophosphate crystals; NPU10420 P—Renin; arb.subst.c.(IRP 68/356; 0 min) = ? × 10-3 int.unit/l arbitrary entitic number(procedure) NPU10421 P—Renin; arb.subst.c.(IRP 68/356; 300 min) = ? × 10-3 int.unit/l NPU03323 NPU09267 P—Renin; subst.c.(0 min)= ? prefix ? mol/l Cells(Synf; spec.)—Pyrophosphate crystals; arb.entitic num.(proc.) = ? NPU09268 P—Renin; subst.c.(300 min)= ? prefix ? mol/l
Urine— Plasma— delta-1- Renin; Pyrroline-5-carboxylate/Creatininium; arbitrary substance concentration(IRP 68/356; 0 minutes after challenge) substance ratio 10-3 international unit/litre 10-3 NPU10420 NPU14246 P—Renin; arb.subst.c.(IRP 68/356; 0 min) = ? × 10-3 int.unit/l U—delta-1-Pyrroline-5-carboxylate/Creatininium; subst.ratio = ? × 10-3 Plasma— Urine— Renin; delta-1- arbitrary substance concentration(IRP 68/356; 300 minutes after Pyrroline-5-carboxylate; challenge) substance concentration 10-3 international unit/litre mol/litre NPU10421 NPU03327 P—Renin; arb.subst.c.(IRP 68/356; 300 min) = ? × 10-3 int.unit/l U—delta-1-Pyrroline-5-carboxylate; subst.c.= ? prefix ? mol/l Plasma— Plasma— Renin; Pyruvatdehydrogenase antibody; arbitrary substance concentration(IRP 68/356; procedure) arbitrary substance concentration(procedure) 10-3 international unit/litre 10³ arbitrary unit/litre M = 42 270 g/mol NPU14556 Recommended calibrator: WHO 1st IRP 68/356 P—Pyruvatdehydrogenase antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l Other term(s): Angiotensin-forming enzyme; Angiotensinogenase NPU03351 Erythrocytes(Blood)— P—Renin; arb.subst.c.(IRP 68/356; proc.) = ? × 10-3 int.unit/l Pyruvate kinase; arbitrary catalytic activity(procedure) Plasma— NPU10322 Renin; Ercs(B)—Pyruvate kinase; arb.cat.act.(proc.) = ? catalytic-activity concentration(procedure) microkatal/litre Erythrocytes(Blood)— M = 42 270 g/mol Pyruvate kinase; Other term(s): Angiotensin-forming enzyme; Angiotensinogenase entitic catalytic activity(37 °C; procedure) NPU03352 attokatal P—Renin; cat.c.(proc.) = ? µkat/l NPU03340 Ercs(B)—Pyruvate kinase; entitic cat.act.(37 °C; proc.) = ? akat Plasma— Renin; substance concentration(0 minutes after challenge) mol/litre NPU09267 P—Renin; subst.c.(0 min)= ? prefix ? mol/l
132 Plasma— Bone marrow— Renin; Reticulum cells; substance concentration(300 minutes after challenge) number concentration mol/litre 109/litre NPU09268 NPU04134 P—Renin; subst.c.(300 min)= ? prefix ? mol/l Marrow—Reticulum cells; num.c. = ? × 109/l
Plasma— Leukocytes(Bone marrow)— Renin; Reticulum cells; substance concentration(procedure) number fraction mol/litre NPU14382 M = 42 270 g/mol Lkcs(Marrow)—Reticulum cells; num.fr. = ? Other term(s): Angiotensin-forming enzyme; Angiotensinogenase NPU03353 Patient— P—Renin; subst.c.(proc.)= ? prefix ? mol/l Retinol absorption; substance rate(procedure) Plasma— mol/day Reno pulmonal syndrome; NPU03837 arbitrary concentration(list; procedure) Pt—Retinol absorption; subst.rate(proc.)= ? prefix ? mol/d NPU14557 P—Reno pulmonal syndrome; arb.c.(list; proc.) Plasma— NPU12542 P—Glomerulus membrane antibody(IgG); arb.c.(proc.) = ? Retinol binding protein; NPU12575 P—Myeloperoxidase antibody(IgG); arb.c.(proc.) = ? substance concentration NPU12572 P—Proteinase 3 antibody(IgG); arb.c.(proc.) = ? micromol/litre M = 21 000 g/mol Plasma— NPU03358 Reno pulmonal syndrome; P—Retinol binding protein; subst.c. = ? µmol/l arbitrary substance concentration(list; procedure) NPU14558 Plasma— P—Reno pulmonal syndrome; arb.subst.c.(list; proc.) Retinol; NPU12552 P—Glomerulus membrane antibody(IgG); arb.subst.c.(proc.) = ? × substance concentration 10³ arb.unit/l micromol/litre NPU12036 P—Myeloperoxidase antibody(IgG); arb.subst.c.(proc.) = ? × 10³ M = 286,44 g/mol arb.unit/l Other term(s): Vitamin A NPU12573 P—Proteinase 3 antibody(IgG); arb.subst.c.(proc.) = ? × 10³ Authority: INN arb.unit/l NPU03357 P—Retinol; subst.c. = ? µmol/l Plasma— Reticulin antibody(Immunoglobulin A); Plasma— arbitrary concentration(procedure) Rheumafactor antibody(Immunoglobulin A); NPU12247 arbitrary concentration(procedure) P—Reticulin antibody(IgA); arb.c.(proc.) = ? Other term(s): Immunoglobulin G Fc antibody NPU10229 Plasma— P—Rheumafactor antibody(IgA); arb.c.(proc.) = ? Reticulin antibody(Immunoglobulin G); arbitrary concentration(procedure) Plasma— NPU12248 Rheumafactor antibody(Immunoglobulin A); P—Reticulin antibody(IgG); arb.c.(proc.) = ? arbitrary substance concentration(procedure) 10³ arbitrary unit/litre Plasma— Other term(s): Rheuma factor Reticulin antibody; NPU12581 arbitrary concentration(list; procedure) P—Rheumafactor antibody(IgA); arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU17105 P—Reticulin antibody; arb.c.(list; proc.) Plasma— NPU12247 P—Reticulin antibody(IgA); arb.c.(proc.) = ? Rheumafactor antibody(Immunoglobulin E); NPU12248 P—Reticulin antibody(IgG); arb.c.(proc.) = ? arbitrary substance concentration(procedure) 10³ arbitrary unit/litre Plasma— Other term(s): Rheuma factor Reticulin antibody; NPU14802 arbitrary concentration(procedure) P—Rheumafactor antibody(IgE); arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU03355 P—Reticulin antibody; arb.c.(proc.) = ? Plasma— Rheumafactor antibody(Immunoglobulin G); Reticulocytes(Blood)— arbitrary concentration(procedure) Reticulocytes(RNA; low concentration); NPU10230 number fraction(procedure) P—Rheumafactor antibody(IgG); arb.c.(proc.) = ? NPU17009 Rtcs(B)—Reticulocytes(RNA; low c.); num.fr.(proc.) = ? Plasma— Rheumafactor antibody(Immunoglobulin G); Blood— arbitrary substance concentration(procedure) Reticulocytes; 10³ arbitrary unit/litre entitic volume Other term(s): Rheuma factor femtolitre NPU14803 NPU17013 P—Rheumafactor antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l B—Reticulocytes; entitic vol. = ? fl Plasma— Blood— Rheumafactor antibody(Immunoglobulin M); Reticulocytes; arbitrary concentration(procedure) number concentration Other term(s): Rheuma factor 109/litre NPU02483 NPU08694 P—Rheumafactor antibody(IgM); arb.c.(proc.) = ? B—Reticulocytes; num.c. = ? × 109/l Synovial fluid(specification)— Erythrocytes(Blood)— Rheumafactor antibody(Immunoglobulin M); Reticulocytes; arbitrary concentration(procedure) number fraction NPU10228 10-3 Synf(spec.)—Rheumafactor antibody(IgM); arb.c.(proc.) = ? NPU03356 Ercs(B)—Reticulocytes; num.fr. = ? × 10-3
133 Plasma— Blood— Rheumafactor antibody(Immunoglobulin M); Rubidium; arbitrary substance concentration(procedure) substance concentration 10³ arbitrary unit/litre micromol/litre Other term(s): Rheuma factor M = 85,47 g/mol NPU12580 Authority: IUPAC/VII-C-TOX P—Rheumafactor antibody(IgM); arb.subst.c.(proc.) = ? × 10³ arb.unit/l NPU03370 B—Rubidium; subst.c. = ? µmol/l Plasma— Rheumafactor antibody(Immunoglobulin M); Plasma— arbitrary substance concentration(WHO calibrator; procedure) Rubidium; 10³ international unit/litre substance concentration NPU16407 micromol/litre P—Rheumafactor antibody(IgM); arb.subst.c.(WHO calib.; proc.) = ? × 10³ M = 85,47 g/mol int.unit/l Authority: IUPAC/VII-C-TOX NPU03372 Patient(Urine)— P—Rubidium; subst.c. = ? µmol/l Riboflavin; substance rate(procedure) Urine— micromol/day Rubidium; NPU03359 substance concentration Pt(U)—Riboflavin; subst.rate(proc.) = ? µmol/d micromol/litre M = 85,47 g/mol Plasma— Authority: IUPAC/VII-C-TOX Ribonucleoprotein antibody(Immunoglobulin G); NPU03373 arbitrary concentration(procedure) U—Rubidium; subst.c. = ? µmol/l Other term(s): rRNP antibody NPU12569 Cells(Blood)— P—Ribonucleoprotein antibody(IgG); arb.c.(proc.) = ? Rubidium; substance content Plasma— micromol/kilogram Ribonucleoprotein antibody(Immunoglobulin G); M = 85,47 g/mol arbitrary substance concentration(procedure) Authority: IUPAC/VII-C-TOX arbitrary unit/litre NPU04894 NPU14504 Cells(B)—Rubidium; subst.cont. = ? µmol/kg P—Ribonucleoprotein antibody(IgG); arb.subst.c.(proc.) = ? arb.unit/l Hair— Plasma— Rubidium; Ribonucleoprotein antibody; substance content arbitrary substance concentration(procedure) micromol/kilogram arbitrary unit/litre M = 85,47 g/mol Other term(s): nRNP-antistof Authority: IUPAC/VII-C-TOX NPU12023 NPU03371 P—Ribonucleoprotein antibody; arb.subst.c.(proc.) = ? arb.unit/l Hair—Rubidium; subst.cont. = ? µmol/kg
Plasma— Urine— Ribonucleoprotein(U1) antibody(Immunoglobulin G); Saccharopine/Creatininium; arbitrary substance concentration(procedure) substance ratio 10³ arbitrary unit/litre 10-3 NPU14505 NPU14247 P—Ribonucleoprotein(U1) antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l U—Saccharopine/Creatininium; subst.ratio = ? × 10-3
Plasma— Urine— RNA polymerase antibody(Immunoglobulin G); Saccharopine; arbitrary substance concentration(procedure) substance concentration 10³ arbitrary unit/litre mol/litre NPU14561 NPU03374 P—RNA polymerase antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l U—Saccharopine; subst.c.= ? prefix ? mol/l
Reticulocytes(Blood)— Plasma— RNA(high concentration); Sarcolemma antibody(Immunoglobulin G); number fraction(procedure) arbitrary concentration(procedure) NPU17011 NPU12536 Rtcs(B)—RNA(high c.); num.fr.(proc.) = ? P—Sarcolemma antibody(IgG); arb.c.(proc.) = ?
Reticulocytes(Blood)— Plasma— RNA(mean concentration); Sarcolemma antibody; number fraction(procedure) arbitrary concentration(procedure) NPU17010 NPU02851 Rtcs(B)—RNA(mean c.); num.fr.(proc.) = ? P—Sarcolemma antibody; arb.c.(proc.) = ?
Reticulocytes(Blood)— Urine— RNA; Sarcosine/Creatininium; number fraction(list; procedure) substance ratio NPU17012 10-3 Rtcs(B)—RNA; num.fr.(list; proc.) NPU14248 NPU17009 Rtcs(B)—Reticulocytes(RNA; low c.); num.fr.(proc.) = ? U—Sarcosine/Creatininium; subst.ratio = ? × 10-3 NPU17010 Rtcs(B)—RNA(mean c.); num.fr.(proc.) = ? NPU17011 Rtcs(B)—RNA(high c.); num.fr.(proc.) = ? Plasma— Sarcosine; Blood— substance concentration Rouleau formation; micromol/litre arbitrary concentration(procedure) M = 89,09 g/mol NPU17096 NPU03396 B—Rouleau formation; arb.c.(proc.) = ? P—Sarcosine; subst.c. = ? µmol/l
134 Urine— Plasma— Sarcosine; Selenium; substance concentration substance concentration micromol/litre micromol/litre M = 89,09 g/mol M = 78,96 g/mol NPU03397 Authority: IUPAC/VII-C-TOX U—Sarcosine; subst.c. = ? µmol/l NPU04156 P—Selenium; subst.c. = ? µmol/l Plasma— Scandium; Urine— substance concentration Selenium; picomol/litre substance concentration M = 44,95 g/mol micromol/litre Authority: IUPAC/VII-C-TOX M = 78,96 g/mol NPU04896 Authority: IUPAC/VII-C-TOX P—Scandium; subst.c. = ? pmol/l NPU03406 U—Selenium; subst.c. = ? µmol/l Blood— Schistocytes; Cells(Blood)— arbitrary concentration(procedure) Selenium; NPU17097 substance content B—Schistocytes; arb.c.(proc.) = ? micromol/kilogram M = 78,96 g/mol Plasma— Authority: IUPAC/VII-C-TOX Scleroderma(Scl-70) antibody(Immunoglobulin G); NPU03405 arbitrary concentration(procedure) Cells(B)—Selenium; subst.cont. = ? µmol/kg NPU12562 P—Scleroderma(Scl-70) antibody(IgG); arb.c.(proc.) = ? Hair— Selenium; Plasma— substance content Scleroderma(Scl-70) antibody; micromol/kilogram arbitrary concentration(procedure) M = 78,96 g/mol NPU03402 Authority: IUPAC/VII-C-TOX P—Scleroderma(Scl-70) antibody; arb.c.(proc.) = ? NPU04899 Hair—Selenium; subst.cont. = ? µmol/kg Patient— Secretin(administered); Plasma— amount-of-substance(intravenous administration) Sensoric neuropathy antibody; nanomol arbitrary substance concentration(list; procedure) M = 3 056 g/mol NPU14562 Authority: IUPAC-IUB 74 P—Sensoric neuropathy antibody; arb.subst.c.(list; proc.) NPU10512 NPU14526 P—Myeline associated glycoprotein antibody(IgM); arb.subst.c. Pt—Secretin(administered); am.s.(i.v.) = ? nmol (proc.) = ? × 10³ arb.unit/l NPU14523 P—Neuropathy M-component; arb.c.(IFE; proc.) = ? Patient— NPU14525 P—Neuropathy(SGPG)-antibody(IgM); arb.subst.c.(proc.) = ? × 10³ Secretin(administered); arb.unit/l substance content(intravenous administration; amount-of- NPU14528 P—Sensoric neuropathy(Hu) antibody(IgG); arb.subst.c.(proc.) = ? substance/body mass) × 10³ arb.unit/l picomol/kilogram NPU14529 P—Sensoric neuropathy(sulfatid) antibody; arb.subst.c.(proc.) = ? × M = 3 056 g/mol 10³ arb.unit/l Authority: IUPAC-IUB 74 NPU10513 Plasma— Pt—Secretin(administered); subst.cont.(i.v.; am.s./body mass) = ? pmol/kg Sensoric neuropathy antibody; property(list) Plasma— NPU17708 Secretin; P—Sensoric neuropathy antibody; prop.(list) substance concentration picomol/litre Plasma— M = 3 056 g/mol Sensoric neuropathy(Hu) antibody(Immunoglobulin G); Authority: IUPAC-IUB 74 arbitrary substance concentration(procedure) NPU03403 10³ arbitrary unit/litre P—Secretin; subst.c. = ? pmol/l NPU14528 P—Sensoric neuropathy(Hu) antibody(IgG); arb.subst.c.(proc.) = ? × 10³ Blood— arb.unit/l Sedimentation reaction; arbitrary length Plasma— arbitrary unit Sensoric neuropathy(sulfatid) antibody; NPU17589 arbitrary substance concentration(procedure) B—Sedimentation reaction; arb.length = ? arb.unit 10³ arbitrary unit/litre NPU14529 Blood— P—Sensoric neuropathy(sulfatid) antibody; arb.subst.c.(proc.) = ? × 10³ Sedimentation reaction; arb.unit/l length(procedure) millimetre Urine— NPU03404 Serine/Creatininium; B—Sedimentation reaction; length(proc.) = ? mm substance ratio 10-3 Blood— NPU14249 Selenium; U—Serine/Creatininium; subst.ratio = ? × 10-3 substance concentration micromol/litre Cerebrospinal fluid— M = 78,96 g/mol Serine; Authority: IUPAC/VII-C-TOX substance concentration NPU03893 micromol/litre B—Selenium; subst.c. = ? µmol/l M = 105,09 g/mol NPU03414 Csf—Serine; subst.c. = ? µmol/l
135 Plasma— Erythrocytes(Blood)— Serine; Sickle cells; substance concentration number fraction micromol/litre NPU14272 M = 105,09 g/mol Ercs(B)—Sickle cells; num.fr. = ? NPU03415 P—Serine; subst.c. = ? µmol/l Plasma— Silicon; Urine— substance concentration Serine; micromol/litre substance concentration M = 28,09 g/mol micromol/litre Authority: IUPAC/VII-C-TOX M = 105,09 g/mol NPU03423 NPU03416 P—Silicon; subst.c. = ? µmol/l U—Serine; subst.c. = ? µmol/l Urine— Thrombocytes(Blood)— Silicon; Serotonin; substance concentration entitic amount-of-substance micromol/litre attomol M = 28,09 g/mol M = 176,2 g/mol Authority: IUPAC/VII-C-TOX Other term(s): 5-Hydroxytryptophane NPU03424 Note: Platelet(s) is a full synonym to Thrombocyte(s) U—Silicon; subst.c. = ? µmol/l NPU03418 Trcs(B)—Serotonin; entitic am.s. = ? amol Blood— Silver; Cerebrospinal fluid— substance concentration Serotonin; nanomol/litre substance concentration M = 107,87 g/mol nanomol/litre Authority: IUPAC/VII-C-TOX M = 176,2 g/mol NPU03891 Other term(s): 5-Hydroxytryptophane B—Silver; subst.c. = ? nmol/l NPU10236 Csf—Serotonin; subst.c. = ? nmol/l Plasma— Silver; Plasma— substance concentration Serotonin; nanomol/litre substance concentration M = 107,87 g/mol nanomol/litre Authority: IUPAC/VII-C-TOX M = 176,2 g/mol NPU03425 Other term(s): 5-Hydroxytryptophane P—Silver; subst.c. = ? nmol/l NPU03417 P—Serotonin; subst.c. = ? nmol/l Urine— Silver; Patient(Urine)— substance concentration Serotonin; nanomol/litre substance rate M = 107,87 g/mol nanomol/day Authority: IUPAC/VII-C-TOX M = 176,2 g/mol NPU03892 Other term(s): 5-Hydroxytryptophane U—Silver; subst.c. = ? nmol/l NPU10237 Pt(U)—Serotonin; subst.rate = ? nmol/d Hair— Silver; Plasma— substance content Sertindol; micromol/kilogram substance concentration M = 107,87 g/mol mol/litre Authority: IUPAC/VII-C-TOX NPU14500 NPU03890 P—Sertindol; subst.c.= ? prefix ? mol/l Hair—Silver; subst.cont. = ? µmol/kg
Plasma— Plasma— Sexual-hormone-binding-globulin; Sjögren syndrome A antibody(Immunoglobulin G); substance concentration arbitrary concentration(procedure) nanomol/litre Other term(s): SSA(Ro) M = 115 000 g/mol NPU12563 NPU03419 P—Sjögren syndrome A antibody(IgG); arb.c.(proc.) = ? P—Sexual-hormone-binding-globulin; subst.c. = ? nmol/l Plasma— Plasma— Sjögren syndrome A antibody(Immunoglobulin G); Sialate; arbitrary substance concentration(procedure) substance concentration 10³ arbitrary unit/litre mol/litre Other term(s): SSA(Ro) NPU03420 NPU12564 P—Sialate; subst.c.= ? prefix ? mol/l P—Sjögren syndrome A antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l
Urine— Plasma— Sialate; Sjögren syndrome A antibody; substance concentration arbitrary concentration(procedure) mol/litre Other term(s): SSA(Ro) NPU03421 NPU03426 U—Sialate; subst.c.= ? prefix ? mol/l P—Sjögren syndrome A antibody; arb.c.(proc.) = ?
Blood— Plasma— Sickle cells; Sjögren syndrome A antibody; arbitrary concentration(procedure) arbitrary substance concentration(procedure) NPU17098 arbitrary unit/litre B—Sickle cells; arb.c.(proc.) = ? Other term(s): SSA(Ro) NPU12000 P—Sjögren syndrome A antibody; arb.subst.c.(proc.) = ? arb.unit/l
136 Plasma— Stomach fluid— Sjögren syndrome antibody; Sodium ion; arbitrary substance concentration(list; procedure) amount-of-substance(procedure) NPU14564 millimol P—Sjögren syndrome antibody; arb.subst.c.(list; proc.) Authority: IFCC/C-BGE NPU12564 P—Sjögren syndrome A antibody(IgG); arb.subst.c.(proc.) = ? × 10³ NPU14117 arb.unit/l Stomf—Sodium ion; am.s.(proc.) = ? mmol NPU12567 P—Sjögren syndrome B antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l System(specification)— Sodium ion; Plasma— amount-of-substance(procedure) Sjögren syndrome B antibody(Immunoglobulin G); millimol arbitrary concentration(procedure) NPU08653 Other term(s): SSB(La) Syst(spec.)—Sodium ion; am.s.(proc.) = ? mmol NPU12566 P—Sjögren syndrome B antibody(IgG); arb.c.(proc.) = ? Urine— Sodium ion; Plasma— amount-of-substance(procedure) Sjögren syndrome B antibody(Immunoglobulin G); millimol arbitrary substance concentration(procedure) Authority: IFCC/C-BGE 10³ arbitrary unit/litre NPU03839 Other term(s): SSB(La) U—Sodium ion; am.s.(proc.) = ? mmol NPU12567 P—Sjögren syndrome B antibody(IgG); arb.subst.c.(proc.) = ? × 10³ arb.unit/l Faeces(specification)— Sodium ion; Plasma— amount-of-substance Sjögren syndrome B antibody; millimol arbitrary concentration(procedure) NPU17622 Other term(s): SSB(La) F(spec.)—Sodium ion; am.s. = ? mmol NPU03427 P—Sjögren syndrome B antibody; arb.c.(proc.) = ? Amniotic fluid— Sodium ion; Plasma— substance concentration Sjögren syndrome B antibody; millimol/litre arbitrary substance concentration(procedure) NPU08648 arbitrary unit/litre Amf—Sodium ion; subst.c. = ? mmol/l NPU12037 P—Sjögren syndrome B antibody; arb.subst.c.(proc.) = ? arb.unit/l Ascites— Sodium ion; Urine— substance concentration Slime; millimol/litre arbitrary concentration(procedure) NPU17033 NPU17179 Asc—Sodium ion; subst.c. = ? mmol/l U—Slime; arb.c.(proc.) = ? Aspirate(specification)— Plasma— Sodium ion; Smith's antibody; substance concentration arbitrary concentration(procedure) millimol/litre Other term(s): anti-Sm NPU14910 NPU03428 Aspir(spec.)—Sodium ion; subst.c. = ? mmol/l P—Smith's antibody; arb.c.(proc.) = ? Blood fraction(specification)— Plasma— Sodium ion; Smith's antibody; substance concentration arbitrary substance concentration(procedure) millimol/litre arbitrary unit/litre NPU17583 NPU12024 B fract.(spec.)—Sodium ion; subst.c. = ? mmol/l P—Smith's antibody; arb.subst.c.(proc.) = ? arb.unit/l Cerebrospinal fluid— Blood— Sodium ion; Smudge cells; substance concentration arbitrary concentration(procedure) millimol/litre NPU17130 Authority: IFCC/C-BGE B—Smudge cells; arb.c.(proc.) = ? NPU10193 Csf—Sodium ion; subst.c. = ? mmol/l Aqueous solution— Sodium chloride; Dialysis solution— molality Sodium ion; millimol/kilogram substance concentration M = 58,45 g/mol millimol/litre NPU03991 Authority: IFCC/C-BGE Aq.sol.—Sodium chloride; molal. = ? mmol/kg NPU10192 Dialysis solution—Sodium ion; subst.c. = ? mmol/l Sweat— Sodium ion/Potassium ion; Drain fluid(specification)— substance ratio Sodium ion; Authority: IFCC/C-BGE substance concentration NPU03432 millimol/litre Sweat—Sodium ion/Potassium ion; subst.ratio = ? NPU17045 Drain fluid(spec.)—Sodium ion; subst.c. = ? mmol/l Secretion(Ileum)— Sodium ion; Plasma— amount-of-substance(procedure) Sodium ion; millimol substance concentration NPU08652 millimol/litre Secr(Ileum)—Sodium ion; am.s.(proc.) = ? mmol Authority: IFCC/C-BGE NPU03429 P—Sodium ion; subst.c. = ? mmol/l
137 Secretion(Ileum)— Pleural fluid— Sodium ion; Solute; substance concentration molality(procedure) millimol/litre millimol/kilogram NPU08650 Authority: IFCC/C-BGE Secr(Ileum)—Sodium ion; subst.c. = ? mmol/l NPU17023 Plf—Solute; molal.(proc.) = ? mmol/kg Stomach fluid— Sodium ion; Sweat— substance concentration Solute; millimol/litre molality(procedure) Authority: IFCC/C-BGE millimol/kilogram NPU14116 Authority: IFCC/C-BGE Stomf—Sodium ion; subst.c. = ? mmol/l NPU17182 Sweat—Solute; molal.(proc.) = ? mmol/kg Sweat— Sodium ion; Urine— substance concentration Solute; millimol/litre molality(procedure) Authority: IFCC/C-BGE millimol/kilogram NPU03430 Authority: IFCC/C-BGE Sweat—Sodium ion; subst.c. = ? mmol/l NPU03434 U—Solute; molal.(proc.) = ? mmol/kg System(specification)— Sodium ion; Plasma— substance concentration Somatostatin; millimol/litre substance concentration NPU08651 picomol/litre Syst(spec.)—Sodium ion; subst.c. = ? mmol/l M = 1 638 g/mol NPU03435 Urine— P—Somatostatin; subst.c. = ? pmol/l Sodium ion; substance concentration Urine— millimol/litre Somatostatin; Authority: IFCC/C-BGE substance concentration NPU03431 picomol/litre U—Sodium ion; subst.c. = ? mmol/l M = 1 638 g/mol NPU14013 Faeces— U—Somatostatin; subst.c. = ? pmol/l Sodium ion; substance content Patient(Urine)— millimol/kilogram Somatostatin; NPU04219 substance rate F—Sodium ion; subst.cont. = ? mmol/kg picomol/day M = 1 638 g/mol Faeces(specification)— NPU14014 Sodium ion; Pt(U)—Somatostatin; subst.rate = ? pmol/d substance content millimol/kilogram NPU08649 F(spec.)—Sodium ion; subst.cont. = ? mmol/kg
Patient(Faeces)— Sodium ion; substance rate(procedure) millimol/day NPU04218 Pt(F)—Sodium ion; subst.rate(proc.) = ? mmol/d
Patient(Urine)— Sodium ion; substance rate(procedure) millimol/day NPU03796 Pt(U)—Sodium ion; subst.rate(proc.) = ? mmol/d
Ascites— Solute; molality(procedure) millimol/kilogram Authority: IFCC/C-BGE NPU17024 Asc—Solute; molal.(proc.) = ? mmol/kg
Faeces— Solute; molality(procedure) millimol/kilogram NPU10767 F—Solute; molal.(proc.) = ? mmol/kg
Plasma— Solute; molality(procedure) millimol/kilogram Authority: IFCC/C-BGE NPU03433 P—Solute; molal.(proc.) = ? mmol/kg
138 Pituitary gland— Pituitary gland— Somatotropin secretion; Somatotropin secretion; substance rate(arginine+insulin, intravenous administration; list; substance rate(clonidine, oral administration; list; procedure) procedure) Other term(s): Growth hormone secretion; Somatotropin stimulation test Note: _M_ (arginine) = 174,20 g/mol; _M_ (insulin) = 5 807,65 g/mol; _M_ Note: _M_ (clonidine) = 230,10 g/mol (somatotropin) = 22 124 g/mol NPU10346 NPU10654 PitGl—Somatotropin secretion; subst.rate(clonidine p.o.; list; proc.) PitGl—Somatotropin secretion; subst.rate(arginine+insulin i.v.; list; proc.) NPU10536 Pt—Clonidine(administered); am.s.(p.o.) = ? µmol NPU09354 Pt—Arginine(administered); subst.cont.(i.v.; am.s./body mass) = ? NPU04139 P—Cortisol; subst.c.(0 min) = ? nmol/l mol/kg NPU04140 P—Cortisol; subst.c.(30 min) = ? nmol/l NPU10547 Pt—Insulin(administered); subst.cont.(i.v.; am.s./body mass) = ? NPU04968 P—Cortisol; subst.c.(60 min) = ? nmol/l µmol/kg NPU04970 P—Cortisol; subst.c.(90 min) = ? nmol/l NPU10548 Pt—Insulin(administered); arb.subst.cont.(i.v.; arb.am.s./body mass; NPU04971 P—Cortisol; subst.c.(120 min) = ? nmol/l proc.) = ? int. unit/kg NPU08736 P—Somatotropin; subst.c.(0 min) = ? pmol/l NPU10553 P—Corticotropin; subst.c.(90 min) = ? pmol/l NPU08738 P—Somatotropin; subst.c.(30 min) = ? pmol/l NPU10641 P—Corticotropin; subst.c.(120 min) = ? pmol/l NPU08740 P—Somatotropin; subst.c.(60 min) = ? pmol/l NPU10642 P—Corticotropin; subst.c.(135 min) = ? pmol/l NPU08742 P—Somatotropin; subst.c.(90 min) = ? pmol/l NPU10643 P—Corticotropin; subst.c.(150 min) = ? pmol/l NPU08743 P—Somatotropin; subst.c.(120 min) = ? pmol/l NPU10644 P—Corticotropin; subst.c.(180 min) = ? pmol/l NPU10357 P—Somatotropin; arb.subst.c.(IS 80/505; 0 min; proc.) = ? × 10-3 NPU04970 P—Cortisol; subst.c.(90 min) = ? nmol/l int.unit/l NPU04971 P—Cortisol; subst.c.(120 min) = ? nmol/l NPU10358 P—Somatotropin; arb.subst.c.(IS 80/505; 30 min; proc.) = ? × 10-3 NPU10645 P—Cortisol; subst.c.(135 min) = ? nmol/l int.unit/l NPU10224 P—Cortisol; subst.c.(150 min) = ? nmol/l NPU10359 P—Somatotropin; arb.subst.c.(IS 80/505; 60 min; proc.) = ? × 10-3 NPU10222 P—Cortisol; subst.c.(180 min) = ? nmol/l int.unit/l NPU08736 P—Somatotropin; subst.c.(0 min) = ? pmol/l NPU10360 P—Somatotropin; arb.subst.c.(IS 80/505; 90 min; proc.) = ? × 10-3 NPU08738 P—Somatotropin; subst.c.(30 min) = ? pmol/l int.unit/l NPU08740 P—Somatotropin; subst.c.(60 min) = ? pmol/l NPU10361 P—Somatotropin; arb.subst.c.(IS 80/505; 120 min; proc.) = ? × 10-3 NPU08742 P—Somatotropin; subst.c.(90 min) = ? pmol/l int.unit/l NPU08743 P—Somatotropin; subst.c.(120 min) = ? pmol/l NPU10646 P—Somatotropin; subst.c.(135 min) = ? pmol/l Pituitary gland— NPU10647 P—Somatotropin; subst.c.(150 min) = ? pmol/l Somatotropin secretion; NPU10648 P—Somatotropin; subst.c.(180 min) = ? pmol/l substance rate(glucose, oral administration; list; procedure) NPU10357 P—Somatotropin; arb.subst.c.(IS 80/505; 0 min; proc.) = ? × 10-3 Other term(s): Growth hormone secretion; Somatotropin suppression test int.unit/l Note: _M_ (glucose) = 180,16 g/mol; _M_ (somatotropin) = 22 124 g/mol NPU10358 P—Somatotropin; arb.subst.c.(IS 80/505; 30 min; proc.) = ? × 10-3 NPU03439 int.unit/l PitGl—Somatotropin secretion; subst.rate(glucose p.o.; list; proc.) NPU10359 P—Somatotropin; arb.subst.c.(IS 80/505; 60 min; proc.) = ? × 10-3 NPU10574 Pt—Glucose(administered); am.s.(p.o.) = ? mmol int.unit/l NPU10575 Pt—Glucose(administered); subst.cont.(p.o.; am.s./body mass) = ? NPU10360 P—Somatotropin; arb.subst.c.(IS 80/505; 90 min; proc.) = ? × 10-3 mmol/kg int.unit/l NPU08736 P—Somatotropin; subst.c.(0 min) = ? pmol/l NPU10361 P—Somatotropin; arb.subst.c.(IS 80/505; 120 min; proc.) = ? × 10-3 NPU08737 P—Somatotropin; subst.c.(15 min) = ? pmol/l int.unit/l NPU08738 P—Somatotropin; subst.c.(30 min) = ? pmol/l NPU10649 P—Somatotropin; arb.subst.c.(IS 80/505; 135 min; proc.) = ? × 10-3 NPU08739 P—Somatotropin; subst.c.(45 min) = ? pmol/l int.unit/l NPU08740 P—Somatotropin; subst.c.(60 min) = ? pmol/l NPU10650 P—Somatotropin; arb.subst.c.(IS 80/505; 150 min; proc.) = ? × 10-3 NPU08741 P—Somatotropin; subst.c.(75 min) = ? pmol/l int.unit/l NPU08742 P—Somatotropin; subst.c.(90 min) = ? pmol/l NPU10651 P—Somatotropin; arb.subst.c.(IS 80/505; 180 min; proc.) = ? × 10-3 NPU08743 P—Somatotropin; subst.c.(120 min) = ? pmol/l int.unit/l NPU04983 P—Somatotropin; subst.c.(min.; proc.) = ? pmol/l NPU08504 B—Glucose; subst.c.(30 min) = ? mmol/l NPU10357 P—Somatotropin; arb.subst.c.(IS 80/505; 0 min; proc.) = ? × 10-3 NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l int.unit/l NPU08506 B—Glucose; subst.c.(90 min) = ? mmol/l NPU10350 P—Somatotropin; arb.subst.c.(IS 80/505; 15 min; proc.) = ? × 10-3 NPU10696 B—Glucose; subst.c.(110 min) = ? mmol/l int.unit/l NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l NPU10358 P—Somatotropin; arb.subst.c.(IS 80/505; 30 min; proc.) = ? × 10-3 NPU10697 B—Glucose; subst.c.(135 min) = ? mmol/l int.unit/l NPU08508 B—Glucose; subst.c.(150 min) = ? mmol/l NPU10351 P—Somatotropin; arb.subst.c.(IS 80/505; 45 min; proc.) = ? × 10-3 NPU08500 B—Glucose; subst.c.(180 min) = ? mmol/l int.unit/l NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l NPU10359 P—Somatotropin; arb.subst.c.(IS 80/505; 60 min; proc.) = ? × 10-3 NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l int.unit/l NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l NPU10355 P—Somatotropin; arb.subst.c.(IS 80/505; 75 min; proc.) = ? × 10-3 NPU10652 P—Glucose; subst.c.(110 min) = ? mmol/l int.unit/l NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l NPU10360 P—Somatotropin; arb.subst.c.(IS 80/505; 90 min; proc.) = ? × 10-3 NPU10653 P—Glucose; subst.c.(135 min) = ? mmol/l int.unit/l NPU04178 P—Glucose; subst.c.(150 min) = ? mmol/l NPU10361 P—Somatotropin; arb.subst.c.(IS 80/505; 120 min; proc.) = ? × 10-3 NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l int.unit/l NPU10637 P—Somatotropin; arb.subst.c.(IS 80/505; min.; proc.) = ? × 10-3 int.unit/l NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l NPU08516 B—Glucose; subst.c.(15 min) = ? mmol/l NPU08504 B—Glucose; subst.c.(30 min) = ? mmol/l NPU08517 B—Glucose; subst.c.(45 min) = ? mmol/l NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l NPU08518 B—Glucose; subst.c.(75 min) = ? mmol/l NPU08506 B—Glucose; subst.c.(90 min) = ? mmol/l NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l NPU08500 B—Glucose; subst.c.(180 min) = ? mmol/l NPU08735 B—Glucose; subst.c.(max.; proc.) = ? mmol/l NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l NPU04186 P—Glucose; subst.c.(15 min) = ? mmol/l NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l NPU04187 P—Glucose; subst.c.(45 min) = ? mmol/l NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l NPU04965 P—Glucose; subst.c.(75 min) = ? mmol/l NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l NPU08734 P—Glucose; subst.c.(max.; proc.) = ? mmol/l
139 Pituitary gland— Pituitary gland— Somatotropin secretion; Somatotropin secretion; substance rate(insulin, intravenous administration; list; procedure) substance rate(octreotide, subcutaneous administration; list; procedure) Other term(s): Growth hormone secretion; Somatotropin stimulation test Other term(s): Growth hormone secretion; Somatotropin suppression test Note: _M_ (insulin) = 5 807,65 g/mol; _M_ (somatotropin) = 22 124 g/mol Note: _M_ (octreotide) = 1 019,26 g/mol; _M_ (somatotropin) = 22 124 g/mol NPU03438 NPU10640 PitGl—Somatotropin secretion; subst.rate(insulin i.v.; list; proc.) PitGl—Somatotropin secretion; subst.rate(octreotide s.c.; list; proc.) NPU10547 Pt—Insulin(administered); subst.cont.(i.v.; am.s./body mass) = ? NPU10638 Pt—Octreotide(administered); am.s.(s.c.) = ? nmol µmol/kg NPU10639 Pt—Octreotide(administered); subst.cont.(s.c.; am.s./body mass) NPU10548 Pt—Insulin(administered); arb.subst.cont.(i.v.; arb.am.s./body mass; = ? nmol/kg proc.) = ? int. unit/kg NPU08736 P—Somatotropin; subst.c.(0 min) = ? pmol/l NPU08736 P—Somatotropin; subst.c.(0 min) = ? pmol/l NPU08737 P—Somatotropin; subst.c.(15 min) = ? pmol/l NPU08737 P—Somatotropin; subst.c.(15 min) = ? pmol/l NPU08738 P—Somatotropin; subst.c.(30 min) = ? pmol/l NPU08738 P—Somatotropin; subst.c.(30 min) = ? pmol/l NPU08739 P—Somatotropin; subst.c.(45 min) = ? pmol/l NPU08739 P—Somatotropin; subst.c.(45 min) = ? pmol/l NPU08740 P—Somatotropin; subst.c.(60 min) = ? pmol/l NPU08740 P—Somatotropin; subst.c.(60 min) = ? pmol/l NPU08741 P—Somatotropin; subst.c.(75 min) = ? pmol/l NPU08741 P—Somatotropin; subst.c.(75 min) = ? pmol/l NPU08742 P—Somatotropin; subst.c.(90 min) = ? pmol/l NPU08742 P—Somatotropin; subst.c.(90 min) = ? pmol/l NPU08743 P—Somatotropin; subst.c.(120 min) = ? pmol/l NPU08743 P—Somatotropin; subst.c.(120 min) = ? pmol/l NPU10633 P—Somatotropin; subst.c.(240 min) = ? pmol/l NPU04982 P—Somatotropin; subst.c.(max.; proc.) = ? pmol/l NPU10634 P—Somatotropin; subst.c.(360 min) = ? pmol/l NPU10357 P—Somatotropin; arb.subst.c.(IS 80/505; 0 min; proc.) = ? × 10-3 NPU04983 P—Somatotropin; subst.c.(min.; proc.) = ? pmol/l int.unit/l NPU10357 P—Somatotropin; arb.subst.c.(IS 80/505; 0 min; proc.) = ? × 10-3 NPU10350 P—Somatotropin; arb.subst.c.(IS 80/505; 15 min; proc.) = ? × 10-3 int.unit/l int.unit/l NPU10358 P—Somatotropin; arb.subst.c.(IS 80/505; 30 min; proc.) = ? × 10-3 NPU10358 P—Somatotropin; arb.subst.c.(IS 80/505; 30 min; proc.) = ? × 10-3 int.unit/l int.unit/l NPU10359 P—Somatotropin; arb.subst.c.(IS 80/505; 60 min; proc.) = ? × 10-3 NPU10351 P—Somatotropin; arb.subst.c.(IS 80/505; 45 min; proc.) = ? × 10-3 int.unit/l int.unit/l NPU10360 P—Somatotropin; arb.subst.c.(IS 80/505; 90 min; proc.) = ? × 10-3 NPU10359 P—Somatotropin; arb.subst.c.(IS 80/505; 60 min; proc.) = ? × 10-3 int.unit/l int.unit/l NPU10361 P—Somatotropin; arb.subst.c.(IS 80/505; 120 min; proc.) = ? × 10-3 NPU10355 P—Somatotropin; arb.subst.c.(IS 80/505; 75 min; proc.) = ? × 10-3 int.unit/l int.unit/l NPU10635 P—Somatotropin; arb.subst.c.(IS 80/505; 240 min; proc.) = ? × 10-3 NPU10360 P—Somatotropin; arb.subst.c.(IS 80/505; 90 min; proc.) = ? × 10-3 int.unit/l int.unit/l NPU10636 P—Somatotropin; arb.subst.c.(IS 80/505; 360 min; proc.) = ? × 10-3 NPU10361 P—Somatotropin; arb.subst.c.(IS 80/505; 120 min; proc.) = ? × 10-3 int.unit/l int.unit/l NPU10637 P—Somatotropin; arb.subst.c.(IS 80/505; min.; proc.) = ? × 10-3 NPU10687 P—Somatotropin; arb.subst.c.(IS 80/505; max.; proc.) = ? × 10-3 int.unit/l int.unit/l NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l Pituitary gland— NPU08516 B—Glucose; subst.c.(15 min) = ? mmol/l Somatotropin secretion; NPU08504 B—Glucose; subst.c.(30 min) = ? mmol/l substance rate(protirelin, intravenous administration; list; procedure) NPU08517 B—Glucose; subst.c.(45 min) = ? mmol/l Note: _M_ (thyrotropin releasing hormone) = ? g/mol NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l NPU10349 NPU08518 B—Glucose; subst.c.(75 min) = ? mmol/l PitGl—Somatotropin secretion; subst.rate(protirelin i.v.; list; proc.) NPU08506 B—Glucose; subst.c.(90 min) = ? mmol/l NPU10454 Pt—Protirelin(administered); am.s.(i.v.) = ? nmol NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l NPU10357 P—Somatotropin; arb.subst.c.(IS 80/505; 0 min; proc.) = ? × 10-3 NPU08500 B—Glucose; subst.c.(180 min) = ? mmol/l int.unit/l NPU08519 B—Glucose; subst.c.(min.; proc.) = ? mmol/l NPU10350 P—Somatotropin; arb.subst.c.(IS 80/505; 15 min; proc.) = ? × 10-3 NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l int.unit/l NPU04186 P—Glucose; subst.c.(15 min) = ? mmol/l NPU10358 P—Somatotropin; arb.subst.c.(IS 80/505; 30 min; proc.) = ? × 10-3 NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l int.unit/l NPU04187 P—Glucose; subst.c.(45 min) = ? mmol/l NPU10351 P—Somatotropin; arb.subst.c.(IS 80/505; 45 min; proc.) = ? × 10-3 NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l int.unit/l NPU04965 P—Glucose; subst.c.(75 min) = ? mmol/l NPU10359 P—Somatotropin; arb.subst.c.(IS 80/505; 60 min; proc.) = ? × 10-3 NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l int.unit/l NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l Plasma— NPU04981 P—Glucose; subst.c.(min.; proc.) = ? mmol/l Somatotropin; arbitrary substance concentration(IRP 66/217; procedure) Pituitary gland— international unit/litre Somatotropin secretion; M = 22 124 g/mol substance rate(levodopa, oral administration; list; procedure) Recommended calibrator: WHO IRP 66/217 Other term(s): Growth hormone secretion; Somatotropin stimulation test Other term(s): Growth hormone; Somatropic hormone Note: _M_ (levodopa) = 197,2 g/mol; _M_ (somatotropin) = 22 124 g/mol Authority: IUPAC-IUB 74 NPU10450 NPU04023 PitGl—Somatotropin secretion; subst.rate(levodopa p.o.; list; proc.) P—Somatotropin; arb.subst.c.(IRP 66/217; proc.) = ? int. unit/l NPU10457 Pt—Levodopa(administered); am.s.(p.o.) = ? mmol NPU08736 P—Somatotropin; subst.c.(0 min) = ? pmol/l Plasma— NPU08737 P—Somatotropin; subst.c.(15 min) = ? pmol/l Somatotropin; NPU08738 P—Somatotropin; subst.c.(30 min) = ? pmol/l arbitrary substance concentration(IS 80/505; 0 minutes after challenge; NPU08739 P—Somatotropin; subst.c.(45 min) = ? pmol/l procedure) NPU08740 P—Somatotropin; subst.c.(60 min) = ? pmol/l 10-3 international unit/litre NPU08741 P—Somatotropin; subst.c.(75 min) = ? pmol/l NPU10357 NPU08742 P—Somatotropin; subst.c.(90 min) = ? pmol/l P—Somatotropin; arb.subst.c.(IS 80/505; 0 min; proc.) = ? × 10-3 int.unit/l NPU08743 P—Somatotropin; subst.c.(120 min) = ? pmol/l NPU04982 P—Somatotropin; subst.c.(max.; proc.) = ? pmol/l Plasma— NPU10357 P—Somatotropin; arb.subst.c.(IS 80/505; 0 min; proc.) = ? × 10-3 Somatotropin; int.unit/l arbitrary substance concentration(IS 80/505; 120 minutes after challenge; NPU10358 P—Somatotropin; arb.subst.c.(IS 80/505; 30 min; proc.) = ? × 10-3 procedure) int.unit/l 10-3 international unit/litre NPU10359 P—Somatotropin; arb.subst.c.(IS 80/505; 60 min; proc.) = ? × 10-3 NPU10361 int.unit/l P—Somatotropin; arb.subst.c.(IS 80/505; 120 min; proc.) = ? × 10-3 int.unit/l NPU10360 P—Somatotropin; arb.subst.c.(IS 80/505; 90 min; proc.) = ? × 10-3 int.unit/l Plasma— NPU10361 P—Somatotropin; arb.subst.c.(IS 80/505; 120 min; proc.) = ? × 10-3 Somatotropin; int.unit/l arbitrary substance concentration(IS 80/505; 135 minutes after challenge; NPU10687 P—Somatotropin; arb.subst.c.(IS 80/505; max.; proc.) = ? × 10-3 procedure) int.unit/l 10-3 international unit/litre NPU10649 P—Somatotropin; arb.subst.c.(IS 80/505; 135 min; proc.) = ? × 10-3 int.unit/l
140 Plasma— Plasma— Somatotropin; Somatotropin; arbitrary substance concentration(IS 80/505; minimum; procedure) arbitrary substance concentration(IS 80/505; 15 minutes after challenge; 10-3 international unit/litre procedure) NPU10637 10-3 international unit/litre P—Somatotropin; arb.subst.c.(IS 80/505; min.; proc.) = ? × 10-3 int.unit/l NPU10350 P—Somatotropin; arb.subst.c.(IS 80/505; 15 min; proc.) = ? × 10-3 int.unit/l Plasma— Somatotropin; Plasma— arbitrary substance concentration(IS 80/505; procedure) Somatotropin; 10-3 international unit/litre arbitrary substance concentration(IS 80/505; 150 minutes after challenge; M = 22 124 g/mol procedure) Recommended calibrator: WHO 1st IS 80/505 10-3 international unit/litre Calibrator(s): WHO IRP 66/217 NPU10650 Other term(s): Growth hormone; Somatropic hormone P—Somatotropin; arb.subst.c.(IS 80/505; 150 min; proc.) = ? × 10-3 int.unit/l Authority: IUPAC-IUB 74 NPU03436 Plasma— P—Somatotropin; arb.subst.c.(IS 80/505; proc.) = ? × 10-3 int.unit/l Somatotropin; arbitrary substance concentration(IS 80/505; 180 minutes after challenge; Plasma— procedure) Somatotropin; 10-3 international unit/litre substance concentration(0 minutes after challenge) NPU10651 picomol/litre P—Somatotropin; arb.subst.c.(IS 80/505; 180 min; proc.) = ? × 10-3 int.unit/l NPU08736 P—Somatotropin; subst.c.(0 min) = ? pmol/l Plasma— Somatotropin; Plasma— arbitrary substance concentration(IS 80/505; 240 minutes after challenge; Somatotropin; procedure) substance concentration(15 minutes after challenge) 10-3 international unit/litre picomol/litre NPU10635 NPU08737 P—Somatotropin; arb.subst.c.(IS 80/505; 240 min; proc.) = ? × 10-3 int.unit/l P—Somatotropin; subst.c.(15 min) = ? pmol/l
Plasma— Plasma— Somatotropin; Somatotropin; arbitrary substance concentration(IS 80/505; 30 minutes after challenge; substance concentration(30 minutes after challenge) procedure) picomol/litre 10-3 international unit/litre NPU08738 NPU10358 P—Somatotropin; subst.c.(30 min) = ? pmol/l P—Somatotropin; arb.subst.c.(IS 80/505; 30 min; proc.) = ? × 10-3 int.unit/l Plasma— Plasma— Somatotropin; Somatotropin; substance concentration(45 minutes challenge) arbitrary substance concentration(IS 80/505; 360 minutes after challenge; picomol/litre procedure) NPU08739 10-3 international unit/litre P—Somatotropin; subst.c.(45 min) = ? pmol/l NPU10636 P—Somatotropin; arb.subst.c.(IS 80/505; 360 min; proc.) = ? × 10-3 int.unit/l Plasma— Somatotropin; Plasma— substance concentration(60 minutes after challenge) Somatotropin; picomol/litre arbitrary substance concentration(IS 80/505; 45 minutes challenge; NPU08740 procedure) P—Somatotropin; subst.c.(60 min) = ? pmol/l 10-3 international unit/litre NPU10351 Plasma— P—Somatotropin; arb.subst.c.(IS 80/505; 45 min; proc.) = ? × 10-3 int.unit/l Somatotropin; substance concentration(75 minutes after challenge) Plasma— picomol/litre Somatotropin; NPU08741 arbitrary substance concentration(IS 80/505; 60 minutes after challenge; P—Somatotropin; subst.c.(75 min) = ? pmol/l procedure) 10-3 international unit/litre Plasma— NPU10359 Somatotropin; P—Somatotropin; arb.subst.c.(IS 80/505; 60 min; proc.) = ? × 10-3 int.unit/l substance concentration(90 minutes after challenge) picomol/litre Plasma— NPU08742 Somatotropin; P—Somatotropin; subst.c.(90 min) = ? pmol/l arbitrary substance concentration(IS 80/505; 75 minutes after challenge; procedure) Plasma— 10-3 international unit/litre Somatotropin; NPU10355 substance concentration(120 minutes after challenge) P—Somatotropin; arb.subst.c.(IS 80/505; 75 min; proc.) = ? × 10-3 int.unit/l picomol/litre NPU08743 Plasma— P—Somatotropin; subst.c.(120 min) = ? pmol/l Somatotropin; arbitrary substance concentration(IS 80/505; 90 minutes after challenge; Plasma— procedure) Somatotropin; 10-3 international unit/litre substance concentration(135 minutes after challenge) NPU10360 picomol/litre P—Somatotropin; arb.subst.c.(IS 80/505; 90 min; proc.) = ? × 10-3 int.unit/l NPU10646 P—Somatotropin; subst.c.(135 min) = ? pmol/l Plasma— Somatotropin; Plasma— arbitrary substance concentration(IS 80/505; maximum; procedure) Somatotropin; 10-3 international unit/litre substance concentration(150 minutes after challenge) NPU10687 picomol/litre P—Somatotropin; arb.subst.c.(IS 80/505; max.; proc.) = ? × 10-3 int.unit/l NPU10647 P—Somatotropin; subst.c.(150 min) = ? pmol/l
141 Plasma— System(specification)— Somatotropin; Streptokinase; substance concentration(180 minutes after challenge) arbitrary substance concentration(IS 62/7; procedure) picomol/litre international unit/litre NPU10648 M = 47 408 g/mol P—Somatotropin; subst.c.(180 min) = ? pmol/l Recommended calibrator: WHO 1st IS 62/7 Other term(s): SK; STK Plasma— NPU04024 Somatotropin; Syst(spec.)—Streptokinase; arb.subst.c.(IS 62/7; proc.) = ? int. unit/l substance concentration(240 minutes after challenge) picomol/litre System(specification)— NPU10633 Streptokinase; P—Somatotropin; subst.c.(240 min) = ? pmol/l arbitrary substance concentration(IS 88/826; procedure) international unit/litre Plasma— M = 47 408 g/mol Somatotropin; Recommended calibrator: WHO 2nd IS 88/826 substance concentration(360 minutes after challenge) Calibrator(s): WHO 1st IS 62/7 picomol/litre Other term(s): SK; STK NPU10634 NPU03489 P—Somatotropin; subst.c.(360 min) = ? pmol/l Syst(spec.)—Streptokinase; arb.subst.c.(IS 88/826; proc.) = ? int. unit/l
Plasma— System(specification)— Somatotropin; Streptokinase; substance concentration(1 day after challenge) substance concentration picomol/litre mol/litre NPU10448 M = 47 408 g/mol P—Somatotropin; subst.c.(1 d) = ? pmol/l Other term(s): SK; STK NPU04025 Plasma— Syst(spec.)—Streptokinase; subst.c.= ? prefix ? mol/l Somatotropin; substance concentration(2 days after challenge) Plasma— picomol/litre Striated muscle antibody(Immunoglobulin G); NPU10449 arbitrary concentration(procedure) P—Somatotropin; subst.c.(2 d) = ? pmol/l NPU12995 P—Striated muscle antibody(IgG); arb.c.(proc.) = ? Plasma— Somatotropin; Plasma— substance concentration(maximum; procedure) Striated muscle antibody; picomol/litre arbitrary concentration(procedure) NPU04982 NPU02852 P—Somatotropin; subst.c.(max.; proc.) = ? pmol/l P—Striated muscle antibody; arb.c.(proc.) = ?
Plasma— Plasma— Somatotropin; Strontium; substance concentration(minimum; procedure) substance concentration picomol/litre nanomol/litre NPU04983 M = 87,62 g/mol P—Somatotropin; subst.c.(min.; proc.) = ? pmol/l Authority: IUPAC/VII-C-TOX NPU03494 Plasma— P—Strontium; subst.c. = ? nmol/l Somatotropin; substance concentration Cells(Blood)— picomol/litre Strontium; M = 22 124 g/mol substance content Other term(s): Growth hormone; Somatropic hormone nanomol/kilogram Authority: IUPAC-IUB 74 M = 87,62 g/mol NPU03437 Authority: IUPAC/VII-C-TOX P—Somatotropin; subst.c. = ? pmol/l NPU04901 Cells(B)—Strontium; subst.cont. = ? nmol/kg Blood— spherocytic; Plasma— arbitrary concentration(procedure) Substance P; NPU17099 substance concentration B—spherocytic; arb.c.(proc.) = ? picomol/litre M = 1 348 g/mol Erythrocytes(Blood)— NPU03498 spherocytic; P—Substance P; subst.c. = ? pmol/l number fraction NPU14110 Urine— Ercs(B)—spherocytic; num.fr. = ? Substance P; substance concentration Patient— picomol/litre Stomach pain; M = 1 348 g/mol property(procedure) NPU14015 NPU14908 U—Substance P; subst.c. = ? pmol/l Pt—Stomach pain; prop.(proc.) = ? Patient(Urine)— Blood— Substance P; Stomatocytes; substance rate arbitrary concentration(procedure) picomol/day NPU17100 M = 1 348 g/mol B—Stomatocytes; arb.c.(proc.) = ? NPU14016 Pt(U)—Substance P; subst.rate = ? pmol/d
Urine— Succinate; substance concentration micromol/litre NPU03499 U—Succinate; subst.c. = ? µmol/l
142 Haemoglobin(Fe; Blood)— Urine— Sulfhaemoglobin(Fe); Succinylacetone; substance fraction substance concentration M = 16 500 g/mol mol/litre NPU03520 M = 158,15 g/mol Hb(Fe; B)—Sulfhaemoglobin(Fe); subst.fr. = ? NPU03508 U—Succinylacetone; subst.c.= ? prefix ? mol/l Cobalamin(Plasma)— Sulfitocobalamin; Plasma— substance fraction Succinyloaminoimidazolecarboxamide riboside; NPU04957 substance concentration Cobalamin(P)—Sulfitocobalamin; subst.fr. = ? mol/litre NPU03509 Urine— P—Succinyloaminoimidazolecarboxamide riboside; subst.c.= ? prefix ? mol/l Sulfo-L-cysteine/Creatininium; substance ratio Intestine, small— 10-3 Sucrose tolerance; NPU14250 property(sucrose, oral administration; list; procedure) U—Sulfo-L-cysteine/Creatininium; subst.ratio = ? × 10-3 Other term(s): Saccharose tolerance Note: _M_ (sucrose) = 342,3 g/mol Plasma— NPU03511 Sulfo-L-cysteine; Intest., small—Sucrose tolerance; prop.(sucrose p.o.; list; proc.) substance concentration NPU10594 Pt—Sucrose(administered); am.s.(p.o.) = ? mmol mol/litre NPU10595 Pt—Sucrose(administered); subst.cont.(p.o.; am.s./body mass) = ? NPU03529 mmol/kg P—Sulfo-L-cysteine; subst.c.= ? prefix ? mol/l NPU08503 B—Glucose; subst.c.(0 min) = ? mmol/l NPU08516 B—Glucose; subst.c.(15 min) = ? mmol/l Urine— NPU08504 B—Glucose; subst.c.(30 min) = ? mmol/l Sulfo-L-cysteine; NPU08517 B—Glucose; subst.c.(45 min) = ? mmol/l substance concentration NPU08501 B—Glucose; subst.c.(60 min) = ? mmol/l mol/litre NPU08518 B—Glucose; subst.c.(75 min) = ? mmol/l NPU03530 NPU08506 B—Glucose; subst.c.(90 min) = ? mmol/l U—Sulfo-L-cysteine; subst.c.= ? prefix ? mol/l NPU08507 B—Glucose; subst.c.(120 min) = ? mmol/l NPU08500 B—Glucose; subst.c.(180 min) = ? mmol/l Patient— NPU08515 B—Glucose; subst.c.(360 min) = ? mmol/l Surface; NPU08502 B—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l area NPU04173 P—Glucose; subst.c.(0 min) = ? mmol/l (metre)² NPU04186 P—Glucose; subst.c.(15 min) = ? mmol/l NPU10218 NPU04174 P—Glucose; subst.c.(30 min) = ? mmol/l Pt—Surface; area = ? m² NPU04187 P—Glucose; subst.c.(45 min) = ? mmol/l NPU04175 P—Glucose; subst.c.(60 min) = ? mmol/l Skin— NPU04965 P—Glucose; subst.c.(75 min) = ? mmol/l Sweat tolerance; NPU04176 P—Glucose; subst.c.(90 min) = ? mmol/l property(Pilocarpine intracutaneously; list; procedure) NPU04177 P—Glucose; subst.c.(120 min) = ? mmol/l NPU17183 NPU04179 P—Glucose; subst.c.(180 min) = ? mmol/l Skin—Sweat tolerance; prop.(Pilocarpine i.c.; list; proc.) NPU04185 P—Glucose; subst.c.(360 min) = ? mmol/l NPU01537 Sweat—Chloride; subst.c. = ? mmol/l NPU03841 P—Glucose; subst.c.incr.(max. c. minus 0 min c.; proc.) = ? mmol/l NPU03941 Sweat—Potassium ion; subst.c. = ? mmol/l NPU03430 Sweat—Sodium ion; subst.c. = ? mmol/l Patient— NPU03432 Sweat—Sodium ion/Potassium ion; subst.ratio = ? Sucrose(administered); NPU17182 Sweat—Solute; molal.(proc.) = ? mmol/kg amount-of-substance(oral administration) NPU08675 Sweat—Sweat; mass(proc.) = ? mg millimol M = 342,30 g/mol Skin(Arm; left)— NPU10594 Sweat tolerance; Pt—Sucrose(administered); am.s.(p.o.) = ? mmol property(Pilocarpine intracutaneously; list; procedure) NPU17185 Patient— Skin(Arm; left)—Sweat tolerance; prop.(Pilocarpine i.c.; list; proc.) Sucrose(administered); NPU01537 Sweat—Chloride; subst.c. = ? mmol/l substance content(oral administration; amount-of-substance/body mass) NPU03941 Sweat—Potassium ion; subst.c. = ? mmol/l millimol/kilogram NPU03430 Sweat—Sodium ion; subst.c. = ? mmol/l M = 342,30 g/mol NPU03432 Sweat—Sodium ion/Potassium ion; subst.ratio = ? NPU10595 NPU17182 Sweat—Solute; molal.(proc.) = ? mmol/kg Pt—Sucrose(administered); subst.cont.(p.o.; am.s./body mass) = ? mmol/kg NPU08675 Sweat—Sweat; mass(proc.) = ? mg
Food— Skin(Arm; right)— Sucrose-1,6-alpha-glucan 3(6)-alpha-glucosyltransferase; Sweat tolerance; substance content property(Pilocarpine intracutaneously; list; procedure) mol/kilogram NPU17184 NPU03999 Skin(Arm; right)—Sweat tolerance; prop.(Pilocarpine i.c.; list; proc.) Food—Sucrose-1,6-alpha-glucan 3(6)-alpha-glucosyltransferase; subst.cont. NPU01537 Sweat—Chloride; subst.c. = ? mmol/l = ? mol/kg NPU03941 Sweat—Potassium ion; subst.c. = ? mmol/l NPU03430 Sweat—Sodium ion; subst.c. = ? mmol/l Patient(Urine)— NPU03432 Sweat—Sodium ion/Potassium ion; subst.ratio = ? 6- NPU17182 Sweat—Solute; molal.(proc.) = ? mmol/kg Sulfatoxymelatonin; NPU08675 Sweat—Sweat; mass(proc.) = ? mg substance rate micromol/day Sweat— NPU09362 Sweat; Pt(U)—6-Sulfatoxymelatonin; subst.rate = ? µmol/d mass(procedure) milligram Blood— NPU08675 Sulfhaemoglobin(Fe); Sweat—Sweat; mass(proc.) = ? mg substance concentration millimol/litre Patient— M = 16 500 g/mol Synovial fluid(specification); NPU04157 relative volumic mass(20 °C/water, 20 °C; procedure) B—Sulfhaemoglobin(Fe); subst.c. = ? mmol/l NPU10185 Pt—Synovial fluid(spec.); rel.volumic mass(20 °C/water, 20 °C; proc.) = ?
143 Blood— Plasma— Target cells; Testosterone(total); arbitrary concentration(procedure) substance concentration(3 days after challenge) NPU17101 nanomol/litre B—Target cells; arb.c.(proc.) = ? NPU10427 P—Testosterone(tot.); subst.c.(3 d) = ? nmol/l Erythrocytes(Blood)— Target cells; Plasma— number fraction Testosterone(total); NPU14273 substance concentration(4 days after challenge) Ercs(B)—Target cells; num.fr. = ? nanomol/litre NPU10428 Urine— P—Testosterone(tot.); subst.c.(4 d) = ? nmol/l Taurine/Creatininium; substance ratio Plasma— 10-3 Testosterone(total); NPU14251 substance concentration U—Taurine/Creatininium; subst.ratio = ? × 10-3 nanomol/litre M = 288,41 g/mol Cerebrospinal fluid— Authority: IUPAC-IUB 89 Taurine; NPU03543 substance concentration P—Testosterone(tot.); subst.c. = ? nmol/l micromol/litre M = 125,14 g/mol Saliva— NPU03540 Testosterone; Csf—Taurine; subst.c. = ? µmol/l substance concentration nanomol/litre Plasma— M = 288,41 g/mol Taurine; Authority: IUPAC-IUB 84 substance concentration NPU03544 micromol/litre Saliva—Testosterone; subst.c. = ? nmol/l M = 125,14 g/mol NPU03541 Sexual-hormone-binding-globulin(Plasma)— P—Taurine; subst.c. = ? µmol/l Testosterone; substance fraction Urine— NPU16485 Taurine; SHBG(P)—Testosterone; subst.fr. = ? substance concentration micromol/litre Patient(Urine)— M = 125,14 g/mol Testosterone; NPU03542 substance rate U—Taurine; subst.c. = ? µmol/l nanomol/day M = 288,41 g/mol Patient— Authority: IUPAC-IUB 89 Testosterone secretion; NPU10231 substance rate(choriogonadotropin, intramuscular administration; list; Pt(U)—Testosterone; subst.rate = ? nmol/d procedure) Note: _M_(choriogonadotropin) = 39 000 g/mol Patient— NPU10429 Tetracosactide(administered); Pt—Testosterone secretion; subst.rate(choriogonadotropin i.m.; list; proc.) amount-of-substance(intramuscular administration) NPU10423 Pt—Choriogonadotropin; arb.subst.cont.(i.m.; arb.am.s./body mass; nanomol proc.; IS 75/537)= ? int. unit/kg M = 2 933,57 g/mol NPU10424 P—Testosterone(tot.); subst.c.(0 d) = ? nmol/l Other term(s): Cosyntropin; Cortrosyn NPU10425 P—Testosterone(tot.); subst.c.(1 d) = ? nmol/l NPU10534 NPU10426 P—Testosterone(tot.); subst.c.(2 d) = ? nmol/l Pt—Tetracosactide(administered); am.s.(i.m.) = ? nmol NPU10427 P—Testosterone(tot.); subst.c.(3 d) = ? nmol/l NPU10428 P—Testosterone(tot.); subst.c.(4 d) = ? nmol/l Patient— Tetracosactide(administered); Plasma— amount-of-substance(intravenous administration) Testosterone(free); nanomol substance concentration M = 2 933,57 g/mol nanomol/litre Other term(s): Cosyntropin; Cortrosyn M = 288,41 g/mol NPU10688 Authority: IUPAC-IUB 84 Pt—Tetracosactide(administered); am.s.(i.v.) = ? nmol NPU03549 P—Testosterone(free); subst.c. = ? nmol/l Patient— Tetracosactide(administered); Plasma— substance content(intramuscular administration; amount-of-substance/body Testosterone(total); mass) substance concentration(0 days after challenge) nanomol/kilogram nanomol/litre M = 2933,57 g/mol NPU10424 Other term(s): Cosyntropin P—Testosterone(tot.); subst.c.(0 d) = ? nmol/l NPU10535 Pt—Tetracosactide(administered); subst.cont.(i.m.; am.s./body mass) = ? Plasma— nmol/kg Testosterone(total); substance concentration(1 day after challenge) Patient— nanomol/litre Tetracosactide(administered); NPU10425 substance content(intravenous administration; amount-of-substance/body P—Testosterone(tot.); subst.c.(1 d) = ? nmol/l mass) nanomol/kilogram Plasma— M = 2 933,57 g/mol Testosterone(total); Other term(s): Cosyntropin substance concentration(2 days after challenge) NPU10689 nanomol/litre Pt—Tetracosactide(administered); subst.cont.(i.v.; am.s./body mass) = ? NPU10426 nmol/kg P—Testosterone(tot.); subst.c.(2 d) = ? nmol/l
144 Patient(Urine)— Cerebrospinal fluid— Tetrahydroaldosterone; Threonine; substance rate(procedure) substance concentration nanomol/day micromol/litre NPU03550 M = 119,12 g/mol Pt(U)—Tetrahydroaldosterone; subst.rate(proc.) = ? nmol/d NPU03557 Csf—Threonine; subst.c. = ? µmol/l Plasma— Tetranectin(monomer); Plasma— substance concentration Threonine; micromol/litre substance concentration M = 20 100 g/mol micromol/litre NPU09334 M = 119,12 g/mol P—Tetranectin(monomer); subst.c. = ? µmol/l NPU03558 P—Threonine; subst.c. = ? µmol/l Plasma— Tetranectin; Urine— mass concentration(procedure) Threonine; milligram/litre substance concentration NPU09260 micromol/litre P—Tetranectin; mass c.(proc.) = ? mg/l M = 119,12 g/mol NPU03559 Blood— U—Threonine; subst.c. = ? µmol/l Thallium; substance concentration Plasma— nanomol/litre Thrombocyte antibody; M = 204,37 g/mol arbitrary substance concentration(procedure) Authority: IUPAC/VII-C-TOX arbitrary unit/litre NPU03551 Other term(s): Thrombocyte specific alloantibody; Thrombocyte autoantibody. B—Thallium; subst.c. = ? nmol/l Other term(s): Platelet(s) is a full synonym to Thrombocyte(s) Authority: ISTH/SSC93 Dialysis solution— NPU03564 Thallium; P—Thrombocyte antibody; arb.subst.c.(proc.) = ? arb.unit/l substance concentration nanomol/litre Thrombocytes(Blood)— M = 204,37 g/mol Thrombocyte antigen; Authority: IUPAC/VII-C-TOX taxon(Zw, Bak) NPU17698 Other term(s): Platelet(s) is a full synonym to Thrombocyte(s) Dialysis solution—Thallium; subst.c. = ? nmol/l NPU03563 Trcs(B)—Thrombocyte antigen; taxon(Zw, Bak) = ? Plasma— Thallium; Blood— substance concentration Thrombocytes; nanomol/litre entitic volume M = 204,37 g/mol femtolitre Authority: IUPAC/VII-C-TOX Other term(s): Platelet(s) is a full synonym to Thrombocyte(s) NPU03552 NPU03562 P—Thallium; subst.c. = ? nmol/l B—Thrombocytes; entitic vol. = ? fl
Urine— Blood— Thallium; Thrombocytes; substance concentration number concentration nanomol/litre 109/litre M = 204,37 g/mol Other term(s): Platelet(s) is a full synonym to Thrombocyte(s) Authority: IUPAC/VII-C-TOX NPU03568 NPU03553 B—Thrombocytes; num.c. = ? × 109/l U—Thallium; subst.c. = ? nmol/l Blood fraction(specification)— Patient(Urine)— Thrombocytes; Thallium; number concentration substance rate 109/litre millimol/day NPU17586 M = 207,34 g/mol B fract.(spec.)—Thrombocytes; num.c. = ? × 109/l Authority: IUPAC/VII-C-TOX NPU10233 Plasma— Pt(U)—Thallium; subst.rate = ? mmol/d Thymidine kinase; arbitrary catalytic-activity concentration(procedure) Patient(Urine)— arbitrary unit/litre Thallium; NPU10578 substance rate P—Thymidine kinase; arb.cat.c.(proc.) = ? arb.unit/l nanomol/day M = 207,34 g/mol Plasma— Authority: IUPAC/VII-C-TOX Thyreoidea-receptor antibody; NPU17699 arbitrary concentration(procedure) Pt(U)—Thallium; subst.rate = ? nmol/d NPU04131 P—Thyreoidea-receptor antibody; arb.c.(proc.)= ? Plasma— Thiocyanate; Plasma— substance concentration Thyreoidea-receptor antibody; mol/litre arbitrary substance concentration(procedure) NPU03555 arbitrary unit/litre P—Thiocyanate; subst.c.= ? prefix ? mol/l NPU14377 P—Thyreoidea-receptor antibody; arb.subst.c.(proc.) = ? arb.unit/l Urine— Threonine/Creatininium; substance ratio 10-3 NPU14252 U—Threonine/Creatininium; subst.ratio = ? × 10-3
145 Plasma— Plasma— Thyroglobulin antibody; Thyrotropin; arbitrary substance concentration(procedure; IRP 65/93) arbitrary substance concentration(IRP 68/38; procedure) international unit/litre 10-3 international unit/litre Recommended calibrator: WHO IRP 65/93 M = 30 000 g/mol NPU03573 Recommended calibrator: WHO IRP 68/38 P—Thyroglobulin antibody; arb.subst.c.(proc.; IRP 65/93) = ? int. unit/l Other term(s): Thyroid stimulating hormone; Thyrotropic hormone; TSH Authority: IUPAC-IUB 74 Plasma— NPU04026 Thyroglobulin; P—Thyrotropin; arb.subst.c.(IRP 68/38; proc.) = ? × 10-3 int.unit/l arbitrary substance concentration(procedure) 10³ arbitrary unit/litre Plasma— NPU03572 Thyrotropin; P—Thyroglobulin; arb.subst.c.(proc.) = ? × 10³ arb.unit/l arbitrary substance concentration(IRP 80/558; 0 minutes after challenge; procedure) Plasma— 10-3 international unit/litre Thyroglobulin; NPU04199 substance concentration P—Thyrotropin; arb.subst.c.(IRP 80/558; 0 min; proc.) = ? × 10-3 int.unit/l mol/litre NPU09009 Plasma— P—Thyroglobulin; subst.c.= ? prefix ? mol/l Thyrotropin; arbitrary substance concentration(IRP 80/558; 120 minutes after challenge; Plasma— procedure) Thyroid antibody; 10-3 international unit/litre arbitrary concentration(procedure) NPU10347 NPU03574 P—Thyrotropin; arb.subst.c.(IRP 80/558; 120 min; proc.) = ? × 10-3 int.unit/l P—Thyroid antibody; arb.c.(proc.) = ? Plasma— Plasma— Thyrotropin; Thyroid microsome antibody; arbitrary substance concentration(IRP 80/558; 15 minutes after challenge; arbitrary concentration(procedure) procedure) NPU03575 10-3 international unit/litre P—Thyroid microsome antibody; arb.c.(proc.) = ? NPU10374 P—Thyrotropin; arb.subst.c.(IRP 80/558; 15 min; proc.) = ? × 10-3 int.unit/l Plasma— Thyroid peroxidase antibody; Plasma— arbitrary concentration(procedure) Thyrotropin; NPU12558 arbitrary substance concentration(IRP 80/558; 20 minutes after challenge; P—Thyroid peroxidase antibody; arb.c.(proc.) = ? procedure) 10-3 international unit/litre Plasma— NPU04200 Thyroid peroxidase antibody; P—Thyrotropin; arb.subst.c.(IRP 80/558; 20 min; proc.) = ? × 10-3 int.unit/l arbitrary substance concentration(procedure) 10³ arbitrary unit/litre Plasma— NPU12229 Thyrotropin; P—Thyroid peroxidase antibody; arb.subst.c.(proc.) = ? × 10³ arb.unit/l arbitrary substance concentration(IRP 80/558; 30 minutes after challenge; procedure) Plasma— 10-3 international unit/litre Thyroid stimulating immunoglobulin; NPU08717 arbitrary concentration(procedure) P—Thyrotropin; arb.subst.c.(IRP 80/558; 30 min; proc.) = ? × 10-3 int.unit/l NPU03576 P—Thyroid stimulating immunoglobulin; arb.c.(proc.) = ? Plasma— Thyrotropin; Plasma— arbitrary substance concentration(IRP 80/558; 40 minutes after challenge; Thyrotropin receptor antibody; procedure) arbitrary substance concentration(procedure) 10-3 international unit/litre arbitrary unit/litre NPU04201 NPU17111 P—Thyrotropin; arb.subst.c.(IRP 80/558; 40 min; proc.) = ? × 10-3 int.unit/l P—Thyrotropin receptor antibody; arb.subst.c.(proc.)= ? arb.unit/l Plasma— Pituitary gland— Thyrotropin; Thyrotropin secretion; arbitrary substance concentration(IRP 80/558; 60 minutes after challenge; substance rate(protirelin, intravenous administration; list; procedure) procedure) Other term(s): Protirelin: Thyrotropin-releasing hormone 10-3 international unit/litre Note: _M_ (protirelin) = 362,4 g/mol; _M_ (thyrotropin) = 30 000 g/mol NPU04202 NPU04198 P—Thyrotropin; arb.subst.c.(IRP 80/558; 60 min; proc.) = ? × 10-3 int.unit/l PitGl—Thyrotropin secretion; subst.rate(protirelin i.v.; list; proc.) NPU10454 Pt—Protirelin(administered); am.s.(i.v.) = ? nmol Plasma— NPU04199 P—Thyrotropin; arb.subst.c.(IRP 80/558; 0 min; proc.) = ? × 10-3 Thyrotropin; int.unit/l arbitrary substance concentration(IRP 80/558; procedure) NPU10374 P—Thyrotropin; arb.subst.c.(IRP 80/558; 15 min; proc.) = ? × 10-3 10-3 international unit/litre int.unit/l M = 30 000 g/mol NPU04200 P—Thyrotropin; arb.subst.c.(IRP 80/558; 20 min; proc.) = ? × 10-3 Recommended calibrator: WHO 2nd IRP 80/558 int.unit/l Calibrator(s): WHO IRP 68/38 NPU08717 P—Thyrotropin; arb.subst.c.(IRP 80/558; 30 min; proc.) = ? × 10-3 Other term(s): Thyroid stimulating hormone; Thyrotropic hormone; TSH int.unit/l Authority: IUPAC-IUB 74 NPU04201 P—Thyrotropin; arb.subst.c.(IRP 80/558; 40 min; proc.) = ? × 10-3 NPU03577 int.unit/l P—Thyrotropin; arb.subst.c.(IRP 80/558; proc.) = ? × 10-3 int.unit/l NPU04202 P—Thyrotropin; arb.subst.c.(IRP 80/558; 60 min; proc.) = ? × 10-3 int.unit/l Plasma— NPU10347 P—Thyrotropin; arb.subst.c.(IRP 80/558; 120 min; proc.) = ? × 10-3 Thyrotropin; int.unit/l arbitrary substance concentration increment(IRP 80/558; maximum NPU08765 P—Thyrotropin; arb.subst.c.incr.(IRP 80/558; max. c. minus 0 min concentration minus 0 minutes concentration) c.) = ? × 10-3 int.unit/l 10-3 international unit/litre NPU08765 P—Thyrotropin; arb.subst.c.incr.(IRP 80/558; max. c. minus 0 min c.) = ? × 10-3 int.unit/l
146 Plasma— Plasma— Thyroxine binding globulin; Tissue polypeptide antigen; arbitrary substance concentration(IS 88/638; procedure) arbitrary concentration(procedure) international unit/litre NPU03584 Recommended calibrator: WHO IS 88/638 P—Tissue polypeptide antigen; arb.c.(proc.) = ? NPU03580 P—Thyroxine binding globulin; arb.subst.c.(IS 88/638; proc.) = ? int. unit/l Plasma— Titanium; Plasma— substance concentration Thyroxine binding globulin; micromol/litre substance concentration M = 47,90 g/mol nanomol/litre Authority: IUPAC/VII-C-TOX NPU08968 NPU04902 P—Thyroxine binding globulin; subst.c. = ? nmol/l P—Titanium; subst.c. = ? µmol/l
Plasma— Urine— Thyroxine(free); Titanium; substance concentration(0 minutes after challenge) substance concentration picomol/litre micromol/litre NPU10370 M = 47,90 g/mol P—Thyroxine(free); subst.c.(0 min) = ? pmol/l Authority: IUPAC/VII-C-TOX NPU03585 Plasma— U—Titanium; subst.c. = ? µmol/l Thyroxine(free); substance concentration(15 minutes after challenge) Plasma— picomol/litre Tocopherol; NPU10371 substance concentration P—Thyroxine(free); subst.c.(15 min) = ? pmol/l micromol/litre M = 430,72 g/mol Plasma— NPU03589 Thyroxine(free); P—Tocopherol; subst.c. = ? µmol/l substance concentration(30 minutes after challenge) picomol/litre Patient— NPU10372 Tolbutamide(administered); P—Thyroxine(free); subst.c.(30 min) = ? pmol/l amount-of-substance(intravenous administration) millimol Plasma— M = 270,34 g/mol Thyroxine(free); NPU10467 substance concentration(60 minutes after challenge) Pt—Tolbutamide(administered); am.s.(i.v.) = ? mmol picomol/litre NPU10373 Patient— P—Thyroxine(free); subst.c.(60 min) = ? pmol/l Tolbutamide(administered); substance content(intravenous administration; amount-of-substance/body Plasma— mass) Thyroxine(free); micromol/kilogram substance concentration(120 minutes after challenge) M = 270,34 g/mol picomol/litre NPU13487 NPU10348 Pt—Tolbutamide(administered); subst.cont.(i.v.; am.s./body mass) = ? µmol/kg P—Thyroxine(free); subst.c.(120 min) = ? pmol/l Plasma— Plasma— Transcobalamin(free); Thyroxine(free); substance concentration substance concentration picomol/litre picomol/litre M = 38 000 g/mol M = 776,93 g/mol Other term(s): Transcobalamin II(free) Authority: IUPAC-IUB 83 NPU08570 NPU03579 P—Transcobalamin(free); subst.c. = ? pmol/l P—Thyroxine(free); subst.c. = ? pmol/l Plasma— Plasma— Transcobalamin(total); Thyroxine(total); substance concentration substance concentration picomol/litre nanomol/litre M = 38 000 g/mol M = 776,93 g/mol Other term(s): Transcobalamin II(total) Authority: IUPAC-IUB 83 NPU03605 NPU03578 P—Transcobalamin(tot.); subst.c. = ? pmol/l P—Thyroxine(tot.); subst.c. = ? nmol/l Plasma— Blood— Transcortin; Tin; substance concentration substance concentration micromol/litre nanomol/litre M = 53 000 g/mol M = 118,69 g/mol Other term(s): Corticosteroid binding globulin Authority: IUPAC/VII-C-TOX NPU03606 NPU03581 P—Transcortin; subst.c. = ? µmol/l B—Tin; subst.c. = ? nmol/l Plasma— Plasma— Transferrin; Tin; substance concentration substance concentration micromol/litre nanomol/litre M = 81 000 g/mol M = 118,69 g/mol NPU03607 Authority: IUPAC/VII-C-TOX P—Transferrin; subst.c. = ? µmol/l NPU03582 P—Tin; subst.c. = ? nmol/l
147 Urine— Urine— Transferrin; Trichloracetate; substance concentration substance concentration micromol/litre micromol/litre M = 81 000 g/mol NPU03618 NPU10768 U—Trichloracetate; subst.c. = ? µmol/l U—Transferrin; subst.c. = ? µmol/l Plasma(fasting Patient)— Plasma— Triglyceride, in HDL; Transferrinreceptor fragment; substance concentration substance concentration millimol/litre nanomol/litre Note: (H)igh (D)ensity (L)ipoprotein Note: Molar mass: Receptor 85 000; Transferrin 81 000; Complex 166 000 NPU03621 NPU17701 P(fPt)—Triglyceride, in HDL; subst.c. = ? mmol/l P—Transferrinreceptor fragment; subst.c. = ? nmol/l Plasma(fasting Patient)— Plasma— Triglyceride, in LDL/Triglyceride, in HDL; Transglutaminase antibody(Immunoglobulin A); substance ratio arbitrary concentration(procedure) NPU17125 NPU17704 P(fPt)—Triglyceride, in LDL/Triglyceride, in HDL; subst.ratio = ? P—Transglutaminase antibody(IgA); arb.c.(proc.) = ? Plasma(fasting Patient)— Plasma— Triglyceride, in LDL; Transglutaminase antibody(Immunoglobulin A); substance concentration arbitrary substance concentration(procedure) millimol/litre 10³ arbitrary unit/litre Note: (L)ow (D)ensity (L)ipoprotein NPU14566 NPU03622 P—Transglutaminase antibody(IgA); arb.subst.c.(proc.) = ? × 10³ arb.unit/l P(fPt)—Triglyceride, in LDL; subst.c. = ? mmol/l
Plasma— Plasma(fasting Patient)— Transthyretin; Triglyceride, in VLDL; substance concentration substance concentration micromol/litre millimol/litre Other term(s): Prealbumin Note: (V)ery (L)ow (D)ensity (L)ipoprotein NPU10319 NPU03623 P—Transthyretin; subst.c. = ? µmol/l P(fPt)—Triglyceride, in VLDL; subst.c. = ? mmol/l
Duodenal fluid— Plasma(fasting Patient)— Triacylglycerol lipase; Triglyceride; catalytic-activity concentration(0-20 minutes postprandial; 37 °C) property(list; procedure) microkatal/litre NPU17124 NPU09249 P(fPt)—Triglyceride; prop.(list; proc.) Duodf—Triacylglycerol lipase; cat.c.(0-20 min; 37 °C) = ? µkat/l NPU03620 P(fPt)—Triglyceride; subst.c. = ? mmol/l NPU03621 P(fPt)—Triglyceride, in HDL; subst.c. = ? mmol/l Duodenal fluid— NPU03622 P(fPt)—Triglyceride, in LDL; subst.c. = ? mmol/l Triacylglycerol lipase; NPU03623 P(fPt)—Triglyceride, in VLDL; subst.c. = ? mmol/l catalytic-activity concentration(20-40 minutes postprandial; 37 °C) NPU17125 P(fPt)—Triglyceride, in LDL/Triglyceride, in HDL; subst.ratio = ? microkatal/litre NPU09250 Amniotic fluid— Duodf—Triacylglycerol lipase; cat.c.(20-40 min; 37 °C) = ? µkat/l Triglyceride; substance concentration Duodenal fluid— millimol/litre Triacylglycerol lipase; NPU10242 catalytic-activity concentration(30-150 minutes postprandial; 37 °C) Amf—Triglyceride; subst.c.=? mmol/l microkatal/litre NPU09253 Ascites— Duodf—Triacylglycerol lipase; cat.c.(30-150 min; 37 °C) = ? µkat/l Triglyceride; substance concentration Amniotic fluid— millimol/litre Triacylglycerol lipase; NPU17015 catalytic-activity concentration(37 °C; procedure) Asc—Triglyceride; subst.c.=? mmol/l microkatal/litre NPU03913 Plasma— Amf—Triacylglycerol lipase; cat.c.(37 °C; proc.) = ? µkat/l Triglyceride; substance concentration Plasma— millimol/litre Triacylglycerol lipase; NPU04094 catalytic-activity concentration(37 °C; procedure) P—Triglyceride; subst.c.=? mmol/l microkatal/litre Other term(s): Lipase; Tributyrase; Triglyceride lipase Plasma(fasting Patient)— NPU03612 Triglyceride; P—Triacylglycerol lipase; cat.c.(37 °C; proc.) = ? µkat/l substance concentration millimol/litre Duodenal fluid— Other term(s): Triglycerides; Triglyceride, total Triacylglycerol lipase; NPU03620 catalytic-activity concentration(40-60 minutes postprandial; 37 °C) P(fPt)—Triglyceride; subst.c. = ? mmol/l microkatal/litre NPU09251 Pleural fluid— Duodf—Triacylglycerol lipase; cat.c.(40-60 min; 37 °C) = ? µkat/l Triglyceride; substance concentration Duodenal fluid— millimol/litre Triacylglycerol lipase; NPU17018 catalytic-activity concentration(60-80 minutes postprandial; 37 °C) Plf—Triglyceride; subst.c.=? mmol/l microkatal/litre NPU09252 Plasma— Duodf—Triacylglycerol lipase; cat.c.(60-80 min; 37 °C) = ? µkat/l Triiodothyronin(3,3',5'-); substance concentration nanomol/litre NPU04158 P—Triiodothyronin(3,3',5'-); subst.c. = ? nmol/l
148 Plasma— Plasma— Tubular base membrane antibody(Immunoglobulin G); Triiodothyronine(free); arbitrary concentration(procedure) substance concentration NPU12554 picomol/litre P—Tubular base membrane antibody(IgG); arb.c.(proc.) = ? M = 651,01 g/mol Authority: IUPAC-IUB 83 Plasma— NPU03625 Tubular base membrane antibody(Immunoglobulin G); P—Triiodothyronine(free); subst.c. = ? pmol/l arbitrary substance concentration(procedure) 10³ arbitrary unit/litre Plasma— NPU12553 Triiodothyronine(total); P—Tubular base membrane antibody(IgG); arb.subst.c.(proc.) = ? × 10³ substance concentration arb.unit/l nanomol/litre M = 651,01 g/mol Plasma— Authority: IUPAC-IUB 83 Tubular base membrane antibody; NPU03624 arbitrary substance concentration(procedure) P—Triiodothyronine(tot.); subst.c. = ? nmol/l arbitrary unit/litre NPU12265 Plasma— P—Tubular base membrane antibody; arb.subst.c.(proc.) = ? arb.unit/l Troponin T; substance concentration Urine— mol/litre Tyramine/Creatininium; NPU04112 substance ratio P—Troponin T; subst.c.= ? prefix ? mol/l 10-3 NPU14255 Faeces— U—Tyramine/Creatininium; subst.ratio = ? × 10-3 Trypsin; arbitrary content(37 °C; procedure) Cerebrospinal fluid— NPU14112 Tyramine; F—Trypsin; arb.cont.(37 °C; proc.) = ? substance concentration mol/litre Duodenal fluid— M = 137,18 g/mol Trypsin; Other term(s): Tyrosamine catalytic-activity concentration(37 °C; procedure) NPU03656 microkatal/litre Csf—Tyramine; subst.c.= ? prefix ? mol/l NPU10610 Duodf—Trypsin; cat.c.(37 °C; proc.) = ? µkat/l Urine— Tyramine; Plasma— substance concentration Trypsin; mol/litre catalytic-activity concentration(37 °C; procedure) M = 137,18 g/mol microkatal/litre Other term(s): Tyrosamine NPU03896 NPU03657 P—Trypsin; cat.c.(37 °C; proc.) = ? µkat/l U—Tyramine; subst.c.= ? prefix ? mol/l
Plasma— Urine— Trypsin+Trypsinogen; Tyramine-O-sulphate/Creatininium; substance concentration substance ratio mol/litre 10-3 Note: Code for Trypsin: EC3.4.21.4; Code for Trypsinogen: CAS9002-08-8 NPU14254 NPU03897 U—Tyramine-O-sulphate/Creatininium; subst.ratio = ? × 10-3 P—Trypsin+Trypsinogen; subst.c.= ? prefix ? mol/l Urine— Plasma— Tyramine-O-sulphate; Tryptophan(free); substance concentration substance concentration micromol/litre micromol/litre NPU03658 M = 204,22 g/mol U—Tyramine-O-sulphate; subst.c. = ? µmol/l Authority: INN NPU03655 Urine— P—Tryptophan(free); subst.c. = ? µmol/l Tyrosine/Creatininium; substance ratio Urine— 10-3 Tryptophan/Creatininium; NPU14256 substance ratio U—Tyrosine/Creatininium; subst.ratio = ? × 10-3 10-3 NPU14253 Cerebrospinal fluid— U—Tryptophan/Creatininium; subst.ratio = ? × 10-3 Tyrosine; substance concentration Cerebrospinal fluid— micromol/litre Tryptophan; M = 181,19 g/mol substance concentration NPU09033 micromol/litre Csf—Tyrosine; subst.c. = ? µmol/l M = 204,22 g/mol Authority: INN Plasma— NPU03653 Tyrosine; Csf—Tryptophan; subst.c. = ? µmol/l substance concentration micromol/litre Urine— M = 181,19 g/mol Tryptophan; NPU03659 substance concentration P—Tyrosine; subst.c. = ? µmol/l micromol/litre M = 204,22 g/mol Urine— Authority: INN Tyrosine; NPU03654 substance concentration U—Tryptophan; subst.c. = ? µmol/l micromol/litre M = 181,19 g/mol NPU03660 U—Tyrosine; subst.c. = ? µmol/l
149 Synovial fluid(specification)— Plasma— Urate; Ubidecarenone; substance concentration substance concentration millimol/litre millimol/litre NPU03960 Other term(s): Coenzyme Q 10; Ubiquinone Synf(spec.)—Urate; subst.c. = ? mmol/l NPU08929 P—Ubidecarenone; subst.c. = ? mmol/l System(specification)— Urate; System(specification)— substance concentration Unidentified substance; millimol/litre arbitrary concentration(procedure) NPU10132 NPU08679 Syst(spec.)—Urate; subst.c. = ? mmol/l Syst(spec.)—Unidentified substance; arb.c.(proc.) = ? Urine— Blood— Urate; Uranium; substance concentration substance concentration millimol/litre picomol/litre NPU03959 M = 238,03 g/mol U—Urate; subst.c. = ? mmol/l Authority: IUPAC/VII-C-TOX NPU03685 Calculus(Urine)— B—Uranium; subst.c. = ? pmol/l Urate; substance content Urine— mol/kilogram Uranium; NPU03689 substance concentration Calculus(U)—Urate; subst.cont. = ? mol/kg picomol/litre M = 238,03 g/mol Patient(Urine)— Authority: IUPAC/VII-C-TOX Urate; NPU03686 substance rate(procedure) U—Uranium; subst.c. = ? pmol/l millimol/day NPU03687 Synovial fluid(specification)— Pt(U)—Urate; subst.rate(proc.) = ? mmol/d Urate crystals; arbitrary concentration(procedure) Patient— NPU03690 Urine sampling; Synf(spec.)—Urate crystals; arb.c.(proc.) = ? duration day Cells(Synovial fluid; specification)— NPU10380 Urate crystals; Pt—Urine sampling; duration = ? d arbitrary entitic number(procedure) NPU03691 Patient— Cells(Synf; spec.)—Urate crystals; arb.entitic num.(proc.) = ? Urine sampling; duration Urine— hour:minute Urate; NPU10323 amount-of-substance(procedure) Pt—Urine sampling; duration = ? h:min millimol NPU17544 Patient— U—Urate; am.s.(proc.) = ? mmol Urine sampling; duration Calculus(Synovial fluid; specification)— hour Urate; NPU10379 arbitrary content(procedure) Pt—Urine sampling; duration = ? h M = 310,20 g/mol NPU14109 Patient— Calculus(Synf; spec.)—Urate; arb.cont.(proc.) = ? Urine sampling; duration Calculus(Urine)— minute Urate; NPU10324 arbitrary content(procedure) Pt—Urine sampling; duration = ? min NPU10369 Calculus(U)—Urate; arb.cont.(proc.) = ?
Plasma— Urate; substance concentration micromol/litre NPU09356 P—Urate; subst.c. = ? µmol/l
Amniotic fluid— Urate; substance concentration millimol/litre NPU08680 Amf—Urate; subst.c. = ? mmol/l
Plasma— Urate; substance concentration millimol/litre NPU03688 P—Urate; subst.c. = ? mmol/l
150 Urine— Urine(test strip); Plasma— property(list; procedure) Valine; Authority: IFCC/C-BGE substance concentration NPU14924 micromol/litre U—Urine(test strip); prop.(list; proc.) M = 117,15 g/mol NPU10504 U—Acetoacetate; arb.c.(proc.) = ? NPU03733 NPU01012 U—Acetoacetate; subst.c.(proc.) = ? mmol/l P—Valine; subst.c. = ? µmol/l NPU01134 U—Albumin; subst.c.(proc.) = ? µmol/l NPU01341 U—Bacterium, nitrite producing; num.c.(proc.) = ? × 109/l Urine— NPU10506 U—Bacterium, nitrite producing; arb.c.(proc.) = ? Valine; NPU01372 U—Bilirubins(tot.); arb.c.(proc.) = ? substance concentration NPU17162 U—Bilirubins(tot.); subst.c.(proc.) = ? µmol/l micromol/litre NPU03842 U—Erythrocytes; num.c.(proc.) = ? × 106/l M = 117,15 g/mol NPU03963 U—Erythrocytes; arb.c.(proc.) = ? NPU03734 NPU04207 U—Glucose; arb.c.(proc.)= ? U—Valine; subst.c. = ? µmol/l NPU02194 U—Glucose; subst.c.(proc.) = ? mmol/l NPU02415 U—Hydrogen ion; pH(proc.) = ? Plasma— NPU02323 U—Haemoglobin(Fe); subst.c.(proc.) = ? nmol/l Valproate(free); NPU02324 U(cell free)—Haemoglobin(Fe); subst.c.(proc.) = ? nmol/l substance concentration NPU04208 U—Haemoglobin; arb.c.(proc.)= ? micromol/litre NPU10505 U—Leukocytes; num.c.(proc.) = ? × 106/l NPU14378 NPU03987 U—Leukocytes; arb.c.(proc.) = ? P—Valproate(free); subst.c. = ? µmol/l NPU04206 U—Protein; arb.c.(proc.)= ? NPU17167 U—Protein; mass c.(proc.) = ? g/l Plasma— NPU03694 Pt—Urine; rel.volumic mass(20 °C/water, 20 °C; proc.) = ? Vanadium; NPU03697 U—Urobilinogen; arb.c.(proc.) = ? substance concentration NPU17168 U—Urobilinogen; subst.c.(proc.) = ? µmol/l nanomol/litre M = 50,94 g/mol Patient— Authority: IUPAC/VII-C-TOX Urine; NPU03737 relative volumic mass(20 °C/water, 20 °C; procedure) P—Vanadium; subst.c. = ? nmol/l NPU03694 Pt—Urine; rel.volumic mass(20 °C/water, 20 °C; proc.) = ? Urine— Vanadium; Patient— substance concentration Urine; nanomol/litre volume(procedure) M = 50,94 g/mol millilitre Authority: IUPAC/VII-C-TOX Authority: IFCC/C-BGE NPU03738 NPU03695 U—Vanadium; subst.c. = ? nmol/l Pt—Urine; vol.(proc.) = ? ml Hair— Urine— Vanadium; Urobilin; substance content arbitrary concentration(procedure) micromol/kilogram NPU03696 M = 50,94 g/mol U—Urobilin; arb.c.(proc.) = ? Authority: IUPAC/VII-C-TOX NPU03736 Urine— Hair—Vanadium; subst.cont. = ? µmol/kg Urobilinogen; arbitrary concentration(procedure) Urine— NPU03697 Vanillylmandelate/Creatininium; U—Urobilinogen; arb.c.(proc.) = ? substance ratio 10-3 Urine— NPU03802 Urobilinogen; U—Vanillylmandelate/Creatininium; subst.ratio = ? × 10-3 substance concentration(procedure) micromol/litre Urine— NPU17168 Vanillylmandelate; U—Urobilinogen; subst.c.(proc.) = ? µmol/l amount-of-substance(procedure) micromol Urine— NPU17627 Uronate/Creatininium; U—Vanillylmandelate; am.s.(proc.) = ? µmol substance ratio 10-3 Urine— NPU03699 Vanillylmandelate; U—Uronate/Creatininium; subst.ratio = ? × 10-3 substance concentration micromol/litre Urine— Other term(s): 4-Hydroxy-3-Methoxymandelate Uronate; NPU08685 substance concentration U—Vanillylmandelate; subst.c. = ? µmol/l micromol/litre NPU03698 Patient(Urine)— U—Uronate; subst.c. = ? µmol/l Vanillylmandelate; substance rate(procedure) Urine— micromol/day Valine/Creatininium; Other term(s): 4-Hydroxy-3-Methoxymandelate substance ratio NPU03739 10-3 Pt(U)—Vanillylmandelate; subst.rate(proc.) = ? µmol/d NPU14257 U—Valine/Creatininium; subst.ratio = ? × 10-3 Plasma— Vasoactive intestinal polypeptide; Cerebrospinal fluid— substance concentration Valine; picomol/litre substance concentration M = 3 381 g/mol micromol/litre NPU03743 M = 117,15 g/mol P—Vasoactive intestinal polypeptide; subst.c. = ? pmol/l NPU03732 Csf—Valine; subst.c. = ? µmol/l
151 Urine— Blood fraction(specification)— Vasoactive intestinal polypeptide; Virocytes; substance concentration number concentration picomol/litre 109/litre M = 3 381 g/mol NPU17618 NPU14017 B fract.(spec.)—Virocytes; num.c. = ? × 109/l U—Vasoactive intestinal polypeptide; subst.c. = ? pmol/l Leukocytes(Blood)— Patient(Urine)— Virocytes; Vasoactive intestinal polypeptide; number fraction substance rate NPU17620 picomol/day Lkcs(B)—Virocytes; num.fr. = ? M = 3 381 g/mol NPU14018 Lung— Pt(U)—Vasoactive intestinal polypeptide; subst.rate = ? pmol/d Water evaporation; mass rate(procedure) Plasma— gram/day Vasopressin; NPU03791 arbitrary substance concentration(IS 77/501; procedure) Lung—Water evaporation; mass rate(proc.) = ? g/d international unit/litre M = 1 084 g/mol Skin(specification)— Recommended calibrator: WHO 1st IS 77/501 Water evaporation; Other term(s): Adiuretin; Antidiuretic hormone mass rate(procedure) Authority: IUPAC-IUB 74 gram/day NPU03744 NPU03790 P—Vasopressin; arb.subst.c.(IS 77/501; proc.) = ? int. unit/l Skin(spec.)—Water evaporation; mass rate(proc.) = ? g/d
Plasma— Air(saturated)— Vasopressin; Water vapour; substance concentration partial pressure(20 °C) picomol/litre kilopascal M = 1 084 g/mol NPU04080 Other term(s): Adiuretin; Antidiuretic hormone Air(sat.)—Water vapour; part.pr.(20 °C) = ? kPa Authority: IUPAC-IUB 74 NPU03745 Air— P—Vasopressin; subst.c. = ? pmol/l Water vapour; relative mass concentration(temperature t; actual/maximum; procedure) Urine— Other term(s): Relative humidity Vasopressin; NPU03846 substance concentration Air—Water vapour; rel.mass c.(temp. t; actual/max.; proc.) = ? picomol/litre M = 1 084 g/mol Urine— Other term(s): Adiuretin; Antidiuretic hormone Xanthine; NPU14009 substance concentration U—Vasopressin; subst.c. = ? pmol/l mol/litre M = 152,11 g/mol Patient(Urine)— NPU03755 Vasopressin; U—Xanthine; subst.c.= ? prefix ? mol/l substance rate picomol/day Intestine, small— M = 1 084 g/mol Xylose tolerance; Other term(s): Adiuretin; Antidiuretic hormone property(Xylose, oral administration; list; procedure) NPU14010 Note: _M_ (xylose) = 150,13 g/mol Pt(U)—Vasopressin; subst.rate = ? pmol/d NPU03764 Intest., small—Xylose tolerance; prop.(Xylose p.o.; list; proc.) Ascites— NPU10596 Pt—Xylose(administered); am.s.(p.o.) = ? mmol Virocytes; NPU10597 Pt—Xylose(administered); subst.cont.(p.o.; am.s./body mass) = ? number concentration mmol/kg 106/litre NPU08744 P—Xylose; subst.c.(0 min)= ? mmol/l NPU08689 NPU10362 P—Xylose; subst.c.(30 min)= ? mmol/l Asc—Virocytes; num.c. = ? × 106/l NPU08745 P—Xylose; subst.c.(60 min)= ? mmol/l NPU10363 P—Xylose; subst.c.(90 min)= ? mmol/l Cerebrospinal fluid— NPU08746 P—Xylose; subst.c.(120 min)= ? mmol/l Virocytes; NPU10021 P—Xylose; subst.c.(180 min)= ? mmol/l number concentration NPU04204 P—Xylose; subst.c.(max.)= ? mmol/l 106/litre NPU04203 U—Xylose; rel.ams.(U 1 d/intake; proc.)= ? NPU08687 Csf—Virocytes; num.c. = ? × 106/l Patient— Xylose(administered); Pleural fluid(specification)— amount-of-substance(oral administration) Virocytes; millimol number concentration M = 150,13 g/mol 106/litre Other term(s): D-Xylose NPU08688 NPU10596 Plf(spec.)—Virocytes; num.c. = ? × 106/l Pt—Xylose(administered); am.s.(p.o.) = ? mmol
Synovial fluid(specification)— Patient— Virocytes; Xylose(administered); number concentration substance content(oral administration; amount-of-substance/body mass) 106/litre millimol/kilogram NPU08690 M = 150,13 g/mol Synf(spec.)—Virocytes; num.c. = ? × 106/l Other term(s): D-Xylose NPU10597 Blood— Pt—Xylose(administered); subst.cont.(p.o.; am.s./body mass) = ? mmol/kg Virocytes; number concentration Urine— 109/litre Xylose; NPU08686 relative amount-of-substance(urine 1 d/intake; procedure) B—Virocytes; num.c. = ? × 109/l NPU04203 U—Xylose; rel.ams.(U 1 d/intake; proc.)= ?
152 Urine— Plasma— Yeast cells; Xylose; arbitrary concentration(procedure) substance concentration(0 minutes after challenge) NPU14314 millimol/litre U—Yeast cells; arb.c.(proc.) = ? NPU08744 P—Xylose; subst.c.(0 min)= ? mmol/l Secretion(Ileum)— Zinc; Plasma— amount-of-substance(procedure) Xylose; micromol substance concentration(30 minutes after challenge) M = 65,38 g/mol millimol/litre NPU08693 NPU10362 Secr(Ileum)—Zinc; am.s.(proc.) = ? µmol P—Xylose; subst.c.(30 min)= ? mmol/l Urine— Plasma— Zinc; Xylose; amount-of-substance substance concentration(60 minutes after challenge) micromol millimol/litre NPU17587 NPU08745 U—Zinc; am.s. = ? µmol P—Xylose; subst.c.(60 min)= ? mmol/l Plasma— Plasma— Zinc; Xylose; substance concentration substance concentration(90 minutes after challenge) micromol/litre millimol/litre M = 65,38 g/mol NPU10363 Authority: IUPAC/VII-C-TOX P—Xylose; subst.c.(90 min)= ? mmol/l NPU03768 P—Zinc; subst.c. = ? µmol/l Plasma— Xylose; Secretion(Ileum)— substance concentration(120 minutes after challenge) Zinc; millimol/litre substance concentration NPU08746 micromol/litre P—Xylose; subst.c.(120 min)= ? mmol/l M = 65,38 g/mol NPU08692 Plasma— Secr(Ileum)—Zinc; subst.c. = ? µmol/l Xylose; substance concentration(180 minutes after challenge) Seminal plasma— millimol/litre Zinc; NPU10021 substance concentration P—Xylose; subst.c.(180 min)= ? mmol/l micromol/litre M = 65,38 g/mol Plasma— Authority: IUPAC/VII-C-TOX Xylose; NPU03769 substance concentration(maximum) SemP—Zinc; subst.c. = ? µmol/l millimol/litre NPU04204 Urine— P—Xylose; subst.c.(max.)= ? mmol/l Zinc; substance concentration Blood— micromol/litre Xylose; M = 65,38 g/mol substance concentration Authority: IUPAC/VII-C-TOX millimol/litre NPU03770 M = 150,13 g/mol U—Zinc; subst.c. = ? µmol/l NPU10771 B—Xylose; subst.c.= ? mmol/l Cells(Blood)— Zinc; Plasma— substance content Xylose; micromol/kilogram substance concentration M = 65,38 g/mol millimol/litre Authority: IUPAC/VII-C-TOX M = 150,13 g/mol NPU03767 NPU10772 Cells(B)—Zinc; subst.cont. = ? µmol/kg P—Xylose; subst.c.= ? mmol/l Faeces— Patient(Urine)— Zinc; Xylose; substance content substance rate(procedure) micromol/kilogram millimol/day M = 65,38 g/mol NPU10773 Authority: IUPAC/VII-C-TOX Pt(U)—Xylose; subst.rate(proc.) = ? mmol/d NPU10261 F—Zinc; subst.cont. = ? µmol/kg Urine— Xylosylserine/Creatininium; Hair— substance ratio Zinc; 10-3 substance content NPU14258 millimol/kilogram U—Xylosylserine/Creatininium; subst.ratio = ? × 10-3 M = 65,38 g/mol Authority: IUPAC/VII-C-TOX Urine— NPU10698 Xylosylserine; Hair—Zinc; subst.cont. = ? mmol/kg substance concentration mol/litre NPU03765 U—Xylosylserine; subst.c.= ? prefix ? mol/l
153 Patient(Urine)— Zinc; substance rate(procedure) micromol/day M = 65,38 g/mol Authority: IUPAC/VII-C-TOX NPU03961 Pt(U)—Zinc; subst.rate(proc.) = ? µmol/d
154